Chronic inflammation with focus on rheumatology and cancer – Research group Per-Johan Jakobsson

Publications

All publications from group members

• Article: TRANSLATIONAL RESEARCH. 2025;275:32-47

  Early vascular aging in chronic kidney disease: focus on microvascular maintenance, senescence signature and potential therapeutics

  Arefin S; Mudrovcic N; Hobson S; Pietrocola F; Ebert T; Ward LJ; Witasp A; Hernandez L; Wennberg L; Lundgren T; Steinmetz-Spah J; Larsson K; Thorell A; Bruno S; Marengo M; Cantaluppi V; Stenvinkel P; Kublickiene K
• Journal article: THE LANCET RHEUMATOLOGY. 2024;:S2665-9913(24)00351-5

  Promise and challenges of mesenchymal stromal cell therapy in severe SLE.

  Parodis I
• Journal article: ARTHRITIS RESEARCH & THERAPY. 2024;26(1):206

  Longitudinal assessment of reactivity and affinity profile of anti-Jo1 autoantibodies to distinct HisRS domains and a splice variant in a cohort of patients with myositis and anti-synthetase syndrome (vol 24, 62, 2022)

  Notarnicola A; Preger C; Lundstrom SL; Renard N; Wigren E; Van Gompel E; Galindo-Feria AS; Persson H; Fathi M; Grunewald J; Jakobsson P-J; Graeslund S; Lundberg IE; Fernandes-Cerqueira C
• Journal article: JOURNAL OF AUTOIMMUNITY. 2024;149:103332

  Autoantibodies against a subunit of mitochondrial respiratory chain complex I in inclusion body myositis

  Notarnicola A; Hellstrom C; Horuluoglu B; Pin E; Preger C; Bonomi F; De Paepe B; De Bleecker JL; van der Kooi AJ; De Visser M; Sacconi S; Machado P; Badrising UA; Rietveld A; Pruijn G; Rothwell S; Lilleker JB; Chinoy H; Benveniste O; Svenungsson E; Idborg H; Jakobsson P-J; Nilsson P; Lundberg IE
• Article: RHEUMATOLOGY INTERNATIONAL. 2024;44(12):3041-3051

  Enhancing clinical reasoning skills for medical students: a qualitative comparison of LLM-powered social robotic versus computer-based virtual patients within rheumatology

  Borg A; Jobs B; Huss V; Gentline C; Espinosa F; Ruiz M; Edelbring S; Georg C; Skantze G; Parodis I
• Journal article: ISCIENCE. 2024;27(11):111108

  Preclinical validation of human recombinant glutamate-oxaloacetate transaminase for the treatment of acute ischemic stroke

  Perez-Mato M; Dopico-Lopez A; Akkoc Y; Lopez-Amoedo S; Correa-Paz C; Candamo-Lourido M; Iglesias-Rey R; Lopez-Arias E; da Silva-Candal A; Bravo SB; Chantada-Vazquez MDP; Arias S; Santamaria-Cadavid M; Estany-Gestal A; Zaghmi A; Gauthier MA; Gutierrez-Fernandez M; Martin A; Llop J; Rodriguez C; Almeida A; Migliavacca M; Polo E; Pelaz B; Gozuacik D; El Yamani N; SenGupta T; Runden-Pran E; Vivancos J; Castellanos M; Diez-Tejedor E; Sobrino T; Rabinkov A; Mirelman D; Castillo J; Campos F
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2024;83(12):1796-1797

  Serum from patients with idiopathic inflammatory myopathy induces skeletal muscle weakness

  Leijding C; Kaewin S; Andreasson KM; Horuluoglu B; Galindo-Feria AS; Van Gompel E; Dastmalchi M; Gastaldello S; Alexanderson H; Lundberg IE; Andersson DC
• Journal article: ANNALS OF THE RHEUMATIC DISEASES. 2024;:ard-2024-226051

  Molecular basis for the disease-modifying effects of belimumab in systemic lupus erythematosus and molecular predictors of early response: blood transcriptome analysis implicates the innate immunity and DNA damage response pathways

  Moysidou G-S; Garantziotis P; Sentis G; Nikoleri D; Malissovas N; Nikoloudaki M; Stergioti E-M; Polia S; Paschalidis N; Filia A; Grigoriou M; Nikolopoulos D; Kapsala N; Katechis S; Fanouriakis A; Bertsias G; Boumpas DT
• Thesis / dissertation: 2024

  Unravelling treatment efficacy and failure in systemic lupus erythematosus

  Gonzalez AG
• Article: RHEUMATOLOGY. 2024;63(11):e294-e296

  Screening for psoriatic arthritis in dermatological settings-are handheld ultrasound devices the gamechangers we hoped for?

  Bartsch V; Fagni F; Krieter M; Ibrahim M; Temiz S-A; Yalcin-Mutlu M; Schett G; Simon D; Hueber AJ
• Article: THE LANCET RHEUMATOLOGY. 2024;6(11):e751-e761

  Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trials

  Parodis I; Lindblom J; Levy RA; Zen M; Cetrez N; Gomez A; Oon S; Henning C; Khamashta M; Quasny HA; Chauhan D; Askanase A; van Vollenhoven R; Nikpour M
• Article: RHEUMATOLOGY. 2024;63(11):3164-3171

  Identification of early risk factors for anti-citrullinated-protein-antibody positive rheumatoid arthritis-a prospective cohort study

  Circiumaru A; Kisten Y; Hansson M; Mathsson-Alm L; Joshua V; Waehaemaa H; Loberg Haarhaus M; Lindqvist J; Padyukov L; Catrina S-B; Fei G; Vivar N; Rezaei H; af Klint E; Antovic A; Rethi B; Catrina AI; Hensvold A
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2024;83(11):e23

  Response to: Correspondence on 'Current myositis clinical trials and tribulations' by Saygin et al

  Saygin D; Werth V; Paik JJ; Park JK; Needham M; Lundberg IE; Christopher-Stine L
• Journal article: RHEUMATOLOGY. 2024;:keae575

  Trajectories of disease evolution upon treatment initiation in systemic lupus erythematosus: results from four clinical trials of belimumab

  Parodis I; Lindblom J; Tsoi A; Palazzo L; Sporre KB; Enman Y; Nikolopoulos D; Beretta L
• Article: CANCER SCIENCE. 2024;115(10):3439-3454

  Multiplex plasma protein assays as a diagnostic tool for lung cancer

  Ahamed MT; Forshed J; Levitsky A; Lehtio J; Bajalan A; Pernemalm M; Eriksson LE; Andersson B
• Article: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2024;68:152534

  Construct validity of PROMIS pain interference, fatigue, and physical function as patient-reported outcomes in adults with idiopathic inflammatory myopathies: An international study from the OMERACT myositis working group

  Romich E; Saygin D; DiRenzo D; Mecoli CA; de Groot I; Lodin K; Regardt M; Sarver C; Kim JY; Park JK; Beer K; Needham M; Alexanderson H; Christopher-Stine L; de Visser M; Raaphorst J
• Article: RHEUMATOLOGY INTERNATIONAL. 2024;44(10):1923-1933

  Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease (COVAD) study

  Palazzo L; Lindblom J; Olsson EK; Nikiphorou E; Wincup C; Saha S; Shaharir SS; Katchamart W; Goo PA; Traboco L; Chen Y-M; Lilleker JB; Nune A; Pauling JD; Agarwal V; Dzifa D; Gutierrez CET; Caballero-Uribe CV; Chinoy H; Agarwak V; Gupta L; Parodis I
• Article: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2024;68:152520

  OMERACT systemic lupus erythematosus domain survey

  Nielsen W; Strand V; Simon L; Pinsker E; Bonilla D; Morand E; Thumboo J; Aringer M; Mosca M; Bruce I; Parodis I; Kim A; Desai M; Enman Y; Shea B; Wallace DJ; Chaichian Y; Navarra S; Aranow C; Mackay M; Trotter K; Tayer-Shifman OE; Duarte-Garcia A; Tam LS; Ugarte-Gil MF; Pons-Estel GJ; Reynolds JA; Nikpour M; Hoi A; Romero-Diaz J; Aggarwal A; Mok CC; Fujio K; Ramsey-Goldman R; Gladman DD; Arnaud L; Bultink IEM; Ruiz-Irastorza G; Ines LS; Appenzeller S; Dobrowolski C; Clarke AE; Kamen DL; Barraclough M; Tani C; Gomez-Puerta J; Werth VP; Katz P; Nowrouzi-Kia B; Johnson SR; Drucker AM; Touma Z
• Article: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2024;68:152529

  Autoantibodies and damage in patients with idiopathic inflammatory myopathies: A longitudinal multicenter study from the MYONET international network

  Espinosa-Ortega F; Lodin K; Dastmalchi M; Vencovsky J; Diederichsen LP; Shinjo SK; Danieli MG; Selva-O'Callaghan A; de Visser M; Griger Z; Ceribelli A; Gomez-Martin D; Andersson H; Mercado MV-D; Chinoy H; Lilleker JB; New P; Krogh NS; Lundberg IE; Alexanderson H
• Article: ARTHRITIS & RHEUMATOLOGY. 2024

  Effectiveness of JAK Inhibitors Compared With Biologic Disease-Modifying Antirheumatic Drugs on Pain Reduction in Rheumatoid Arthritis: Results From a Nationwide Swedish Cohort Study

  Eberhard A; Di Giuseppe D; Askling J; Bergman S; Bower H; Chatzidionysiou K; Forsblad-d'Elia H; Kastbom A; Olofsson T; Frisell T; Turesson C
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2024

  Self-reported physical activity and fatigue and its associations to anxiety and depression in adult patients with idiopathic inflammatory myopathies: a MIHRA psychological impact and MIHRA exercise and rehabilitation scientific working groups collaboration.

  Andreasson KM; Espinosa-Ortega F; Sandlund H; Alexanderson H
• Article: RHEUMATOLOGY INTERNATIONAL. 2024;44(9):1679-1689

  Neuropsychiatric involvement in systemic lupus erythematosus contributes to organ damage beyond the nervous system: a post-hoc analysis of 5 phase III randomized clinical trials

  Nikolopoulos D; Cetrez N; Lindblom J; Parodis I
• Article: JOURNAL OF IMMUNOLOGICAL METHODS. 2024;532:113717

  Belimumab concentration measurements using a homologous anti-idiotype immunoassay

  Loeff FC; Parodis I; Walhelm T; Jonsen A; Nikolopoulos D; Sjowall C; Bengtsson AA; Kos D; van Leeuwen A; van den Broek B; Dijk L; Jeremiasse J; Blomjous BS; Voskuyl AE; Wolbink GJ; Bultin IEM; Rispens T
• Article: RHEUMATOLOGY. 2024;63(9):2494-2502

  Patients with NPSLE experience poorer HRQoL and more fatigue than SLE patients with no neuropsychiatric involvement, irrespective of neuropsychiatric activity

  Nikolopoulos D; Cetrez N; Lindblom J; Palazzo L; Enman Y; Parodis I
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2024;83(9):1132-1143

  Disentangling the riddle of systemic lupus erythematosus with antiphospholipid syndrome: blood transcriptome analysis reveals a less-pronounced IFN-signature and distinct molecular profiles in venous versus arterial events

  Nikolopoulos D; Loukogiannaki C; Sentis G; Garantziotis P; Manolakou T; Kapsala N; Nikoloudaki M; Pieta A; Flouda S; Parodis I; Bertsias G; Fanouriakis A; Filia A; Boumpas DT
• Article: RHEUMATOLOGY. 2024;63(8):2093-2100

  Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis: results from the MYONET registry

  Hum RM; Lilleker JB; Lamb JA; Oldroyd AGS; Wang G; Wedderburn LR; Diederichsen LP; Schmidt J; Danieli MG; Oakley P; Griger Z; Phuong TNT; Kodishala C; Vazquez-Del Mercado M; Andersson H; De Paepe B; De Bleecker JL; Maurer B; McCann L; Pipitone N; McHugh N; New RP; Ollier WE; Krogh NS; Vencovsky J; Lundberg IE; Chinoy H
• Corrigendum: RHEUMATOLOGY. 2024;63(8):2316

  Correction to: Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis: results from the MYONET registry.
• Article: RHEUMATOLOGY AND THERAPY. 2024;11(4):897-911

  Cardiovascular Risk Evaluation in Psoriatic Arthritis by Aortic Stiffness and the Systemic Coronary Risk Evaluation (SCORE): Results of the Prospective PSOCARD Cohort Study

  Triantafyllias K; Liverakos S; Muthuraman M; Cavagna L; Parodis I; Schwarting A
• Article: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2024;67:152476

  The impact of pain on daily activities in patients with idiopathic inflammatory myopathies: Report from the OMERACT myositis working group

  Saygin D; Alexanderson H; Direnzo D; Raaphorst J; de Visser M; Ren D; Regardt M; de Groot I; Sarver C; Kim JY; Lodin K; Beer K; Needham M; Park JK; Christopher-Stine L; Mecoli CA
• Article: NATURE NEUROSCIENCE. 2024;27(8):1534-1544

  NG2 glia protect against prion neurotoxicity by inhibiting microglia-to-neuron prostaglandin E2 signaling

  Liu Y; Guo J; Matoga M; Korotkova M; Jakobsson P-J; Aguzzi A
• Article: EUROPEAN JOURNAL OF CANCER. 2024;207:114172

  Corticosteroids and other immunosuppressants for immune-related adverse events and checkpoint inhibitor effectiveness in melanoma.

  Verheijden RJ; Burgers FH; Janssen JC; Putker AE; Veenstra SPGR; Hospers GAP; Aarts MJB; Hehenkamp KW; Doornebosch VLE; Verhaert M; van den Berkmortel FWPJ; Chatzidionysiou K; Llobell A; Barros M; Maria ATJ; Takeji A; García Morillo J-S; Lidar M; van Eijs MJM; Blank CU; Aspeslagh S; Piersma D; Kapiteijn E; Labots M; Boers-Sonderen MJ; van der Veldt AAM; Haanen JBAG; May AM; Suijkerbuijk KPM
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2024;83(8):984-997

  Expression of HIF1α in intestinal epithelium restricts arthritis inflammation by inhibiting RIPK3-induced cell death machinery

  Lyu P; Wen J; Zhang W; Liu N; Stolzer I; Giessl A; Jia Y; Mauro D; Zhang F; Ciccia F; Soulat D; Guenther C; Schett G; Bozec A
• Article: MODERN RHEUMATOLOGY. 2024;34(4):756-766

  Gender differences in patient experience in idiopathic inflammatory myopathies: Subanalysis from the COVAD dataset

  Yoshida A; Kim M; Kuwana M; Ravichandran N; Makol A; Sen P; Lilleker JB; Agarwal V; Kardes S; Day J; Milchert M; Joshi M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; Nikiphorou E; Chatterjee T; Tan AL; Nune A; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L
• Article: RHEUMATOLOGY INTERNATIONAL. 2024;44(7):1233-1244

  Collating the voice of people with autoimmune diseases: Methodology for the Third Phase of the COVAD Studies

  Kadam E; Javaid M; Sen P; Saha S; Ziade N; Day J; Wincup C; Andreoli L; Parodis I; Tan AL; Shinjo SK; Dey D; Cavagna L; Chatterjee T; Knitza J; Wang G; Dalbeth N; Velikova T; Battista S; Cheng K; Boyd P; Kobert L; Gracia-Ramos AE; Mittal S; Makol A; Gutierrez CET; Uribe CVC; Kuwana M; Burmester G-R; Guillemin F; Nikiphorou E; Chinoy H; Aggarwal V; Gupta L
• Editorial comment: ARP RHEUMATOLOGY. 2024;3(2):81-82

  Lessons learnt from the recent recommendations for the non-pharmacological management of systemic sclerosis

  Santiago T; Fernandes R; Ferreira R; Parodis I; Bostrom C
• Editorial comment: ANNALS OF THE RHEUMATIC DISEASES. 2024;83(7):826-829

  Current myositis clinical trials and tribulations

  Saygin D; Werth V; Paik JJ; Park JK; Needham M; Lundberg IE; Christopher-Stine L
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2024;83(7):889-900

  Molecular characterisation of lupus low disease activity state (LLDAS) and DORIS remission by whole-blood transcriptome-based pathways in a pan-European systemic lupus erythematosus cohort

  Parodis I; Lindblom J; Barturen G; Ortega-Castro R; Cervera R; Pers J-O; Genre F; Hiepe F; Gerosa M; Kovacs L; De Langhe E; Piantoni S; Stummvoll G; Vasconcelos C; Vigone B; Witte T; Alarcon-Riquelme ME; Beretta L
• Article: RHEUMATOLOGY. 2024;:keae317

  Anti-FHL1 autoantibodies in adult patients with myositis: a longitudinal follow-up analysis

  Galindo-Feria AS; Lodin K; Horuluoglu B; Sarrafzadeh-Zargar S; Wigren E; Graslund S; Danielsson O; Wahren-Herlenius M; Dastmalchi M; Lundberg IE
• Conference publication: 2024;:613.2-61614

  POS1282 IMPROVED ACTIVITY PERFORMANCE USING A POWER ENHANCING GLOVE IN PERSONS WITH INCLUSION BODY MYOSITIS (IBM)

  Regardt M; Alexanderson H; Hunn S; Alfano L; Mischke R; De Groot I; Dihkan A; Saketkoo LA
• Article: KIDNEY INTERNATIONAL REPORTS. 2024;9(6):1817-1835

  Interferon and B-cell Signatures Inform Precision Medicine in Lupus Nephritis

  Parodis I; Lindblom J; Toro-Dominguez D; Beretta L; Borghi MO; Castillo J; Carnero-Montoro E; Enman Y; Mohan C; Alarcon-Riquelme ME; Barturen G; Nikolopoulos D; PRECISESADS Clinical Consortium OBOPREC
• Article: NATURE MEDICINE. 2024;30(6):1593-1601

  Bispecific T cell engager therapy for refractory rheumatoid arthritis

  Bucci L; Hagen M; Rothe T; Raimondo MG; Fagni F; Tur C; Wirsching A; Wacker J; Wilhelm A; Auger J-P; Pachowsky M; Eckstein M; Alivernini S; Zoli A; Kroenke G; Uderhardt S; Bozec A; D'Agostino M-A; Schett G; Grieshaber-Bouyer R
• Article: ARTHRITIS & RHEUMATOLOGY. 2024;76(6):857-868

  CCL19-Positive Lymph Node Stromal Cells Govern the Onset of Inflammatory Arthritis via Tropomyosin Receptor Kinase

  Schaelter F; Azizov V; Frech M; Duerholz K; Schmid E; Hendel A; Sarfati I; Maeda Y; Sokolova M; Miyagawa I; Focke K; Sarter K; van Baarsen LGM; Krautwald S; Schett G; Zaiss MM
• Conference publication: 2024;:1010.2-101011

  POS0549 OUTCOMES OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS TREATED WITH INTRAVENOUS OR SUBCUTANEOUS BELIMUMAB: A POST-HOC EFFICACY META-ANALYSIS BY BICLA CRITERIA

  Parodis I; Lindblom J; Çetrez N; Palazzo L; Oon S; Ala H; Van Vollenhoven RF; Morand E; Levitsky A; Nikpour M
• Conference publication: 2024;:1001-1002

  POS1132 POOR HEALTH-RELATED QUALITY OF LIFE DESPITE LOW DISEASE ACTIVITY OR REMISSION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

  Parodis I; Lindblom J; Çetrez N; Palazzo L; Ala H; Nikpour M; Levitsky A; Strand V
• Conference publication: 2024;:839.2-840

  POS0474 ULTRASOUND REMISSION RATES AFTER 1 YEAR ARE HIGH IN EARLY RA PATIENTS ON INDUCTION TREATMENT: RESULTS FROM THE RANDOMIZED NORD-STAR TRIAL

  Heiberg MS; Kisten Y; Kazemi A; Rezaei H; Af Klint E; Ljosa MKA; Brodin E; Stevens D; Bakland G; Karoliussen LF; Bolton-King P; Lindqvist J; Lend K; Lampa J; Uhlig T; Lund Hetland M; Rudin A; Nordström D; Gudbjornsson B; Nurmohamed MT; Østergaard M; Grondal G; Sokka-Isler T; Hammer HB; Van Vollenhoven RF; Haavardsholm E
• Article: IMMUNO-ONCOLOGY AND TECHNOLOGY. 2024;22:100713

  Effect of glucocorticoids for the management of immune-related adverse events on outcome in melanoma patients treated with immunotherapy-a retrospective and biomarker study.

  Costa Svedman F; Liapi M; Månsson-Broberg A; Chatzidionysiou K; Egyhazi Brage S
• Article: ARTHRITIS & RHEUMATOLOGY. 2024;76(6):894-904

  Modulation of Interleukin-23 Signaling With Guselkumab in Biologic-Naive Patients Versus Tumor Necrosis Factor Inhibitor-Inadequate Responders With Active Psoriatic Arthritis

  Siebert S; Coates LC; Schett G; Raychaudhuri SP; Chen W; Gao S; Seridi L; Chakravarty SD; Shawi M; Lavie F; Sharaf M; Zimmermann M; Kollmeier AP; Xu XL; Rahman P; Mease PJ; Deodhar A
• Review: MEDITERRANEAN JOURNAL OF RHEUMATOLOGY. 2024;35(2):328

  Evolving Concepts in Treat-to-Target Strategies for Systemic Lupus Erythematosus

  Nikolopoulos D; Lourenco MH; Depascale R; Triantafyllias K; Parodis I
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2024;83(6):720-729

  EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis

  Parodis I; Girard-Guyonvarc'h C; Arnaud L; Distler O; Domjan A; Van den Ende CHM; Fligelstone K; Kocher A; Larosa M; Lau M; Mitropoulos A; Ndosi M; Poole JL; Redmond A; Ritschl V; Alexanderson H; Sjoberg Y; von Perner G; Uhlig T; Varju C; Vriezekolk JE; Welin E; Westhovens R; Stamm TA; Bostrom C
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2024;83(6):706-719

  EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update

  Gossec L; Kerschbaumer A; Ferreira RJO; Aletaha D; Baraliakos X; Bertheussen H; Boehncke W-H; Esbensen BA; Mcinnes IB; Mcgonagle D; Winthrop KL; Balanescu A; Balint PV; Burmester GR; Canete JD; Claudepierre P; Eder L; Hetland ML; Iagnocco A; Kristensen LE; Lories R; Queiro R; Mauro D; Marzo-Ortega H; Mease PJ; Nash P; Wagenaar W; Savage L; Schett G; Shoop-Worrall SJW; Tanaka Y; van den Bosch FE; van der Helm-van Mil A; Zabotti A; van der Heijde D; Smolen JS
• Journal article: RHEUMATOLOGY. 2024;:keae278

  Can we predict kidney involvement in patients with systemic lupus erythematosus? A retrospective cohort study with independent validation

  Katechis S; Nikolopoulos D; Flouda S; Adamichou C; Chavatza K; Kapsala N; Katsimbri P; Bertsias G; Boumpas DT; Fanouriakis A
• Editorial comment: RHEUMATOLOGY. 2024;63(5):1189-1191

  Moving forward together: collaborative landscapes of research in idiopathic inflammatory myopathies and calcinosis

  Saketkoo LA; Valenzuela A; Kim S; McCann LJ; Lood C; Wahezi DM; Werth VP; Yi B; Alexanderson H; Maillard S; Pilkington C; Fligelstone K; Limbach B; Orandi AB; Regardt M; Russell A-M; Davuluri S; deGroot I; Ernste F; Paik JJ; von Muhlen CA; Dimachkie MM; Machado PM; Naddaf E; Shafranski BM; Gupta L; Zulian F; Chung L
• Article: RHEUMATOLOGY. 2024;63(5):1466-1473

  Autoantibodies against the melanoma differentiation-associated protein 5 in patients with dermatomyositis target the helicase domains

  Van Gompel E; Demirdal D; Fernandes-Cerqueira C; Horuluoglu B; Galindo-Feria A; Wigren E; Graslund S; De Langhe E; Benveniste O; Notarnicola A; Chemin K; Lundberg IE
• Article: RHEUMATOLOGY. 2024;63(5):1341-1351

  COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study

  Andreoli L; Lini D; Schreiber K; Parodis I; Sen P; Ravichandran N; Day J; Joshi M; Jagtap K; Nune A; Nikiphorou E; Agarwal V; Saha S; Tan AL; Shinjo SK; Ziade N; Velikova T; Milchert M; Gracia-Ramos AE; Cavagna L; Kuwana M; Knitza J; Makol A; Patel A; Pauling JD; Wincup C; Barman B; Tehozol EAZ; Serrano JR; de la Torre IG; Colunga-Pedraza IJ; Merayo-Chalico J; Chibuzo OC; Katchamart W; Akarawatcharangura Goo P; Shumnalieva R; Chen Y-M; Hoff LS; El Kibbi L; Halabi H; Vaidya B; Shaharir SS; Hasan ATMT; Dey D; Gutierrez CET; Caballero-Uribe CV; Lilleker JB; Salim B; Gheita T; Chatterjee T; Saavedra MA; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L
• Article: NATURE. 2024;629(8010):184-192

  Metabolic rewiring promotes anti-inflammatory effects of glucocorticoids

  Auger J-P; Zimmermann M; Faas M; Stifel U; Chambers D; Krishnacoumar B; Taudte RV; Grund C; Erdmann G; Scholtysek C; Uderhardt S; Ben Brahim O; Mate MP; Stoll C; Boettcher M; Palumbo-Zerr K; Mangan MSJ; Dzamukova M; Kieler M; Hofmann M; Blueml S; Schabbauer G; Mougiakakos D; Sonnewald U; Hartmann F; Simon D; Kleyer A; Grueneboom A; Finotto S; Latz E; Hofmann J; Schett G; Tuckermann J; Kroenke G
• Article: CLINICAL RHEUMATOLOGY. 2024;43(5):1591-1604

  Association between enthesitis/dactylitis resolution and patient-reported outcomes in guselkumab-treated patients with psoriatic arthritis

  Rahman P; Mcinnes IB; Deodhar A; Schett G; Mease PJ; Shawi M; Cua DJ; Sherlock JP; Kollmeier AP; Xu XL; Sheng S; Ritchlin CT; McGonagle D
• Article: INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES. 2024;27(5):e15178

  Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: A sub-study by the COVAD group

  Shumnalieva R; Ravichandran N; Hannah J; Javaid M; Darooka N; Roy D; Gonzalez DE; Velikova T; Milchert M; Kuwana M; Joshi M; Gracia-Ramos AE; Boyd P; Yaadav P; Cheng K; Kobert L; Cavagna L; Sen P; Day J; Makol A; Gutierrez CET; Caballero-Uribe CV; Saha S; Parodis I; Dey D; Nikiphorou E; Distler O; Kadam E; Tan AL; Shinjo SK; Ziade N; Knitza J; Chinoy H; Aggarwal R; Agarwal V; Gupta L
• Article: LUPUS. 2024;33(6):615-628

  Factors associated with non-adherence to medications in systemic lupus erythematosus: Results from a Swedish survey

  Emamikia S; Gomez A; Adahl T; von Perner G; Enman Y; Chatzidionysiou K; Arkema EV; Parodis I
• Article: ARTHRITIS & RHEUMATOLOGY. 2024;76(5):670-674

  Difficult-to-Treat Psoriatic Arthritis: A Conceptual Approach

  Fagni F; Motta F; Schett G; Selmi C
• Article: INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES. 2024;27(5):e15161

  Listening to patients, for the patients: The COVAD Study-Vision, organizational structure, and challenges

  Joshi M; Darooka N; Saha S; Dyball S; Sen P; Yaadav P; Javaid M; Kadam E; Shinjo SK; Dey D; Cavagna L; Makol A; Gutierrez CET; Caballero Uribe CV; Kuwana M; Burmester G-R; Ziade N; Wincup C; Andreoli L; Parodis I; Tan AL; Guillemin F; Knitza J; Wang G; Dalbeth N; Velikova T; Gracia-Ramos AE; Nikiphorou E; Day J; Chinoy H; Aggarwal R; Agarwal V; Gupta L
• Review: RHEUMATOLOGY INTERNATIONAL. 2024;44(5):765-778

  Efficacy of lifestyle interventions in the management of systemic lupus erythematosus: a systematic review of the literature

  Tsoi A; Gomez A; Bostroem C; Pezzella D; Chow JW; Girard-Guyonvarc'h C; Stamm T; Arnaud L; Parodis I
• Article: RHEUMATOLOGY INTERNATIONAL. 2024;44(5):851-861

  Obesity and tobacco smoking are independently associated with poor patient-reported outcomes in SLE: a cross-sectional study

  Gomez A; Parodis I; Sjowall C
• Review: EXPERT OPINION ON PHARMACOTHERAPY. 2024;25(6):705-716

  Advances in the pharmacological management of systemic lupus erythematosus

  Tsoi A; Nikolopoulos D; Parodis I
• Article: RMD OPEN. 2024;10(2):e004314

  Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia: exploring the subclinical psoriatic arthritis stage

  Zabotti A; Fagni F; Gossec L; Giovannini I; Sticherling M; Tullio A; Baraliakos X; De Marco G; De Vita S; Errichetti E; Quartuccio L; Silvagni E; Smolen JS; Tinazzi I; Watad A; Schett G; McGonagle DG; Simon D
• Letter: LUPUS SCIENCE AND MEDICINE. 2024;11(1):e001215

  Enhancing lupus outcomes by means of biology beyond overt clinical features, exemplified in an in-depth investigation of the effects of circadian rhythm disruption

  Parodis I
• Article: RMD OPEN. 2024;10(2):e004171

  Recommendations for physical activity and exercise in persons living with Systemic Lupus Erythematosus (SLE): consensus by an international task force

  Blaess J; Geneton S; Goepfert T; Appenzeller S; Bordier G; Davergne T; Fuentes Y; Haglo H; Hambly K; Kinnett-Hopkins D; Su K-Y; Legge A; Li L; Mak A; Padjen I; Sciascia S; Sheikh SZ; Soriano-Maldonado A; Ugarte-Gil MF; Yusof MYM; Parodis I; Arnaud L
• Preprint: BIORXIV. 2024

  Serum from patients with Idiopathic inflammatory myopathy induces skeletal muscle weakness

  Leijding C; Andreasson K; Horuluoglu B; Galindo-Feria AS; Van Gompel E; Dastmalchi M; Gastaldello S; Alexanderson H; Lundberg I; Andersson D
• Article: MICROBIOLOGY SPECTRUM. 2024;12(4):e0298123-e02923

  The serological immunogenicity of the third and fourth doses of COVID-19 vaccine in patients with inflammatory rheumatic diseases on different biologic or targeted DMARDs: a Swedish nationwide study (COVID-19-REUMA)

  Frodlund M; Nived P; Chatzidionysiou K; Soedergren A; Klingberg E; Hansson M; Ohlsson S; Pin E; Bengtsson A; Klareskog L; Kapetanovic M
• Journal article: REVISTA COLOMBIANA DE REUMATOLOGIA. 2024;31:s74-s81

  The lung as a target and as an initiator of rheumatoid arthritis-associated immunity: Implications for interstitial lung disease

  Haarhaus ML; Klareskog L
• Article: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2024;65:152379

  Patient global assessment and inflammatory markers in patients with idiopathic inflammatory myopathies - A longitudinal study

  Lodin K; -Ortega FE; Dastmalchi M; Vencovsky J; Andersson H; Chinoy H; Lilleker JB; Shinjo SK; Maurer B; Griger Z; Ceribelli A; Torres-Ruiz J; Mercado MV-D; Leonard D; Alexanderson H; Lundberg IE
• Article: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2024;65:152380

  OMERACT 2023 Systemic Lupus Erythematosus Special Interest Group: Winnowing and Binning Preliminary Candidate Domains for the Core Outcome Set

  Nielsen W; Strand V; Simon LS; Parodis I; Kim AHJ; Desai M; Enman Y; Wallace D; Chaichian Y; Navarra S; Aranow C; MacKay M; Trotter K; Tayer-Shifman OE; Duarte-Garcia A; Tam LS; Ugarte-Gil MF; PonsEstel GJ; Reynolds JA; Nikpour M; Hoi A; Romero-Diaz J; Papachristos D; Aggarwal A; Mok CC; Fujio K; Ramsey-Goldman R; Howe A; Kia BN; Bonilla D; Thumboo J; Mosca M; Aringer M; Johnson SR; Drucker AM; Morand E; Bruce I; Touma Z
• Review: ARTHRITIS & RHEUMATOLOGY. 2024;76(4):497-504

  CD19 Chimeric Antigen Receptor T Cell Treatment: Unraveling the Role of B Cells in Systemic Lupus Erythematosus

  Taubmann J; Mueller F; Mutlu MY; Voelkl S; Aigner M; Bozec A; Mackensen A; Grieshaber-Bouyer R; Schett G
• Article: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2024;65:152408

  Effect modification of cancer on the association between dysphagia and mortality in early idiopathic inflammatory myopathies

  Leclair V; Notarnicola A; Krystufkova O; Mann H; Andersson H; Diederichsen LP; Vencovsky J; Holmqvist M; Lundberg IE; Steele RJ; Hudson M
• Article: NATURE IMMUNOLOGY. 2024;25(4):682-692

  CD200+ fibroblasts form a pro-resolving mesenchymal network in arthritis.

  Rauber S; Mohammadian H; Schmidkonz C; Atzinger A; Soare A; Treutlein C; Kemble S; Mahony CB; Geisthoff M; Angeli MR; Raimondo MG; Xu C; Yang K-T; Lu L; Labinsky H; Saad MSA; Gwellem CA; Chang J; Huang K; Kampylafka E; Knitza J; Bilyy R; Distler JHW; Hanlon MM; Fearon U; Veale DJ; Roemer FW; Bäuerle T; Maric HM; Maschauer S; Ekici AB; Buckley CD; Croft AP; Kuwert T; Prante O; Cañete JD; Schett G; Ramming A
• Article: LUPUS. 2024;33(5):481-489

  Satisfaction and effectiveness of switching from intravenous to subcutaneous belimumab treatment in daily clinical practice.

  Frade-Sosa B; Salman-Monte TC; Narváez J; Peralta I; Sandoval S; Magallares B; Heredia S; Sapena N; Riveros-Frutos A; Olivé A; Corominas H; Cortés-Hernández J; Gómez-Puerta JA
• Review: RHEUMATOLOGY ADVANCES IN PRACTICE. 2024;8(2):rkae037

  Lifestyle interventions in the management of systemic sclerosis: a systematic review of the literature

  Parodis I; Tsoi A; Gomez A; Chow JW; Girard-Guyonvarc'h C; Stamm T; Bostrom C
• Article: RHEUMATOLOGY ADVANCES IN PRACTICE. 2024;8(2):rkae028

  Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey

  Yoshida A; Li Y; Maroufy V; Kuwana M; Sazliyana Shaharir S; Makol A; Sen P; Lilleker JB; Agarwal V; Kadam E; Akawatcharangura Goo P; Day J; Milchert M; Chen Y-M; Dey D; Velikova T; Saha S; Edgar Gracia-Ramos A; Parodis I; Nikiphorou E; Tan AL; Nune A; Cavagna L; Toro Gutierrez CE; Caballero-Uribe CV; Saavedra MA; Shinjo SK; Ziade N; El Kibbi L; Knitza J; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L
• Article: RHEUMATOLOGY ADVANCES IN PRACTICE. 2024;8(2):rkae063

  Determinants of tofacitinib discontinuation in adult patients with rheumatoid arthritis during long-term extension studies up to 9.5 years

  Curtis JR; Wollenhaupt J; Tas SW; Chatzidionysiou K; Wang L; Roberts K; Tsekouras V
• Conference publication: 2024;:273-277

  Creating Virtual Patients using Robots and Large Language Models: A Preliminary Study with Medical Students

  Borg A; Parodis I; Skantze G
• Article: ARTHRITIS RESEARCH & THERAPY. 2024;26(1):61

  Urinary prostanoids are elevated by anti-TNF and anti-IL6 receptor disease-modifying antirheumatic drugs but are not predictive of response to treatment in early rheumatoid arthritis

  Liu J; Idborg H; Korotkova M; Lend K; van Vollenhoven R; Lampa J; Rudin A; Nordstrom D; Gudbjornsson B; Grondal G; Uhlig T; Horslev-Petersen K; Merete HL; Ostergaard M; Nurmohamed M; Jakobsson P-J
• Article: JOURNAL OF CLINICAL MEDICINE. 2024;13(5):1485

  Factors Associated with Survival and Discontinuation of Anti-Malarial Agents in Systemic Lupus Erythematosus: Results from a Tertiary Swedish Referral Centre

  Walhelm T; Wirestam L; Enman Y; Parodis I; Sjowall C
• Article: RHEUMATOLOGY. 2024;:keae128

  Characteristics and risk factors of COVID-19 breakthrough infections in Idiopathic Inflammatory Myopathies: Results from the COVAD study

  Hoff LS; Naveen R; Sen P; Day J; Joshi M; Nune A; Nikiphorou E; Saha S; Tan AL; Shinjo SK; Ziade N; Velikova T; Milchert M; Jagtap K; Parodis I; Edgar Gracia-Ramos A; Cavagna L; Kuwana M; Knitza J; Chen YM; Makol A; Agarwal V; Patel A; Pauling JD; Wincup C; Barman B; Zamora Tehozol EA; Rojas Serrano J; Garcia-De La Torre I; Colunga-Pedraza IJ; Merayo-Chalico J; Chibuzo OC; Katchamart W; Akarawatcharangura Goo P; Shumnalieva R; El Kibbi L; Halabi H; Vaidya B; Shaharir SS; Hasan ATMT; Dey D; Toro Gutierrez CE; Caballero-Uribe CV; Lilleker JB; Salim B; Gheita T; Chatterjee T; Distler O; Saavedra MA; Chinoy H; Agarwal V; Aggarwal R; Gupta L
• Article: THE LANCET. 2024;403(10429):850-859

  Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial

  Rech J; Tascilar K; Hagen M; Kleyer A; Manger B; Schoenau V; Hueber AJ; Kleinert S; Baraliakos X; Braun J; Kiltz U; Fleck M; Rubbert-Roth A; Kofler DM; Behrens F; Feuchtenberger M; Zaenker M; Voll R; Venhoff N; Thiel J; Glaser C; Feist E; Burmester GR; Karberg K; Strunk J; Canete J; Senolt L; Filkova M; Naredo E; Largo R; Kronke G; D'Agostino M-A; Ostergaard M; Schett G
• Article: RHEUMATOLOGY. 2024;63(3):657-664

  Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey study

  Ziade N; Aoude M; Hmamouchi I; Naveen R; Lilleker JB; Sen P; Joshi M; Agarwal V; Kardes S; Day J; Makol A; Milchert M; Gheita T; Salim B; Velikova T; Edgar Gracia-Ramos A; Parodis I; Nikiphorou E; Chatterjee T; Tan AL; Saavedra MA; Shinjo SK; Knitza J; Kuwana M; Nune A; Cavagna L; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L
• Article: RHEUMATOLOGY. 2024;63(3):798-808

  Determinants of neuropsychiatric flares in patients with systemic lupus erythematosus: results from five phase III trials of belimumab

  Palazzo L; Lindblom J; Cetrez N; Ala H; Parodis I
• Conference publication: 2024;:a24-a25

  O23 Interferon upregulation and B and plasma cell gene dysregulation patterns reveal three distinct lupus nephritis subgroups with differential anticipated response to targeted therapies

  Parodis I; Lindblom J; Toro-Domínguez D; Beretta L; Borghi MO; Castillo J; Carnero-Montoro E; Enman Y; Mohan C; Alarcón-Riquelme ME; Barturen G; Nikolopoulos D
• Conference publication: 2024;:a17-a18

  O15 B cell, T cell, cytotoxic/NK cell, and mitochondrial gene dysregulation patterns separate neuropsychiatric systemic lupus erythematosus patients into two distinct subgroups with differential anticipated response to targeted therapies

  Lindblom J; Nikolopoulos D; Toro-Domínguez D; Carnero-Montoro E; Borghi MO; Castillo J; Iacobaeus E; Enman Y; Mohan C; Beretta L; Alarcón-Riquelme ME; Barturen G; Parodis I
• Conference publication: 2024;:a161.1-a1a161

  P156 Recommendations of nonpharmacological management of SLE and SSc: Assessing alignment with clinical care

  Marchiori F; Schriemer R; Ende EVD; Kocher A; Ritschl V; Barten B; Galetti I; Westhovens R; Distler O; Bostrom C; Parodis I
• Conference publication: 2024;:a59.1-a5a59

  P23 Presence of anti-Sm autoantibodies is associated with abatement of attainability of LLDAS and DORIS remission in systemic lupus erythematosus

  Lourenço MH; Cetrez N; Tsoi A; Lindblom J; Nikolopoulos D; Parodis I
• Conference publication: 2024;:a58.2-a5a58

  P22 Consistent benefits from belimumab irrespective of antiphospholipid autoantibody profile, yet not in the presence of lupus anticoagulant

  Tsoi A; Lindblom J; Cetrez N; Parodis I
• Conference publication: 2024;:a28.2-a2a29

  O28 Unveiling the impact of neuropsychiatric involvement in systemic lupus erythematosus on damage accrual

  Nikolopoulos D; Cetrez N; Lindblom J; Parodis I
• Conference publication: 2024;:a14-a15

  O11 Unsupervised machine-learning identifies distinct clusters based on B cell phenotyping and autoantibody profiles in patients with systemic lupus erythematosus

  Gatto M; Depascale R; Cetrez N; Lindblom J; Nikolopoulos D; Doria A; Parodis I
• Conference publication: 2024;:a119.1-a1a119

  P110 Impact of neuropsychiatric involvement on health-related quality of life in patients with systemic lupus erythematosus

  Nikolopoulos D; Cetrez N; Lindblom J; Parodis I
• Conference publication: 2024;:a86.1-a8a86

  P62 Machine learning approaches for prediction of renal flares in systemic lupus erythematosus: knowledge-driven models outperformed data-driven models

  Cetrez N; Lindblom J; Mutten RD; Nikolopoulos D; Parodis I
• Conference publication: 2024;:a85.2-a8a86

  P61 Harnessing machine learning to predict neuropsychiatric events in systemic lupus erythematosus

  Cetrez N; Lindblom J; Mutten RD; Nikolopoulos D; Parodis I
• Conference publication: 2024;:a21

  O20 Lupus low disease activity state and organ damage in relation to quality of life in SLE: a cohort study with up to 11 years of follow-up

  Parodis I; Stephens T; Dominicus A; Eek D; Sjöwall C
• Conference publication: 2024;:a140-a141

  P134 Factors associated with discordance between patient and physician perception of disease activity among patients with systemic lupus erythematosus: an international collaborative study

  Ghosh S; Narayanan RS; Bechman K; Parodis I; Kadam E; Katchamart W; Goo PA; Gracia-Ramos AE; Sen P; Nikiphorou E; Saha S; Tan AL; Velikova T; Milchert M; Knitza J; Caballero C; Dzifa D; Chinoy H; Aggarwal R; Agarwal V; Gupta L; Wincup C
• Conference publication: 2024;:a39-a40

  O42 Patients with systemic lupus erythematosus experience poor health-related quality of life despite a low disease activity state or remission

  Parodis I; Lindblom J; Cetrez N; Palazzo L; Ala H; Nikpour M; Levitsky A; Strand V
• Article: ZEITSCHRIFT FUR RHEUMATOLOGIE. 2024;83(2):142-150

  Treatment patterns of individualized real-life tapering approaches based on shared decision-making in rheumatoid arthritis

  Birkner B; Rech J; Edelmann E; Verheyen F; Schett G; Stargardt T
• Conference publication: 2024;:a36.2-a3a37

  O39 Immune deposit resorption in per-protocol repeat kidney biopsy performed in patients with proliferative lupus nephritis

  Cetrez N; Tamirou F; Nieuwland S; Aydin S; Parodis I; Houssiau FA
• Article: ECLINICALMEDICINE. 2024;69:102476

  Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee

  Greco R; Alexander T; Del Papa N; Mueller F; Saccardi R; Sanchez-Guijo F; Schett G; Sharrack B; Snowden JA; Tarte K; Onida F; Sanchez-Ortega I; Burman J; Llorente CC; Cervera R; Ciceri F; Doria A; Henes J; Lindsay J; Mackensen A; Muraro PA; Ricart E; Rovira M; Zuckerman T; Yakoub-Agha I; Farge D
• Article: RHEUMATOLOGY. 2024;:keae120

  Lupus Low Disease Activity State and organ damage in relation to quality of life in systemic lupus erythematosus: a cohort study with up to 11 years of follow-up.

  Parodis I; Stephens T; Dominicus A; Eek D; Sjöwall C
• Article: NEW ENGLAND JOURNAL OF MEDICINE. 2024;390(8):687-700

  CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-up

  Mueller F; Taubmann J; Bucci L; Wilhelm A; Bergmann C; Voelkl S; Aigner M; Rothe T; Minopoulou I; Tur C; Knitza J; Kharboutli S; Kretschmann S; Vasova I; Spoerl S; Reimann H; Munoz L; Gerlach RG; Schaefer S; Grieshaber-Bouyer R; Korganow A-S; Farge-Bancel D; Mougiakakos D; Bozec A; Winkler T; Kroenke G; Mackensen A; Schett G
• Preprint: BIORXIV. 2024

  Dnmt3amutations limit normal and autoreactive Tfh differentiation

  Shen Y; Li Z; Boddul S; Kasza Z; Espinosa A; Klareskog L; Wermeling F
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2024;83(3):277-287

  In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammation

  Pertsinidou E; Saevarsdottir S; Manivel VA; Klareskog L; Alfredsson L; Mathsson-Alm L; Hansson M; Cornillet M; Serre G; Holmdahl R; Skriner K; Jakobsson P-J; Westerlind H; Askling J; Roennelid J
• Review: LUPUS SCIENCE AND MEDICINE. 2024;11(1):e001114

  Clinical trial outcomes for SLE: what we have and what we need

  Arnaud L; Parodis I; Devilliers H; Chasset F
• Review: RMD OPEN. 2024;10(1):e003880

  Metabolic and molecular imaging in inflammatory arthritis

  de Sousa RN; Tascilar K; Corte G; Atzinger A; Minopoulou I; Ohrndorf S; Waldner M; Schmidkonz C; Kuwert T; Knieling F; Kleyer A; Ramming A; Schett G; Simon D; Fagni F
• Article: MOLECULAR ONCOLOGY. 2024;18(2):317-335

  High-content screening of drug combinations of an mPGES-1 inhibitor in multicellular tumor spheroids leads to mechanistic insights into neuroblastoma chemoresistance

  Zaghmi A; Aybay E; Jiang L; Shang M; Steinmetz-Spah J; Wermeling F; Kogner P; Korotkova M; Ostling P; Jakobsson P-J; Seashore-Ludlow B; Larsson K
• Article: RHEUMATOLOGY. 2024;63(2):338-348

  Belimumab and antimalarials combined against renal flares in patients treated for extra-renal systemic lupus erythematosus: results from 4 phase III clinical trials

  Gomez A; Jagerback S; Sjowall C; Parodis I
• Article: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2024;64:152339

  Responsiveness and meaningful thresholds of PROMIS pain interference, fatigue, and physical function forms in adults with idiopathic inflammatory myopathies: Report from the OMERACT Myositis Working Group

  Saygin D; Direnzo D; Raaphorst J; De Groot I; Bingham CO; Lundberg IE; Regardt M; Sarver C; De Visser M; Maxwell LJ; Beaton D; Kim JY; Needham M; Alexanderson H; Christopher-stine L; Mecoli CA; Park JK
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2024;42(2):277-287

  Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank

  Loganathan A; Zanframundo G; Yoshida A; Faghihi-Kashani S; Ventura IB; Dourado-Kashani E; Bozan F; Sambataro G; Yamano Y; Bae SS; Lim D; Ceribelli A; Isailovic N; Selmi C; Fertig N; Bravi E; Kaneko Y; Saraiva AP; Jovani V; Bachiller-Corral J; Cifrian J; Mera-Varela A; Moghadam-Kia S; Wolff V; Campagne J; Meyer A; Giannini M; Triantafyllias K; Knitza J; Gupta L; Molad Y; Iannone F; Cavazzana I; Piga M; De Luca G; Tansley S; Bozzalla-Cassione E; Bonella F; Corte TJ; Doyle TJ; Fiorentino D; Gonzalez-Gay MA; Hudson M; Kuwana M; Lundberg IE; Mammen AL; McHugh NJ; Miller FW; Montecucco C; Oddis CV; Rojas-Serrano J; Schmidt J; Scire CA; Callaghan AS-O; Werth VP; Alpini C; Bozzini S; Cavagna L; Aggarwal R
• Review: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2024;42(2):413-424

  Mental health in paediatric and adult myositis-related diseases: current state of research, interventions, and future steps from the MIHRA Psychological Impact Scientific Working Group

  Lanis A; Alexanderson H; Ardalan K; Edison S; Graham CD; de Groot I; Gupta L; Kim S; Knight AM; Kobert L; Livermore P; Lood C; Pilkington C; Regardt M; Rubinstein TB; Shenoi S; Turnier L; Voet NBM; Wahezi DM; Saketkoo LA
• Article: LUPUS. 2024;33(2):166-171

  Impaired serotonin synthesis in hippocampus of murine lupus represents an early neuropsychiatric event

  Nikolopoulos D; Nakos-Bimpos M; Manolakou T; Polissidis A; Boumpas DT
• Review: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2024;42(2):403-412

  Performance of the 2017 EULAR/ACR Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a scoping review

  Saygin D; Glaubitz S; Zeng R; Bottai M; de Visser M; Dimachkie MM; Fiorentino D; Gerhardson I; Kuwana M; Miller FW; Needham M; Rider LG; Salem Y; Schlueter S; Shinjo SK; Wang G; Werth VP; Aggarwal R; Lundberg IE
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2024;42(2):207-212

  Collaborative research in myositis-related disorders: MIHRA, a global shared community model

  Saketkoo LA; Paik JJ; Alexanderson H; Dimachkie MM; Ernste FC; Naddaf E; Shafranski B; Gupta L; Mecoli CA; Saygin D; Albayda J; Basharat P; Day JA; Valenzuela A; Bromley R; de Groot I; Edison SE; Lanis A; Lood C; Regardt M; Yi BY; Benitez AC; Chinoy H; Christopher-Stine L; Isenberg DA; Lang B; Oddis CV; van Royen A; Vencovsky J; Werth VP; Machado PM
• Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2024;121(3):e2315354120

  Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents Infection of Omicron lineages

  Marcotte H; Cao Y; Zuo F; Simonelli L; Sammartino JC; Pedotti M; Sun R; Cassaniti I; Hagbom M; Piralla A; Yang J; Du L; Percivalle E; Bertoglio F; Schubert M; Abolhassani H; Sherina N; Guerra C; Borte S; Rezaei N; Kumagai-Braesch M; Xue Y; Su C; Yan Q; He P; Groenwall C; Klareskog L; Calzolai L; Cavalli A; Wang Q; Robbiani DF; Hust M; Shi Z; Feng L; Svensson L; Chen L; Bao L; Baldanti F; Xiao J; Qin C; Hammarstrom L; Yang X; Varani L; Xie XS; Pan-Hammarstrom Q
• Article: RHEUMATOLOGY. 2024;:keae023

  Predictors of renal flares in systemic lupus erythematosus: a post-hoc analysis of four phase III clinical trials of belimumab

  Jagerback S; Gomez A; Parodis I
• Article: RHEUMATOLOGY. 2024;63(1):127-139

  Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and-2 surveys

  Naveen P; Sen P; Griger Z; Day J; Joshi M; Nune A; Nikiphorou E; Saha S; Tan AL; Shinjo SK; Ziade N; Velikova T; Milchert M; Jagtap K; Parodis I; Gracia-Ramos AE; Cavagna L; Kuwana M; Knitza J; Chen YM; Makol A; Agarwal V; Patel A; Pauling JD; Wincup C; Barman B; Zamora Tehozol EA; Rojas Serrano J; Garcia-De La Torre I; Colunga-Pedraza IJ; Merayo-Chalico J; Chibuzo OC; Katchamart W; Akarawatcharangura Goo P; Shumnalieva R; Hoff LS; El Kibbi L; Halabi H; Vaidya B; Shaharir SS; Hasan ATMT; Dey D; Toro Gutierrez CE; Caballero-Uribe CV; Lilleker JB; Salim B; Gheita T; Chatterjee T; Distler O; Saavedra MA; Chinoy H; Agarwal V; Aggarwal R; Gupta L
• Article: RHEUMATOLOGY. 2024;63(1):41-49

  Enthesitis in patients with psoriatic arthritis treated with secukinumab or adalimumab: a post hoc analysis of the EXCEED study

  Kaeley GS; Schett G; Conaghan PG; McGonagle D; Behrens F; Goupille P; Gaillez C; Parikh B; Bakewell C
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2024;83(1):15-29

  EULAR recommendations for the management of systemic lupus erythematosus: 2023 update

  Fanouriakis A; Kostopoulou M; Andersen J; Aringer M; Arnaud L; Bae S-C; Boletis J; Bruce IN; Cervera R; Doria A; Doerner T; Furie RA; Gladman DD; Houssiau FA; Ines LS; Jayne D; Kouloumas M; Kovacs L; Mok CC; Morand EF; Moroni G; Mosca M; Mucke J; Mukhtyar CB; Nagy G; Navarra S; Parodis I; Pego-Reigosa JM; Petri M; Pons-Estel BA; Schneider M; Smolen JS; Svenungsson E; Tanaka Y; Tektonidou MG; Teng YKO; Tincani A; Vital EM; van Vollenhoven RF; Wincup C; Bertsias G; Boumpas DT
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2024;83(1):72-87

  L-arginine metabolism inhibits arthritis and inflammatory bone loss

  Cao S; Li Y; Song R; Meng X; Fuchs M; Liang C; Kachler K; Meng X; Wen J; Schloetzer-Schrehardt U; Taudte V; Gessner A; Kunz M; Schleicher U; Zaiss MM; Kastbom A; Chen X; Schett G; Bozec A
• Article: AUTOIMMUNITY REVIEWS. 2024;23(1):103422

  Is per-protocol kidney biopsy required in lupus nephritis?

  Parodis I; Moroni G; Calatroni M; Bellis E; Gatto M
• Article: AUTOIMMUNITY REVIEWS. 2024;23(1):103418

  When should targeted therapies be used in the treatment of lupus nephritis: Early in the disease course or in refractory patients?

  Parodis I; Depascale R; Doria A; Anders H-J
• Article: JOURNAL OF DIABETES INVESTIGATION. 2024;15(1):131-138

  Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study

  Chatterjee T; Ravichandran N; Nair N; Gracia-Ramos AE; Barman B; Sen P; Joshi M; Saha S; Nune A; Pande AKR; Velikova T; Parodis I; Tan AL; Shinjo SK; Boro H; Agarwal V; Aggarwal R; Gupta L
• Article: RHEUMATOLOGY INTERNATIONAL. 2024;44(1):89-97

  Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey

  Ahmed S; Gupta L; Kuwana M; Pauling JD; Day J; Ravichandran N; Joshi M; Parodis I; Sen P; Jagtap K; Nikiphorou E; Saha S; Agarwal V; Chatterjee T; Lilleker JB; Kardes S; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Tan AL; Nune A; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Distler O; Wibowo SAK; Barman B; Singh YP; Ranjan R; Jain A; Pandya SC; Pilania RK; Sharma A; Manoj MM; Gupta V; Kavadichanda CG; Patro PS; Ajmani S; Phatak S; Goswami RP; Chowdhury AC; Mathew AJ; Shenoy P; Asranna A; Bommakanti KT; Shukla A; Pande AR; Chandwar K; Cansu DU; Wincup C; Del Papa N; Sambataro G; Fabiola A; Govoni M; Parisi S; Bocci EB; Sebastiani GD; Fusaro E; Sebastiani M; Quartuccio L; Franceschini F; Sainaghi PP; Orsolini G; De Angelis R; Danielli MG; Venerito V; Traboco LS; Serrano JR; La Torre IG-D; Tehozol EAZ; Loarce-Martos J; Prieto-Gonzalez S; Gil-Vila A; Gonzalez RA; Yoshida A; Nakashima R; Sato S; Kimura N; Kaneko Y; Tomaras S; Gromova MA; Aharonov O; Hmamouchi I; Hoff LS; Giannini M; Maurier F; Campagne J; Meyer A; Nagy-Vincze M; Langguth D; Limaye V; Needham M; Srivastav N; Hudson M; Landon-Cardinal O; Shaharir SS; Zuleta WGR; Silva JAP; Fonseca JE; Zimba O; Chinoy H; Aggarwal R; Agarwal V; Makol A
• Journal article: FRONTIERS IN IMMUNOLOGY. 2024;15:1372927

  High-mannose glycans from Schistosoma mansoni eggs are important for priming of Th2 responses via Dectin-2 and prostaglandin E2.

  Almeida L; van Roey R; Patente TA; Otto F; Veldhuizen T; Ghorasaini M; van Diepen A; Schramm G; Liu J; Idborg H; Korotkova M; Jakobsson P-J; Giera M; Hokke CH; Everts B
• Letter: INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES. 2024;27(1):e14961

  Flares of autoimmune rheumatic disease following COVID-19 infection: Observations from the COVAD study

  Sandhu NK; Ravichandraan N; Nune A; Day J; Sen P; Nikiphorou E; Tan AL; Joshi M; Saha S; Shinjo SK; Jagtap K; Agarwal V; Ziade N; Velikova T; Milchert M; Parodis I; Gracia-Ramos AE; Cavagna L; Kuwana M; Knitza J; Makol A; Patel A; Pauling JD; Wincup C; Barman B; Tehozol EAZ; Serrano JR; Torre IG-DL; Colunga-Pedraza IJ; Merayo-Chalico J; Okwara CC; Katchamart W; Goo PA; Shumnalieva R; Chen Y-M; Hoff LS; Kibbi LE; Halabi H; Vaidya B; Shaharir SS; Hasan ATMT; Dey D; Gutierrez CET; Caballero-Uribe CV; Lilleker JB; Salim B; Gheita T; Saavedra MA; Chatterjee T; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L
• Article: JOURNAL OF AUTOIMMUNITY. 2024;142:103136

  K2P2.1 is a regulator of inflammatory cell responses in idiopathic inflammatory myopathies

  Nelke C; Muentefering T; Cengiz D; Theissen L; Dobelmann V; Schroeter CB; Block H; Preu C; Michels APE; Lichtenberg S; Pawlitzki M; Pfeuffer S; Huntemann N; Zarbock A; Briese T; Kittl C; Dittmayer C; Budde T; Lundberg IE; Stenzel W; Meuth SG; Ruck T
• Review: JOURNAL OF INFLAMMATION RESEARCH. 2024;17:3563-3585

  The Role of Exercise to Improve Physiological, Physical and Psychological Health Outcome in Idiopathic Inflammatory Myopathies (IIM)

  Lodin K; Espinosa-Ortega F; Lundberg IE; Alexanderson H
• Article: FRONTIERS IN IMMUNOLOGY. 2024;15:1372927

  High-mannose glycans from Schistosoma mansoni eggs are important for priming of Th2 responses via Dectin-2 and prostaglandin E2

  Almeida L; van Roey R; Patente TA; Otto F; Veldhuizen T; Ghorasaini M; van Diepen A; Schramm G; Liu J; Idborg H; Korotkova M; Jakobsson P-J; Giera M; Hokke CH; Everts B
• Article: RHEUMATOLOGY INTERNATIONAL. 2024;44(1):73-80

  COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group

  Panchawagh S; Ravichandran N; Barman B; Nune A; Javaid M; Gracia-Ramos AE; Day J; Joshi M; Kuwana M; Saha S; Pande AR; Caballero-Uribe CV; Velikova T; Parodis I; Knitza J; Kadam E; Tan AL; Shinjo SK; Boro H; Aggarwal R; Agarwal V; Chatterjee T; Gupta L
• Article: RMD OPEN. 2023;9(4):e003648

  Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden

  Bower H; Frisell T; di Giuseppe D; Delcoigne B; Lindstrom U; Turesson C; Chatzidionysiou K; Lindqvist E; Knight A; Forsblad-d'Elia H; Askling J
• Article: JOURNAL OF CLINICAL MEDICINE. 2023;12(24):7542

  COVID-19 Vaccination-Related Delayed Adverse Events among Patients with Systemic Lupus Erythematosus

  Dey M; Doskaliuk B; Lindblom J; Nikiphorou E; Wincup C; Fathima M; Saha S; Shaharir SS; Katchamart W; Goo PA; Traboco L; Chen Y-M; Kadam E; Lilleker JB; Nune A; Pauling JD; Agarwal V; Dey D; Toro Gutierrez CE; Caballero CV; Chinoy H; Aggarwal R; Agarwal V; Gupta L; Parodis I
• Article: RHEUMATOLOGY. 2023;62(12):3838-3848

  Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period-a cross-sequential study based on COVAD surveys

  Jagtap K; Naveen R; Day J; Sen P; Vaidya B; Nune A; Nikiphorou E; Tan AL; Agarwal V; Saha S; Shinjo SK; Ziade N; Joshi M; Velikova T; Milchert M; Parodis I; Edgar Gracia-Ramos A; Cavagna L; Kuwana M; Knitza J; Makol A; Patel A; Pauling JD; Wincup C; Barman B; Zamora Tehozol EA; Rojas Serrano J; Garcia-De La Torre I; Colunga-Pedraza IJ; Merayo-Chalico J; Chibuzo OC; Katchamart W; Goo PA; Shumnalieva R; Chen Y-M; Hoff LS; El Kibbi L; Halabi H; Sazliyana Shaharir S; Hasan ATMT; Dey D; Gutierrez CET; Caballero-Uribe CV; Lilleker JB; Salim B; Gheita T; Chatterjee T; Saavedra MA; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L
• Article: RHEUMATOLOGY. 2023;62(12):3916-3923

  Sensitivity analysis of EQ-5D-3L index scores in terms of discriminative and known-groups validity in SLE: introducing Adequate Health State

  Hua N; Gomez A; Lindblom J; Emamikia S; Enman Y; Grannas D; Heintz E; Regardt M; Parodis I
• Article: REVUE DE MEDECINE INTERNE. 2023;44:A318

  New therapeutic approaches for inflammatory myopathies

  Lundberg IE
• Article: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2023;63:152259

  Effects of secukinumab on synovitis and enthesitis in patients with psoriatic arthritis: 52-week clinical and ultrasound results from the randomised, double-blind ULTIMATE trial with open label extension

  D'Agostino MA; Carron P; Gaillez C; Conaghan PG; Naredo E; Lopez-Rdz A; Senolt L; Burgos-Vargas R; Hanova P; Padovano I; Cazenave T; Stoenoiu MS; Backhaus M; Mouterde G; Bao W; Goyanka P; Boers M; Schett G
• Article: BEST PRACTICE AND RESEARCH: CLINICAL RHEUMATOLOGY. 2023;37(4):101894

  Reframing health disparities in SLE: A critical reassessment of racial and ethnic differences in lupus disease outcomes

  Parodis I; Lanata C; Nikolopoulos D; Blazer A; Yazdany J
• Article: RMD OPEN. 2023;9(4):e003612

  Tolerability of low to moderate biomechanical stress during leisure sport activity in patients with psoriasis and psoriatic arthritis

  Fagni F; Mutlu MY; Temiz SA; Minopoulou I; Krieter M; Schett G; Kleyer A; Simon D; Hueber AJ
• Review: NATURE REVIEWS. RHEUMATOLOGY. 2023;19(12):790-804

  Immune mechanisms of depression in rheumatoid arthritis

  Brock J; Basu N; Schlachetzki JCM; Schett G; Mcinnes IB; Cavanagh J
• Editorial comment: JOURNAL OF RHEUMATOLOGY. 2023;51(1):jrheum.2023-jrheum.0947

  More Evidence on the Validity of the Measurement Properties of PROMIS Computerized Adaptive Tests in Systemic Lupus Erythematosus

  Touma Z; Parodis I; Strand V
• Letter: NATURE COMMUNICATIONS. 2023;14(1):7172

  Failure to apply standard limit-of-detection or limit-of-quantitation criteria to specialized pro-resolving mediator analysis incorrectly characterizes their presence in biological samples

  O'Donnell VB; Schebb NH; Milne GL; Murphy MP; Thomas CP; Steinhilber D; Gelhaus SL; Kuehn H; Gelb MH; Jakobsson P-J; Blair IA; Murphy RC; Freeman BA; Brash AR; Fitzgerald GA
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2023;52(6):591-600

  Evaluation of an individually tailored smoking-cessation intervention for patients with rheumatoid arthritis in an outpatient clinic

  Karlsson M-L; Hertzberg-Nyquist K; Saevarsdottir S; Lundberg IE; Demmelmaier I; Pettersson S; Chatzidionysiou K
• Article: RHEUMATOLOGY. 2023;62(11):3672-3679

  Performance of the 2016 ACR-EULAR Myositis Response Criteria in adult dermatomyositis/polymyositis therapeutic trials and consensus profiles

  Saygin D; Kim H; Douglas C; Erman B; Wilkerson J; McGrath JA; Oddis CV; Lundberg IE; Amato AA; Garcia-De La Torre I; Chinoy H; Fiorentino D; Chung L; Song Y-W; Miller FW; Ruperto N; Vencovsky J; Aggarwal R; Rider LG
• Review: EXPERT OPINION ON THERAPEUTIC TARGETS. 2023;27(11):1115-1123

  The anti-inflammatory and vasoprotective properties of mPGES-1 inhibition offer promising therapeutic potential

  Steinmetz-Spah J; Jakobsson P-J
• Article: ARTHRITIS & RHEUMATOLOGY. 2023;75(11):1910-1922

  Rheumatoid Arthritis-Specific Autoimmunity in the Lung Before and at the Onset of Disease

  Joshua V; Loberg Haarhaus M; Hensvold A; Wahamaa H; Gerstner C; Hansson M; Israelsson L; Stalesen R; Skoeld M; Grunewald J; Klareskog L; Groenwall C; Rethi B; Catrina A; Malmstrom V
• Corrigendum: JOURNAL OF AUTOIMMUNITY. 2023;140:103052

  Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus (vol 136, 103025, 2023)

  Lindblom J; Toro-Dominguez D; Carnero-Montoro E; Beretta L; Borghi MO; Castillo J; Enman Y; Mohan C; Alarcon-Riquelme ME; Barturen G; Parodis I
• Article: DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY. 2023;148:104920

  Two granzyme A/K homologs in Zebra mbuna have different specificities, one classical tryptase and one with chymase activity.

  Aybay E; Elkhalifa M; Akula S; Wernersson S; Hellman L
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2023;41(11):2301-2311

  The prevalence of pulmonary arterial hypertension in patients with mixed connective tissue disease: a systematic review and meta-analysis

  Hassan AB; Hozayen RF; Mustafa ZS; Lundberg IE; Jahrami HA
• Article: JOURNAL OF RHEUMATOLOGY. 2023;50(11):61-65

  Proceedings of the Collaborative Research Network Meeting at the GRAPPA 2022 Annual Meeting

  Ng BCK; Jadon D; Behrens F; de Wit M; FitzGerald O; Gladman DD; Mease PJ; O'Sullivan D; Pennington SR; Schett G; Chandran V; de Vlam K
• Article: ARTHRITIS & RHEUMATOLOGY. 2023;75(11):1923-1934

  Baricitinib Improves Bone Properties and Biomechanics in Patients With Rheumatoid Arthritis: Results of the Prospective Interventional BARE BONE Trial

  Simon D; Minopoulou I; Kemenes S; Bayat S; Tascilar K; Mutlu MY; Valor-Mendez L; Kroenke G; Hueber AJ; Schett G; Kleyer A
• Review: NATURE REVIEWS. RHEUMATOLOGY. 2023;19(11):695-712

  Epidemiology of the idiopathic inflammatory myopathies.

  Khoo T; Lilleker JB; Thong BY-H; Leclair V; Lamb JA; Chinoy H
• Article: EMBO MOLECULAR MEDICINE. 2023;15(10):e17240

  Single-cell profiling of muscle-infiltrating T cells in idiopathic inflammatory myopathies

  Argyriou A; Horuluoglu B; Galindo-Feria AS; Diaz-Boada JS; Sijbranda M; Notarnicola A; Dani L; van Vollenhoven A; Ramskold D; Nennesmo I; Dastmalchi M; Lundberg IE; Diaz-Gallo L-M; Chemin K
• Preprint: MEDRXIV. 2023;MEDRXIV

  GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets.

  Dand N; Stuart PE; Bowes J; Ellinghaus D; Nititham J; Saklatvala JR; Teder-Laving M; Thomas LF; Traks T; Uebe S; Assmann G; Baudry D; Behrens F; Billi AC; Brown MA; Burkhardt H; Capon F; Chung R; Curtis CJ; Duckworth M; Ellinghaus E; FitzGerald O; Gerdes S; Griffiths CEM; Gulliver S; Helliwell P; Ho P; Hoffmann P; Holmen OL; Huang Z-M; Hveem K; Jadon D; Köhm M; Kraus C; Lamacchia C; Lee SH; Ma F; Mahil SK; McHugh N; McManus R; Modalsli EH; Nissen MJ; Nöthen M; Oji V; Oksenberg JR; Patrick MT; Perez-White BE; Ramming A; Rech J; Rosen C; Sarkar MK; Schett G; Schmidt B; Tejasvi T; Traupe H; Voorhees JJ; Wacker EM; Warren RB; Wasikowski R; Weidinger S; Wen X; Zhang Z; BSTOP study group; Estonian Biobank research team; Barton A; Chandran V; Esko T; Foerster J; Franke A; Gladman DD; Gudjonsson JE; Gulliver W; Hüffmeier U; Kingo K; Kõks S; Liao W; Løset M; Mägi R; Nair RP; Rahman P; Reis A; Smith CH; Di Meglio P; Barker JN; Tsoi LC; Simpson MA; Elder JT
• Article: RHEUMATOLOGY. 2023;62(10):3291-3301

  Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys

  Sen P; Naveen R; Houshmand N; Kia SM; Joshi M; Saha S; Jagtap K; Agarwal V; Nune A; Nikiphorou E; Tan AL; Shinjo SK; Ziade N; Velikova T; Milchert M; Parodis I; Gracia-Ramos AE; Cavagna L; Kuwana M; Knitza J; Makol A; Patel A; Pauling JD; Wincup C; Barman B; Tehozol EAZ; Serrano JR; de la Torre I; Colunga-Pedraza IJ; Merayo-Chalico J; Chibuzo OC; Katchamart W; Akawatcharangura Goo P; Shumnalieva R; Chen Y-M; Hoff LS; El Kibbi L; Halabi H; Vaidya B; Shaharir SS; Hasan ATMT; Dey D; Gutierrez CET; Caballero-Uribe CV; Lilleker JB; Salim B; Gheita T; Chatterjee T; Distler O; Saavedra MA; Day J; Chinoy H; Kardes S; Kardes SA; Andreoli L; Lini D; Screiber K; Vince MN; Singh YP; Ranjan R; Jain A; Pandya SC; Pilania RK; Sharma A; Manoj MM; Gupta V; Kavadichanda CG; Patro PS; Ajmani S; Phatak S; Goswami RP; Chowdhury AC; Mathew AJ; Shenoy P; Asranna A; Bommakanti KT; Shukla A; Pande AR; Chandwar K; Ghodke A; Boro H; Fazal ZZ; Cansu DU; Yildirim R; Gasparyan AY; Del Papa N; Sambataro G; Fabiola A; Govoni M; Parisi S; Bocci EB; Sebastiani GD; Fusaro E; Sebastiani M; Quartuccio L; Franceschini F; Sainaghi PP; Orsolini G; De Angelis R; Danielli MG; Venerito V; Grignaschi S; Giollo A; Alluno A; Ioannone F; Fornaro M; Traboco LS; Wibowo SAK; Loarce-Martos J; Prieto-Gonzalez S; Gonzalez RA; Yoshida A; Nakashima R; Sato S; Kimura N; Kaneko Y; Gono T; Tomaras S; Proft FN; Holzer M-T; Gromova MA; Aharonov O; Griger Z; Hmamouchi I; El Bouchti I; Baba Z; Giannini M; Maurier F; Campagne J; Meyer A; Langguth D; Limaye V; Needham M; Srivastav N; Hudson M; Landon-Cardinal O; Zuleta WGR; Arbelaez A; Cajas J; Silva JAP; Fonseca JE; Zimba O; Bohdana D; Ima-Edomwonyi U; Dedeke I; Airenakho E; Madu NH; Yerima A; Olaosebikan H; Becky A; Koussougbo OD; Palalane E; So H; Ugarte-Gil MF; Chinchay L; Bernaola JP; Pimentel V; Fathi HM; Mohammed RHA; Harifi G; Fuentes-Silva Y; Cabriza K; Losanto J; Colaman N; Cachafeiro-Vilar A; Bautista GG; Ho EJG; Gonzalez R; Nunez LS; Cristian Vergara M; Baez JT; Alonzo H; Pastelin CBS; Salinas RG; Obiols AQ; Chavez N; Ordonez AB; Argueta S; Llerena GAR; Sierra-Zorita R; Arrieta D; Hidalgo ER; Saenz R; Escalante MI; Morales R; Calapaqui W; Quezada I; Arredondo G; Agarwal V; Aggarwal R; Gupta L
• Article: RHEUMATOLOGY. 2023;62(10):3448-3458

  Identification of circulating microRNA patterns in patients in psoriasis and psoriatic arthritis

  Haschka J; Simon D; Bayat S; Messner Z; Kampylafka E; Fagni F; Skalicky S; Hackl M; Resch H; Zwerina J; Kleyer A; Cavallaro A; Sticherling M; Schett G; Kocijan R; Rech J
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2023;41(10):1985-1990

  Original research on Behçet's syndrome: a bibliometric analysis over 20 years (2000-2019)

  Bolla E; Chatzidionysiou K; Tektonidou MG; Sfikakis PP
• Article: RHEUMATOLOGY INTERNATIONAL. 2023;43(10):1925-1934

  Healthcare utilization and unmet needs of patients with antisynthetase syndrome: An international patient survey

  Weiss M; Holzer MT; Muehlensiepen F; Ignatyev Y; Fiehn C; Bauhammer J; Schmidt J; Schlueter S; Dihkan A; Scheibner D; Schneider U; Valor-Mendez L; Corte G; Gupta L; Chinoy H; Lundberg I; Cavagna L; Distler JHW; Schett G; Knitza J
• Conference publication: ANNALS OF ONCOLOGY. 2023;34:s688-s689

  Association of immune-related adverse events (irAE) requiring glucocorticoids (GCs) with outcome and biomarkers in advanced cutaneous malignant melanoma (CMM) treated with immune checkpoint inhibitors (ICI)

  Svedman FC; Liapi M; Chatzidionysiou A; Mansson-Broberg A; Brage SE
• Article: NATURE REVIEWS. RHEUMATOLOGY. 2023;19(10):650-665

  Imaging in inflammatory arthritis: progress towards precision medicine

  Minopoulou I; Kleyer A; Yalcin-Mutlu M; Fagni F; Kemenes S; Schmidkonz C; Atzinger A; Pachowsky M; Engel K; Folle L; Roemer F; Waldner M; D'Agostino M-A; Schett G; Simon D
• Article: EBIOMEDICINE. 2023;96:104804

  Distinct HLA associations with autoantibody-defined subgroups in idiopathic inflammatory myopathies

  Leclair V; Galindo-Feria AS; Rothwell S; Krystufkova O; Zargar SS; Mann H; Diederichsen LP; Andersson H; Klein M; Tansley S; Ronnblom L; Lindblad-Toh K; Syvanen A-C; Wahren-Herlenius M; Sandling JK; McHugh N; Lamb JA; Vencovsky J; Chinoy H; Holmqvist M; Bianchi M; Padyukov L; Lundberg IE; Diaz-Galloc L-M
• Review: JOURNAL OF CLINICAL MEDICINE. 2023;12(19):6268

  B Cell Tolerance and Targeted Therapies in SLE

  Parodis I; Long X; Karlsson MCI; Huang X
• Article: DIAGNOSTICS. 2023;13(19):3080

  Detection of Myositis Autoantibodies by Multi-Analytic Immunoassays in a Large Multicenter Cohort of Patients with Definite Idiopathic Inflammatory Myopathies

  Ghirardello A; Gatto M; Franco C; Zanatta E; Padoan R; Ienna L; Gallo N; Zen M; Lundberg IE; Mahler M; Doria A; Iaccarino L
• Corrigendum: ARTHRITIS RESEARCH & THERAPY. 2023;25(1):170

  Effect of guselkumab on serum biomarkers in patients with active psoriatic arthritis and inadequate response to tumor necrosis factor inhibitors: results from the COSMOS phase 3b study (vol 25, 150, 2023)

  Schett G; Chen W; Gao S; Chakravarty SD; Shawi M; Lavie F; Zimmermann M; Sharaf M; Coates LC; Siebert S
• Article: RHEUMATOLOGY. 2023;62(9):e263-e268

  Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study

  Ali SS; Naveen R; Sen P; Day J; Joshi M; Nune A; Nikiphorou E; Saha S; Tan AL; Shinjo SK; Ziade N; Velikova T; Milchert M; Jagtap K; Parodis I; Edgar Gracia-Ramos A; Cavagna L; Kuwana M; Knitza J; Chen YM; Makol A; Agarwal V; Patel A; Pauling JD; Wincup C; Barman B; Zamora Tehozol EA; Rojas Serrano J; La Torre IG-D; Colunga-Pedraza IJ; Merayo-Chalico J; Chibuzo OC; Katchamart W; Goo PA; Shumnalieva R; Hoff LS; El Kibbi L; Halabi H; Vaidya B; Shaharir SS; Hasan ATMT; Dey D; Gutierrez CET; Caballero-Uribe CV; Lilleker JB; Salim B; Gheita T; Chatterjee T; Distler O; Saavedra MA; Chinoy H; Agarwal V; Aggarwal R; Gupta L
• Article: ACR OPEN RHEUMATOLOGY. 2023;5(9):474-480

  Distinct Fluorescence Optical Imaging Patient Clusters Emerge for Seropositive and Seronegative Rheumatoid Arthritis

  Kisten Y; Arnaud L; Levitsky A; Gyori N; Larsson P; Hensvold A; Catrina A; af Klint E; Rezaei H
• Article: CLINICAL IMMUNOLOGY. 2023;254:109713

  Molecular architecture of proliferative lupus nephritis as elucidated using 50-plex imaging mass cytometry proteomics

  Titus ASCLS; Tan Y; Tran P; Lindblom J; Ivbievbiokun M; Xu Y; Zheng J; Parodis I; Cai Q; Chang A; Chen S-H; Zhao M; Mohan C
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2023;82(9):1162-1170

  EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis

  Zabotti A; De Marco G; Gossec L; Baraliakos X; Aletaha D; Iagnocco A; Gisondi P; Balint PV; Bertheussen H; Boehncke W-H; Damjanov NS; de Wit M; Errichetti E; Marzo-Ortega H; Protopopov M; Puig L; Queiro R; Ruscitti P; Savage L; Schett G; Siebert S; Stamm TA; Studenic P; Tinazzi I; Van den Bosch FE; van der Helm-van Mil A; Watad A; Smolen JS; McGonagle DG
• Article: RHEUMATOLOGY INTERNATIONAL. 2023;43(9):1651-1664

  Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study

  Doskaliuk B; Ravichandran N; Sen P; Day J; Joshi M; Nune A; Nikiphorou E; Saha S; Tan AL; Shinjo SK; Ziade N; Velikova T; Milchert M; Jagtap K; Parodis I; Gracia-Ramos AE; Cavagna L; Kuwana M; Knitza J; Chen YM; Makol A; Agarwal V; Patel A; Pauling JD; Wincup C; Barman B; Tehozol EAZ; Serrano JR; Garcia-De La Torre I; Colunga-Pedraza IJ; Merayo-Chalico J; Chibuzo OC; Katchamart W; Goo PA; Shumnalieva R; Hoff LS; Kibbi LE; Halabi H; Vaidya B; Shaharir SS; Hasan ATMT; Dey D; Gutierrez CET; Caballero-Uribe CV; Lilleker JB; Salim B; Gheita T; Chatterjee T; Distler O; Saavedra MA; Chinoy H; Agarwal V; Aggarwal R; Gupta L
• Article: RHEUMATOLOGY INTERNATIONAL. 2023;43(9):1637-1649

  High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey

  Grignaschi S; Kim M; Zanframundo G; Ravichandran N; Lilleker J; Sen P; Joshi M; Agarwal V; Kardes S; Day J; Makol A; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; Nikiphorou E; Chatterjee T; Tan AL; Saavedra M; Shinjo SK; Ziade N; Knitza J; Kuwana M; Nune A; Distler O; Chinoy H; Cavagna L; Agarwal V; Aggarwal R; Gupta L; COVID SG
• Article: KIDNEY INTERNATIONAL REPORTS. 2023;8(9):1822-1830

  Effect of Belimumab on Preventing de novo Renal Lupus Flares

  Parodis I; Lindblom J; Cetrez N; Palazzo L; Ala H; Houssiau FA; Sjoewall C; Rovin BH
• Review: JOINT BONE SPINE. 2023;90(5):105578

  Rationale, current state and opportunities in combining biologic disease modifying antirheumatic drugs in rheumatoid and psoriatic arthritis

  Mutlu MY; Tascilar K; Schett G
• Article: ARTHRITIS & RHEUMATOLOGY. 2023;75(9):1619-1627

  Amelioration of Fibrotic Remodeling of Human 3-Dimensional Full-Thickness Skin by Transglutamase 2 Inhibition

  Zhou X; Trinh-Minh T; Matei A-E; Gyoerfi A-H; Hong X; Bergmann C; Schett G; Atkinson J; Bowcutt R; Patel J; Johnson TS; Distler JHW
• Journal article: FABAD JOURNAL OF PHARMACEUTICAL SCIENCES. 2023

  Synthesis and Biological Evaluation of Novel Paracetamol-Triazole Conjugates

  KULABAŞ N; GÜRBOĞA M; BİNGÖL ÖZAKPINAR Ö; LİU J; JAKOBSSON P-J; DANIŞ Ö; OGAN A; KÜÇÜKGÜZEL İ
• Corrigendum: NATURE COMMUNICATIONS. 2023;14(1):5019

  Publisher Correction: A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage (vol 14, 5019, 2023)

  Ladds MJGW; van Leeuwen IMM; Drummond CJ; Chu S; Healy AR; Popova G; Fernandez AP; Mollick T; Darekar S; Sedimbi SK; Nekulova M; Sachweh MCC; Campbell J; Higgins M; Tuck C; Popa M; Safont MM; Gelebart P; Fandalyuk Z; Thompson AM; Svensson R; Gustavsson A-L; Johansson L; Faernegardh K; Yngve U; Saleh A; Haraldsson M; D'Hollander ACA; Franco M; Zhao Y; Hakansson M; Walse B; Larsson K; Peat EM; Pelechano V; Lunec J; Vojtesek B; Carmena M; Earnshaw WC; McCarthy AR; Westwood NJ; Arsenian-Henriksson M; Lane DP; Bhatia R; McCormack E; Lain S
• Article: JOURNAL OF CLINICAL MEDICINE. 2023;12(16):5377

  Intracardiac Thrombi in Morbus Adamantiades-Behcet in Two Swedish Patients

  Da Mutten R; Borg A; Chatzidionysiou K; Parodis I
• Article: ARTHRITIS RESEARCH & THERAPY. 2023;25(1):150

  Effect of guselkumab on serum biomarkers in patients with active psoriatic arthritis and inadequate response to tumor necrosis factor inhibitors: results from the COSMOS phase 3b study

  Schett G; Chen W; Gao S; Chakravarty SD; Shawi M; Lavie F; Zimmermann M; Sharaf M; Coates LC; Siebert S
• Article: ARTHRITIS & RHEUMATOLOGY. 2023;75(8):1445-1455

  Familial Co-Aggregation of Idiopathic Inflammatory Myopathies and Cancer: A Swedish Population-Based Study

  Che WI; Baecklund F; Hellgren K; Kuja-Halkola R; Lundberg IE; Westerlind H; Holmqvist M
• Article: BRITISH JOURNAL OF PHARMACOLOGY. 2023;180(15):1981-1998

  Microsomal prostaglandin E synthase-1 inhibition prevents adverse cardiac remodelling after myocardial infarction in mice

  Zhang Y; Steinmetz-Spah J; Idborg H; Zhu L; Li H; Rao H; Chen Z; Guo Z; Hu L; Xu C; Chen H; Korotkova M; Jakobsson P-J; Wang M
• Article: PROSTAGLANDINS AND OTHER LIPID MEDIATORS. 2023;167:106738

  Microsomal prostaglandin E synthase-1 inhibition promotes shunting in arachidonic acid metabolism during inflammatory responses in vitro

  Liu J; Peng B; Steinmetz-Spah J; Idborg H; Korotkova M; Jakobsson P-J
• Article: DIAGNOSIS. 2023;10(3):218-224

  Developing a European longitudinal and interprofessional curriculum for clinical reasoning

  Hege I; Adler M; Donath D; Durning SJ; Edelbring S; Elven M; Bogusz A; Georg C; Huwendiek S; Koerner M; Kononowicz AA; Parodis I; Sodergren U; Wagner FL; Edstrom DW
• Review: RMD OPEN. 2023;9(3):e003297

  Systematic literature review informing the EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis

  Parodis I; Gomez A; Tsoi A; Chow JW; Pezzella D; Girard C; Stamm TA; Bostrom C
• Journal article: EUROPEAN MEDICAL JOURNAL RHEUMATOLOGY. 2023;10(1):33-44

  Predictors of Renal Flares in Systemic Lupus Erythematosus

  Gómez Á; Jägerback S; Parodis I
• Article: RHEUMATOLOGY. 2023;62(7):2453-2463

  Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study

  Naveen R; Nikiphorou E; Joshi M; Sen P; Lindblom J; Agarwal V; Lilleker JB; Tan AL; Salim B; Ziade N; Velikova T; Gracia-Ramos AE; Kuwana M; Day J; Makol A; Distler O; Chinoy H; Traboco LS; Wibowo SAK; Tehozol EAZ; Serrano JR; Garcia-De La Torre I; Aggarwal R; Gupta L; Agarwal V; Parodis I
• Article: RHEUMATOLOGY. 2023;62(7):2366-2376

  COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritis

  Naveen R; Parodis I; Joshi M; Sen P; Lindblom J; Agarwal V; Lilleker JB; Tan AL; Nune A; Shinjo SK; Salim B; Ziade N; Velikova T; Edgar Gracia-Ramos A; Saavedra MA; Day J; Makol A; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L; Nikiphorou E
• Article: RHEUMATOLOGY INTERNATIONAL. 2023;43(7):1265-1275

  Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey

  Naveen R; Thakare D; Kuwana M; Pauling J; Day J; Joshi M; Parodis I; Sen P; Jagtap K; Nikiphorou E; Saha S; Agarwal V; Chatterjee T; Lilleker J; Kardes S; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Tan AL; Nune A; Cavagna L; Saavedra M; Shinjo SK; Ziade N; Knitza J; Distler O; Chinoy H; Aggarwal R; Gupta L; Agarwal V; Makol A
• Conference publication: 2023;:a51.1-a5a51

  LSO-028 Predictors of de novo renal flares in systemic lupus erythematosus – time to revisit belimumab dose for extra-renal disease? Results from five phase III clinical trials of belimumab

  Parodis I; Lindblom J; Çetrez N; Palazzo L; Ala H; Houssiau F; Sjöwall C; Rovin B
• Conference publication: 2023;:a149.1-a1a149

  LP-170 Predictors of neuropsychiatric flares In Patients With Systemic Lupus Erythematosus: Results From Five Phase III clinical trials of belimumab

  Palazzo L; Lindblom J; Cetrez N; Ala H; Parodis I
• Conference publication: 2023;:a52.1-a5a52

  LSO-030 Predictors of renal flares in systemic lupus erythematosus: a post-hoc analysis of four phase III clinical trials of belimumab

  Gomez A; Jägerback S; Parodis I
• Conference publication: 2023;:a22.2-a2a23

  LO-027 COVID-19 vaccine safety during pregnancy in women with systemic lupus erythematosus

  Giannopoulou N; Gupta L; Andreoli L; Lini D; Nikiphorou E; Aggarwal R; Agarwal V; Parodis I
• Conference publication: 2023;:a16.2-a1a17

  LO-019 Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 vaccination in autoimmune disease (COVAD) study

  Olsson EK; Naveen R; Nikiphorou E; Lindblom J; Saha S; Shaharir SS; Katchamart W; Goo PA; Traboco L; Chen Y-M; Jagtap K; Lilleker J; Nune A; Pauling J; Wincup C; Agarwal V; Dzifa D; Toro Gutierrez CE; Caballero CV; Chinoy H; Agarwal V; Aggarwal R; Gupta L; Parodis I
• Conference publication: 2023;:a75

  LSO-065 Belimumab in combination with antimalarial agents prevent renal flares in patients with systemic lupus erythematosus and moderate-to-high extra-renal activity: results from four randomised clinical trials

  Gomez A; Jägerback S; Sjöwall C; Parodis I
• Article: ARTHRITIS & RHEUMATOLOGY. 2023;75(7):1152-1165

  Contribution of Type H Blood Vessels to Pathologic Osteogenesis and Inflammation in an Experimental Spondyloarthritis Model

  Kaaij MH; van Hamburg JP; van Rooijen CCN; Grueneboom A; Kan YY; Pots D; Schett G; van Ruijven LJ; van Duivenvoorde LM; Huitema LFA; Baeten DLP; Tas SW
• Editorial comment: JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (JAMA). 2023;329(24):2130-2131

  CD19-Targeting CAR T-Cell Therapy for Antisynthetase Syndrome

  Lundberg IE; Galindo-Feria AS; Horuluoglu B
• Article: SCIENTIFIC REPORTS. 2023;13(1):10058

  Peripheral blood cellular dynamics of rheumatoid arthritis treatment informs about efficacy of response to disease modifying drugs

  Hedman AK; Winter E; Yoosuf N; Benita Y; Berg L; Brynedal B; Folkersen L; Klareskog L; Maciejewski M; Sirota-Madi A; Spector Y; Ziemek D; Padyukov L; Shen-Orr SS; Jelinsky SA
• Article: RADIATION ONCOLOGY. 2023;18(1):98

  Chromosomal radiosensitivity in oncological and non-oncological patients with rheumatoid arthritis and connective tissue diseases

  Rzepka D; Schenker H; Geinitz H; Silberberger E; Kaudewitz D; Schuster B; Kuhlmann L; Schonath M; Gaona HA; Aschacher B; Fietkau R; Schett G; Distel L
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:574.1-57574

  AUTOANTIBODIES AGAINST A SUBUNIT OF MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX I IN INCLUSION BODY MYOSITIS

  Notarnicola A; Hellstrom C; Horuluoglu B; Preger C; Bonomi F; De Paepe B; De Bleecker J; Van der Kooi AJ; De Visser M; Sacconi S; Machado P; Badrising UA; Rietveld A; Pruijn G; Rothwell S; Lilleker JB; Chinoy H; Benveniste O; Svenungsson E; Idborg H; Jakobsson PJ; Nilsson P; Lundberg IE
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:78.1-7879

  IDENTIFICATION OF EARLY RISK FACTORS IN A NOVEL PREDICTION MODEL FOR ACPA POSITIVE RA

  Circiumaru A; Kisten Y; Hansson M; Mathsson-Alm L; Joshua V; Wahamaa H; Haarhaus ML; Lindqvist J; Guozhong F; Pomiano NV; Rezaei H; Af Klint E; Antovic A; Rethi B; Catrina A; Hensvold A
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:1164.1-111165

  AN UNUSUAL INITIAL PRESENTATION OF VEXAS SYNDROME

  Galindo-Feria AS; Chatzidionysiou K
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:946.1-94946

  PROGRESSIVE PULMONARY FIBROSIS IN ANTISYNTHETASE SYNDROME: A SINGLE CENTER COHORT

  Garcia IP; Svensson AM; Galindo-Feria AS; Notarnicola A; Dani L; Lundberg IE; Dastmalchi M
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:292.1-29292

  TISSUE RESIDENT MEMORY AND CYTOTOXIC T CELLS ARE CLONALLY EXPANDED IN THE MUSCLE OF PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES

  Galindo-Feria AS; Argyriou A; Horuluoglu B; Diaz-Boada JS; Notarnicola A; Dani L; Van Vollenhoven A; Ramskold D; Nennesmo I; Dastmalchi M; Lundberg IE; Diaz-Gallo LM; Chemin K
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:575.1-57575

  DETECTION OF HISRS SPECIFIC AUTOREACTIVE CD4+T CELLS IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES

  Horuluoglu B; Galindo-Feria AS; Kumar R; Kozhukh G; Diaz-Boada JS; Ramskold D; Chemin K; Malmstrom V; Lundberg IE
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:856

  SYSTEMATIC LITERATURE REVIEW INFORMING THE EULAR POINTS TO CONSIDER TASK FORCE ON THE INITIATION OF TARGETED THERAPIES IN PATIENTS WITH INFLAMMATORY ARTHRITIDES AND A HISTORY OF CANCER

  Sebbag E; Molina Collada J; Lauper K; Aletaha D; Askling J; Benesova K; Bertheussen H; Bitoun S; Bolek EC; Burmester GR; Canhao H; Chatzidionysiou K; Curtis J; Danlos FX; Guimaraes V; Hetland ML; Iannone F; Kostine M; Kragstrup TW; Kvien TK; Regierer A; Schulze-Koops H; Silva-Fernandez L; Szekanecz Z; Buch MH; Finckh A; Gottenberg JE
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:863

  SERONEGATIVE RHEUMATOID ARTHRITIS (RA) - IS IT REALLY RA?

  Wettersand EB; Chatzidionysiou K
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:902-903

  FACTORS ASSOCIATED WITH SURVIVAL AND DISCONTINUATION OF ANTIMALARIAL AGENTS IN SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM A SWEDISH LONGITUDINAL REGISTRY

  Walhelm T; Wirestam L; Enman Y; Parodis I; Sjowall C
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:1088.1-101088

  PREDICTORS OF NEUROPSYCHIATRIC FLARES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM FIVE PHASE III CLINICAL TRIALS OF BELIMUMAB

  Palazzo L; Lindblom J; Cetrez N; Ala H; Parodis I
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:909.2-90910

  PREDICTORS OF DE NOVO RENAL FLARES IN SYSTEMIC LUPUS ERYTHEMATOSUS - TIME TO REVISIT BELIMUMAB DOSE FOR EXTRA-RENAL DISEASE? RESULTS FROM FIVE PHASE III CLINICAL TRIALS OF BELIMUMAB

  Parodis I; Lindblom J; Cetrez N; Palazzo L; Ala H; Houssiau F; Sjowall C; Rovin BH
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:1495.3-141496

  COVID-19 VACCINE SAFETY DURING PREGNANCY IN WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS

  Giannopoulou N; Gupta L; Andreoli L; Lini D; Nikiphorou E; Aggarwal R; Agarwal V; Parodis I
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:1467.3-141468

  LOW-DOSE BELIMUMAB AND ANTIMALARIAL AGENTS PREVENT RENAL FLARES IN SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM FOUR RANDOMISED CLINICAL TRIALS

  Gomez A; Jagerback S; Sjowall C; Parodis I
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:34.1-3434

  PREDICTORS OF RENAL FLARES IN SYSTEMIC LUPUS ERYTHEMATOSUS: A POST-HOC ANALYSIS OF FOUR PHASE III CLINICAL TRIALS OF BELIMUMAB

  Jagerback S; Gomez A; Parodis I
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:540.2-54541

  BREAKTHROUGH SARS-COV-2 INFECTION IN FULLY VACCINATED PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM THE COVID-19 VACCINATION IN AUTOIMMUNE DISEASE (COVAD) STUDY

  Olsson EK; Ravichandran N; Nikiphorou E; Lindblom J; Saha S; Shaharir SS; Katchamart W; Goo PA; Traboco L; Chen YM; Jagtap K; Lilleker JB; Nune A; Pauling J; Wincup C; Agarwal V; Dzifa D; Toro Gutierrez CE; Vinicio Caballero C; Chinoy H; Agarwal V; Aggarwal R; Gupta L; Parodis I
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:56.1-5656

  PREVALENCE, CHARACTERISTICS, AND PREDICTORS OF BREAKTHROUGH COVID-19 INFECTIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS: DATA FROM THE COVID-19 VACCINATION IN AUTOIMMUNE DISEASE (COVAD) STUDY

  Ravichandran N; Parodis I; Gupta L; Katsuyuki Shinjo S; Ziade N; Milchert M; Cavagna L; Tan AL; Lilleker JB; Nune A; Pauling J; Wincup C; Katchamart W; Goo PA; Study C; Chinoy H; Aggarwal R; Agarwal V; Nikiphorou E
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:375-376

  POST COVID-19 SYNDROME IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES: RESULTS FROM THE COVAD STUDY

  Sen P; Ravichandran N; Joshi M; Saha S; Jagtap K; Agarwal V; Distler O; Nikiphorou E; Tan AL; Shinjo SK; Ziade N; Velikova T; Milchert M; Parodis I; Gracia-Ramos AE; Cavagna L; Kuwana M; Knitza J; Makol A; Patel A; Pauling J; Wincup C; Barman B; Zamora-Tehozol EA; Rojas-Serrano J; Garcia-De La Torre I; Colunga-Pedraza IJ; Merayo-Chalico J; Katchamart W; Goo PA; Chen YM; Hoff LS; Kibbi L; Halabi H; Vaidya B; Shaharir SS; Shumnalieva R; Hasan ATMT; Dzifa D; Toro Gutierrez CE; Vinicio Caballero C; Lilleker JB; Salim B; Gheita TA; Chatterjee T; Nune A; Saavedra MA; Day J; Chinoy H; Agarwal V; Aggarwal R; Gupta L
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:952-953

  IMPAIRED HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES: A CROSS-SECTIONAL ANALYSIS FROM AN INTERNATIONAL SURVEY

  Yoshida A; Li Y; Maroufy V; Kuwana M; Ravichandran N; Makol A; Sen P; Lilleker JB; Agarwal V; Kardes S; Day J; Milchert M; Joshi M; Gheita TA; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; Nikiphorou E; Tan AL; Nune A; Cavagna L; Saavedra MA; Katsuyuki Shinjo S; Ziade N; Knitza J; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:942-943

  MULTIMORBIDITY AND PROMIS HEALTH OUTCOMES IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES: DATA FROM A LARGE, GLOBAL E-SURVEY (COVAD STUDY)

  Fornaro M; Venerito V; Iannone F; Ravichandran N; Nikiphorou E; Joshi M; Tan AL; Saha S; Shinjo SK; Agarwal V; Ziade N; Velikova T; Jagtap K; Milchert M; Parodis I; Gracia-Ramos AE; Cavagna L; Kuwana M; Knitza J; Makol A; Dzifa D; Toro Gutierrez CE; Vinicio Caballero C; Distler O; Day J; Study C; Chinoy H; Agarwal V; Aggarwal R; Gupta L
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:555-556

  COMORBIDITIES, COMPLEX MULTIMORBIDITY AND PROMIS HEALTH OUTCOMES AMONGAUTOIMMUNE RHEUMATIC DISEASES: DATA FROM THE COVAD STUDY

  Gupta L; Ravichandran N; Venerito V; Dey M; Sen P; Saha S; Tan AL; Shinjo SK; Agarwal V; Joshi M; Ziade N; Velikova T; Jagtap K; Milchert M; Parodis I; Gracia-Ramos AE; Cavagna L; Kuwana M; Knitza J; Makol A; Dzifa D; Gutierrez CET; Caballero CV; Distler O; Day J; Chinoy H; Aggarwal R; Agarwal V; Nikiphorou E
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:948

  PATIENT GLOBAL ASSESSMENT AND INFLAMMATORY MARKERS IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES - A LONGITUDINAL STUDY FROM THE MYONET COHORT

  Lodin K; Espinosa-Ortega F; Dastmalchi M; Alexanderson H; Vencovsky J; Andersson H; Chinoy H; Lilleker JB; Krogh NS; New RP; Katsuyuki Shinjo S; Maurer B; Griger Z; Tavor Y; Ceribelli A; Gomez D; Vazquez-Del Mercado Espinosa M; Leonard D; Erler A; Lundberg IE
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:47

  CHRONIC TENOSYNOVITIS IS ASSOCIATED WITH LOSS OF GRIP STRENGTH IN PATIENTS WITH PSORIASIS AND PSORIATIC ARTHRITIS

  Bayat S; Coppers B; Kleyer A; Godonou ET; Valor L; Simon D; Fagni F; Corte G; Schoenau V; Tascilar K; Hueber A; Sticherling M; Schett G; Liphardt AM
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:1763-1764

  CHANGES IN SERUM CYTOKINES AND COLLAGEN PROTEINS CORRELATE WITH DURABILITY OF GUSELKUMAB EFFICACY AND CONTINUED DISEASE IMPROVEMENT THROUGH 2 YEARS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS

  Siebert S; Schett G; Raychaudhuri SP; Guma M; Chen W; Gao S; Chakravarty SD; Shawi M; Rahman P
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:406-407

  INDIVIDUALS AT RISK FOR RHEUMATOID ARTHRITIS - SELF MONITORING OF SYMPTOMS USING A DIGITAL APPLICATION ENABLES IDENTIFICATION OF HIGH RISK PATIENTS - RESULTS FROM THE PROSPECTIVE REMTORA TRIAL

  Pfeuffer N; Knitza J; Grahammer M; Simon D; Hartmann F; Schuster L; Tascilar K; Kroenke G; Schett G; Kleyer A
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:300-301

  BONE DENSITY, MICROSTRUCTURE AND BIOMECHANICS OVER A 7-YEAR OBSERVATION PERIOD IN RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS - INFLUENCE OF AUTOIMMUNITY, DISEASE ACTIVITY AND BIOLOGICAL DMARD TREATMENT

  Kemenes S; Tascilar K; Kleyer A; Minopoulou I; Fagni F; Zekovic A; Isnardi CA; Liphardt AM; Bayat S; Schuster L; Schett G; Simon D
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:1262-1263

  SERUM LEVELS OF INTERLEUKIN-36. TO DISTINGUISH BEHCET'S SYNDROME AND PSORIATIC ARTHRITIS

  Bettiol A; Fagni F; Mattioli I; Bagni G; Vitiello G; Grassi A; Della Bella C; Benagiano M; Troilo A; Holownia KS; Simon D; Argento FR; Sota J; Fabiani C; Becatti M; Fiorillo C; Schett G; Lopalco G; Cantarini L; Prisco D; Silvestri E; Emmi G; D'elios MM
• Editorial comment: ARTHRITIS & RHEUMATOLOGY. 2023;75(6):1072

  Clinical Images: Increased bone metabolism in secondary hyperparathyroidism

  Valor-Mendez L; Atzinger A; Reis P; Manger B; Schett G
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:1456-1458

  EVALUATING GLOBAL PATTERNS IN TREATMENT AND PREVALENCE OF COMORBIDITIES IN SYSTEMIC LUPUS ERYTHEMATOSUS

  Holloway A; Lee SY; Nikiphorou E; Parodis I; Ravichandran N; Day J; Joshi M; Saha S; Shaharir SS; Katchamart W; Goo PA; Traboco L; Chen YM; Sen P; Lilleker JB; Nune A; Pauling J; Tan AL; Ziade N; Milchert M; Gracia-Ramos AE; Vinicio Caballero C; Agarwal V; Aggarwal R; Gupta L; Wincup C
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:56-57

  COVID-19 VACCINE SAFETY DURING PREGNANCY AND BREASTFEEDING IN WOMEN WITH AUTOIMMUNE DISEASES: RESULTS FROM THE COVAD STUDY

  Andreoli L; Lini D; Schreiber K; Sen P; Ravichandran N; Parodis I; Toro Gutierrez CE; Katchamart W; Goo PA; Shumnalieva R; Chibuzo OC; Velikova T; Day J; Joshi M; Katsuyuki Shinjo S; Gracia-Ramos AE; Cavagna L; Kuwana M; Knitza J; Makol A; Chen YM; Study C; Chinoy H; Agarwal V; Aggarwal R; Gupta L
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:2053-2054

  RISK FACTORS FOR DEVELOPING RHEUMATIC IMMUNE-RELATED ADVERSE EVENTS AFTER IMMUNOTHERAPY WITH IMMUNE CHECKPOINT INHIBITORS

  Liapi M; Chatzidionysiou K
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:533.1-53533

  THE IMPACT OF IMMUNOMODULATING TREATMENT ON THE SEROLOGICAL IMMUNOGENICITY FOLLOWING THREE DOSES OF COVID-19 VACCINE AND PERSISTENCE OF IMMUNOGENICITY OF TWO VACCINE DOSES IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES - A SWEDISH STUDY (COVID19-REUMA)

  Frodlund M; Nived P; Chatzidionysiou K; Sodergren A; Klingberg E; Hansson M; Pin E; Klareskog L; Kapetanovic MC
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:71.2-7171

  SYNOVIAL IMPRINTING OF SKIN-DERIVED IMMUNE CELLS INITIATES SPREADING OF INFLAMMATION FROM SKIN TO JOINT IN PSORIATIC ARTHRITIS

  Raimondo MG; Rauber S; Mohammadian H; Vogg M; Xu C; Rigau AR; Luber M; Labinsky H; Soare A; Distler J; Fearon U; Veale D; Sticherling M; Canete JDD; Schett G; Ramming A
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:1126.2-111127

  DOMAINS IMPACTING MINIMAL DISEASE ACTIVITY NON-ACHIEVEMENT IN PATIENTS WITH PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO TNFI RECEIVING GUSELKUMAB (COSMOS)

  Coates L; Selmi C; Schett G; Richette P; Ramirez J; Noel W; Rampakakis E; Zimmermann M; Sharaf M; Mcgonagle D
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:215.1-21216

  DOES SUBJECTIVELY PERCEIVED LOSS OF HAND FUNCTION SUFFICIENTLY REPRESENT ULTRASONOGRAPHY-DETECTED SYNOVITIS AND TENOSYNOVITIS IN PATIENTS WITH PSORIASIS AND PSORIATIC ARTHRITIS?

  Coppers B; Bayat S; Godonou ET; Valor L; Simon D; Fagni F; Corte G; Tascilar K; Hueber A; Schonau V; Sticherling M; Schett G; Kleyer A; Liphardt AM
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:758.1-75759

  AUTOMATIC SCORING OF EROSION, SYNOVITIS AND BONE OEDEMA IN RHEUMATOID ARTHRITIS USING DEEP LEARNING ON HAND MAGNETIC RESONANCE IMAGING

  Schlereth M; Kleyer A; Utz J; Folle L; Bayat S; Fagni F; Minopoulou I; Tascilar K; Taubmann J; Uder M; Heimann T; Qiu J; Schett G; Breininger K; Simon D
• Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023;24(10):8817

  Serum Interleukin-36 α as a Candidate Biomarker to Distinguish Behcet's Syndrome and Psoriatic Arthritis

  Bettiol A; Fagni F; Mattioli I; Bagni G; Vitiello G; Grassi A; Della Bella C; Benagiano M; Troilo A; Holownia KS; Simon D; Argento FR; Sota J; Fabiani C; Becatti M; Fiorillo C; Schett G; Lopalco G; Cantarini L; Prisco D; Silvestri E; Emmi G; D'Elios MM
• Article: VACCINE. 2023;41(20):3247-3257

  The impact of immunomodulating treatment on the immunogenicity of COVID-19 vaccines in patients with immune-mediated inflammatory rheumatic diseases compared to healthy controls. A Swedish nationwide study (COVID19-REUMA)

  Frodlund M; Nived P; Chatzidionysiou A; Sodergren A; Klingberg E; Bengtsson A; Hansson M; Olsson S; Pin E; Klareskog L; Kapetanovic MC
• Article: BMC HEALTH SERVICES RESEARCH. 2023;23(1):463

  Mind the gap: analysis of two pilot projects of a home telehealth service for persons with complex conditions in a Swedish hospital

  Sacchi C; Andersson K; Roczniewska M; Luckhaus JL; Malmqvist M; Rodmalm LP; Lodin K; Mosson R; Danapfel P; Wannheden C; Mazzocato P
• Thesis / dissertation: 2023

  Risk factors and outcomes in inflammatory myopathies

  Leclair, Valérie
• Letter: RHEUMATOLOGY. 2023;62(5):e147-e152

  Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study

  Dey M; Naveen R; Nikiphorou E; Sen P; Saha S; Lilleker JB; Agarwal V; Kardes S; Day J; Milchert M; Joshi M; Gheita T; Salim B; Velikova T; Edgar Gracia-Ramos A; Parodis I; Selva O'Callaghan A; Kim M; Chatterjee T; Tan AL; Makol A; Nune A; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Kuwana M; Distler O; Barman B; Singh YP; Ranjan R; Jain A; Pandya SC; Pilania RK; Sharma A; Manoj MM; Gupta V; Kavadichanda CG; Patro PS; Ajmani S; Phatak S; Goswami RP; Chowdhury AC; Mathew AJ; Shenoy P; Asranna A; Bommakanti KT; Shukla A; Pande AR; Chandwar K; Pauling JD; Wincup C; Cansu DU; Zamora Tehozol EA; Rojas Serrano J; Garcia-De La Torre I; Del Papa N; Sambataro G; Fabiola A; Govoni M; Parisi S; Bartoloni Bocci E; Sebastiani GD; Fusaro E; Sebastiani M; Quartuccio L; Franceschini F; Sainaghi PP; Orsolini G; De Angelis R; Danielli MG; Venerito V; Traboco LS; Hoff LS; Kusumo Wibowo SA; Tomaras S; Langguth D; Limaye V; Needham M; Srivastav N; Yoshida A; Nakashima R; Sato S; Kimura N; Kaneko Y; Loarce-Martos J; Prieto-Gonzalez S; Gil-Vila A; Aranega Gonzalez R; Chinoy H; Agarwal V; Aggarwal R; Gupta L
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2023;82(5):646-657

  Microglia activation in the presence of intact blood-brain barrier and disruption of hippocampal neurogenesis via IL-6 and IL-18 mediate early diffuse neuropsychiatric lupus

  Nikolopoulos D; Manolakou T; Polissidis A; Filia A; Bertsias G; Koutmani Y; Boumpas DT
• Article: KIDNEY INTERNATIONAL. 2023;103(5):973-985

  Identification of proteinase 3 autoreactive CD4+T cells and their T-cell receptor repertoires in antineutrophil cytoplasmic antibody-associated vasculitis

  Sharma RK; Yoosuf N; Afonso M; Scheffschick A; Avik A; Bartoletti A; Horuluoglu B; Boada JSD; Boddul SK; Jonasdottir AD; Lovstrom B; Brauner H; Raposo B; Chemin K; Bruchfeld A; Gunnarsson I; Malmstrom V
• Article: ARTHRITIS & RHEUMATOLOGY. 2023;75(5):768-781

  Identification of a Distinct Monocyte-Driven Signature in Systemic Sclerosis Using Biophysical Phenotyping of Circulating Immune Cells

  Matei A-E; Kubankova M; Xu L; Gyoerfi A-H; Boxberger E; Soteriou D; Papava M; Prater J; Hong X; Bergmann C; Kraeter M; Schett G; Guck J; Distler JHW
• Journal article: RHEUMATOLOGY. 2023;62(Supplement_2)

  P065 Post COVID-19 Syndrome in patients with autoimmune rheumatic diseases: Results from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) study

  Gupta L; Sen P; Naveen R; Joshi M; Saha S; Jagtap K; Agarwal V; Distler O; Nikiphorou E; Tan AL; Shinjo SK; Ziade N; Milchert M; Parodis I; Kuwana M; Makol A; Pauling JD; Wincup C; Lilleker J; Nune A; Day J; Chinoy H; Agarwal V; Aggarwal R
• Journal article: RHEUMATOLOGY. 2023;62(Supplement_2)

  OA29 Flares following COVID-19 vaccination in patients with idiopathic inflammatory myopathies: combined analysis from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) studies

  Gupta L; Naveen R; Griger Z; Agarwal V; Sen P; Joshi M; Saha S; Jagtap K; Distler O; Nikiphorou E; Tan AL; Shinjo SK; Ziade N; Milchert M; Parodis I; Kuwana M; Makol A; Pauling J; Wincup C; Lilleker J; Nune A; Day J; Chinoy H; Agarwal V; Aggarwal R
• Preprint: BIORXIV. 2023

  Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents infection of Omicron lineages

  Marcotte H; Cao Y; Zuo F; Simonelli L; Sammartino JC; Pedotti M; Sun R; Cassaniti I; Hagbom M; Piralla A; Yang J; Du L; Percivalle E; Bertoglio F; Schubert M; Abolhassani H; Sherina N; Guerra C; Borte S; Razaei N; Kumagai-Braesch M; Xue Y; Grönwall C; Klareskog L; Calzolai L; Cavalli A; Wang Q; Robbiani D; Hust M; Shi Z; Feng L; Svensson L; Chen L; Bao L; Baldanti F; Qin C; Xiao J; Hammarström L; Yang XL; Varani L; Xie XS; Pan-Hammarström Q
• Journal article: BMC GENOMICS. 2023;24(1):207

  Restoration of aberrant gene expression of monocytes in systemic lupus erythematosus via a combined transcriptome-reversal and network-based drug repurposing strategy

  Nikolakis D; Garantziotis P; Sentis G; Fanouriakis A; Bertsias G; Frangou E; Nikolopoulos D; Banos A; Boumpas DT
• Thesis / dissertation: 2023

  Studies on autoantibodies and inflammatory markers in patients with idiopathic inflammatory myopathies

  Espinosa Ortega, Hector Fabricio
• Article: RHEUMATOLOGY. 2023;62(4):1711-1715

  Anti-transcription intermediary factor 1-gamma IgG2 isotype is associated with cancer in adult dermatomyositis: an ENMC multinational study

  Cordel N; Dechelotte B; Jouen F; Lamb JA; Chinoy H; New P; Vencovsky J; Mann H; Galindo-Feria AS; Dani L; Selva-O'Callaghan A; Werth VP; Ravishankar A; Landon-Cardinal O; Tressieres B; Boyer O
• Article: RHEUMATOLOGY. 2023;62(4):1476-1484

  Patient-individual tapering of DMARDs in rheumatoid arthritis patients in a real-world setting

  Birkner B; Rech J; Edelmann E; Verheyen F; Schett G; Stargardt T
• Article: JOURNAL OF AUTOIMMUNITY. 2023;136:103025

  Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus

  Lindblom J; Toro-Dominguez D; Carnero-Montoro E; Beretta L; Borghi MO; Castillo J; Enman Y; Mohan C; Alarcon-Riquelme ME; Barturen G; Parodis I
• Article: AUTOIMMUNITY REVIEWS. 2023;22(4):103292

  COVID-19 vaccine safety during pregnancy in women with systemic lupus erythematosus

  Giannopoulou N; Gupta L; Andreoli L; Lini D; Nikiphorou E; Aggarwal R; Agarwal V; Parodis I
• Article: JOURNAL OF AUTOIMMUNITY. 2023;136:103022

  The human bone marrow plasma cell compartment in rheumatoid arthritis-Clonal relationships and anti-citrulline autoantibody producing cells

  Hensvold A; Horuluoglu B; Sahlstrom P; Thyagarajan R; Boada JSD; Hansson M; Mathsson-Alm L; Gerstner C; Sippl N; Israelsson L; Wedin R; Steen J; Klareskog L; Rethi B; Catrina AI; Diaz-Gallo L-M; Malmstrom V; Gronwall C
• Article: INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES. 2023;26(4):727-739

  Pain in individuals with idiopathic inflammatory myopathies, other systemic autoimmune rheumatic diseases, and without rheumatic diseases: A report from the COVAD study

  Shinjo SK; Kim M; Hoff LS; Misse RG; Sen P; Naveen R; Day J; Cordeiro RA; Goncalves Junior J; Chatterjee TB; Lilleker JB; Agarwal V; Kardes S; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; O'Callaghan AS; Nikiphorou E; Makol A; Tan AL; Cavagna LA; Saavedra MA; Ziade N; Knitza J; Kuwana M; Nune A; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L
• Article: ACR OPEN RHEUMATOLOGY. 2023;5(4):227-240

  Guselkumab, a Selective Interleukin-23 p19 Subunit Inhibitor, Resolves Dactylitis in Patients With Active Psoriatic Arthritis: Pooled Results Through Week 52 From Two Phase 3 Studies

  McGonagle D; McInnes IBB; Deodhar A; Schett G; Shawi M; Chakravarty SDD; Kollmeier APP; Xu XLL; Sheng S; Xu S; Ritchlin CTT; Rahman P; Mease PJJ
• Review: ARTHRITIS & RHEUMATOLOGY. 2023;75(4):493-498

  Concepts of Entheseal Pain

  De Lorenzis E; Natalello G; Simon D; Schett G; D'Agostino MA
• Article: ARTHRITIS & RHEUMATOLOGY. 2023;75(4):517-532

  Reset of Inflammatory Priming of Joint Tissue and Reduction of the Severity of Arthritis Flares by Bromodomain Inhibition

  Friscic J; Reinwald C; Boettcher M; Houtman M; Euler M; Chen X; Walker KI; Kirchner P; Zhu H; Wirth B; Weidner D; Krueger R; Trajkovic V; Ekici ABB; Klein K; Mougiakakos D; Ospelt C; Schett G; Hoffmann MHH
• Review: RMD OPEN. 2023;9(1):e002898

  Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study

  van der Togt CJT; van den Bemt B; Aletaha D; Alten R; Chatzidionysiou K; Galloway J; Isaac J; Mulleman D; Verschueren P; Vulto AG; Welsing PMJ; Verhoef L; den Broeder AA
• Article: RHEUMATOLOGY. 2023;62(3):1204-1215

  Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-survey

  Yoshida A; Kim M; Kuwana M; Ravichandran N; Makol A; Sen P; Lilleker JB; Agarwal V; Kardes S; Day J; Milchert M; Joshi M; Gheita T; Salim B; Velikova T; Edgar Gracia-Ramos A; Parodis I; Selva O'Callaghan A; Nikiphorou E; Chatterjee T; Tan AL; Nune A; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L
• Article: RHEUMATOLOGY. 2023;62(SI2):SI226-SI234

  Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease features

  Sherman MA; Graf R; Sabbagh SE; Galindo-Feria AS; Pinal-Fernandez I; Pak K; Kishi T; Flegel WA; Targoff IN; Miller FW; Lundberg IE; Rider LG; Mammen AL
• Article: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2023;58:152111

  Reliability and validity of PROMIS physical function, pain interference, and fatigue as patient reported outcome measures in adult idiopathic inflammatory myopathies: International study from the OMERACT myositis working group

  DiRenzo D; Saygin D; de Groot I; Bingham III CO; Lundberg IE; Needham M; Park JK; Regardt M; Sarver C; Song YW; Maxwell L; Beaton D; de Visser M; Christopher-Stine L; Mecoli CA; Alexanderson H
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2023;82(2):235-245

  Low copy numbers of complement C4 and C4A deficiency are risk factors for myositis, its subgroups and autoantibodies

  Zhou D; King EH; Rothwell S; Krystufkova O; Notarnicola A; Coss S; Abdul-Aziz R; Miller KE; Dang A; Yu GR; Drew J; Lundstrom E; Pachman LM; Mamyrova G; Curiel RV; De Paepe B; De Bleecker JL; Payton A; Ollier W; O'Hanlon TP; Targoff IN; Flegel WA; Sivaraman V; Oberle E; Akoghlanian S; Driest K; Spencer CH; Wu YL; Nagaraja HN; Ardoin SP; Chinoy H; Rider LG; Miller FW; Lundberg IE; Padyukov L; Vencovsky J; Lamb JA; Yu C-Y
• Article: LUPUS. 2023;32(2):252-262

  Urine Galectin-3 binding protein reflects nephritis activity in systemic lupus erythematosus

  Faustini F; Idborg H; Fuzzi E; Larsson A; Lie W-R; Poetzsch S; Okitsu SL; Svenungsson E; Gunnarsson I
• Article: ARTHRITIS & RHEUMATOLOGY. 2023;75(2):164-170

  Combination of Two Monoclonal Anti-Citrullinated Protein Antibodies Induced Tenosynovitis, Pain, and Bone Loss in Mice in a Peptidyl Arginine Deiminase-4-Dependent Manner

  Krishnamurthy A; Circiumaru A; Sun J; Kisten Y; Damberg P; Sakuraba K; Sandor K; Jarvoll P; Zhou T; Malmstrom V; Svensson CI; Hensvold A; Catrina AI; Klareskog L; Rethi B
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2023;82(2):e41

  Response to: 'Correspondence on 'EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups'' by Irfan et al

  Lundberg IE; Miller FW; Rider LG; Werth VP; Tjarnlund A; Bottai M
• Article: JOURNAL OF INTERNAL MEDICINE. 2023;293(2):200-211

  Familial autoimmunity in patients with idiopathic inflammatory myopathies

  Che WI; Westerlind H; Lundberg IE; Hellgren K; Kuja-Halkola R; Holmqvist ME
• Review: ARTHRITIS & RHEUMATOLOGY. 2023;75(2):153-163

  Genetic Influences in Cancer-Associated Myositis

  Patasova K; Lundberg IEE; Holmqvist M
• Journal article: LUPUS. 2023;32(2):225-230

  Relapses are common in severe hematologic systemic lupus erythematosus and may be prevented by early institution of immunosuppressive agents: Α real-life single-center study

  Moysidou G-S; Garantziotis P; Nikolopoulos D; Katsimbri P; Fanouriakis A; Boumpas DT
• Article: LAKARTIDNINGEN. 2023;120:22097

  Fanconis syndrom – en ovanlig biverkan av tenofovirdisoproxil.

  Lodin K; Rosenborg S; Hemmingsson P
• Thesis / dissertation: 2023

  Ultrasound and fluorescence optical imaging biomarkers for early diagnosis and prediction of rheumatoid arthritis

  Kisten, Yogan
• Article: FRONTIERS IN MEDICINE. 2023;10:1146353

  Molecular signature of methotrexate response among rheumatoid arthritis patients

  Brynedal B; Yoosuf N; Ulfarsdottir TB; Ziemek D; Maciejewski M; Folkersen L; Westerlind H; Mueller M; Sahlstrom P; Jelinsky SA; Hensvold A; Padyukov L; Pomiano NV; Catrina A; Klareskog L; Berg L
• Editorial comment: FRONTIERS IN PHARMACOLOGY. 2023;14:1135803

  Editorial: Disease-modifying antirheumatic drugs: Approaches and lessons learned from traditional medicine

  Mei L; Gao K; He X; Jakobsson P-J; Huang R
• Review: ANNALS OF THE RHEUMATIC DISEASES. 2023;82(1):3-18

  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update

  Smolen JS; Landewe RBM; Bergstra SA; Kerschbaumer A; Sepriano A; Aletaha D; Caporali R; Edwards CJ; Hyrich KL; Pope JE; de Souza S; Stamm TA; Takeuchi T; Verschueren P; Winthrop KL; Balsa A; Bathon JM; Buch MH; Burmester GR; Buttgereit F; Cardiel MH; Chatzidionysiou K; Codreanu C; Cutolo M; den Broeder AA; El Aoufy K; Finckh A; Fonseca JE; Gottenberg J-E; Haavardsholm EA; Iagnocco A; Lauper K; Li Z; McInnes IB; Mysler EF; Nash P; Poor G; Ristic GG; Rivellese F; Rubbert-Roth A; Schulze-Koops H; Stoilov N; Strangfeld A; van der Helm-van Mil A; van Duuren E; Vliet Vlieland TPM; Westhovens R; van der Heijde D
• Review: PATIENT RELATED OUTCOME MEASURES. 2023;14:1-13

  Impact of Belimumab on Patient-Reported Outcomes in Systemic Lupus Erythematosus: Insights from Clinical Trials and Real-World Evidence

  Gomez A; Enman Y; Parodis I
• Article: JOURNAL OF AUTOIMMUNITY. 2023;134:102951

  Autoantigenic properties of the aminoacyl tRNA synthetase family in idiopathic inflammatory myopathies

  Preger C; Notarnicola A; Hellstrom C; Wigren E; Fernandes-Cerqueira C; Kvarnstrom M; Wahren-Herlenius M; Idborg H; Lundberg IE; Persson H; Graslund S; Jakobsson P-J
• Article: RHEUMATOLOGY INTERNATIONAL. 2023;43(1):47-58

  COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey

  Hoff LS; Ravichandran N; Shinjo SK; Day J; Sen P; Junior JG; Lilleker JB; Joshi M; Agarwal V; Kardes S; Kim M; Milchert M; Makol A; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; O'Callaghan AS; Nikiphorou E; Tan AL; Chatterjee T; Cavagna L; Saavedra MA; Ziade N; Knitza J; Kuwana M; Nune A; Distler O; Cansu DU; Traboco L; Wibowo SAK; Tehozol EAZ; Serrano JR; Garcia-De La Torre I; Wincup C; Pauling JD; Chinoy H; Agarwal V; Aggarwal R; Gupta L
• Conference publication: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2023;41(2):460-462

  LONGITUDINAL ASSESSMENT OF ANTI-JO1 AUTOANTIBODY AND HISRS PROTEIN LEVELS IN A LARGE COHORT OF MYOSITIS PATIENTS

  Notarnicola A; Adams RA; Espinosa-Ortega F; Guy L; Preger C; Fernandes-Cerqueira C; Lundberg IE
• Conference publication: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2023;41(2):521-522

  PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES WHO REPORT LOW LEVELS OF PHYSICAL ACTIVITY REPORT HIGHER LEVELS OF ANXIETY AND DEPRESSION - A CROSS-SECTIONAL STUDY OF SELF-REPORTED DATA

  Andreasson KM; Sandlund H; Alexanderson H
• Editorial comment: FRONTIERS IN PHARMACOLOGY. 2023;14:1223761

  Editorial: Insights in inflammation pharmacology: 2022

  Patrignani P; Ballerini P; Jakobsson P-J; Steinhilber D
• Review: FRONTIERS IN MEDICINE. 2023;10:1217147

  Janus kinase inhibitors in systemic lupus erythematosus: implications for tyrosine kinase 2 inhibition

  Nikolopoulos D; Parodis I
• Conference publication: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2023;41(2):428

  MUSCLE T CELL SIGNATURES AND CLONALLY EXPANDED CYTOTOXIC T CELLS ARE IDENTIFIED IN IDIOPATHIC INFLAMMATORY MYOPATHIES USING SINGLE-CELL SEQUENCING

  Argyriou A; Galindo-Feria A; Horuluoglu B; Diaz-Boada JS; Notarnicola A; Dani L; Van Vol-Lenhoven A; Ramskold D; Nennesmo I; Dastmalchi M; Lundberg IE; Diaz-Gallo LM; Chemin K
• Article: FRONTIERS IN MEDICINE. 2023;10:1247354

  Obesity is associated with pain and impaired mobility despite therapy in systemic lupus erythematosus

  Borg A; Lindblom J; Gomez A; Soltani A; Enman Y; Heintz E; Regardt M; Grannas D; Emamikia S; Parodis I
• Review: RMD OPEN. 2023;9(1):e002591

  Pain in autoimmune inflammatory myopathies: a scoping review.

  Leclair V; Tsui H; Hudson M
• Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2023;52:91-92

  Patient global assessment and inflammatory markers in patients with idiopathic inflammatory myopathies - a longitudinal study

  Lodin K; Espinosa-Ortegal F; Dastmalchil M; Vencovsky J; Andersson H; Chinoy H; Lilleker J; Krogh NS; Shinjo SK; Maurer B; Griger Z; Tavor Y; Ceribelli A; Torres-Ruiz J; Vazquez-Del Mercado M; Leonard D; Erler AA; Alexanderson H; Lundberg I
• Article: FRONTIERS IN IMMUNOLOGY. 2023;14:1211295

  Extended cleavage specificities of human granzymes A and K, two closely related enzymes with conserved but still poorly defined functions in T and NK cell-mediated immunity.

  Aybay E; Ryu J; Fu Z; Akula S; Enriquez EM; Hallgren J; Wernersson S; Olsson A-K; Hellman L
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:29

  EULAR POINTS TO CONSIDER ON THE INITIATION OF TARGETED THERAPIES IN PATIENTS WITH INFLAMMATORY ARTHRITIDES AND A HISTORY OF CANCER

  Sebbag E; Lauper K; Collada JM; Aletaha D; Askling J; Benesova K; Bertheussen H; Bitoun S; Bolek EC; Burmester GR; Canhao H; Chatzidionysiou K; Curtis J; Danlos FX; Guimaraes V; Hetland ML; Iannone F; Kostine M; Kragstrup TW; Kvien TK; Regierer A; Schulze-Koops H; Silva-Fernandez L; Szekanecz Z; Buch MH; Finckh A; Gottenberg JE
• Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2023;25:406-407

  HFA-PEFF scoring of new onset idiopathic inflammatory myopathy patients reveals diastolic dysfunction

  Andersson D; Lindstedt M; Da Silva C; Andreasson K; Manouras A; Lundberg IE; Alexandersson H; Faxen J
• Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2023;52:45

  Determinants of neuropsychiatric flares in patients with systemic lupus erythematosus: results from five phase Ill clinical trials of belimumab

  Palazzo L; Lindblom J; Cetrez N; Ala H; Parodis I
• Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2023;52:46

  De novo renal flares in SLE patients treated for active extra renal disease within five phase Ill clinical trials of belimumab. Implications for revisiting belimumab dose

  Parodis I; Lindblom J; Cetrez N; Palazzo L; Ala H; Houssiau F; Sjowall C; Rovin B
• Conference publication: RHEUMATOLOGY. 2023;62

  POST COVID-19 SYNDROME IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES: RESULTS FROM THE COVID-19 VACCINATION IN AUTOIMMUNE DISEASES (COVAD) STUDY

  Gupta L; Sen P; Naveen R; Joshi M; Saha S; Jagtap K; Agarwal V; Distler O; Nikiphorou E; Tan AL; Shinjo SK; Ziade N; Milchert M; Parodis I; Kuwana M; Makol A; Pauling JD; Wincup C; Lilleker J; Nune A; Day J; Chinoy H; Agarwal V; Aggarwal R
• Conference publication: RHEUMATOLOGY. 2023;62

  FLARES FOLLOWING COVID-19 VACCINATION IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES: COMBINED ANALYSIS FROM THE COVID-19 VACCINATION IN AUTOIMMUNE DISEASES (COVAD) STUDIES

  Gupta L; Naveen R; Griger Z; Agarwal V; Sen P; Joshi M; Saha S; Jagtap K; Distler O; Nikiphorou E; Tan AL; Shinjo SK; Ziade N; Milchert M; Parodis I; Kuwana M; Makol A; Pauling J; Wincup C; Lilleker J; Nune A; Day J; Chinoy H; Agarwal V; Aggarwal R
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2023;82:1110-1112

  IDENTIFYING DETERMINANTS OF FAVOURABLE AND POOR PHYSICAL FUNCTION IN SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM AN INTERNATIONAL COLLABORATIVE STUDY

  Lee SY; Holloway A; Nikiphorou E; Parodis I; Ravichandran N; Day J; Joshi M; Saha S; Jagtap K; Katchamart W; Goo PA; Vaidya B; Velikova T; Sen P; Katsuyuki Shinjo S; Agarwal V; Tan AL; Ziade N; Milchert M; Gracia-Ramos AE; Vinicio Caballero C; Chinoy H; Agarwal V; Aggarwal R; Gupta L; Wincup C
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2023;75:241-244

  COVID-19 Vaccination-related Delayed Adverse Events Among Patients with Systemic Lupus Erythematosus: Results from the COVAD Study

  Fathima M; Doskaliuk B; Lindblom J; Nikiphorou E; Wincup C; Saha S; Shaharir SS; Katchamart W; Goo PA; Traboco L; Chen Y-M; Jagtap K; Lilleker J; Nune A; Pauling J; Agarwal V; Dzifa D; Toro Gutierrez CE; Vinicio Caballero C; Chinoy H; Aggarwal R; Agarwal V; Gupta L; Parodis I
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2023;75:260-262

  New-Onset Systemic Autoimmune Diseases Following COVID-19 Vaccination - Results from the COVAD Study

  Shumnalieva R; Hannah J; Roy D; Naveen R; Javaid M; Gonzalez D; Joshi M; Gracia-Ramos AE; Cavagna L; Sen P; Day J; Saha S; Parodis I; Nikiphorou E; Kadam E; Knitza J; Aggarwal R; Agarwal V; Gupta L
• Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2023;52:97-98

  Self-reported levels of physical activity and the association to pain, fatigue, anxiety and depression among patients with idiopathic inflammatory myopathies

  Andreasson K; Ortega FE; Sandlund H; Alexanderson H
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2023;75:276-277

  Self-reported Levels of Physical Activity and the Association to Pain, Fatigue, Anxiety and Depression Among Patients with Idiopathic Inflammatory Myopathies

  Andreasson K; Espinosa-Ortega F; Sandlund H; Alexanderson H
• Journal article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2023;41(1):74-81

  From first symptoms to diagnosis of systemic lupus erythematosus: mapping the journey of patients in an observational study

  Kapsala NN; Nikolopoulos DS; Flouda SP; Chavatza AP; Tseronis DD; Aggelakos MD; Katsimbri PP; Bertsias GK; Fanouriakis AC; Boumpas DT
• Article: FRONTIERS IN IMMUNOLOGY. 2023;14:1203848

  A network-based approach reveals long non-coding RNAs associated with disease activity in lupus nephritis: key pathways for flare and potential biomarkers to be used as liquid biopsies

  Sentis G; Loukogiannaki C; Malissovas N; Nikolopoulos D; Manolakou T; Flouda S; Grigoriou M; Banos A; Boumpas DTT; Filia A
• Article: RMD OPEN. 2023;9(1):e002705

  Antibodies against citrullinated proteins of IgA isotype are associated with progression to rheumatoid arthritis in individuals at-risk

  Sokolova MV; Hartmann F; Sieghart D; Bang H; Steiner G; Kleyer A; Schett G; Steffen U
• Article: DIAGNOSTICS. 2023;13(1):148

  An AI-Powered Clinical Decision Support System to Predict Flares in Rheumatoid Arthritis: A Pilot Study

  Labinsky H; Ukalovic D; Hartmann F; Runft V; Wichmann A; Jakubcik J; Gambel K; Otani K; Morf H; Taubmann J; Fagni F; Kleyer A; Simon D; Schett G; Reichert M; Knitza J
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2023;75:2294-2296

  Relapse Rate After Glucocorticoid-free Remission in Idiopathic Inflammatory Myopathies with Validation of the International Myositis Assessment & Clinical Studies Group (IMACS) Criteria for Remission and Relapse

  Tsuji H; Espinosa-Ortega F; Dastmalchi M; Lundberg I; Lodin K
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2023;75:4882-4884

  Mitochondrial-Mediated Neutrophil Activation in Dermatomyositis (DM) and Inclusion Body Myositis (IBM): Insights into Pathogenesis and Therapeutic Implications

  Gonzalez-Chapa JA; Albayda J; Horuluoglu B; Michailidou D; Macedo MB; Christopher-Stine L; Lundberg I; Lood C
• Review: THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE. 2023;15:1759720x231192315

  Application of clinical and molecular profiling data to improve patient outcomes in psoriatic arthritis

  FitzGerald O; Behrens F; Barton A; Bertheussen H; Boutouyrie-Dumont B; Coates L; Davies O; de Wit M; Fagni F; Goodyear CS; Gurke R; Hahnefeld L; Huppertz C; Ioannidis V; Ibberson M; Katz A; Klippstein M; Koehm M; Korish S; Mackay S; Martin DA; O'Sullivan D; Patel K; Rueping S; Schett G; Scholich K; Schwenk JM; Siebert S; Simon D; Vivekanantham A; Pennington SR
• Conference publication: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2023;41(2):418

  ANTI-FHL1 AUTOANTIBODIES IN ADULT MYOSITIS PATIENTS: BASELINE AND LONGITUDINAL FOLLOW-UP ANALYSIS

  Galindo-Feria AS; Lodin K; Horuluoglu B; Sarrafzadeh-Zargar S; Wigren E; Graslund S; Danielsson O; Mohammad AJ; Leonard D; Sjowall C; Husmark T; Hemberg M; Puksic S; Lappas T; Hanna B; Wahren-Herlenius M; Dastmalchi M; Lundberg IE
• Editorial comment: THE LANCET RHEUMATOLOGY. 2023;5(1):E4-E6

  Molecular signature-based decision making in the era of targeted therapies for systemic lupus erythematosus

  Parodis I
• Editorial comment: INNERE MEDIZIN (GERMANY). 2023;64(3):276

  Rheumatologist Georg Schett receives Leibniz Prize 2023
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2023;75:4092-4093

  Integration of Basic Science into Virtual Patient Cases to Enhance Clinical Reasoning Skills

  Rombo K; Borg A; Parodis I
• Article: FRONTIERS IN IMMUNOLOGY. 2023;14:1251034

  Transcriptomic characterization of classical monocytes highlights the involvement of immuno-inflammation in bone erosion in Rheumatoid Arthritis

  Sales LP; Hounkpe BW; Perez MO; Caparbo VF; Domiciano DS; Borba EF; Schett G; Figueiredo CP; Pereira RMR
• Article: FRONTIERS IN IMMUNOLOGY. 2023;14:1174537

  Suppression of neutrophils by sodium exacerbates oxidative stress and arthritis

  Zlatar L; Mahajan A; Munoz-Becerra M; Weidner D; Bila G; Bilyy R; Titze J; Hoffmann MH; Schett G; Herrmann M; Steffen U; Munoz LE; Knopf J
• Article: FRONTIERS IN PHARMACOLOGY. 2023;14:1183720

  The multiple functions of miR-574-5p in the neuroblastoma tumor microenvironment

  Proestler E; Donzelli J; Nevermann S; Breitwieser K; Koch LF; Best T; Fauth M; Wickstrom M; Harter PN; Kogner P; Lavieu G; Larsson K; Saul MJ
• Article: PLOS ONE. 2023;18(12):e0295838

  Anakinra or tocilizumab in patients admitted to hospital with severe covid-19 at high risk of deterioration (IMMCoVA): A randomized, controlled, open-label trial

  Sunden-Cullberg J; Chen P; Habel H; Skorup P; Janols H; Rasmuson J; Niward K; Balkhed AO; Chatzidionysiou K; Asgeirsson H; Blennow O; Parke A; Svensson A-K; Muvva JR; Ljunggren H-G; Horne A-C; Aden U; Henter J-I; Sonnerborg A; Vesterbacka J; Nowak P; Lampa J
• Article: FRONTIERS IN IMMUNOLOGY. 2023;14:1257085

  Serum profiling identifies CCL8, CXCL13, and IL-1RA as markers of active disease in patients with systemic lupus erythematosus

  Lindblom J; Beretta L; Borghi MO; Alarcon-Riquelme ME; Parodis I
• Article: RHEUMATOLOGY. 2022;62(1):65-76

  COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study

  Sen P; Ravichandran N; Nune A; Lilleker JB; Agarwal V; Kardes S; Kim M; Day J; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; O'Callaghan AS; Nikiphorou E; Chatterjee T; Tan AL; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Kuwana M; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L
• Thesis / dissertation: 2022

  Studies on anti-inflammatory and vasoactive effects of mPGES-1 inhibition

  Steinmetz-Späh, Julia
• Article: JOURNAL OF LIPID RESEARCH. 2022;63(12):100310

  Biosynthesis of prostaglandin 15dPGJ₂ -glutathione and 15dPGJ₂-cysteine conjugates in macrophages and mast cells via MGST3

  Steinmetz-Spah J; Liu J; Singh R; Ekoff M; Boddul S; Tang X; Bergqvist F; Idborg H; Heitel P; Ronnberg E; Merk D; Wermeling F; Haeggstrom JZ; Nilsson G; Steinhilber D; Larsson K; Korotkova M; Jakobsson P-J
• Article: JOURNAL OF AUTOIMMUNITY. 2022;133:102903

  Autoantibodies targeting malondialdehyde-modifications in rheumatoid arthritis regulate osteoclasts via inducing glycolysis and lipid biosynthesis

  Sakuraba K; Krishnamurthy A; Sun J; Zheng X; Xu C; Peng B; Engstrom M; Jakobsson P-J; Wermeling F; Catrina S; Gronwall C; Catrina AI; Rethi B
• Article: RHEUMATOLOGY INTERNATIONAL. 2022;42(12):2151-2158

  COVAD survey 2 long-term outcomes: unmet need and protocol

  Fazal ZZ; Sen P; Joshi M; Ravichandran N; Lilleker JB; Agarwal V; Kardes S; Kim M; Day J; Makol A; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; Nikiphorou E; Tan AL; Chatterjee T; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Selva-O'Callaghan A; Nune A; Knitza J; Kuwana M; Toro Gutierrez C-E; Vinicio Caballero-Uribe C; Dey D; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L
• Journal article: INDIAN JOURNAL OF ENDOCRINOLOGY AND METABOLISM. 2022;26(Suppl 8):s71

  Abstract 167

  Chatterjee T; Naveen R; Gracia-Ramos AE; Barman B; Sen P; Joshi M; Saha S; Nune A; Pande A; Velikova T; Parodis I; Tan AL; Shinjo SK; Boro H; Agarwal V; Aggarwal R; Gupta L
• Article: RHEUMATOLOGY. 2022;61(12):4991-4996

  ELISA, protein immunoprecipitation and line blot assays for anti-TIF1-gamma autoantibody detection in cancer-associated dermatomyositis

  Selickaja S; Galindo-Feria AS; Dani L; Mimori T; Ronnelid J; Holmqvist M; Lundberg IE; Venalis P
• Article: RHEUMATOLOGY. 2022;61(12):4752-4762

  Impact of remission and low disease activity on health-related quality of life in patients with systemic lupus erythematosus

  Emamikia S; Oon S; Gomez A; Lindblom J; Borg A; Enman Y; Morand E; Grannas D; van Vollenhoven RF; Nikpour M; Parodis I
• Editorial comment: JOURNAL OF CLINICAL MEDICINE. 2022;11(22):6869

  Clinical Heterogeneity, Unmet Needs and Long-Term Outcomes in Patients with Systemic Lupus Erythematosus

  Sjowall C; Parodis I
• Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022;23(22):13941

  B Cell Kinetics upon Therapy Commencement for Active Extrarenal Systemic Lupus Erythematosus in Relation to Development of Renal Flares: Results from Three Phase III Clinical Trials of Belimumab

  Parodis I; Gomez A; Lindblom J; Chow JW; Sjowall C; Sciascia S; Gatto M
• Article: RHEUMATIC DISEASE CLINICS OF NORTH AMERICA. 2022;48(4):861-874

  Environmental Risks for Inflammatory Myopathies

  Che WI; Lundberg IE; Holmqvist M
• Review: JOURNAL OF INTERNAL MEDICINE. 2022;292(5):745-763

  Where traditional Chinese medicine meets Western medicine in the prevention of rheumatoid arthritis

  Jakobsson P-J; Robertson L; Welzel J; Zhang M; Yang Z; Gao K; Huang R; Wen Z; Korotkova M; Goransson U
• Article: AUTOIMMUNITY REVIEWS. 2022;21(11):103188

  Do biological agents improve health-related quality of life in patients with systemic lupus erythematosus? Results from a systematic search of the literature

  Gomez A; Parodis I
• Review: JOURNAL OF INTERNAL MEDICINE. 2022;292(5):717-732

  An update on polymyalgia rheumatica

  Lundberg IE; Sharma A; Turesson C; Mohammad AJ
• Article: SCIENCE ADVANCES. 2022;8(43):eabo5840

  ATR-mediated DNA damage responses underlie aberrant B cell activity in systemic lupus erythematosus

  Manolakou T; Nikolopoulos D; Gkikas D; Filia A; Samiotaki M; Stamatakis G; Fanouriakis A; Politis P; Banos A; Alissafi T; Verginis P; Boumpas DT
• Article: CELLS. 2022;11(20):3330

  High-Dimensional Cytometry Dissects Immunological Fingerprints of Idiopathic Inflammatory Myopathies

  Nelke C; Pawlitzki M; Schroeter CB; Huntemann N; Dobelmann V; Preusse C; Roos A; Allenbach Y; Benveniste O; Wiendl H; Lundberg IE; Stenzel W; Meuth SG; Ruck T
• Article: SCIENTIFIC REPORTS. 2022;12(1):17671

  Impaired muscle strength is associated with ultrastructure damage in myositis

  Aguilar-Vazquez A; Chavarria-Avila E; Salazar-Paramo M; Armendariz-Borunda J; Toriz-Gonzalez G; Rodriguez-Baeza M; Sandoval-Rodriguez A; Villanueva-Perez A; Godinez-Rubi M; Medina-Preciado J-D; Lundberg I; Lozano-Torres Y; Gomez-Rios C-A; Pizano-Martinez O; Martinez-Garcia E-A; Martin-Marquez B-T; Duran-Barragan S; Palacios-Zarate B-L; Llamas-Garcia A; Gomez-Limon L; Vazquez-Del Mercado M
• Article: RHEUMATOLOGY. 2022;61(10):3952-3962

  Effectiveness of baricitinib and tofacitinib compared with bDMARDs in RA: results from a cohort study using nationwide Swedish register data

  Barbulescu A; Askling J; Chatzidionysiou K; Forsblad-d'Elia H; Kastbom A; Lindstrom U; Turesson C; Frisell T
• Article: RHEUMATOLOGY. 2022;61(10):4076-4086

  Myositis-Specific Autoantibodies and QTc Changes by ECG in Idiopathic Inflammatory Myopathis

  Korsholm SS; Andersson DC; Knudsen JB; Dastmalchi M; Diederichsen ACP; Gerke O; Witting N; Jacobsen S; Pecini R; Friis T; Krogager ME; Lundberg IE; Diederichsen L
• Article: RHEUMATOLOGY. 2022;61(10):4145-4154

  Autoantibodies against four-and-a-half-LIM domain 1 (FHL1) in inflammatory myopathies: results from an Australian single-centre cohort

  Galindo-Feria AS; Horuluoglu B; Day J; Fernandes-Cerqueira C; Wigren E; Graslund S; Proudman S; Lundberg IE; Limaye V
• Journal article: EUROPEAN HEART JOURNAL. 2022;43(Supplement_2):ehac544.822

  Left ventricular dysfunction in a cohort of new onset idiopathic inflammatory myopathy without known heart disease

  Lindstedt M; Andreasson K; Da Silva C; Manouras A; Alexanderson H; Andersson DC
• Article: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2022;56:152050

  Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: A multinational real-world cohort analysis.

  Yang C; Williams RD; Swerdel JN; Almeida JR; Brouwer ES; Burn E; Carmona L; Chatzidionysiou K; Duarte-Salles T; Fakhouri W; Hottgenroth A; Jani M; Kolde R; Kors JA; Kullamaa L; Lane J; Marinier K; Michel A; Stewart HM; Prats-Uribe A; Reisberg S; Sena AG; Torre CO; Verhamme K; Vizcaya D; Weaver J; Ryan P; Prieto-Alhambra D; Rijnbeek PR
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2022;81(10):1409-1419

  Cross-species transcriptome analysis for early detection and specific therapeutic targeting of human lupus nephritis

  Frangou E; Garantziotis P; Grigoriou M; Banos A; Nikolopoulos D; Pieta A; Doumas SA; Fanouriakis A; Hatzioannou A; Manolakou T; Alissafi T; Verginis P; Athanasiadis E; Dermitzakis E; Bertsias G; Filia A; Boumpas DT
• Article: MUSCLE AND NERVE. 2022;66(4):426-437

  COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathies

  Gil-Vila A; Ravichandran N; Selva-O'Callaghan A; Sen P; Nune A; Gaur PS; Gonzalez RA; Lilleker JB; Joshi M; Agarwal V; Kardes S; Kim M; Day J; Makol A; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; Nikiphorou E; Tan AL; Chatterjee T; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Kuwana M; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L
• Article: RMD OPEN. 2022;8(2):e002465

  Risk of lung cancer in rheumatoid arthritis and in relation to autoantibody positivity and smoking

  Chatzidionysiou K; di Giuseppe D; Soderling J; Catrina A; Askling J
• Conference publication: 2022;:a33.1-a3a33

  PO.1.21 Attainment of EQ-5D-3L full health state after therapy is associated with decelerated organ damage accrual in systemic lupus erythematosus

  Lindblom J; Zetterberg S; Borg A; Emamikia S; Von Perner G; Enman Y; Heintz E; Regardt M; Grannas D; Gomez A; Parodis I
• Conference publication: 2022;:a29.1-a2a29

  PO.1.12 Transcriptome profiling and autoimmunity-related serological markers identify TP53 and C3aR as drug targets in neuropsychiatric systemic lupus erythematosus

  Lindblom J; Toro-Domínguez D; Carnero-Montoro E; Borghi M; Castillo J; Iacobaeus E; Enman Y; Repsilber D; Mohan C; Alarcón-Riquelme M; Barturen G; Parodis I
• Conference publication: 2022;:a110.2-a1a111

  PO.7.149 Associations between abnormal bmi and patient-reported health-related quality of life before and after therapeutic intervention in patients with systemic lupus erythematosus

  Borg A; Soltani A; Emamikia S; Lindblom J; Gomez A; Von Perner G; Enman Y; Heintz E; Regardt M; Grannas D; Parodis I
• Conference publication: 2022;:a109.1-a1a109

  PO.7.146 Sensitivity analysis of EQ-5D-3L index scores in relation to discriminative and known-groups validity in systemic lupus erythematosus

  Hua N; Gomez A; Lindblom J; Von Perner G; Enman Y; Regardt M; Heintz E; Emamikia S; Grannas D; Parodis I
• Conference publication: 2022;:a78.2-a7a78

  PO.5.99 Drug repurposing for treating lupus nephritis based on transcriptome profiling and autoimmunity-related serological markers

  Parodis I; Lindblom J; Toro-Domínguez D; Carnero-Montoro E; Borghi M; Castillo J; Enman Y; Repsilber D; Mohan C; Alarcón-Riquelme M; Barturen G
• Conference publication: 2022;:a7-a8

  S04.2 Medication adherence in patients with systemic lupus erythematosus: results from a Swedish survey

  Emamikia S; Gomez Gonzalez A; Ådahl T; Von Perner G; Enman Y; Chatzidionysiou K; Arkema E; Parodis I
• Conference publication: 2022;:a92

  PO.6.120 Non-pharmacological management of systemic lupus erythematosus and systemic sclerosis: a systematic literature review to inform eular recommendations

  Parodis I; Gomez A; Tsoi A; Chow J; Pezzella D; Girard C; Stamm T; Boström C
• Conference publication: 2022;:a35.2-a3a36

  PO.2.27 Early changes in the circulating B cell compartment associated with response to treatment and occurrence of flares in patients receiving therapy for active systemic lupus erythematosus

  Gatto M; Gomez Gonzales A; Lindblom J; Doria A; Parodis I
• Conference publication: 2022;:a9-a10

  S06.1 B cell kinetics upon therapy commencement for active extra-renal systemic lupus erythematosus in relation to development of renal flares

  Parodis I; Gomez A; Lindblom J; Chow J; Sjöwall C; Sciascia S; Gatto M
• Conference publication: 2022;:a109.2-a1a110

  PO.7.147 Obesity and tobacco smoking are independently associated with poor patient-reported outcomes in patients with systemic lupus erythematosus from a Swedish tertiary referral centre

  Gomez A; Parodis I; Sjöwall C
• Conference publication: 2022;:a97-a98

  PO.6.128 Factors associated with survival and discontinuation of antimalarial agents in systemic lupus erythematosus: results from a swedish longitudinal registry

  Walhelm T; Wirestam L; Parodis I; Sjöwall C
• Conference publication: 2022;:a91-a92

  PO.6.119 Low-dose belimumab and antimalarial agents prevent renal flares in systemic lupus erythematosus: results from four randomised clinical trials

  Gomez A; Jägerback S; Sjöwall C; Parodis I
• Conference publication: 2022;:a82

  PO.5.104 Evaluation of traditional laboratory markers as predictors of renal flares: a post-hoc analysis of four phase iii clinical trials of SLE

  Jägerback S; Gomez A; Parodis I
• Conference publication: 2022;:a73-a74

  PO.4.92 Taxonomy, treatment, targets and remission in systemic lupus erythematosus: the 3TR-SLE study protocol

  Parodis I; Voskuyl A; Alarcón-Riquelme M; Beretta L
• Review: JOURNAL OF CLINICAL MEDICINE. 2022;11(19):5759

  Current Insights on Biomarkers in Lupus Nephritis: A Systematic Review of the Literature

  Palazzo L; Lindblom J; Mohan C; Parodis I
• Article: JOURNAL OF CLINICAL MEDICINE. 2022;11(17):5207

  Low Serum BAFF Concentration Is Associated with Response to TNF Inhibitors in Seropositive Patients with Rheumatoid Arthritis

  Hernandez-Breijo B; Parodis I; Novella-Navarro M; Martinez-Feito A; Navarro-Compan V; Diaz-Almiron M; Pascual-Salcedo D; Balsa A; Plasencia-Rodriguez C
• Thesis / dissertation: 2022

  Characterization of immune specificities in idiopathic inflammatory myopathies

  Galindo-Feria, Angeles Shunashy
• Journal article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2022;40(9):1769-1778

  Remission or low disease activity at pregnancy onset are linked to improved foetal outcomes in women with systemic lupus erythematosus: results from a prospective observational study

  Ntali S; Nikolopoulos D; Pantazi L; Emmanouilidou E; Papagoras C; Fanouriakis A; Dimopoulou D; Kallitsakis I; Boki K; Dania V; Sidiropoulos PI; Boumpas DT; Bertsias G
• Article: RHEUMATOLOGY. 2022;61(9):3647-3656

  The occurrence of multiple treatment switches in axial spondyloarthritis. Results from five Nordic rheumatology registries

  Di Giuseppe D; Lindstrom U; Aaltonen K; Relas H; Provan S; Gudbjornsson B; Hetland ML; Askling J; Kauppi M; Geirsson AJ; Chatzidionysiou K; Jorgensen TS; Dreyer L; Michelsen B; Jacobsson L; Glintborg B
• Article: RHEUMATOLOGY. 2022;61(9):3596-3605

  Comparison of treatment retention of originator vs biosimilar products in clinical rheumatology practice in Sweden

  Di Giuseppe D; Lindstrom U; Bower H; Delcoigne B; Frisell T; Chatzidionysiou K; Sjowall C; Lindqvist E; Askling J
• Article: ARTHRITIS RESEARCH & THERAPY. 2022;24(1):203

  Neither low social support nor low decision latitude at work is associated with disease remission among patients with rheumatoid arthritis: results from the Swedish EIRA study

  Hedenstierna L; Hedstrom AK; Klareskog L; Di Giuseppe D; Alfredsson L; Askling J; Ernestam S; Saevarsdottir S; Ljung L
• Article: LAKARTIDNINGEN. 2022;119:22023

  [Myositis-related interstitial lung disease - a systemic autoimmune desease often overlooked].

  Lodin K; Notarnicola A; Dastmalchi M; Dani L; Mari Svensson A; Rönnelid J; Sköld M; E Lundberg I
• Review: METABOLITES. 2022;12(8):721

  Prostanoid Metabolites as Biomarkers in Human Disease

  Idborg H; Pawelzik S-C
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2022;81(8):e140

  Association of subcutaneous belimumab and long-term antimalarial treatment reduces antiphospholipid antibodies levels in systemic lupus erythematosus: post-hoc analysis of a randomised placebo-controlled trial-comment on: 'Effect of belimumab treatment on antiphospholipid antibody levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus' by Chatzidionysiou et al.

  Bettiol A; Pregnolato F; Sciascia S; Emmi G; Prisco D; Meroni PL
• Article: ARTHRITIS & RHEUMATOLOGY. 2022;74(8):1440-1450

  Complement C4 Copy Number Variation is Linked to SSA/Ro and SSB/La Autoantibodies in Systemic Inflammatory Autoimmune Diseases

  Lundtoft C; Pucholt P; Martin M; Bianchi M; Lundstrom E; Eloranta M-L; Sandling JK; Sjowall C; Jonsen A; Gunnarsson I; Rantapaa-Dahlqvist S; Bengtsson AA; Leonard D; Baecklund E; Jonsson R; Hammenfors D; Forsblad-d'Elia H; Eriksson P; Mandl T; Bucher SM; Norheim KB; Johnsen SJA; Omdal R; Kvarnstrom M; Wahren-Herlenius M; Notarnicola A; Andersson H; Molberg O; Diederichsen LP; Almlof J; Syvanen A-C; Kozyrev SV; Lindblad-Toh K; Nilsson B; Blom AM; Lundberg IE; Nordmark G; Diaz-Gallo LM; Svenungsson E; Ronnblom L
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2022;81(8):e141

  Response to: 'Association of subcutaneous belimumab and long-term antimalarial treatment reduces antiphospholipid antibodies levels in systemic lupus erythematosus: post-hoc analysis of a randomised placebo-controlled trial-comment on: 'Effect of belimumab treatment on antiphospholipid antibody levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus' by Chatzidionysiou et al' by Bettiol et al

  Chatzidionysiou K; Samoli E; Sfikakis PP; Tektonidou MG
• Journal article: RHEUMATOLOGY INTERNATIONAL. 2022;42(8):1307-1319

  Tailored treatment strategies and future directions in systemic lupus erythematosus

  Nikolopoulos D; Fotis L; Gioti O; Fanouriakis A
• Article: SCIENTIFIC REPORTS. 2022;12(1):11876

  Integrated single cell and spatial transcriptomics reveal autoreactive differentiated B cells in joints of early rheumatoid arthritis

  Hardt U; Carlberg K; af Klint E; Sahlstrom P; Larsson L; van Vollenhoven A; Machado SH; Israelsson L; Amara K; Chemin K; Korotkova M; Hedestam GBK; Catrina AI; Teichmann SA; Stahl PL; Malmstrom V
• Article: JOURNAL OF AUTOIMMUNITY. 2022;131:102857

  Modulating T-cell activation with antisense oligonucleotides targeting lymphocyte cytosolic protein 2

  Iyer VS; Boddul SV; Johnsson A-K; Raposo B; Sharma RK; Shen Y; Kasza Z; Lim KW; Chemin K; Nilsson G; Malmstrom V; Phan AT; Wermeling F
• Preprint: BIORXIV. 2022

  Autoantigenic properties of the aminoacyl tRNA synthetase family in idiopathic inflammatory myopathies

  Preger C; Notarnicola A; Hellström C; Wigren E; Fernandes-Cerqueira C; Idborg H; Lundberg IE; Persson H; Gräslund S; Jakobsson P-J
• Article: BEST PRACTICE AND RESEARCH: CLINICAL RHEUMATOLOGY. 2022;36(2):101767

  Autoantibodies: Pathogenic or epiphenomenon

  Galindo-Feria AS; Wang G; Lundberg IE
• Article: PROSTHETICS AND ORTHOTICS INTERNATIONAL. 2022;46(3):232-238

  Low health-related quality of life in adult individuals with multiple limb deficiencies compared with population-based reference values

  Alexanderson H; Frimore L; Espinosa F; Wikstrom M; Stockselius A
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2022;81:439

  CAN WE ENHANCE ADHERENCE TO MEDICATIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS? RESULTS FROM A QUALITATIVE STUDY

  Emamikia S; Gentline C; Enman Y; Parodis I
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2022;81:326

  DRUG REPURPOSING FOR TREATING LUPUS NEPHRITIS BASED ON TRANSCRIPTOME PROFILING AND AUTOIMMUNITY-RELATED SEROLOGICAL MARKERS

  Parodis I; Lindblom J; Toro-Dominguez D; Borghi MO; Enman Y; Repsilber D; Mohan C; Alarcon-Riquelme M; Barturen G
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2022;81:326

  TRANSCRIPTOME PROFILING AND AUTOIMMUNITY-RELATED SEROLOGICAL MARKERS IDENTIFY TP53 AND C3AR AS DRUG TARGETS IN NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS

  Lindblom J; Toro-Dominguez D; Borghi MO; Iacobaeus E; Enman Y; Repsilber D; Mohan C; Alarcon-Riquelme M; Barturen G; Parodis I
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2022;81:1098-1099

  SYSTEMATIC LITERATURE REVIEW TO INFORM THE EULAR TASK FORCE FOR RECOMMENDATIONS/POINTS TO CONSIDER FOR THE NON-PHARMACOLOGICAL MANAGEMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS AND SYSTEMIC SCLEROSIS

  Parodis I; Gomez A; Tsoi A; Chow JW; Pezzella D; Girard C; Stamm T; Bostrom C
• Journal article: RHEUMATOLOGY & AUTOIMMUNITY. 2022;2(2):57-68

  Anti-Jo1 autoantibodies, from clinic to the bench

  Galindo-Feria AS; Horuluoglu B; Lundberg IE
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2022;81:484.1-48484

  DISRUPTED HIPPOCAMPAL NEUROGENESIS MEDIATED BY IL-6 AND IL-18 INDUCE NEUROPSYCHIATRIC CHANGES IN MURINE LUPUS

  Nikolopoulos D; Manolakou T; Polissidis A; Filia A; Koutmani Y; Boumpas D
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2022;81:1017

  TREATMENT OF IMMUNE CHECKPOINT INHIBITOR-INDUCED INFLAMMATORY ARTHRITIS AND POLYMYALGIA RHEUMATICA

  Liapi M; Chatzidionysiou K
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2022;81:588

  RECOMMENDATIONS FOR COST-EFFECTIVE USE OF BIOLOGICAL AND TARGETED SYNTHETIC DMARDS IN INFLAMMATORY ARTHRITIS: RESULTS FROM AN INTERNATIONAL DELPHI STUDY

  Van der Togt C; Van den Bemt B; Aletaha D; Alten R; Chatzidionysiou K; Galloway J; Isaacs J; Mulleman D; Verschueren P; Vulto A; Welsing P; Verhoef LM; Den Broeder A
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2022;81:748

  HIGH FATIGUE SCORES IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES: A MULTIGROUP COMPARATIVE STUDY FROM THE COVAD E-SURVEY.

  Grignaschi S; Cavagna L; Kim M; R N; Lilleker JB; Sen P; Agarwal V; Kardes S; Day J; Makol A; Milchert M; Gheita TA; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; Selva-O'callaghan A; Nikiphorou E; Chatterjee T; Tan AL; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Kuwana M; Nune A; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2022;81:334-336

  COVID-19 SEVERITY AND VACCINE BREAKTHROUGH INFECTIONS IN IDIOPATHIC INFLAMMATORY MYOPATHIES, OTHER SYSTEMIC AUTOIMMUNE AND INFLAMMATORY DISEASES, AND HEALTHY INDIVIDUALS: RESULTS FROM THE COVID-19 VACCINATION IN AUTOIMMUNE DISEASES (COVAD) STUDY.

  Gupta L; Hoff LS; R N; Sen P; Katsuyuki Shinjo S; Day J; Lilleker JB; Agarwal V; Kardes S; Kim M; Makol A; Milchert M; Gheita TA; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; Selva-O'callaghan A; Nikiphorou E; Chatterjee T; Tan AL; Nune A; Cavagna L; Saavedra MA; Ziade N; Knitza J; Kuwana M; Distler O; Chinoy H; Agarwal V; Aggarwal R
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2022;81:105-106

  TREATMENT PATTERNS OF IDIOPATHIC INFLAMMATORY MYOPATHIES: RESULTS FROM AN INTERNATIONAL COHORT OF OVER 1,400 PATIENTS

  Aoude M; Gupta L; Hmamouchi I; Grignaschi S; Cavagna L; Kim M; R N; Lilleker JB; Sen P; Agarwal V; Kardes S; Day J; Makol A; Milchert M; Gheita TA; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; Selva-O'callaghan A; Nikiphorou E; Chatterjee T; Tan AL; Saavedra MA; Shinjo SK; Knitza J; Kuwana M; Nune A; Distler O; Chinoy H; Agarwal V; Aggarwal R; Ziade N
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2022;81:966-967

  COVID-19 VACCINATION-RELATED ADVERSE EVENTS AMONG AUTOIMMUNE DISEASE PATIENTS: RESULTS FROM THE COVID-19 VACCINATION IN AUTOIMMUNE DISEASES (COVAD) STUDY

  Sen P; R N; Nune A; Lilleker JB; Agarwal V; Kardes S; Kim M; Day J; Milchert M; Gheita TA; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; Selva-O'callaghan A; Nikiphorou E; Chatterjee T; Tan AL; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Kuwana M; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2022;81:720-722

  IMPAIRED PROMIS PHYSICAL FUNCTION IN IDIOPATHIC INFLAMMATORY MYOPATHY PATIENTS: RESULTS FROM THE MULTICENTER COVAD PATIENT REPORTED E-SURVEY

  Yoshida A; Kim M; Kuwana M; R N; Lilleker JB; Sen P; Agarwal V; Kardes S; Day J; Makol A; Milchert M; Gheita TA; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; Selva-O'callaghan A; Nikiphorou E; Chatterjee T; Tan AL; Nune A; Cavagna L; Saavedra MA; Katsuyuki Shinjo S; Ziade N; Knitza J; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2022;81:1402

  OBESITY AND TOBACCO SMOKING ARE INDEPENDENTLY ASSOCIATED WITH POOR PATIENT-REPORTED OUTCOMES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS FROM A SWEDISH TERTIARY REFERRAL CENTRE

  Gomez A; Parodis I; Sjowall C
• Journal article: BIOMACROMOLECULES. 2022;23(5):1864-1872

  New Perspectives for Developing Therapeutic Bioconjugates of Metabolite-Depleting Enzymes: Lessons Learned Combating Glutamate Excitotoxicity

  Zaghmi A; Perez-Mato M; Dopico-Lopez A; Candamo-Lourido M; Campos F; Gauthier MA
• Preprint: MEDRXIV. 2022

  Implication of DNA methylation changes at chromosome 1q21.1 in the brain pathology of Primary Progressive Multiple Sclerosis

  Pahlevan Kakhki M; Starvaggi Cucuzza C; Giordano A; Badam T; Strid P; Shchetynsky K; Harroud A; Gyllenberg A; Liu Y; Boddul S; James T; Sorosina M; Filippi M; Esposito F; Wermeling F; Gustafsson M; Casaccia P; Kockum I; Hillert J; Olsson T; Kular L; Jagodic M
• Article: RHEUMATOLOGY ADVANCES IN PRACTICE. 2022;6(2):rkac048

  Atherosclerosis in Vietnamese patients with systemic sclerosis and its relationship to disease and traditional risk factors

  Nguyen Thi Phuong T; Dao Thi T; Lundberg IE; Nguyen Huy B
• Article: EMBO REPORTS. 2022;23(5):e54096

  Helminthic dehydrogenase drives PGE₂ and IL-10 production in monocytes to potentiate Treg induction

  Prodjinotho UF; Gres V; Henkel F; Lacorcia M; Dandl R; Haslbeck M; Schmidt V; Winkler AS; Sikasunge C; Jakobsson P-J; Henneke P; Bieren JE-V; da Costa CP
• Preprint: RESEARCH SQUARE. 2022

  Peripheral blood cellular dynamics of Rheumatoid arthritis treatment informs about efficacy of response to disease modifying drugs

  Jelinsky SA; Hedman ÅK; Winter E; Yoosuf N; Benita Y; Berg L; Brynedal B; Folkersen L; Klareskog L; Maciejewski M; Sirota-Madi A; Spector Y; Ziemek D; Padyukov L; Shen-Orr SS
• Article: LIFE SCIENCES. 2022;295:120394

  Omega-3 fatty acids decrease CRYAB, production of oncogenic prostaglandin E₂ and suppress tumor growth in medulloblastoma

  Ljungblad L; Bergqvist F; Tummler C; Madawala S; Olsen TK; Andonova T; Jakobsson P-J; Johnsen JI; Pickova J; Strandvik B; Kogner P; Gleissman H; Wickstrom M
• Article: RHEUMATOLOGY. 2022;61(4):1680-1689

  Early prediction of clinical response to anti-TNF treatment using multi-omics and machine learning in rheumatoid arthritis

  Yoosuf N; Maciejewski M; Ziemek D; Jelinsky SA; Folkersen L; Muller M; Sahlstrom P; Vivar N; Catrina A; Berg L; Klareskog L; Padyukov L; Brynedal B
• Review: BIOMEDICINE & PHARMACOTHERAPY. 2022;148:112687

  Comparison of immune checkpoint inhibitor-induced arthritis and reactive arthritis to inform therapeutic strategy

  Jensen AK; Chatzidionysiou K; Torp CK; Sorensen AS; Tenstad HB; Schafer VS; Kostine M; Jacobsen S; Leipe J; Kragstrup TW
• Article: CANCER RESEARCH. 2022;82(7):1380-1395

  Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma Growth but Promotes Metastasis

  Elwakeel E; Brueggemann M; Wagih J; Lityagina O; Elewa MAF; Han Y; Froemel T; Popp R; Nicolas AM; Schreiber Y; Gradhand E; Thomas D; Nuesing R; Steinmetz-Spaeh J; Savai R; Fokas E; Fleming I; Greten FR; Zarnack K; Bruene B; Weigert A
• Article: BRITISH JOURNAL OF PHARMACOLOGY. 2022;179(7):1433-1449

  Effects of microsomal prostaglandin E synthase-1 inhibition on resistance artery tone in patients with end stage kidney disease

  Steinmetz-Spah J; Arefin S; Larsson K; Jahan J; Mudrovcic N; Wennberg L; Stenvinkel P; Korotkova M; Kublickiene K; Jakobsson P-J
• Article: JOURNAL OF CLINICAL MEDICINE. 2022;11(7):1857

  How Can We Enhance Adherence to Medications in Patients with Systemic Lupus Erythematosus? Results from a Qualitative Study

  Emamikia S; Gentline C; Enman Y; Parodis I
• Article: ARTHRITIS RESEARCH & THERAPY. 2022;24(1):62

  Longitudinal assessment of reactivity and affinity profile of anti-Jo1 autoantibodies to distinct HisRS domains and a splice variant in a cohort of patients with myositis and anti-synthetase syndrome

  Notarnicola A; Preger C; Lundstrom SL; Renard N; Wigren E; Van Gompel E; Galindo-Feria AS; Persson H; Fathi M; Grunewald J; Jakobsson P-J; Graslund S; Lundberg IE; Fernandes-Cerqueira C
• Article: RHEUMATOLOGY. 2022;61(3):1148-1157

  Autoantibody profiles delineate distinct subsets of scleromyositis

  Leclair V; D'Aoust J; Gyger G; Landon-Cardinal O; Meyer A; O'Ferrall E; Karamchandani J; Massie R; Ellezam B; Satoh M; Troyanov Y; Fritzler MJ; Hudson M
• Review: CURRENT OPINION IN RHEUMATOLOGY. 2022;34(2):139-149

  Diagnostic, predictive and prognostic biomarkers in systemic lupus erythematosus: current insights

  Lindblom J; Mohan C; Parodis I
• Article: JOURNAL OF CRANIOFACIAL SURGERY. 2022;33(2):463-468

  The Volume Difference Along the External Surface of the Zygomatic Bone: A Novel Method of Measuring Zygomatic Bone Asymmetry

  Rahbin S; Toufani T; Al-Khabbaz A-M; Lindblom J; Sunnergren O; Darabi H; Qureshi AR; Alinasab B
• Article: ARTHRITIS CARE AND RESEARCH. 2022;74(3):468-477

  Factors Associated With Treatment Response in Patients With Idiopathic Inflammatory Myopathies: A Registry-Based Study

  Espinosa-Ortega F; Holmqvist M; Dastmalchi M; Lundberg IE; Alexanderson H
• Editorial comment: THE LANCET RHEUMATOLOGY. 2022;4(3):E157-E159

  Patient-reported outcomes with anifrolumab in patients with systemic lupus erythematosus

  Stamm T; Parodis I; Studenic P
• Review: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2022;40(2):309-319

  Defining anti-synthetase syndrome: a systematic literature review

  Zanframundo G; Faghihi-Kashani S; Scire CA; Bonella F; Corte TJ; Doyle TJ; Fiorentino D; Gonzalez-Gay MA; Hudson M; Kuwana M; Lundberg IE; Mammen A; McHugh N; Miller FW; Montecucco C; Oddis CV; Rojas-Serrano J; Schmidt J; Selva-O'Callaghan A; Werth VP; Sakellariou G; Aggarwal R; Cavagna L
• Review: ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS. 2022;70(1):8

  Treat-to-Target in Lupus Nephritis. What is the Role of the Repeat Kidney Biopsy?

  Parodis I; Tamirou F; Houssiau FA
• Article: COMMUNICATIONS BIOLOGY. 2022;5(1):129

  Three-dimensional spatial transcriptomics uncovers cell type localizations in the human rheumatoid arthritis synovium

  Vickovic S; Schapiro D; Carlberg K; Lotstedt B; Larsson L; Hildebrandt F; Korotkova M; Hensvold AH; Catrina AI; Sorger PK; Malmstrom V; Regev A; Stahl PL
• Article: ARTHRITIS & RHEUMATOLOGY. 2022;74(2):342-352

  Contribution of Rare Genetic Variation to Disease Susceptibility in a Large Scandinavian Myositis Cohort

  Bianchi M; Kozyrev SV; Notarnicola A; Hultin Rosenberg L; Karlsson A; Pucholt P; Rothwell S; Alexsson A; Sandling JK; Andersson H; Cooper RG; Padyukov L; Tjarnlund A; Dastmalchi M; Meadows JRS; Pyndt Diederichsen L; Molberg O; Chinoy H; Lamb J; Ronnblom L; Lindblad-Toh K; Lundberg IE
• Journal article: AMERICAN JOURNAL OF MEDICINE. 2022;135(2):244-253.e3

  First Diagnosis of Systemic Lupus Erythematosus in Hospitalized Patients: Clinical Phenotypes and Pitfalls for the Non-Specialist

  Kapsala N; Nikolopoulos D; Flouda S; Chavatza A; Tseronis D; Aggelakos M; Katsimbri P; Bertsias G; Fanouriakis A; Boumpas DT
• Article: BRAIN SCIENCES. 2022;12(2):192

  Biomarkers in Neuropsychiatric Systemic Lupus Erythematosus: A Systematic Literature Review of the Last Decade

  Lindblom J; Mohan C; Parodis I
• Review: JOURNAL OF CLINICAL MEDICINE. 2022;11(2):340

  Patient-Reported Outcomes in Systemic Lupus Erythematosus. Can Lupus Patients Take the Driver's Seat in Their Disease Monitoring?

  Parodis I; Studenic P
• Article: JOURNAL OF CLINICAL INVESTIGATION. 2022;132(1):e147334

  The CD6/ALCAM pathway promotes lupus nephritis via T cell-mediated responses

  Chalmers SA; Ramachandran RA; Garcia SJ; Der E; Herlitz L; Ampudia J; Chu D; Jordan N; Zhang T; Parodis I; Gunnarsson I; Ding H; Shen N; Petri M; Mok CC; Saxena R; Polu KR; Connelly S; Ng CT; Mohan C; Putterman C
• Editorial comment: ANNALS OF THE RHEUMATIC DISEASES. 2022;81(1):15-19

  From sequential to combination and personalised therapy in lupus nephritis: moving towards a paradigm shift?

  Parodis I; Houssiau FA
• Editorial comment: FRONTIERS IN MEDICINE. 2022;9:1020859

  Editorial: Advance in B-cell therapies for the treatment of rheumatic and musculoskeletal diseases.

  Md Yusof MY; Alivernini S; Chatzidionysiou K
• Article: FRONTIERS IN PHARMACOLOGY. 2022;13:979788

  World Health Organization (WHO) International Classification of Functioning, Disability and Health (ICF) Core Set Development for Interstitial Lung Disease

  Saketkoo LA; Escorpizo R; Varga J; Keen KJ; Fligelstone K; Birring SS; Alexanderson H; Pettersson H; Chaudhry HA; Poole JL; Regardt M; LeSage D; Sarver C; Lanario J; Renzoni E; Scholand MB; Lammi MR; Kowal-Bielecka O; Distler O; Frech T; Shapiro L; Varju C; Volkmann ER; Bernstein EJ; Drent M; Obi ON; Patterson KC; Russell A-M
• Review: FRONTIERS IN MEDICINE. 2022;9:952304

  B cells in systemic lupus erythematosus: Targets of new therapies and surveillance tools

  Parodis I; Gatto M; Sjowall C
• Article: FRONTIERS IN MEDICINE. 2022;9:1092325

  EQ-5D full health state after therapy heralds reduced hazard to accrue subsequent organ damage in systemic lupus erythematosus

  Lindblom J; Zetterberg S; Emamikia S; Borg A; von Perner G; Enman Y; Heintz E; Regardt M; Grannas D; Gomez A; Parodis I
• Article: RHEUMATOLOGY INTERNATIONAL. 2022;42(1):23-29

  COVID-19 vaccination in autoimmune disease (COVAD) survey protocol

  Sen P; Gupta L; Lilleker JB; Aggarwal V; Kardes S; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; O'Callaghan AS; Nikiphorou E; Tan AL; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Kuwana M; Cagnotto G; Nune A; Distler O; Chinoy H; Aggarwal V; Aggarwal R
• Editorial comment: FRONTIERS IN IMMUNOLOGY. 2022;13:962088

  Editorial: Clinical, Molecular and Adverse Responses to B-Cell Therapies in Autoimmune Disease

  Sciascia S; Parodis I; Karim MY
• Review: FRONTIERS IN IMMUNOLOGY. 2022;13:866087

  Aminoacyl-tRNA Synthetases: On Anti-Synthetase Syndrome and Beyond

  Galindo-Feria AS; Notarnicola A; Lundberg IE; Horuluoglu B
• Article: FRONTIERS IN MEDICINE. 2022;9:852162

  Early Changes in B and Plasma Cell Subsets and Traditional Serological Markers as Predictors of SRI-4 Response to Therapy in Systemic Lupus Erythematosus

  Parodis I; Gomez A; Lindblom J; Chow JW; Doria A; Gatto M
• Article: FRONTIERS IN IMMUNOLOGY. 2022;13:796508

  Early B Cell and Plasma Cell Kinetics Upon Treatment Initiation Portend Flares in Systemic Lupus Erythematosus: A Post-Hoc Analysis of Three Phase III Clinical Trials of Belimumab

  Parodis I; Gomez A; Chow JW; Borg A; Lindblom J; Gatto M
• Review: FRONTIERS IN PHARMACOLOGY. 2022;13:838782

  Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators-What is the Evidence so far?

  Schebb NH; Kuehn H; Kahnt AS; Rund KM; O'Donnell VB; Flamand N; Peters-Golden M; Jakobsson P-J; Weylandt KH; Rohwer N; Murphy RC; Geisslinger G; FitzGerald GA; Hanson J; Dahlgren C; Alnouri MW; Offermanns S; Steinhilber D
• Article: CRITICAL REVIEWS IN IMMUNOLOGY. 2022;42(4):21-36

  Using Autoantibodies to Diagnose Systemic Autoimmune Diseases Triggered by Immune Checkpoint Inhibitors: A Clinical Perspective.

  Flores-Chávez A; Brito-Zerón P; Retamozo S; Bitoun S; Fisher BA; Liew D; Suijkerbuijk K; Chatzidionysiou K; Suárez-Almazor M; Lambotte O; Mariette X; Ramos-Casals M
• Article: CANCER RESEARCH. 2022;82(1):36-45

  CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies

  Jiang L; Ingelshed K; Shen Y; Boddul SV; Iyer VS; Kasza Z; Sedimbi S; Lane DP; Wermeling F
• Review: NATURE REVIEWS. RHEUMATOLOGY. 2022;18(1):9-21

  Differentiating between UCTD and early-stage SLE: from definitions to clinical approach

  Sciascia S; Roccatello D; Radin M; Parodis I; Yazdany J; Pons-Estel G; Mosca M
• Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2022;149(1):65-75.e8

  SARS-CoV-2-specific B- and T-cell immunity in a population-based study of young Swedish adults

  Bjorkander S; Du L; Zuo F; Ekstrom S; Wang Y; Wan H; Sherina N; Schoutens L; Andrell J; Andersson N; Georgelis A; Bergstrom A; Marcotte H; Kull I; Hammarstrom L; Melen E; Pan-Hammarstrom Q
• Article: FRONTIERS IN IMMUNOLOGY. 2022;13:804822

  Antibodies to a Citrullinated Porphyromonas gingivalis Epitope Are Increased in Early Rheumatoid Arthritis, and Can Be Produced by Gingival Tissue B Cells: Implications for a Bacterial Origin in RA Etiology

  Sherina N; de Vries C; Kharlamova N; Sippl N; Jiang X; Brynedal B; Kindstedt E; Hansson M; Mathsson-Alm L; Israelsson L; Stalesen R; Saevarsdottir S; Holmdahl R; Hensvold A; Johannsen G; Eriksson K; Sallusto F; Catrina AI; Roennelid J; Groenwall C; Yucel-Lindberg T; Alfredsson L; Klareskog L; Piccoli L; Malmstroem V; Amara K; Lundberg K
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2022;74:4451-4453

  Autoantibodies and Damage in Patients with Idiopathic Inflammatory Myopathies: A Longitudinal Multicenter Study from the EuroMyositis International Network

  Espinosa-Ortega F; Lodin K; Holmqvist M; Dastmalchi M; Ceribelli A; Venkovsky J; Chinoy H; Diederichsen L; Shinjo S; Lundberg I; Alexanderson H
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2022;74:4324-4325

  Transfer of Monoclonal ACPAs Induces Pain, Bone Loss and Tenosynovitis in Mice in a Peptidyl Arginine Deiminase-4 Dependent Manner

  Krishnamurthy A; Sun J; Circiumaru A; Kisten Y; Sakuraba K; Tran T; Damberg P; Jarvoll P; Lu L; Andor KS; Zhou T; Malmstrom V; Svensson CI; Hensvold A; Catrina A; Klareskog L; Rethi B
• Conference publication: ACTA PHYSIOLOGICA. 2022;236:137

  Skeletal muscle force decline after exposure to serum from patients with idopathic inflammatory myopathy

  Landberg C; Gastaldello S; Andreasson K; Schiffer T; Carlstrom M; Lundberg IE; Alexanderson H; Andersson DC
• Conference publication: EUROPEAN HEART JOURNAL. 2022;43:822

  Left ventricular dysfunction in a cohort of new onset idiopathic inflammatory myopathy without known heart disease

  Lindstedt M; Andreasson K; Da Silva C; Manouras A; Alexanderson H; Andersson DC
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2022;74:4151-4152

  Drug Repurposing for Treating Lupus Nephritis Based on Transcriptome Profiling and Autoimmunity-Related Serological Markers

  Parodis I; Lindblom J; Toro-Dominguez D; Carnero-Montoro E; Borghi MO; Castillo J; Enman Y; Mohan C; Alarcon-Riquelme M; Barturen G
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2022;74:4417-4418

  Transcriptome Profiling and Autoimmunity-related Serological Markers Identify Tumour Protein P53 and Complement C3a Receptor 1 as Drug Targets in Neuropsychiatric Systemic Lupus Erythematosus

  Lindblom J; Toro-Dominguez D; Carnero-Montoro E; Orietta Borghi M; Castillo J; Iacobaeus E; Enman Y; Mohan C; Alarcon-Riquelme M; Barturen G; Parodis I
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2022;74:3446

  Shared Epitope Allomorphs Directly Influence Antigen-specific T-cell Responses in RA

  Kumar R; Dubnovitsky A; Gerstner C; Yoosuf N; Turcinov S; Boddul S; Wermeling F; Klareskog L; Padyukov L; Malmstrom V
• Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2022;28(3_SUPPL):226-227

  Implication of DNA methylation changes at chromosome 1q21.1 in the brain pathology of primary progressive multiple sclerosis

  Kakhki MP; Cucuzza CS; Gyllenberg A; Badam TVS; Liu Y; Boddul S; James T; Wermeling F; Gustafsson M; Casaccia P; Kockum I; Hillert J; Olsson T; Kular L; Jagodic M
• Journal article: ORGANIC COMMUNICATIONS. 2022;15(4):356-377

  Synthesis and evaluation of antiproliferative and mPGES-1 inhibitory activities of novel carvacrol-triazole conjugates

  Demirbolat I; Kulabas N; Guerboga M; oezakpinar OB; ciftci G; Yelekci K; Liu J; Jakobsson P-J; Danis O; Ogan A; Kuecuekguezel I
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2022;74:332-336

  COVID-19 Vaccination-related Short-term Adverse Events in Patients with Idiopathic Inflammatory Myositis and Autoimmune Multimorbidity: Results from the COVID-19 Vaccination in Autoimmune Diseases Survey

  Dey M; Naveen R; Nikiphorou E; Sen P; Lilleker JB; Agarwal V; Kardes S; Day J; Milchert M; Joshi M; Gheita TA; Salim B; Velikova T; Edgar Gracia-Ramos A; Parodis I; Selva O'Callaghan A; Kim M; Chatterjee T; Tan AL; Makol A; Nune A; Cavagna L; Saavedra Salinas MA; Shinjo S; Ziade N; Knitza J; Kuwana M; Distler O; Chinoy H; Pauling J; Wincup C; Agarwal V; Aggarwal R; Gupta L
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2022;74:3018-3021

  Breakthrough Infections in COVID-19 Vaccinated Patients with Systemic Sclerosis: A Survival Analysis from a Multicenter International Patient-Reported Survey

  Ahmed S; Naveen R; Pauling J; Thakare D; Wincup C; Del Papa N; Sambataro G; Atzeni F; Parisi S; Govoni M; Bocci EB; Sebastiani GD; Fusaro E; Sebastiani M; Quartuccio L; Franceschini F; Sainaghi PP; Orsolini G; De Angelis R; Danielli MG; Venerito V; Sen P; Kim M; Gracia-Ramos AE; Yoshida A; Lilleker JB; Agarwal V; Kardes S; Day J; Joshi M; Milchert M; Gheita TA; Salim B; Parodis I; Selva O'Callaghan A; Nikiphorou E; Chatterjee T; Tan AL; Nune A; Cavagna L; Shinjo S; Ziade N; Knitza J; Chinoy H; Distler O; Kuwana M; Aggarwal R; Gupta L; Agarwal V; Makol A
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2022;74:1926-1928

  Low-dose Belimumab and Antimalarial Agents Prevent Renal Flares in Systemic Lupus Erythematosus: Results from Four Randomised Clinical Trials

  Gomez A; Jagerback S; Sjowall C; Parodis I
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2022;74:2094-2098

  Short-term Safety of COVID-19 Vaccination in Systemic Sclerosis Patients: Report from a Global Patient-Reported E-survey

  Thakare D; Naveen R; Pauling J; Ahmed S; Wincup C; Del Papa N; Sambataro G; Atzeni F; Govoni M; Parisi S; Bocci EB; Sebastiani GD; Fusaro E; Sebastiani M; Quartuccio L; Franceschini F; Sainaghi PP; Orsolini G; De Angelis R; Danielli MG; Venerito V; Sen P; Kim M; Gracia-Ramos AE; Yoshida A; Lilleker JB; Agarwal V; Kardes S; Day J; Milchert M; Joshi M; Gheita TA; Salim B; Parodis I; Selva O'Callaghan A; Nikiphorou E; Chatterjee T; Tan AL; Nune A; Cavagna L; Shinjo S; Ziade N; Knitza J; Chinoy H; Distler O; Kuwana M; Aggarwal R; Gupta L; Agarwal V; Makol A
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2022;74:4115-4120

  COVID-19 Vaccination in Autoimmune Diseases Study: Vaccine Safety in Systemic Lupus Erythematosus

  Naveen R; Nikiphorou E; Joshi M; Sen P; Agarwal V; Kardes S; Lilleker JB; Chinoy H; Distler O; Kim M; Tan AL; Shinjo S; Salim B; Gheita TA; Ziade N; Velikova T; Chatterjee T; Nune A; Milchert M; Gracia-Ramos AE; O'Callaghan AS; Salinas MAS; Cavagna L; Kuwana M; Knitza J; Day J; Makol A; Aggarwal R; Agarwal V; Gupta L; Traboco LS; Parodis I
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2022;74:1090-1093

  Evaluation of Traditional Laboratory Markers as Predictors of Renal Flares: A Post-hoc Analysis of Four Phase III Clinical Trials of SLE

  Jagerback S; Gomez A; Parodis I
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2022;74:3717-3720

  Vaccine Hesitancy Among Patients with Idiopathic Inflammatory Myopathies and Rheumatic Diseases in 2021-2022: A Comparative Analysis of COVID-19 Vaccination in Autoimmune Diseases Surveys

  Naveen R; Joshi M; Sen P; Agarwal V; Shinjo S; Kardes S; Lilleker JB; Chinoy H; Makol A; Distler O; Kim M; Nikiphorou E; Tan AL; Salim B; Gheita TA; Ziade N; Velikova T; Chatterjee T; Nune A; Milchert M; Parodis I; Edgar Gracia-Ramos A; Selva O'Callaghan A; Saavedra Salinas MA; Cavagna L; Kuwana M; Knitza J; Day J; Toro Gutierrez CE; Caballero C; Dey D; Zamora Tehozol E; Rojas Serrano J; Garcia-De La Torre I; Colunga I; Merayo-Chalico J; Pauling J; Wincup C; Gasparyan AY; Agarwal V; Aggarwal R; Gupta L
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2022;74:1768-1772

  COVID-19 Vaccination in Autoimmune Diseases Study: Vaccine Safety in Rheumatoid Arthritis

  Naveen R; Parodis I; Joshi M; Sen P; Kim M; Agarwal V; Kardes S; Lilleker JB; Chinoy H; Distler O; Tan AL; Shinjo S; Salim B; Gheita TA; Ziade N; Velikova T; Chatterjee T; Nune A; Milchert M; Gracia-Ramos AE; O'Callaghan AS; Salinas MAS; Cavagna L; Kuwana M; Knitza J; Day J; Makol A; Pauling J; Wincup C; Tehozol EZ; Serrano JR; Garcia-De La Torre I; Aggarwal R; Agarwal V; Gupta L; Nikiphorou E
• Journal article: INDIAN JOURNAL OF RHEUMATOLOGY. 2022;17(2):188-191

  Vaccine hesitancy in patients with autoimmune diseases: Data from the coronavirus disease-2019 vaccination in autoimmune diseases study

  Sen P; Lilleker JB; Agarwal V; Kardes S; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; O'Callaghan AS; Nikiphorou E; Tan AL; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Kuwana M; Cagnotto G; Nune A; Distler O; Chinoy H; Aggarwal R; Gupta L
• Journal article: FRONTIERS IN IMMUNOLOGY. 2022;13:1074044

  Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study

  Nikoloudaki M; Nikolopoulos D; Koutsoviti S; Flouri I; Kapsala N; Repa A; Katsimbri P; Theotikos E; Pitsigavdaki S; Pateromichelaki K; Bertsias A; Elezoglou A; Sidiropoulos P; Fanouriakis A; Boumpas D; Bertsias G
• Journal article: FRONTIERS IN NEUROLOGY. 2022;13:889613

  Demyelinating Syndromes in Systemic Lupus Erythematosus: Data From the "Attikon" Lupus Cohort

  Nikolopoulos D; Kitsos D; Papathanasiou M; Kapsala N; Garantziotis P; Pieta A; Gioti O; Grivas A; Voumvourakis K; Boumpas D; Fanouriakis A
• Article: SCIENTIFIC REPORTS. 2021;11(1):24512

  Biased TCR gene usage in citrullinated Tenascin C specific T-cells in rheumatoid arthritis

  Sharma RK; Boddul SV; Yoosuf N; Turcinov S; Dubnovitsky A; Kozhukh G; Wermeling F; Kwok WW; Klareskog L; Malmstrom V
• Article: NATURE REVIEWS DISEASE PRIMERS. 2021;7(1):86

  Idiopathic inflammatory myopathies

  Lundberg IE; Fujimoto M; Vencovsky J; Aggarwal R; Holmqvist M; Christopher-Stine L; Mammen AL; Miller FW
• Review: INTERNATIONAL JOURNAL OF WOMEN'S DERMATOLOGY. 2021;7(5Part A):583-587

  Importance of collaboration of dermatology and rheumatology to advance the field for lupus and dermatomyositis.

  Werth VP; Askanase AD; Lundberg IE
• Article: RMD OPEN. 2021;7(3):e001987

  Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision

  Bower H; Frisell T; di Giuseppe D; Delcoigne B; Ahlenius G-M; Baecklund E; Chatzidionysiou K; Feltelius N; Forsblad-d'Elia H; Kastbom A; Klareskog L; Lindqvist E; Lindstrom U; Turesson C; Sjowall C; Askling J
• Review: LAKARTIDNINGEN. 2021;118:21114

  [Overview of immune-related side effects from immune checkpoint inhibitors. Part 2: Endocrine, rheumatologic and skin toxicity].

  Helgadottir H; Falkenius J; Eriksson H; Girnita A; Sahlberg L; Bensing S; Chatzidionysiou K; Masucci G; Ullenhag G
• Preprint: RESEARCH SQUARE. 2021

  Biased TCR gene usage in citrullinated Tenascin C specific T-cells in rheumatoid arthritis

  Sharma R; Boddul S; Yoosuf N; Turcinov S; Dubnovitsky A; Kozhukh G; Wermeling F; Kwok W; Klareskog L; Malmström V
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2021;50(6):479-484

  Temperature response to cold challenge and mobile phone thermography as outcome measures for systemic sclerosis-related Raynaud's phenomenon

  Herrick AL; Heal C; Wilkinson J; Dinsdale G; Manning J; Gunnarsson K; Jakobsson P-J; Murray A
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2021;80(11):1461-1466

  Familial aggregation and heritability: a nationwide family-based study of idiopathic inflammatory myopathies

  Che WI; Westerlind H; Lundberg IE; Hellgren K; Kuja-Halkola R; Holmqvist M
• Review: CURRENT OPINION IN RHEUMATOLOGY. 2021;33(6):537-543

  Polymyositis: does it really exist as a distinct clinical subset?

  Leclair V; Notarnicola A; Vencovsky J; Lundberg IE
• Article: INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH. 2021;18(21):11202

  Clinical Reasoning Needs to Be Explicitly Addressed in Health Professions Curricula: Recommendations from a European Consortium

  Parodis I; Andersson L; Durning SJ; Hege I; Knez J; Kononowicz AA; Lidskog M; Petreski T; Szopa M; Edelbring S
• Review: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021;22(21):11327

  Cytokines as Biomarkers in Systemic Lupus Erythematosus: Value for Diagnosis and Drug Therapy

  Idborg H; Oke V
• Article: RHEUMATOLOGY. 2021;60(10):4616-4623

  Venous thromboembolism in ANCA-associated vasculitis: a population-based cohort study.

  Liapi M; Jayne D; Merkel PA; Segelmark M; Mohammad AJ
• Article: RHEUMATOLOGY. 2021;60(10):4703-4716

  EQ-5D-3L full health state discriminates between drug and placebo in clinical trials of systemic lupus erythematosus

  Lindblom J; Gomez A; Borg A; Emamikia S; Ladakis D; Matilla J; Pehr M; Cobar F; Enman Y; Heintz E; Regardt M; Parodis I
• Article: JOURNAL OF EXTRACELLULAR VESICLES. 2021;10(12):e12143

  Small extracellular vesicle-derived miR-574-5p regulates PGE2-biosynthesis via TLR7/8 in lung cancer

  Donzelli J; Proestler E; Riedel A; Nevermann S; Hertel B; Guenther A; Gattenloehner S; Savai R; Larsson K; Saul MJ
• Article: JOURNAL OF RHEUMATOLOGY. 2021;48(10):1512-1518

  Effectiveness of a Second Biologic After Failure of a Non-tumor Necrosis Factor Inhibitor As First Biologic in Rheumatoid Arthritis

  Chatzidionysiou K; Hetland ML; Frisell T; Di Giuseppe D; Hellgren K; Glintborg B; Nordstrom D; Peltomaa R; Aaltonen K; Trokovic N; Kristianslund EK; Kvien TK; Provan SA; Gudbjornsson B; Grondal G; Dreyer L; Kristensen LE; Jorgensen TS; Jacobsson LTH; Askling J
• Article: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2021;51(5):983-988

  Distribution and trajectory of direct and indirect costs of idiopathic inflammatory myopathies

  Leclair V; Moshtaghi-Svensson J; Regardt M; Hudson M; Lundberg IE; Holmqvist M
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2021;50(5):390-397

  Evaluation of risk factors and biomarkers related to arterial and venous thrombotic events in idiopathic inflammatory myopathies

  Notarnicola A; Barsotti S; Nasman L; Tang Q; Holmqvist M; Lundberg IE; Antovic A
• Article: RHEUMATOLOGY. 2021;60(9):4205-4217

  Contribution of abnormal BMI to adverse health-related quality of life outcomes after a 52-week therapy in patients with SLE

  Borg A; Gomez A; Cederlund A; Cobar F; Qiu V; Lindblom J; Emamikia S; Enman Y; Pettersson S; Parodis I
• Review: BEST PRACTICE AND RESEARCH: CLINICAL RHEUMATOLOGY. 2021;35(3):101695

  Exercise as a multi-modal disease-modifying medicine in systemic sclerosis: An introduction by The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS)

  Pettersson H; Alexanderson H; Poole JL; Varga J; Regardt M; Russell A-M; Salam Y; Jensen K; Mansour J; Frech T; Feghali-Bostwick C; Varju C; Baldwin N; Heenan M; Fligelstone K; Holmner M; Lammi MR; Scholand MB; Shapiro L; Volkmann ER; Saketkoo LA
• Article: ARTHRITIS CARE AND RESEARCH. 2021;73(9):1312-1321

  Pain Over Two Years After Start of Biologic Versus Conventional Combination Treatment in Early Rheumatoid Arthritis: Results From a Swedish Randomized Controlled Trial

  Olofsson T; Wallman JK; Joud A; Schelin MEC; Ernestam S; van Vollenhoven R; Saevarsdottir S; Lampa J
• Review: BEST PRACTICE AND RESEARCH: CLINICAL RHEUMATOLOGY. 2021;35(3):101707

  A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc

  Saketkoo LA; Frech T; Varju C; Domsic R; Farrell J; Gordon JK; Mihai C; Sandorfi N; Shapiro L; Poole J; Volkmann ER; Lammi M; McAnally K; Alexanderson H; Pettersson H; Hant F; Kuwana M; Shah AA; Smith V; Hsu V; Kowal-Bielecka O; Assassi S; Cutolo M; Kayser C; Shanmugam VK; Vonk MC; Fligelstone K; Baldwin N; Connolly K; Ronnow A; Toth B; Suave M; Farrington S; Bernstein EJ; Crofford LJ; Czirjak L; Jensen K; Hinchclif M; Hudson M; Lammi MR; Mansour J; Morgan ND; Mendoza F; Nikpour M; Pauling J; Riemekasten G; Russell A-M; Scholand MB; Seigart E; Rodriguez-Reyna TS; Hummers L; Walker U; Steen V
• Article: RHEUMATOLOGY. 2021;60(9):4348-4354

  De novo lupus nephritis during treatment with belimumab

  Parodis I; Vital EM; Hassan S-U; Jonsen A; Bengtsson AA; Eriksson P; Leonard D; Gunnarsson I; Ronnblom L; Sjowall C
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2021;80(9):1175-1182

  Quality indicators for systemic lupus erythematosus based on the 2019 EULAR recommendations: development and initial validation in a cohort of 220 patients

  Chavatza K; Kostopoulou M; Nikolopoulos D; Gioti O; Togia K; Andreoli L; Aringer M; Boletis J; Doria A; Houssiau FA; Jayne D; Mosca M; Svenungsson E; Tincani A; Bertsias G; Fanouriakis A; Boumpas DT
• Journal article: RHEUMATOLOGY. 2021;60(9):4166-4174

  Demyelination with autoimmune features: a distinct clinical entity? Results from a longitudinal cohort

  Nikolopoulos D; Kitsos D; Papathanasiou M; Chondrogianni M; Theodorou A; Garantziotis P; Pieta A; Doskas T; Bertsias G; Voumvourakis K; Boumpas DT; Fanouriakis A
• Review: JOURNAL OF CLINICAL MEDICINE. 2021;10(16):3566

  Fatigue in Systemic Lupus Erythematosus and Rheumatoid Arthritis: A Comparison of Mechanisms, Measures and Management

  Dey M; Parodis I; Nikiphorou E
• Article: BIOMEDICINES. 2021;9(8):961

  In Vivo Lentiviral Gene Delivery of HLA-DR and Vaccination of Humanized Mice for Improving the Human T and B Cell Immune Reconstitution

  Kumar S; Koenig J; Schneider A; Wermeling F; Boddul S; Theobald SJ; Vollmer M; Kloos D; Lachmann N; Klawonn F; Lienenklaus S; Talbot SR; Bleich A; Wenzel N; von Kaisenberg C; Keck J; Stripecke R
• Letter: ACTA NEUROPATHOLOGICA. 2021;142(2):395-397

  Capillary basement membrane reduplication in myositis patients with mild clinical features of systemic sclerosis supports the concept of 'scleromyositis'.

  Ellezam B; Leclair V; Troyanov Y; Meyer A; Hudson M; Landon-Cardinal O
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2021;80(8):1086-1093

  Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study

  Bower H; Frisell T; Di Giuseppe D; Delcoigne B; Ahlenius G-M; Baecklund E; Chatzidionysiou K; Feltelius N; Forsblad-d'Elia H; Kastbom A; Klareskog L; Lindqvist E; Lindstrom U; Turesson C; Sjowall C; Askling J
• Article: ARTHRITIS & RHEUMATOLOGY. 2021;73(8):1394-1407

  Expert Perspective: Management of Refractory Inflammatory Myopathy

  Lundberg IE
• Letter: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2021;141(8):2079-2083

  Genetic Analysis of MPO Variants in Four Psoriasis in Patients from

  Haskamp S; Horowitz JS; Oji V; Philipp S; Sticherling M; Schaekel K; Schuhmann S; Prinz JC; Burkhardt H; Behrens F; Boehm B; Koehm M; Rech J; Simon D; Schett G; Morrison K; Gerdes S; Assmann G; Nimeh A; Schuster V; Jacobi A; Weyergraf A; Reis A; Uebe S; Wilsmann-Theis D; Moessner R; Hueffmeier U
• Review: AUTOIMMUNITY REVIEWS. 2021;20(7):102851

  Histopathological features of systemic sclerosis-associated myopathy: A scoping review.

  Lefebvre F; Giannini M; Ellezam B; Leclair V; Troyanov Y; Hoa S; Bourré-Tessier J; Satoh M; Fritzler MJ; Senécal J-L; Hudson M; Meyer A; Landon-Cardinal O
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2021;80(7):e116

  Response to: 'Comment on: standardisation of myositis-specific antibodies: where are we today?' by Infantino et al

  Ronnelid J; Espinosa-Ortega F; Lundberg IE
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2021;80(7):e119

  How to use the Lupus Low Disease Activity State (LLDAS) in clinical trials

  Parodis I; Nikpour M
• Article: LUPUS SCIENCE AND MEDICINE. 2021;8(1):e000515

  Myocardial infarctions, subtypes and coronary atherosclerosis in SLE: a case-control study

  Samuelsson I; Parodis I; Gunnarsson I; Zickert A; Hofman-Bang C; Wallen H; Svenungsson E
• Article: JOURNAL OF CLINICAL INVESTIGATION. 2021;131(13):144201

  Passive transfer of fibromyalgia symptoms from patients to mice

  Goebel A; Krock E; Gentry C; Israel MR; Jurczak A; Urbina CM; Sandor K; Vastani N; Maurer M; Cuhadar U; Sensi S; Nomura Y; Menezes J; Baharpoor A; Brieskorn L; Sandstrom A; Tour J; Kadetoff D; Haglund L; Kosek E; Bevan S; Svensson CI; Andersson DA
• Article: GENES AND IMMUNITY. 2021;22(3):194-202

  Variants in BANK1 are associated with lupus nephritis of European ancestry

  Bolin K; Imgenberg-Kreuz J; Leonard D; Sandling JK; Alexsson A; Pucholt P; Haarhaus ML; Almlof JC; Nititham J; Jonsen A; Sjowall C; Bengtsson AA; Rantapaa-Dahlqvist S; Svenungsson E; Gunnarsson I; Syvanen A-C; Lerang K; Troldborg A; Voss A; Molberg O; Jacobsen S; Criswell L; Ronnblom L; Nordmark G
• Article: SCIENTIFIC REPORTS. 2021;11(1):11632

  BAFF predicts immunogenicity in older patients with rheumatoid arthritis treated with TNF inhibitors

  Hernandez-Breijo B; Navarro-Compan V; Plasencia-Rodriguez C; Parodis I; Gehin JE; Martinez-Feito A; Novella-Navarro M; Mezcua A; Warren DJ; Nozal P; Pascual-Salcedo D; Balsa A
• Article: RMD OPEN. 2021;7(2):e001662

  Tocilizumab decreases T cells but not macrophages in the synovium of patients with rheumatoid arthritis while it increases the levels of serum interleukin-6 and RANKL

  Chatzidionysiou K; Circiumaru A; Rethi B; Joshua V; Engstrom M; Hensvold A; af Klint E; Catrina A
• Article: CELLULAR AND MOLECULAR IMMUNOLOGY. 2021;18(6):1463-1475

  Serum-circulating His-tRNA synthetase inhibits organ-targeted immune responses

  Adams RA; Fernandes-Cerqueira C; Notarnicola A; Mertsching E; Xu Z; Lo W-S; Ogilvie K; Chiang KP; Ampudia J; Rosengren S; Cubitt A; King DJ; Mendlein JD; Yang X-L; Nangle LA; Lundberg IE; Jakobsson P-J; Schimmel P
• Other: EUROPEAN JOURNAL OF IMMUNOLOGY. 2021;51(6):1309

  Anca Catrina 1971-2021 Obituary

  Klareskog L; Rethi B; Hensvold A; Wahamaa H; Jakobsson P-J
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2021;80:643

  MYOCARDIAL INFARCTIONS, SUBTYPES, LOCATIONS AND CORONARY ATHEROSCLEROSIS IN SLE - A COMPARATIVE STUDY WITH MATCHED CONTROLS

  Samuelsson I; Parodis I; Gunnarsson I; Zickert A; Hofman-Bang C; Wallen H; Svenungsson E
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2021;80:305-306

  URINE-GALECTINE 3 BINDING PROTEIN (U-GAL3BP) IS A SENSITIVE MARKER OF KIDNEY INFLAMMATION AND RESPONSE TO TREATMENT IN LUPUS

  Faustini F; Idborg H; Svenungsson E; Poetzsch S; Okitsu S; Larsson A; Gunnarsson I
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2021;80:87

  TENOSYNOVITIS, SYNOVIAL HYPERTROPHY AND FEET BURSITIS ARE USEFUL ULTRASOUND BIOMARKERS FOR PREDICTING ARTHRITIS DEVELOPMENT IN A POPULATION AT-RISK FOR RHEUMATOID ARTHRITIS

  Kisten Y; Circiumaru A; Loberg M; Vivar-Pomiano N; Antovic A; Rezaei H; Af Klint E; Hensvold A; Catrina A
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2021;80:439.2-43440

  COMBINED ANALYSIS OF METABOLIC AND TRANSCRIPTOMIC KIDNEY PROFILES OF NZW/B-F1 MURINE LUPUS UNCOVERS BIOLOGICAL MECHANISMS PRECEDING THE ONSET OF NEPHRITIS

  Manolakou T; Tsiara I; Nikolopoulos D; Garantziotis P; Benaki D; Gikas E; Frangou E; Mikroa E; Boumpas D
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2021;80:21.1-2122

  HIPPOCAMPAL IMMUNE CELL TRAFFICKING AND A MYELOID PREDOMINANT INFLAMMATORY RESPONSE WITH ENHANCED ANTIGEN PRESENTATION AND DECREASED LEVELS OF NEUROTRANSMITTERS UNDERLY THE NEUROPSYCHIATRIC PHENOTYPE OF THE NZW/NZB MURINE LUPUS MODEL

  Nikolopoulos D; Manolakou T; Filia A; Nakos-Bimpos M; Polissidis A; Boumpas D
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2021;80:635-636

  EULAR RECOMMENDATION-BASED QUALITY INDICATORS (QIS) FOR SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): ELABORATION, FINAL SET, PERFORMANCE AND INITIAL VALIDATION

  Chavatza K; Kostopoulou M; Nikolopoulos D; Gioti O; Togia K; Flouda S; Kapsala N; Kosmetatou M; Moysidou GS; Grivas A; Pieta A; Ntourou A; Rapsomaniki P; Gerogianni T; Tseronis D; Aggelakos M; Karageorgas T; Katsimpri P; Andreoli L; Aringer M; Boletis N; Doria A; Houssiau F; Jayne D; Mosca M; Svenungsson E; Tincani A; Bertsias G; Fanouriakis A; Boumpas D
• Journal article: ANNALS OF THE RHEUMATIC DISEASES. 2021;80(6):758-766

  Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus

  Adamichou C; Genitsaridi I; Nikolopoulos D; Nikoloudaki M; Repa A; Bortoluzzi A; Fanouriakis A; Sidiropoulos P; Boumpas DT; Bertsias GK
• Journal article: ANNALS OF THE RHEUMATIC DISEASES. 2021;80(Suppl 1):260.2-26261

  POS0101 ADVERSE HEALTH-RELATED QUALITY OF LIFE OUTCOME DESPITE ADEQUATE CLINICAL RESPONSE TO TREATMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS

  Gomez A; Lindblom J; Qiu V; Cederlund A; Borg A; Emamikia S; Enman Y; Lampa J; Parodis I
• Corrigendum: JOURNAL OF DIABETES RESEARCH. 2021;2021:9827150-1

  Protective Effect of the HIF-1A Pro582Ser Polymorphism on Severe Diabetic Retinopathy (vol 2019, 2936962, 2019)

  Ekberg NR; Eliasson S; Li YW; Zheng X; Chatzidionysiou K; Falhammar H; Gu HF; Catrina S-B
• Article: RHEUMATOLOGY. 2021;60(5):2217-2222

  Mortality over 14 years in MTX-refractory patients randomized to a strategy of addition of infliximab or sulfasalazine and hydroxychloroquine

  Miller H; Wallman JK; Petersson IF; Saevarsdottir S; Soderlng J; Ernestam S; Askling J; van Vollenhoven R; Neovius M
• Article: BMC CANCER. 2021;21(1):544

  Using patients' own knowledge of early sensations and symptoms to develop an interactive, individualized e-questionnaire to facilitate early diagnosis of lung cancer

  Levitsky A; Bernhardson B-M; Henoch I; Olin M; Kolbeck K; Rystedt N; Tishelman C; Eriksson LE
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2021;50(3):178-182

  Social stressors and risk of rheumatoid arthritis and their relationship to known modifiable risk factors: results from the Swedish EIRA study

  Hedenstierna L; Opava CH; Askling J; Jiang X; Ernestam S; Alfredsson L; Klareskog L; Saevarsdottir S
• Review: CLINICAL RHEUMATOLOGY. 2021;40(5):1687-1695

  Treatment of rheumatic immune-related adverse events due to cancer immunotherapy with immune checkpoint inhibitors-is it time for a paradigm shift?

  Chatzidionysiou K; Liapi M; Tsakonas G; Gunnarsson I; Catrina A
• Article: INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES. 2021;24(5):663-670

  Clinical characteristics of Vietnamese patients with idiopathic inflammatory myopathies and autoantibodies to aminoacyl-transfer RNA synthetases

  Phuong TNT; Ngoc LNT; Ronnelid J; Padyukov L; Lundberg IE
• Article: ARTHRITIS RESEARCH & THERAPY. 2021;23(1):132

  Proteome study of cutaneous lupus erythematosus (CLE) and dermatomyositis skin lesions reveals IL-16 is differentially upregulated in CLE

  Niewold TB; Meves A; Lehman JS; Popovic-Silwerfeldt K; Hayry A; Soderlund-Matell T; Charlesworth CM; Madden B; Lundberg IE; Wahren-Herlenius M; Svenungsson E; Oke V
• Journal article: EXPERT REVIEW OF CLINICAL IMMUNOLOGY. 2021;17(4):317-329

  Treatment of neuropsychiatric systemic lupus erythematosus: clinical challenges and future perspectives

  Nikolopoulos D; Fanouriakis A; Bertsias G
• Journal article: CLINICAL RHEUMATOLOGY. 2021;40(4):1447-1456

  The role of plasma exchange in antineutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis

  Bellos I; Michelakis I; Nikolopoulos D
• Preprint: RESEARCH SQUARE. 2021

  Early Prediction of Clinical Response to Anti-TNF Treatment using Multi-omics and Machine Learning in Rheumatoid Arthritis

  Yoosuf N; Maciejewski M; Ziemek D; Jelinsky SA; Folkersen L; Müller M; Sahlström P; Vivar N; Catrina A; Berg L; Klareskog L; Padyukov L; Brynedal B
• Article: MED. 2021;2(3):281-295.e4

  Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection

  Sherina N; Piralla A; Du L; Wan H; Kumagai-Braesch M; Andrell J; Braesch-Andersen S; Cassaniti I; Percivalle E; Sarasini A; Bergami F; Di Martino R; Colaneri M; Vecchia M; Sambo M; Zuccaro V; Bruno R; Sachs M; Oggionni T; Meloni F; Abolhassani H; Bertoglio F; Schubert M; Byrne-Steele M; Han J; Hust M; Xue Y; Hammarstrom L; Baldanti F; Marcotte H; Pan-Hammarstrom Q
• Preprint: BIORXIV. 2021

  CRISPR enriches for cells with mutations in a p53-related interactome, and this can be inhibited

  Jiang L; Ingelshed K; Shen Y; Boddul SV; Iyer VS; Kasza Z; Sedimbi S; Lane DP; Wermeling F
• Preprint: BIORXIV. 2021

  A rapid CRISPR competitive assay forin vitroandin vivodiscovery of potential drug targets affecting the hematopoietic system

  Shen Y; Jiang L; Iyer VS; Raposo B; Boddul S; Kasza Z; Wermeling F
• Article: EMBO REPORTS. 2021;22(3):e51329

  Phosphodiesterase 4A confers resistance to PGE2-mediated suppression in CD25⁺/CD54⁺ NK cells

  Chen Z; Yang Y; Neo SY; Shi H; Chen Y; Wagner AK; Larsson K; Tong L; Jakobsson P-J; Alici E; Wu J; Cao Y; Wang K; Liu LL; Mao Y; Sarhan D; Lundqvist A
• Article: RHEUMATOLOGY. 2021;60(3):1260-1272

  Impact of overweight and obesity on patient-reported health-related quality of life in systemic lupus erythematosus

  Gomez A; Butrus FH; Johansson P; Akerstrom E; Soukka S; Emamikia S; Enman Y; Pettersson S; Parodis I
• Article: TRANSLATIONAL RESEARCH. 2021;229:69-82

  Identifying novel B-cell targets for chronic inflammatory autoimmune disease by screening of chemical probes in a patient-derived cell assay

  Sundstrom Y; Shang M-M; Panda SK; Gronwall C; Wermeling F; Gunnarsson I; Lundberg IE; Sundstrom M; Jakobsson P-J; Berg L
• Article: CELL DEATH AND DISEASE. 2021;12(2):135

  Inhibition of mPGES-1 attenuates efficient resolution of acute inflammation by enhancing CX3CL1 expression

  Rappl P; Roesser S; Maul P; Bauer R; Huard A; Schreiber Y; Thomas D; Geisslinger G; Jakobsson P-J; Weigert A; Bruene B; Schmid T
• Article: RHEUMATOLOGY. 2021;60(2):820-828

  The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries

  Courvoisier DS; Chatzidionysiou K; Mongin D; Lauper K; Mariette X; Morel J; Gottenberg J-E; Bergstra SA; Suarez MP; Codreanu C; Kvien TK; Santos MJ; Pavelka K; Hetland ML; Askling J; Turesson C; Kubo S; Tanaka Y; Iannone F; Choquette D; Nordstrom DC; Rotar Z; Lukina G; Gabay C; Van Vollenhoven R; Finckh A
• Article: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2021;51(1):331-337

  Overall and site-specific cancer before and after diagnosis of idiopathic inflammatory myopathies: A nationwide study 2002-2016

  Dani L; Che WI; Lundberg IE; Hellgren K; Holmqvist M
• Journal article: BIOMATERIALS. 2021;269:120461

  Treating brain diseases using systemic parenterally-administered protein therapeutics: Dysfunction of the brain barriers and potential strategies

  Zaghmi A; Drouin-Ouellet J; Brambilla D; Gauthier MA
• Article: FRONTIERS IN MEDICINE. 2021;8:788243

  Cardiovascular Autonomic Function Changes and Predictors During a 2-Year Physical Activity Program in Rheumatoid Arthritis: A PARA 2010 Substudy

  Hupin D; Sarajlic P; Venkateshvaran A; Friden C; Nordgren B; Opava CH; Lundberg IE; Baeck M
• Editorial comment: FRONTIERS IN PHARMACOLOGY. 2021;12:707811

  Editorial: Traditional Medicine and Rheumatology

  Yang Z; Tang X; Liang H; Gao K; Wang M; He X; Jakobsson P-J; Huang R
• Article: FRONTIERS IN MEDICINE. 2021;8:651249

  Adverse Health-Related Quality of Life Outcome Despite Adequate Clinical Response to Treatment in Systemic Lupus Erythematosus

  Gomez A; Qiu V; Cederlund A; Borg A; Lindblom J; Emamikia S; Enman Y; Lampa J; Parodis I
• Article: FRONTIERS IN IMMUNOLOGY. 2021;12:627986

  A Comprehensive Evaluation of the Relationship Between Different IgG and IgA Anti-Modified Protein Autoantibodies in Rheumatoid Arthritis

  Gronwall C; Liljefors L; Bang H; Hensvold AH; Hansson M; Mathsson-Alm L; Israelsson L; Joshua V; Svard A; Stalesen R; Titcombe PJ; Steen J; Piccoli L; Sherina N; Clavel C; Svenungsson E; Gunnarsson I; Saevarsdottir S; Kastbom A; Serre G; Alfredsson L; Malmstrom V; Ronnelid J; Catrina AI; Lundberg K; Klareskog L
• Article: COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL. 2021;19:5360-5370

  A rapid CRISPR competitive assay for in vitro and in vivo discovery of potential drug targets affecting the hematopoietic system

  Shen Y; Jiang L; Iyer VS; Raposo B; Dubnovitsky A; Boddul SV; Kasza Z; Wermeling F
• Article: JOURNAL OF RHEUMATOLOGY. 2021;48(1):94-100

  Functional Index-3: A Valid and Reliable Functional Outcome Assessment Measure in Patients With Dermatomyositis and Polymyositis

  Ernste FC; Chong C; Crowson CS; Kermani TA; Mhuircheartaigh ON; Alexanderson H
• Article: JOURNAL OF TRANSLATIONAL AUTOIMMUNITY. 2021;4:100087

  In vitro and ex vivo functional characterization of human HLA-DRB1*04 restricted T cell receptors

  Boddul SV; Sharma RK; Dubnovitsky A; Raposo B; Gerstner C; Shen Y; Iyer VS; Kasza Z; Kwok WW; Winkler AR; Klareskog L; Malmstrom V; Bettini M; Wermeling F
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2021;73:62-63

  Arthritis Progression in at Risk Individuals Is Associated with ACPAs Not AMPAs

  Circiumaru A; Kisten Y; Hansson M; Wahamaa H; Sun M; Joshua V; Rezaei H; Af Klint E; Antovic A; Catrina A; Hensvold AH
• Conference publication: EUROPEAN JOURNAL OF IMMUNOLOGY. 2021;51:397

  A rapid CRISPR competitive assay for in vitro and in vivo discovery of potential drug targets affecting the hematopoietic system

  Shen Y; Jiang L; Iyer VS; Raposo B; Boddul SV; Kasza Z; Wermeling F
• Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2021;94(6)

  Proteinase 3 reactive CD4+T cells and their TCR repertoire in ANCA associated vasculitis

  Kumar R; Yoosuf N; Scheffschick A; Avik A; Bartoletti A; Raposo B; Boddul S; Jonasdottir A; Lovstrom B; Chemin K; Bruchfeld A; Gunnarsson I; Malmstrom V
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2021;73:1440-1441

  Patients with Recent Onset, Active Polymyositis (PM), Dermatomyositis (DM) and Antisynthetase Syndrome (ASS) Have Reduced Muscle Endurance but Not Reduced Muscle Strength Compared to Patients with Established, Low-active Disease

  Andreasson K; Alexanderson H
• Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2021;50:63-64

  Patients with idiopathic inflammatory myopathies who report low levels of physical activity also report higher levels of anxiety and depression: a cross-sectional study of self-reported data

  Andreasson K; Sandlund H; Alexanderson H
• Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2021;50:62-63

  Patients with recent-onset, active polymyositis, dermatomyositis, and anti-synthetase syndrome have reduced muscle endurance but not reduced muscle strength compared to patients with established, low-active disease

  Andreasson K; Sandlund H; Alexanderson H
• Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2021;50:45-46

  Impact of overweight and obesity on patient-reported health-related quality of life in systemic lupus erythematosus

  Gomez A; Butrus FH; Johansson P; Akerstrom E; Soukka S; Komujuni SK; Enman Y; Pettersson S; Parodis I
• Conference publication: EUROPEAN JOURNAL OF IMMUNOLOGY. 2021;51:141

  Identification and characterization of antigen specific CD4+T-cells in patients with Jo1+myositis

  Horuluoglu B; Feria ASG; Chemin K; Kozukh G; Dubnovitsky A; Malmstrom V; Lundberg IE
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2021;73:1414-1416

  Detection of Autoantibodies Against Muscle-Specific Four-and-a-Half-LIM Domain 1 (FHL1) in Inflammatory Myopathies: Results from a Single-Center Cohort

  Galindo-Feria AS; Horuluoglu B; Day J; Cerqueira C; Wigren E; Graslund S; Proudman S; Lundberg IE; Limaye V
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2021;73:3164-3165

  Investigation of Antigen Specific CD4⁺ T Cells in Patients with Idiopathic Inflammatory Myopathies

  Horuluoglu B; Galindo-Feria AS; Chemin K; Kozhukh G; Dubnovitsky A; Malmstrom V; Lundberg IE
• Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2021;50:67

  Detection of autoantibodies against muscle-specific four-and-a-half-LIM domain-1 (FHL1) in inflammatory myopathies: results from a single-centre cohort

  Galindo-Feria AS; Horuluoglu B; Proudman S; Day J; Wigren E; Graslund S; Fernandes-Cerqueira C; Lundberg IE; Limaye V
• Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2021;50:49-50

  Myositis-specific and myositis-associated autoantibodies predict trajectories of damage over time in idiopathic inflammatory myopathies

  Espinosa-Ortega F; Holmqvist M; Lodin K; Dastmalchi M; Danieli MG; Venkovsky J; Knitza J; Oliveira S; Diederichsen LP; Wedderburn L; Andersson H; del Mercado MV; Gomez-Martin D; Torres J; Callaghan ASO; Benveniste O; De Visser M; De Bleecker J; McCann L; De Langhe E; Rietveld A; Chinoy H; Krogh NS; Alexanderson H; Lundberg IE
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2021;73:2699-2700

  Associations Between Early Changes in Circulating B Cell Subsets and Severe Flare in Systemic Lupus Erythematosus -Results from Three Phase III Trials of Belimumab

  Parodis I; Gomez A; Lindblom J; Borg A; Emamikia S; Gatto M
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2021;73:2695-2696

  Early Increase in Circulating Memory B Cells Portends Clinical Response to Treatment in Pooled Data from Three Phase III Trials of Belimumab

  Parodis I; Gomez A; Lindblom J; Borg A; Emamikia S; Gatto M
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2021;73:2604-2606

  The Impact of Remission and Low Disease Activity Attainment on Health-related Quality of Life in Two Phase III Clinical Trials of Belimumab in Systemic Lupus Erythematosus

  Emamikia S; Oon S; Gomez A; Lindblom J; Borg A; Enman Y; Morand E; Grannas D; van Vollenhoven R; Nikpour M; Parodis I
• Review: METHODS IN MOLECULAR BIOLOGY. 2021;2197:51-85

  CpG Oligonucleotides as Vaccine Adjuvants.

  Kayraklioglu N; Horuluoglu B; Klinman DM
• Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2021;50:41-42

  De novo lupus nephritis in patients receiving belimumab therapy

  Parodis I; Vital EM; Jonsen A; Hassan SU; Leonard D; Eriksson P; Bengtsson AA; Gunnarsson I; Ronnblom L; Sjowall C
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2021;73:2586-2588

  Serum B Cell Activating Factor Reflects Good EULAR Response to TNF Inhibition in Patients with Rheumatoid Arthritis

  Hernandez-Breijo B; Parodis I; Plasencia-Rodriguez C; Diaz-Almiron M; Martinez-Feito A; Novella-Navarro M; Pascual-Salcedo D; Balsa A
• Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2021;50:1-2

  THURSDAY SESSION Abstracts

  Parodis I; Adamichou C; Aydin S; Gomez A; Demoulin N; Weinmann-Menke J; Houssiau FA; Tamirou F
• Journal article: COMMUNICATIONS BIOLOGY. 2020;3(1):729

  Sustained blood glutamate scavenging enhances protection in ischemic stroke

  Zaghmi A; Dopico-Lopez A; Perez-Mato M; Iglesias-Rey R; Hervella P; Greschner AA; Bugallo-Casal A; da Silva A; Gutierrez-Fernandez M; Castillo J; Perez FC; Gauthier MA
• Article: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2020;50(6):1387-1393

  Lymphopenia as a risk factor for neurologic involvement and organ damage accrual in patients with systemic lupus erythematosus: A multi-center observational study

  Yavuz S; Cansu DU; Nikolopoulos D; Crisafulli F; Antunes AM; Adamichou C; Reid S; Stagnaro C; Andreoli L; Tincani A; Moraes-Fontes MF; Mosca M; Leonard D; Jonsen A; Bengtsson A; Svenungsson E; Gunnarsson I; Dahlqvist SR; Sjowall C; Bertsias G; Fanouriakis A; Ronnblom L
• Letter: THE LANCET RESPIRATORY MEDICINE. 2020;8(12):e90-e91

  An ode to the primal tonic of dance-congratulating the Life of Breath project

  Saketkoo LA; Alexanderson H; Lammi MR; LeSage D; Jensen K; Scholand MB; Volkmann ER; Russell A-M
• Article: ARTHRITIS CARE AND RESEARCH. 2020;72(12):1800-1808

  Economic Evaluation of Damage Accrual in an International Systemic Lupus Erythematosus Inception Cohort Using a Multistate Model Approach.

  Barber MRW; Hanly JG; Su L; Urowitz MB; St Pierre Y; Romero-Diaz J; Gordon C; Bae S-C; Bernatsky S; Wallace DJ; Merrill JT; Isenberg DA; Rahman A; Ginzler EM; Petri M; Bruce IN; Dooley MA; Fortin PR; Gladman DD; Sanchez-Guerrero J; Steinsson K; Ramsey-Goldman R; Khamashta MA; Aranow C; Mackay M; Alarcón GS; Manzi S; Nived O; Jönsen A; Zoma AA; van Vollenhoven RF; Ramos-Casals M; Ruiz-Irastorza G; Lim SS; Kalunian KC; Inanc M; Kamen DL; Peschken CA; Jacobsen S; Askanase A; Farewell V; Stoll T; Buyon J; Clarke AE
• Preprint: BIORXIV. 2020

  Persistence of SARS-CoV-2 specific B- and T-cell responses in convalescent COVID-19 patients 6-8 months after the infection

  Sherina N; Piralla A; Du L; Wan H; Kumagai-Braesh M; Andréll J; Braesch-Andersen S; Cassaniti I; Percivalle E; Sarasini A; Bergami F; Di Martino R; Colaneri M; Vecchia M; Sambo M; Zuccaro V; Bruno R; Oggionni T; Meloni F; Abolhassani H; Bertoglio F; Schubert M; Byrne-Steele M; Han J; Hust M; Xue Y; Hammarström L; Baldanti F; Marcotte H; Pan-Hammarström Q
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2020;79(11):e153

  Response to: 'Semi-quantitative analysis of line blot assay for myositis-specific and myositis-associated antibodies: a better performance?' by Cavazzana et al

  Ronnelid J; Espinosa-Ortega F; Lundberg IE
• Article: RHEUMATOLOGY. 2020;59(11):3424-3434

  Per-protocol repeat kidney biopsy portends relapse and long-term outcome in incident cases of proliferative lupus nephritis

  Parodis I; Adamichou C; Aydin S; Gomez A; Demoulin N; Weinmann-Menke J; Houssiau FA; Tamirou F
• Thesis / dissertation: 2020

  Studies on pathogenesis, clinical features and comorbidities of idiopathic inflammatory myopathies

  Notarnicola, Antonella
• Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2020;295(41):13981-13993

  Generation and validation of recombinant antibodies to study human aminoacyl-tRNA synthetases

  Preger C; Wigren E; Ossipova E; Marks C; Lengqvist J; Hofstrom C; Andersson O; Jakobsson P-J; Graslund S; Persson H
• Article: ARTHRITIS & RHEUMATOLOGY. 2020;72(10):1658-1667

  Anti-Citrullinated Protein Antibody Specificities, Rheumatoid Factor Isotypes, and Incident Cardiovascular Events in Patients With Rheumatoid Arthritis

  Westerlind H; Ronnelid J; Hansson M; Alfredsson L; Mathsson-Alm L; Serre G; Cornillet M; Holmdahl R; Jakobsson P-J; Skriner K; Klareskog L; Saevarsdottir S; Askling J
• Article: CARDIOVASCULAR RESEARCH (CVR). 2020;116(12):1972-1980

  Mechanistic definition of the cardiovascular mPGES-1/COX-2/ADMA axis

  Kirkby NS; Raouf J; Ahmetaj-Shala B; Liu B; Mazi SI; Edin ML; Chambers MG; Korotkova M; Wang X; Wahli W; Zeldin DC; Nusing R; Zhou Y; Jakobsson P-J; Mitchell JA
• Article: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2020;50(5):943-948

  Assessing the content validity of patient-reported outcome measures in adult myositis: A report from the OMERACT myositis working group

  Esfandiary T; Park JK; Alexanderson H; Regardt M; Needham M; de Groot I; Sarver C; Lundberg IE; de Visser M; Song YW; DiRenzo D; Bingham COIII; Christopher-Stine L; Mecoli CA
• Article: JOURNAL OF RHEUMATOLOGY. 2020;47(10):1584-1586

  Proceedings of the 2019 Canadian Inflammatory Myopathy Study Symposium: Clinical Trial Readiness in Myositis.

  Leclair V; Landon-Cardinal O; Aggarwal R; Bansback N; Campbell C; Feldman BM; Jarry M; McNamara S; White B; Hudson M; CIMS Investigators
• Review: CURRENT VASCULAR PHARMACOLOGY. 2020;18(6):549-565

  Cardiovascular Disease in Systemic Lupus Erythematosus: Recent Data on Epidemiology, Risk Factors and Prevention

  Kostopoulou M; Nikolopoulos D; Parodis I; Bertsias G
• Preprint: RESEARCH SQUARE. 2020

  BAFF Predicts Immunogenicity in Older Patients With Rheumatoid Arthritis Treated With TNF Inhibitors

  Hernández-Breijo B; Navarro-Compán V; Plasencia-Rodríguez C; Parodis I; Gehin JE; Martínez-Feito A; Novella-Navarro M; Mezcua A; Warren DJ; Nozal P; Pascual-Salcedo D; Balsa A
• Article: AMERICAN JOURNAL OF HUMAN GENETICS. 2020;107(3):527-538

  Myeloperoxidase Modulates Inflammation in Generalized Pustular Psoriasis and Additional Rare Pustular Skin Diseases

  Haskamp S; Bruns H; Hahn M; Hoffmann M; Gregor A; Loehr S; Hahn J; Schauer C; Ringer M; Flamann C; Frey B; Lesner A; Thiel CT; Ekici AB; von Hoersten S; Assmann G; Riepe C; Euler M; Schaekel K; Philipp S; Prinz JC; Moessner R; Kersting F; Sticherling M; Sefiani A; Lyahyai J; Sondermann W; Oji V; Schulz P; Wilsmann-Theis D; Sticht H; Schett G; Reis A; Uebe S; Frey S; Hueffmeier U
• Article: MEDITERRANEAN JOURNAL OF RHEUMATOLOGY. 2020;31(Suppl 2):247-252

  The Rheumatologist's Role in the Battle Against COVID-19: Insights from the Front Line and Challenges for the Future.

  Koutsianas C; Chatzidionysiou K
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2020;38(5):841-847

  Validation of new classification criteria of rheumatoid arthritis in an international multicentre study

  Li R; Sun X; Ye H; Liu J; Zhao J; Liu X; Mei Y; Zhang Z; Guo J; Bi L; Wang G; Leng X; Gu F; Sun L; Zou Q; Fang Y; Jiang Q; Chatzidionysiou K; Priya S; Janardana R; Nair A; Catrine AI; Danda D; Li ZG
• Article: RHEUMATOLOGY. 2020;59(9):2237-2249

  ALCAM and VCAM-1 as urine biomarkers of activity and long-term renal outcome in systemic lupus erythematosus

  Parodis I; Gokaraju S; Zickert A; Vanarsa K; Zhang T; Habazi D; Botto J; Alves CS; Giannopoulos P; Larsson A; Svenungsson E; Gunnarsson I; Mohan C
• Article: RMD OPEN. 2020;6(2):e001363

  How do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registers

  Chatzidionysiou K; Delcoigne B; Frisell T; Hetland ML; Glintborg B; Dreyer L; Cordtz R; Zobbe K; Nordstrom D; Trokovic N; Aaltonen K; Provan SA; Grondal G; Gudbjornsson B; Askling J
• Article: RMD OPEN. 2020;6(2):e001278

  Association between number and type of different ACPA fine specificities with lung abnormalities in early, untreated rheumatoid arthritis

  Joshua V; Hensvold AH; Reynisdottir G; Hansson M; Cornillet M; Nogueira L; Serre G; Nyren S; Karimi R; Eklund A; Skold M; Grunewald J; Chatzidionysiou K; Catrina A
• Article: RMD OPEN. 2020;6(2):e001357

  Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodies.

  Landon-Cardinal O; Baril-Dionne A; Hoa S; Meyer A; Leclair V; Bourré-Tessier J; Mansour A-M; Zarka F; Makhzoum J-P; Nehme J; Rich E; Goulet J-R; Grodzicky T; Koenig M; Joyal F; Richard I; Hudson M; Targoff I; Satoh M; Fritzler MJ; Troyanov Y; Senécal J-L
• Article: JOURNAL OF RHEUMATOLOGY. 2020;47(9):1392-1396

  Reproductive Pattern in Women with Idiopathic Inflammatory Myopathy: A Population-based Study

  Che WI; Hellgren K; Lundberg IE; Holmqvist M
• Article: RHEUMATOLOGY. 2020;59(9):2572-2580

  Pregnancy outcomes in women with idiopathic inflammatory myopathy, before and after diagnosis-a population-based study

  Che WI; Hellgren K; Stephansson O; Lundberg IE; Holmqvist M
• Journal article: MEDITERRANEAN JOURNAL OF RHEUMATOLOGY. 2020;31(3):330

  Interstitial Pneumonia with Autoimmune Features (IPAF): A Single-Centre, Prospective Study.

  Karampeli M; Thomas K; Flouda S; Chavatza A; Nikolopoulos D; Pieta A; Tseronis D; Aggelakos M; Kassara D; Tzavara V; Katsimbri P; Boumpas D; Karageorgas T
• Journal article: MEDITERRANEAN JOURNAL OF RHEUMATOLOGY. 2020;31(3):366

  Mitophagy Balance in Various Cell Subsets in Patients with ANCA-Associated Vasculitis and Correlation with the Presence of Anti-Neutrophil Cytoplasmic Antibodies.

  Banos A; Thomas K; Garantziotis P; Malissovas N; Filia A; Pieta A; Nikolopoulos D; Moustafa S; Panagiotopoulos A; Boumpas DT; Vassilopoulos D
• Preprint: RESEARCH SQUARE. 2020

  Molecular Biomarkers of Anti-TNF Response in Patients with Rheumatoid Arthritis

  Yoosuf N; Maciejewski M; Ziemek D; Jelinsky S; Folkersen L; Müller M; Sahlström P; Vivar N; Catrina A; Berg L; Klareskog L; Padyukov L; Brynedal B
• Preprint: RESEARCH SQUARE. 2020

  Effects of a two-year health-enhancing physical activity program on skeletal muscle protein profiles in people with rheumatoid arthritis

  Ossipova E; Idborg H; Fridén C; Jakobsson P-J; Kosek E; Malm C; Nordgren B; Opava C; Tegner Y; Vanluyten J; Korotkova M; Lundberg I
• Article: NEUROLOGICAL RESEARCH. 2020;42(8):670-675

  An evidence of brain-heart disorder: mental stress-induced myocardial ischemia regulated by inflammatory cytokines

  Liu M; Liu J; Zhang L; Xu W; He D; Wei W; Ge Y; Dandu C
• Article: THE FASEB JOURNAL. 2020;34(8):11101-11114

  Establishment of an in vitro 3D model for neuroblastoma enables preclinical investigation of combined tumor-stroma drug targeting

  Kock A; Bergqvist F; Steinmetz J; Elfman LHM; Korotkova M; Johnsen JI; Jakobsson P-J; Kogner P; Larsson K
• Article: PHYTOCHEMISTRY LETTERS. 2020;38:6-11

  Bisabolane sesquiterpenes from the leaves of Lindera benzoin reduce prostaglandin E2 formation in A549 cells

  Ryen AH; Goels T; Steinmetz J; Tahir A; Jakobsson P-J; Backlund A; Urban E; Glasl S
• Article: ACS OMEGA. 2020;5(28):17242-17254

  Descriptive Proteome Analysis to Investigate Context-Dependent Treatment Responses to OXPHOS Inhibition in Colon Carcinoma Cells Grown as Monolayer and Multicellular Tumor Spheroids

  Steinmetz J; Senkowski W; Lengqvist J; Rubin J; Ossipova E; Herman S; Larsson R; Jakobsson P-J; Fryknas M; Kultima K
• Article: ARTHRITIS RESEARCH & THERAPY. 2020;22(1):170

  Presence of autoantibodies in "seronegative" rheumatoid arthritis associates with classical risk factors and high disease activity

  Reed E; Hedstrom AK; Hansson M; Mathsson-Alm L; Brynedal B; Saevarsdottir S; Cornillet M; Jakobsson P-J; Holmdahl R; Skriner K; Serre G; Alfredsson L; Ronnelid J; Lundberg K
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2020;79(7):e86

  Response to: 'Comment on: 'Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria' by Greco et al' by Knitza et al

  Tjarnlund A; Lundberg IE
• Article: RMD OPEN. 2020;6(2):e001183

  Strategies for the assessment of competences during rheumatology training across Europe: results of a qualitative study.

  Najm A; Alunno A; Sivera F; Ramiro S; Haines C; Working Group on Training in Rheumatology across E
• Letter: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2020;140(7):1451-1455.e13

  Rare Loss -of -Function Mutation in SERPINA3 in Generalized Pustular Psoriasis

  Frey S; Sticht H; Wilsmann-Theis D; Gerschuetz A; Wolf K; Loehr S; Haskamp S; Frey B; Hahn M; Ekici AB; Uebe S; Thiel C; Reis A; Burkhardt H; Behrens F; Koehm M; Rech J; Schett G; Assmann G; Kingo K; Koks S; Moessner R; Prinz JC; Oji V; Schulz P; Munoz LE; Kremer AE; Wenzel J; Hueffmeier U
• Article: JOURNAL OF CLINICAL MEDICINE. 2020;9(6):E1813-1813

  Use of Antimalarial Agents Is Associated with Favourable Physical Functioning in Patients with Systemic Lupus Erythematosus

  Gomez A; Soukka S; Johansson P; Akerstrom E; Emamikia S; Enman Y; Chatzidionysiou K; Parodis I
• Review: MEDITERRANEAN JOURNAL OF RHEUMATOLOGY. 2020;31(Suppl 1):120-128

  Beyond Methotrexate and Biologics in RA - Efficacy of JAK Inhibitors and their Place in the Current Treatment Armamentarium.

  Chatzidionysiou K
• Article: MUSCULOSKELETAL CARE. 2020;18(2):150-160

  Experiences of physical activity and exercise in individuals with systemic sclerosis: A qualitative study

  Pettersson H; Nordin A; Svenungsson E; Alexanderson H; Bostrom C
• Review: ANNALS OF THE RHEUMATIC DISEASES. 2020;79(6):685-699

  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

  Smolen JS; Landewe RBM; Bijlsma JWJ; Burmester GR; Dougados M; Kerschbaumer A; McInnes IB; Sepriano A; van Vollenhoven RF; de Wit M; Aletaha D; Aringer M; Askling J; Balsa A; Boers M; den Broeder AA; Buch MH; Buttgereit F; Caporali R; Cardiel MH; De Cock D; Codreanu C; Cutolo M; Edwards CJ; van Eijk-Hustings Y; Emery P; Finckh A; Gossec L; Gottenberg J-E; Hetland ML; Huizinga TWJ; Koloumas M; Li Z; Mariette X; Mueller-Ladner U; Mysler EF; da Silva JAP; Poor G; Pope JE; Rubbert-Roth A; Ruyssen-Witrand A; Saag KG; Strangfeld A; Takeuchi T; Voshaar M; Westhovens R; van der Heijde D
• Review: CLINICA CHIMICA ACTA. 2020;505:108-118

  Nrf2 in early vascular ageing: Calcification, senescence and therapy

  Arefin S; Buchanan S; Hobson S; Steinmetz J; Alsalhi S; Shiels PG; Kublickiene K; Stenvinkel P
• Review: ANNALS OF THE RHEUMATIC DISEASES. 2020;79(6):713-723

  2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis

  Fanouriakis A; Kostopoulou M; Cheema K; Anders H-J; Aringer M; Bajema I; Boletis J; Frangou E; Houssiau FA; Hollis J; Karras A; Marchiori F; Marks SD; Moroni G; Mosca M; Parodis I; Praga M; Schneider M; Smolen JS; Tesar V; Trachana M; van Vollenhoven RF; Voskuyl AE; Teng YKO; van Leew B; Bertsias G; Jayne D; Boumpas DT
• Article: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2020;50(3):492-497

  Performance of the new EULAR/ACR classification criteria for idiopathic inflammatory myopathies (IIM) in a large monocentric IIM cohort

  Barsotti S; Dastmalchi M; Notarnicola A; Leclaire V; Dani L; Gheorghe K; Ekholm L; Bottai M; Tjarnlund A; Lundberg IE
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2020;79:762-763

  SIMILAR CARDIOVASCULAR COMORBIDITY AND HIGHER DEPRESSION RATES IN PSORIATIC ARTHRITIS COMPARED TO AGE- AND SEX-MATCHED RHEUMATOID ARTHRITIS AND DIABETES MELLITUS PATIENTS

  Fragoulis GE; Evangelatos G; Tentolouris N; Fragkiadaki K; Panopoulos S; Konstantonis G; Iliopoulos A; Chatzidionysiou K; Sfikakis P; Tektonidou M
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2020;79:200-201

  ACPA-INDUCED PAIN-BEHAVIOR, BONE LOSS AND TENDON INFLAMMATION IN MICE: A NOVEL MODEL FOR THE PRE-DISEASE PHASES OF ACPA-POSITIVE RHEUMATOID ARTHRITIS

  Krishnamurthy A; Kisten Y; Circiumaru A; Sakurabas K; Jarvolli P; Andrade JJJ; Damberg P; Wahamaa H; Malmstrom V; Klareskog L; Svensson C; Rethi B; Catrina A
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2020;79:1265

  PATIENTS WITH INFLAMMATORY MYOPATHIES WHO DO NOT REACH HEALTH ENHANCING LEVELS OF PHYSICAL ACTIVITY REPORT HIGHER LEVELS OF ANXIETY AND DEPRESSION - A CROSS-SECTIONAL STUDY OF SELF-REPORTED DATA

  Andreasson K; Sandlund H; Alexanderson H
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2020;79:664-665

  ASSOCIATION OF OVERWEIGHT/OBESITY WITH IMPAIRED HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

  Gomez A; Butrus FH; Johansson P; Akerstrom E; Soukka S; Emamikia S; Enman Y; Pettersson S; Parodis I
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2020;79:398-399

  AUTOANTIBODIES CAN PARTLY PREDICT SEVERITY OF DAMAGE BUT NOT EXTENT IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOSITIS

  Espinosa-Ortega F; Holmqvist M; Dastmalchi M; Mammen A; Lundberg IE; Alexanderson H
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2020;79:1247

  SPECIFIC ACPA REACTIVITIES AND INFLAMMATORY BIOMARKERS ALONG WITH ULTRASOUND TENOSYNOVITIS ARE ASSOCIATED WITH ARTHRITIS ONSET IN A POPULATION AT RISK FOR RHEUMATOID ARTHRITIS

  Circiumaru A; Kisten Y; Hansson M; Joshua V; Sun M; Rezaei H; Af Klint E; Antovic A; Catrina A; Hensvold A
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2020;79:1004.1-101004

  COMPARATIVE RISK OF CANCER ASSOCIATED WITH FIRST-LINE DMARDS USE IN RHEUMATOID ARTHRITIS: REAL WORLD EVIDENCE FROM THE OHDSI NETWORK

  Duarte-Salles T; Recalde M; Weaver J; Burn E; Marinier K; Diaz Y; Illingens B; Vizcaya D; Chatzidionysiou K; Ryan P; Prieto-Alhambra D
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2020;79:134.2-13134

  DEVELOPMENT AND VALIDATION OF PATIENT-LEVEL PREDICTION MODELS FOR ADVERSE HEALTH OUTCOMES AMONGST ADULT RA PATIENTS INITIATING FIRST-LINE TREATMENT OF METHOTREXATE MONOTHERAPY: A MULTINATIONAL REAL-WORLD COHORT ANALYSIS INCLUDING 164,735 SUBJECTS

  Yang C; Williams R; Swerdel J; Jani M; Duarte-Salles T; Chatzidionysiou K; Prieto-Alhambra D; Ryan P; Rijnbeek P
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2020;79:331.1-33331

  FIRST LINE TREATMENT WITH CONVENTIONAL SYNTHETIC DISEASE MODIFYING ANTIRHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS: A MULTINATIONAL POPULATION-BASED COHORT FROM 14 REAL WORLD HEALTHCARE DATABASES AND 9 COUNTRIES - REALITY VERSUS GUIDELINES

  Sena AG; Granados D; Hughes N; Fakhouri W; Hottgenroth A; Kolde R; Reisberg S; Torre CO; Duarte-Salles T; Diaz Y; Golib-Dzib JF; Brouwer ES; Burn E; Lane J; Vizcaya D; Wirta SB; De Wilde M; Verhamme K; Rijnbeek P; Theander E; Chatzidionysiou K; Prieto-Alhambra D; Ryan P
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2020;79:297

  BAFF CONTRIBUTES TO THE DEVELOPMENT OF IMMUNOGENICITY IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TNF INHIBITORS

  Hernandez-Breijo B; Parodis I; Gehin J; Plasencia C; Navarro-Compan V; Martinez-Feito A; Warren DJ; Mezcua A; Novella-Navarro M; Nozal P; Balsa A
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2020;79:102-103

  2019 UPDATE OF THE JOINT EUROPEAN LEAGUE AGAINST RHEUMATISM AND EUROPEAN RENAL ASSOCIATION-EUROPEAN DIALYSIS AND TRANSPLANT ASSOCIATION (EULAR/ERA-EDTA) RECOMMENDATIONS FOR THE MANAGEMENT OF LUPUS NEPHRITIS

  Fanouriakis A; Kostopoulou M; Cheema K; Anders HJ; Aringer M; Bajema I; Boletis JN; Frangou E; Houssiau F; Hollis J; Karras A; Marchiori F; Marks S; Moroni G; Mosca M; Parodis I; Praga M; Schneider M; Smolen JS; Tesar V; Trachana M; Vollenhoven RV; Voskuyl A; Teng YKO; Van Leeuw B; Bertsias G; Jayne D; Boumpas D
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2020;79:347

  GLOMERULAR AND TUBULOINTERSTITIAL LESIONS IN PER-PROTOCOL REPEAT BUT NOT BASELINE KIDNEY BIOPSY PORTEND RELAPSE AND LONG-TERM RENAL FUNCTION IMPAIRMENT, RESPECTIVELY, IN INCIDENT CASES OF PROLIFERATIVE LUPUS NEPHRITIS

  Parodis I; Adamichou C; Aydin S; Gomez A; Demoulin N; Weinmann-Menke J; Houssiau F; Tamirou F
• Journal article: LUPUS SCIENCE AND MEDICINE. 2020;7(1):e000394

  Transition to severe phenotype in systemic lupus erythematosus initially presenting with non-severe disease: implications for the management of early disease

  Nikolopoulos DS; Kostopoulou M; Pieta A; Flouda S; Chavatza K; Banos A; Boletis J; Katsimbri P; Boumpas DT; Fanouriakis A
• Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2020;21(10):E3463-3463

  Autoantibody and Cytokine Profiles during Treatment with Belimumab in Patients with Systemic Lupus Erythematosus

  Parodis I; Akerstrom E; Sjowall C; Sohrabian A; Jonsen A; Gomez A; Frodlund M; Zickert A; Bengtsson AA; Roennelid J; Gunnarsson I
• Article: LAKARTIDNINGEN. 2020;117:FXMD

  ABC om cancer utan känd primärtumör.

  Lodin K; Söderholm R; Carstens H
• Article: HAEMATOLOGICA. 2020;105(5):1339-1350

  An intronic deletion in megakaryoblastic leukemia 1 is associated with hyperproliferation of B cells in triplets with Hodgkin lymphoma

  Record J; Sendel A; Kritikou JS; Kuznetsov NV; Brauner H; He M; Nagy N; Oliveira MMS; Griseti E; Haase CB; Dahlstrom J; Boddul S; Wermeling F; Thrasher AJ; Liu C; Andersson J; Claesson H-E; Winqvist O; Burns SO; Bjorkholm M; Westerberg LS
• Article: RHEUMATOLOGY. 2020;59(5):1026-1030

  Identification of a novel autoantigen eukaryotic initiation factor 3 associated with polymyositis

  Betteridge Z; Chinoy H; Vencovsky J; Winer J; Putchakayala K; Ho P; Lundberg I; Danko K; Cooper R; McHugh N
• Letter: LUPUS SCIENCE AND MEDICINE. 2020;7(1):e000415

  Could severe COVID-19 be considered a complementopathy?

  Chatzidionysiou K; Svenungsson E; Faustini F
• Article: SCIENCE TRANSLATIONAL MEDICINE. 2020;12(540):eaay0605

  An anti-inflammatory eicosanoid switch mediates the suppression of type-2 inflammation by helminth larval products

  Jimenez MDLR; Lechner A; Alessandrini F; Bohnacker S; Schindela S; Trompette A; Haimerl P; Thomas D; Henkel F; Mourao A; Geerlof A; da Costa CP; Chaker AM; Bruene B; Nuesing R; Jakobsson P-J; Nockher WA; Feige MJ; Haslbeck M; Ohnmacht C; Marsland BJ; Voehringer D; Harris NL; Schmidt-Weber CB; Esser-von Bieren J
• Article: SCIENTIFIC REPORTS. 2020;10(1):6078

  PAM3 protects against DSS-induced colitis by altering the M2:M1 ratio

  Horuluoglu BH; Kayraklioglu N; Tross D; Klinman D
• Review: BEST PRACTICE AND RESEARCH: CLINICAL RHEUMATOLOGY. 2020;34(2):101547

  Exercise therapy in patients with idiopathic inflammatory myopathies and systemic lupus erythematosus - A systematic literature review

  Alexanderson H; Bostrom C
• Review: PROSTAGLANDINS AND OTHER LIPID MEDIATORS. 2020;147:106383

  A review on mPGES-1 inhibitors: From preclinical studies to clinical applications

  Bergqvist F; Morgenstern R; Jakobsson P-J
• Article: ARTHRITIS & RHEUMATOLOGY. 2020;72(4):658-666

  Prediction of Damage Accrual in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index

  Legge A; Kirkland S; Rockwood K; Andreou P; Bae S-C; Gordon C; Romero-Diaz J; Sanchez-Guerrero J; Wallace DJ; Bernatsky S; Clarke AE; Merrill JT; Ginzler EM; Fortin PR; Gladman DD; Urowitz MB; Bruce IN; Isenberg DA; Rahman A; Alarcon GS; Petri M; Khamashta MA; Dooley MA; Ramsey-Goldman R; Manzi S; Zoma AA; Aranow C; Mackay M; Ruiz-Irastorza G; Lim SS; Inanc M; van Vollenhoven RF; Jonsen A; Nived O; Ramos-Casals M; Kamen DL; Kalunian KC; Jacobsen S; Peschken CA; Askanase A; Hanly JG
• Journal article: LUPUS. 2020;29(5):514-522

  Evolving phenotype of systemic lupus erythematosus in Caucasians: low incidence of lupus nephritis, high burden of neuropsychiatric disease and increased rates of late-onset lupus in the 'Attikon' cohort

  Nikolopoulos D; Kostopoulou M; Pieta A; Karageorgas T; Tseronis D; Chavatza K; Flouda S; Rapsomaniki P; Banos A; Kremasmenou E; Tzavara V; Katsimbri P; Fanouriakis A; Boumpas DT
• Article: ARTHRITIS RESEARCH & THERAPY. 2020;22(1):56

  Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort

  Panopoulos S; Chatzidionysiou K; Tektonidou MG; Bournia VK; Drosos AA; Liossis S-NC; Dimitroulas T; Sakkas L; Boumpas D; Voulgari PV; Daoussis D; Thomas K; Georgiopoulos G; Vosvotekas G; Sidiropoulos P; Bertsias G; Vassilopoulos D; Sfikakis PP
• Article: BMC CARDIOVASCULAR DISORDERS. 2020;20(1):141

  The important effect of 5-HTTLPR polymorphism on the risk of depression in patients with coronary heart disease: a meta-analysis

  Zhang L-J; Zeng X-T; Zhao M-J; He D-F; Liu J-Y; Liu M-Y
• Article: MEDITERRANEAN JOURNAL OF RHEUMATOLOGY. 2020;31(1):1-2

  Mediterranean Journal of Rheumatology March 2020 Highlights.

  Chatzidionysiou K
• Article: MEDITERRANEAN JOURNAL OF RHEUMATOLOGY. 2020;31(1):87-91

  Development and Implementation of a Pilot Registry for Monitoring the Efficacy and Safety of Novel Therapies in Patients with Systemic Lupus Erythematosus.

  Adamichou C; Flouri I; Fanouriakis A; Nikoloudaki M; Nikolopoulos D; Repa A; Boki K; Chatzidionysiou K; Garyfallos A; Boumpas D; Sidiropoulos P; Bertsias G
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2020;79(3):356-362

  Neuropsychiatric events in systemic lupus erythematosus: a longitudinal analysis of outcomes in an international inception cohort using a multistate model approach.

  Hanly JG; Urowitz MB; Gordon C; Bae S-C; Romero-Diaz J; Sanchez-Guerrero J; Bernatsky S; Clarke AE; Wallace DJ; Isenberg DA; Rahman A; Merrill JT; Fortin PR; Gladman DD; Bruce IN; Petri M; Ginzler EM; Dooley MA; Ramsey-Goldman R; Manzi S; Jönsen A; Alarcón GS; van Vollenhoven RF; Aranow C; Mackay M; Ruiz-Irastorza G; Lim S; Inanc M; Kalunian KC; Jacobsen S; Peschken CA; Kamen DL; Askanase A; Farewell V
• Article: BRAIN, BEHAVIOR, & IMMUNITY - HEALTH. 2020;3:100059

  Properties of the Sickness Questionnaire in an Australian sample with chronic medically unexplained symptoms

  Andreasson A; Mcnaughton D; Beath A; Lodin K; Wicksell RK; Lekander M; Jones MP
• Article: JOURNAL OF APPLIED LABORATORY MEDICINE. 2020;5(2):320-331

  Evaluation of a New Skeletal Troponin I Assay in Patients with Idiopathic Inflammatory Myopathies

  Bamberg K; Mehtala L; Arola O; Laitinen S; Nordling P; Strandberg M; Strandberg N; Paltta J; Mali M; Espinosa-Ortega F; Pirila L; Lundberg IE; Savukoski T; Pettersson K
• Review: CLINICAL RHEUMATOLOGY. 2020;39(3):957-961

  Lung cancer in rheumatoid arthritis. Is there a need for better risk assessment and screening?

  Fragoulis GE; Chatzidionysiou K
• Conference publication: LUPUS SCIENCE AND MEDICINE. 2020;7(Suppl 1):a113

  P170 Antimalarial agent use is associated with favourable physical functioning in patients with systemic lupus erythematosus

  Parodis I; Soukka S; Gomez A; Enman Y; Johansson P; Emamikia S; Chatzidionysiou K
• Conference publication: LUPUS SCIENCE AND MEDICINE. 2020;7(Suppl 1):a106

  P156 Accelerated coronary atherosclerosis – a major cause of myocardial infarction in systemic lupus erythematosus

  Samuelsson I; Parodis I; Gunnarsson I; Zickert A; Hofman-Bang C; Wallén H; Svenungsson E
• Conference publication: LUPUS SCIENCE AND MEDICINE. 2020;7(Suppl 1):a44

  P33 Cytokine and autoantibody profiles during treatment with belimumab in patients with systemic lupus erythematosus

  Parodis I; Åkerström E; Sjöwall C; Sohrabian A; Jönsen A; Gomez A; Frodlund M; Zickert A; Bengtsson AA; Rönnelid J; Gunnarsson I
• Conference publication: LUPUS SCIENCE AND MEDICINE. 2020;7(Suppl 1):a26-A27

  O34 Variants in BANK1 are associated with lupus nephritis

  Bolin K; Leonard D; Sandling JK; Alexsson A; Pucholt P; Haarhaus ML; Nititham J; Jönsen A; Sjöwall C; Bengtsson AA; Rantapää-Dahlqvist S; Svenungsson E; Gunnarsson I; Syvänen A-C; Lerang K; Troldborg A; Voss A; Molberg Ø; Jacobsen S; Criswell L; Rönnblom L; Nordmark G
• Conference publication: LUPUS SCIENCE AND MEDICINE. 2020;7(Suppl 1):a26

  O33 Per-protocol repeat kidney biopsy portends relapse and long-term outcome in incident cases of proliferative lupus nephritis

  Parodis I; Adamichou C; Aydin S; Gomez A; Demoulin N; Weinmann-Menke J; Houssiau FA; Tamirou F
• Conference publication: LUPUS SCIENCE AND MEDICINE. 2020;7(Suppl 1):a96

  P137 De novo lupus nephritis during belimumab treatment

  Parodis I; Vital EM; Jönsen A; Hassan S-U; Leonard D; Eriksson P; Bengtsson AA; Gunnarsson I; Rönnblom L; Sjöwall C
• Article: JCI INSIGHT. 2020;5(3):134189

  Neutrophil dysregulation is pathogenic in idiopathic inflammatory myopathies

  Seto N; Jiram Torres-Ruiz J; Carmona-Rivera C; Pinal-Fernandez I; Pak K; Purmalek MM; Hosono Y; Fernandes-Cerqueira C; Gowda P; Arnett N; Gorbach A; Benveniste O; Gomez-Martin D; Selva-O'Callaghan A; Milisenda JC; Grau-Junyent JM; Christopher-Stine L; Miller FW; Lundberg IE; Kahlenberg JM; Schiffenbauer AI; Mammen A; Rider LG; Kaplan MJ
• Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2020;117(6):3103-3113

  IL-4 controls activated neutrophil FcγR2b expression and migration into inflamed joints

  Panda SK; Wigerblad G; Jiang L; Jimenez-Andrade Y; Iyer VS; Shen Y; Boddul SV; Guerreiro-Cacais AO; Raposo B; Kasza Z; Wermeling F
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2020;79(2):304-307

  Effect of belimumab treatment on antiphospholipid antibody levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus

  Chatzidionysiou K; Samoli E; Sfikakis PP; Tektonidou MG
• Article: BRAIN, BEHAVIOR, & IMMUNITY - HEALTH. 2020;2:100028

  Patients with ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) and chronic pain report similar level of sickness behavior as individuals injected with bacterial endotoxin at peak inflammation

  Jonsjo MA; Astrom J; Jones MP; Karshikoff B; Lodin K; Holmstrom L; Agreus L; Wicksell RK; Axelsson J; Lekander M; Olsson GL; Kemani M; Andreasson A
• Journal article: ANNALS OF THE RHEUMATIC DISEASES. 2020;79(2):232-241

  In an early SLE cohort the ACR-1997, SLICC-2012 and EULAR/ACR-2019 criteria classify non-overlapping groups of patients: use of all three criteria ensures optimal capture for clinical studies while their modification earlier classification and treatment

  Adamichou C; Nikolopoulos D; Genitsaridi I; Bortoluzzi A; Fanouriakis A; Papastefanakis E; Kalogiannaki E; Gergianaki I; Sidiropoulos P; Boumpas DT; Bertsias GK
• Journal article: ANNALS OF THE RHEUMATIC DISEASES. 2020;79(2):242-253

  Transcriptome reprogramming and myeloid skewing in haematopoietic stem and progenitor cells in systemic lupus erythematosus

  Grigoriou M; Banos A; Filia A; Pavlidis P; Giannouli S; Karali V; Nikolopoulos D; Pieta A; Bertsias G; Verginis P; Mitroulis I; Boumpas DT
• Article: NATURE REVIEWS DISEASE PRIMERS. 2020;6(1):7

  Lupus nephritis

  Anders H-J; Saxena R; Zhao M-H; Parodis I; Salmon JE; Mohan C
• Article: ARTHRITIS RESEARCH & THERAPY. 2020;22(1):5

  Statin-induced anti-HMGCR myopathy: successful therapeutic strategies for corticosteroid-free remission in 55 patients.

  Meyer A; Troyanov Y; Drouin J; Oligny-Longpré G; Landon-Cardinal O; Hoa S; Hervier B; Bourré-Tessier J; Mansour A-M; Hussein S; Morin V; Rich E; Goulet J-R; Chartrand S; Hudson M; Nehme J; Makhzoum J-P; Zarka F; Villeneuve E; Raynauld J-P; Landry M; O'Ferrall EK; Ferreira J; Ellezam B; Karamchandani J; Larue S; Massie R; Isabelle C; Deschênes I; Leclair V; Couture H; Targoff IN; Fritzler MJ; Senécal J-L
• Preprint: BIORXIV. 2020

  Identifying novel B-cell targets for chronic inflammatory autoimmune disease by screening of chemical probes in a patient-derived cell assay

  Sundström Y; Shang M-M; Panda SK; Grönwall C; Wermeling F; Gunnarsson I; Lundberg I; Sundström M; Jakobsson P-J; Berg L
• Article: OSTEOARTHRITIS AND CARTILAGE OPEN. 2020;1(3-4):100017

  Evaluation of three scoring methods for Fluorescence Optical Imaging in erosive hand osteoarthritis and rheumatoid arthritis.

  Maugesten Ø; Ohrndorf S; Glinatsi D; Ammitzbøll-Danielsen M; Kisten Y; Østergaard M; Terslev L; Uhlig T; Kvien TK; Haugen IK
• Article: RESEARCH INVOLVEMENT AND ENGAGEMENT. 2020;6:6

  Development and formative evaluation of patient research partner involvement in a multi-disciplinary European translational research project.

  Birch R; Simons G; Wähämaa H; McGrath CM; Johansson EC; Skingle D; Bayliss K; Starling B; Gerlag DM; Buckley CD; Stack RJ; Raza K; Falahee M
• Article: FRONTIERS IN PHARMACOLOGY. 2020;11:613

  Anti-Inflammatory Properties of Chemical Probes in Human Whole Blood: Focus on Prostaglandin E₂ Production

  Bergqvist F; Sundstrom Y; Shang M-M; Gunnarsson I; Lundberg IE; Sundstrom M; Jakobsson P-J; Berg L
• Review: FRONTIERS IN MEDICINE. 2020;7:316

  B Cell Therapy in Systemic Lupus Erythematosus: From Rationale to Clinical Practice

  Parodis I; Stockfelt M; Sjowall C
• Article: JOURNAL OF AUTOIMMUNITY. 2020;106:102340

  Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus

  Enocsson H; Wirestam L; Dahle C; Padyukov L; Jonsen A; Urowitz MB; Gladman DD; Romero-Diaz J; Bae S-C; Fortin PR; Sanchez-Guerrero J; Clarke AE; Bernatsky S; Gordon C; Hanly JG; Wallace DJ; Isenberg DA; Rahman A; Merrill JT; Ginzler E; Alarcon GS; Chatham WW; Petri M; Khamashta M; Aranow C; Mackay M; Dooley MA; Manzi S; Ramsey-Goldman R; Nived O; Steinsson K; Zoma AA; Ruiz-Irastorza G; Lim SS; Kalunian KC; Inanc M; van Vollenhoven RF; Ramos-Casals M; Kamen DL; Jacobsen S; Peschken CA; Askanase A; Stoll T; Bruce IN; Wettero J; Sjowall C
• Article: ARTHRITIS & RHEUMATOLOGY. 2020;72(1):67-77

  Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study

  Hanly JG; Li Q; Su L; Urowitz MB; Gordon C; Bae S-C; Romero-Diaz J; Sanchez-Guerrero J; Bernatsky S; Clarke AE; Wallace DJ; Isenberg DA; Rahman A; Merrill JT; Fortin PR; Gladman DD; Bruce IN; Petri M; Ginzler EM; Dooley MA; Steinsson K; Ramsey-Goldman R; Zoma AA; Manzi S; Nived O; Jonsen A; Khamashta MA; Alarcon GS; Svenungsson E; van Vollenhoven RF; Aranow C; Mackay M; Ruiz-Irastorza G; Ramos-Casals M; Lim SS; Inanc M; Kalunian KC; Jacobsen S; Peschken CA; Kamen DL; Askanase A; Theriault C; Farewell V
• Article: BIOMEDICINE & PHARMACOTHERAPY. 2020;121:109581

  Microsomal prostaglandin E synthase-1 promotes lung metastasis via SDF-1/CXCR4-mediated recruitment of CD11b⁺Gr1⁺MDSCs from bone marrow

  Takahashi R; Amano H; Ito Y; Eshima K; Satoh T; Iwamura M; Nakamura M; Kitasato H; Uematsu S; Raouf J; Jakobsson P-J; Akira S; Majima M
• Article: FRONTIERS IN MEDICINE. 2020;7:484

  Chinese Herbal Formula Huayu-Qiangshen-Tongbi Decoction Compared With Leflunomide in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis: An Open-Label, Randomized, Controlled, Pilot Study

  Wu J; Chen X; Lv Y; Gao K; Liu Z; Zhao Y; Chen X; He X; Chu Y; Wu X; Ou A; Wen Z; Zhang J; Peng J; Huang Z; Jakobsson P-J; Huang Q; Huang R
• Review: COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL. 2020;18:2237-2246

  Designing custom CRISPR libraries for hypothesis-driven drug target discovery

  Iyer VS; Jiang L; Shen Y; Boddul SV; Panda SK; Kasza Z; Schmierer B; Wermeling F
• Article: JOURNAL OF RHEUMATOLOGY. 2020;47(1):72-81

  Construction of a Frailty Index as a Novel Health Measure in Systemic Lupus Erythematosus

  Legge A; Kirkland S; Rockwood K; Andreou P; Bae S-C; Gordon C; Romero-Diaz J; Sanchez-Guerrero J; Wallace DJ; Bernatsky S; Clarke AE; Merrill JT; Ginzler EM; Fortin P; Gladman DD; Urowitz MB; Bruce IN; Isenberg DA; Rahman A; Alarcon GS; Petri M; Khamashta MA; Dooley MA; Ramsey-Goldman R; Manzi S; Zoma AA; Aranow C; Mackay M; Ruiz-Irastorza G; Lim SS; Inanc M; van Vollenhoven RF; Jonsen A; Nived O; Ramos-Casals M; Kamen DL; Kalunian KC; Jacobsen S; Peschken CA; Askanase A; Hanly JG
• Article: FRONTIERS IN PHARMACOLOGY. 2020;11:196

  Proteomics-Based Characterization of miR-574-5p Decoy to CUGBP1 Suggests Specificity for mPGES-1 Regulation in Human Lung Cancer Cells

  Emmerich AC; Wellstein J; Ossipova E; Baumann I; Lengqvists J; Kultima K; Jakobsson P-J; Steinhilber D; Saul MJ
• Article: THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE. 2020;12:1759720X20976975

  Higher depression rates and similar cardiovascular comorbidity in psoriatic arthritis compared with rheumatoid arthritis and diabetes mellitus

  Fragoulis GE; Evangelatos G; Tentolouris N; Fragkiadaki K; Panopoulos S; Konstantonis G; Iliopoulos A; Chatzidionysiou K; Sfikakis PP; Tektonidou MG
• Article: ARTHRITIS & RHEUMATOLOGY. 2020;72(1):179-191

  Proinflammatory Histidyl-Transfer RNA Synthetase-Specific CD4+T Cells in the Blood and Lungs of Patients With Idiopathic Inflammatory Myopathies

  Galindo-Feria AS; Albrecht I; Fernandes-Cerqueira C; Notarnicola A; James EA; Herrath J; Dastmalchi M; Sandalova T; Ronnblom L; Jakobsson P-J; Fathi M; Achour A; Grunewald J; Malmstrom V; Lundberg IE
• Review: LUPUS SCIENCE AND MEDICINE. 2020;7(1):e000389

  Prediction of prognosis and renal outcome in lupus nephritis

  Parodis I; Tamirou F; Houssiau FA
• Article: FRONTIERS IN IMMUNOLOGY. 2020;11:585282

  Extracellular miR-574-5p Induces Osteoclast Differentiation via TLR 7/8 in Rheumatoid Arthritis

  Hegewald AB; Breitwieser K; Ottinger SM; Mobarrez F; Korotkova M; Rethi B; Jakobsson P-J; Catrina AI; Wahamaa H; Saul MJ
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2020;38(1):67-73

  Anti-transcriptional intermediary factor 1 gamma antibodies in cancer-associated myositis: a longitudinal study

  Dani L; Holmqvist M; Martinez MA; Trallero-Araguas E; Dastmalchi M; Svensson J; Labrador-Horrillo M; Selva-O'Callaghan A; Lundberg IE
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2020;38(1):42-49

  Features of repeated muscle biopsies and phenotypes of monocytes in paired blood samples and clinical long-term response to treatment in patients with idiopathic inflammatory myopathy: a pilot study

  Tang Q; Gheorghe KR; Zhang X-M; Lindroos E; Alexanderson H; Wick C; Bruton M; Fernandes-Cerqueira C; Harris RA; Nennesmo I; Lundberg IE
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2020;72

  Citrulline Reactive B Cells Are Present in the Lungs of Risk RA and Early Untreated RA

  Joshua V; Loberg-Haarhaus M; Krishnamurthy A; Sun M; Gerstner C; Hensvold A; Amara K; Israelsson L; Stalesen R; Rethi B; Skold M; Grunewald J; Wahamaa H; Gronwall C; Malmstrom V; Catrina A
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2020;72

  Identification and Validation of Citrulline Specific TCRs in CD4+T Cells in Rheumatoid Arthritis

  Kumar R; Yoosuf N; Boddul S; Gerstner C; Turcinov S; Dubnovitsky A; Wermeling F; Chemin K; Malmstrom V
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2020;72

  Presence of Ultrasound Imaging Biomarkers Are Good Predictors of Arthritis Development in a Population at Risk for Rheumatoid Arthritis

  Kisten Y; Circiumaru A; Loberg-Haarhaus M; Vivar N; Antovic A; Rezaei H; Af Klint E; Hensvold A; Catrina A
• Editorial comment: ZEITSCHRIFT FUR RHEUMATOLOGIE. 2020;79(1):113

  Georg Schett awarded the Franziskus Blondel Medal
• Preprint: BIORXIV. 2019

  Anti-inflammatory properties of chemical probes in human whole blood: focus on prostaglandin E2 production

  Bergqvist F; Sundström Y; Shang M; Gunnarsson I; Lundberg I; Sundström M; Jakobsson P-J; Berg L
• Article: BIOLOGY OF SEX DIFFERENCES. 2019;10(1):60

  Sex differences in clinical presentation of systemic lupus erythematosus

  Sepulveda JIR; Bolin K; Mofors J; Leonard D; Svenungsson E; Jonsen A; Bengtsson C; Nordmark G; Dahlqvist SR; Bengtsson AA; Ronnblom L; Sjowall C; Gunnarsson I; Wahren-Herlenius M; Zickert A; Bjork A; Jonsen A; Sjowali C; Enocsson H; Wettero J; Eriksson P; Thorlacius GE; Lundberg IE; Sanding JK; SeNiveda JIR; Lindblad-Toh K; Ronnblom L; Padyukov L; Hultin-Rosenberg L; Eloranta M-L; Dahiqvist SR
• Article: SCIENTIFIC REPORTS. 2019;9(1):18975

  Exploring inflammatory signatures in arthritic joint biopsies with Spatial Transcriptomics

  Carlberg K; Korotkova M; Larsson L; Catrina AI; Stahl PL; Malmstrom V
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2019;78(12):1621-1631

  Anticitrullinated protein antibodies facilitate migration of synovial tissue-derived fibroblasts

  Sun M; Rethi B; Krishnamurthy A; Joshua V; Circiumaru A; Hensvold AH; Ossipova E; Gronwall C; Liu Y; Engstrom M; Catrina SB; Steen J; Malmstrom V; Klareskog L; Svensson C; Ospelt C; Wahamaa H; Catrina AI
• Article: BRITISH JOURNAL OF PHARMACOLOGY. 2019;176(24):4625-4638

  Biological characterization of new inhibitors of microsomal PGE synthase-1 in preclinical models of inflammation and vascular tone

  Larsson K; Steinmetz J; Bergqvist F; Arefin S; Spahiu L; Wannberg J; Pawelzik S-C; Morgenstern R; Stenberg P; Kublickiene K; Korotkova M; Jakobsson P-J
• Article: PROSTAGLANDINS AND OTHER LIPID MEDIATORS. 2019;145:106361

  Urinary prostaglandin D₂ and E₂ metabolites associate with abdominal obesity, glucose metabolism, and triglycerides in obese subjects

  Pawelzik S-C; Avignon A; Idborg H; Boegner C; Stanke-Labesque F; Jakobsson P-J; Sultan A; Back M
• Article: ARTHRITIS CARE AND RESEARCH. 2019;71(12):1556-1565

  International Consortium for Health Outcome Measurement Set of Outcomes That Matter to People Living With Inflammatory Arthritis: Consensus From an International Working Group

  Oude Voshaar MAH; Das Gupta Z; Bijlsma JWJ; Boonen A; Chau J; Courvoisier DS; Curtis JR; Ellis B; Ernestam S; Gossec L; Hale C; Hornjeff J; Leung KYY; Lidar M; Mease P; Michaud K; Mody GM; Ndosi M; Opava CH; Pinheiro GRC; Salt M; Soriano ER; Taylor WJ; Voshaar MJH; Weel AEAM; de Wit M; Wulffraat N; van de Laar MAFJ; Vonkeman HE
• Article: RHEUMATOLOGY. 2019;58(12):2170-2176

  Predictors of low disease activity and clinical remission following belimumab treatment in systemic lupus erythematosus

  Parodis I; Johansson P; Gomez A; Soukka S; Emamikia S; Chatzidionysiou K
• Article: INFECTION AND IMMUNITY. 2019;87(12):e00742-e00719

  Critical Role of B Cells in Toll-Like Receptor 7-Mediated Protection against Listeria monocytogenes Infection

  Kayraklioglu N; Horuluoglu B; Elango M; Klinman DM
• Article: ARTHRITIS RESEARCH & THERAPY. 2019;21(1):259

  Increased levels of anti-dsDNA antibodies in immune complexes before treatment with belimumab associate with clinical response in patients with systemic lupus erythematosus

  Sohrabian A; Parodis I; Carlstromer-Berthen N; Frodlund M; Jonsen A; Zickert A; Sjowall C; Bengtsson AA; Gunnarsson I; Ronnelid J
• Thesis / dissertation: 2019

  On the origin of ACPA : exploring the role of P. gingivalis in the development of rheumatoid arthritis

  Sherina, Natalia
• Article: SCIENTIFIC REPORTS. 2019;9(1):16504

  Early symptoms and sensations as predictors of lung cancer: a machine learning multivariate model

  Levitsky A; Pernemalm M; Bernhardson B-M; Forshed J; Kolbeck K; Olin M; Henriksson R; Lehtio J; Tishelman C; Eriksson LE
• Article: RHEUMATIC DISEASE CLINICS OF NORTH AMERICA. 2019;45(4):569-581

  Idiopathic Inflammatory Myopathies

  Vencovsky J; Alexanderson H; Lundberg IE
• Article: JOURNAL OF RHEUMATOLOGY. 2019;46(11):1509-1514

  Acute Coronary Syndrome in Idiopathic Inflammatory Myopathies: A Population-based Study

  Leclair V; Svensson J; Lundberg IE; Holmqvist M
• Article: THE LANCET RHEUMATOLOGY. 2019;1(3):E163-E173

  Definitions of remission in systemic lupus erythematosus: a post-hoc analysis of two randomised clinical trials

  Parodis I; Emamikia S; Gomez A; Gentline C; Arkema EV; Chatzidionysiou K; van Vollenhoven RF
• Journal article: CURRENT OPINION IN RHEUMATOLOGY. 2019;31(6):669-677

  Update on the pathogenesis of central nervous system lupus

  Nikolopoulos D; Fanouriakis A; Boumpas DT
• Book chapter: POLYMER-PROTEIN CONJUGATES FROM PEGYLATION AND BEYOND. 2019;p. 389-406

  In vivo properties of therapeutic bioconjugates composed of proteins and architecturally/functionally complex polymers

  Zaghmi A; A. Greschner A; Gauthier MA
• Corrigendum: AMERICAN JOURNAL OF HUMAN GENETICS. 2019;105(4):880

  Distinct HLA Associations with Rheumatoid Arthritis Subsets Defined by Serological Subphenotype (vol 105, pg 616, 2019)

  Terao C; Brynedal B; Chen Z; Jiang X; Westerlind H; Hansson M; Jakobsson P-J; Lundberg K; Skriner K; Serre G; Ronnelid J; Mathsson-Alm L; Brink M; Dahlqvist SR; Padyukov L; Gregersen PK; Barton A; Alfredsson L; Klareskog L; Raychaudhuri S
• Letter: AUTOIMMUNITY REVIEWS. 2019;18(10):102372

  Antimalarial agents diminish while methotrexate, azathioprine and mycophenolic acid increase BAFF levels in systemic lupus erythematosus

  Hernandez-Breijo B; Gomez A; Soukka S; Johansson P; Parodis I
• Article: JOURNAL OF PATHOLOGY. 2019;249(2):215-226

  Mitochondrial dysfunction and role of harakiri in the pathogenesis of myositis

  Boehler JF; Horn A; Novak JS; Li N; Ghimbovschi S; Lundberg IE; Alexanderson H; Munters LA; Jaiswal JK; Nagaraju K
• Published conference paper: JOURNAL OF RHEUMATOLOGY. 2019;46(10):1351-1354

  OMERACT 2018 Modified Patient-reported Outcome Domain Core Set in the Life Impact Area for Adult Idiopathic Inflammatory Myopathies

  Regardt M; Mecoli CA; Park JK; de Groot I; Sarver C; Needham M; de Visser M; Shea B; Bingham COIII; Lundberg IE; Song YW; Christopher-Stine L; Alexanderson H
• Review: BEST PRACTICE AND RESEARCH: CLINICAL RHEUMATOLOGY. 2019;33(5):101476

  Established rheumatoid arthritis - Redefining the concept

  Chatzidionysiou K; Fragoulis GE
• Article: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS. 2019;108(10):1879-1886

  Urinary PGE₂ metabolite levels in hospitalised infants with infections compared to age-matched controls

  Hamrin J; Perez-Manzo M; Idborg H; Jakobsson P-J; Bjork L; Eriksson M; Nilsson A; Herlenius E
• Journal article: CLINICAL RHEUMATOLOGY. 2019;38(10):2709-2716

  The effect of concomitant hand osteoarthritis on pain and disease activity in patients with rheumatoid arthritis

  Ruiz-Medrano E; Espinosa-Ortega HF; Alejandro Arce-Salinas C
• Meeting abstract: BRAIN, BEHAVIOR, AND IMMUNITY. 2019;81:44

  Sickness behavior assessed with the Sickness Questionnaire is elevated in patients with ME/CFS and chronic pain compared to the general population and primary care patients

  Jonsjo M; Kemani M; Agreus L; Lodin K; Astrom J; Wicksell R; Lekander M; Olsson G; Holmstrom L; Andreasson A
• Editorial comment: THE LANCET RHEUMATOLOGY. 2019;1(2):E76-E77

  Symptom-based stratification of autoimmune diseases

  Idborg H
• Meeting abstract: BRAIN, BEHAVIOR, AND IMMUNITY. 2019;81:41-42

  Validation of the English translation of the Sickness Questionnaire in an Australian population sample with medically unexplained symptoms

  Andreasson A; McNaughton D; Jones MP; Beath A; Lodin K; Wicksell R; Lekander M
• Article: AMERICAN JOURNAL OF HUMAN GENETICS. 2019;105(3):616-624

  Distinct HLA Associations with Rheumatoid Arthritis Subsets Defined by Serological Subphenotype

  Terao C; Brynedal B; Chen Z; Jiang X; Westerlind H; Hansson M; Jakobsson P-J; Lundberg K; Skriner K; Serre G; Ronnelid J; Mathsson-Alm L; Brink M; Dahlqvist SR; Padyukov L; Gregersen PK; Barton A; Alfredsson L; Klareskog L; Raychaudhuri S
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2019;48(5):362-366

  Association of female sex and positive rheumatoid factor with low serum infliximab and anti-drug antibodies, related to treatment failure in early rheumatoid arthritis: results from the SWEFOT trial population

  Hambardzumyan K; Hermanrud C; Marits P; Vivar N; Ernestam S; Wallman JK; van Vollenhoven RF; Fogdell-Hahn A; Saevarsdottir S
• Article: INTERNATIONAL JOURNAL OF OBESITY. 2019;43(9):1724-1734

  Inflammation increases MMP levels via PGE₂ in human vascular wall and plasma of obese women

  Ozen G; Boumiza S; Deschildre C; Topal G; Longrois D; Jakobsson PJ; Michel JB; Jacob MP; Chahed K; Norel X
• Review: ANNALS OF THE RHEUMATIC DISEASES. 2019;78(9):1160-1166

  2018 EULAR recommendations for a core data set to support observational research and clinical care in giant cell arteritis

  Ehlers L; Askling J; Bijlsma HWJ; Cid MC; Cutolo M; Dasgupta B; Dejaco C; Dixon WG; Feltelius N; Finckh A; Gilbert K; Mackie SL; Mahr A; Matteson EL; Neill L; Salvarani C; Schmidt WA; Strangfeld A; van Vollenhoven RF; Buttgereit F
• Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2019;116(34):16955-16960

  Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk

  Tengvall K; Huang J; Hellstrom C; Kammer P; Bistrom M; Ayoglu B; Bomfim IL; Stridh P; Butt J; Brenner N; Michel A; Lundberg K; Padyukov L; Lundberg IE; Svenungsson E; Ernberg I; Olafsson S; Dilthey AT; Hillert J; Alfredsson L; Sundstrom P; Nilsson P; Waterboer T; Olsson T; Kockum I
• Article: ARTHRITIS & RHEUMATOLOGY. 2019;71(8):1297-1307

  Evaluating the Properties of a Frailty Index and Its Association With Mortality Risk Among Patients With Systemic Lupus Erythematosus

  Legge A; Kirkland S; Rockwood K; Andreou P; Bae S-C; Gordon C; Romero-Diaz J; Sanchez-Guerrero J; Wallace DJ; Bernatsky S; Clarke AE; Merrill JT; Ginzler EM; Fortin P; Gladman DD; Urowitz MB; Bruce IN; Isenberg DA; Rahman A; Alarcon GS; Petri M; Khamashta MA; Dooley MA; Ramsey-Goldman R; Manzi S; Steinsson K; Zoma AA; Aranow C; Mackay M; Ruiz-Irastorza G; Lim SS; Nanc MI; van Vollenhoven RF; Jonsen A; Nived O; Ramos-Casals M; Kamen DL; Kalunian KC; Jacobsen S; Peschken CA; Askan N; Hanly JG
• Article: CLINICAL PHARMACOLOGY AND THERAPEUTICS. 2019;106(2):374-382

  A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires

  Costedoat-Chalumeau N; Houssiau F; Izmirly P; Le Guern V; Navarra S; Jolly M; Ruiz-Irastorza G; Baron G; Hachulla E; Agmon-Levin N; Shoenfeld Y; Dall'Ara F; Buyon J; Deligny C; Cervera R; Lazaro E; Bezanahary H; Leroux G; Morel N; Viallard J-F; Pineau C; Galicier L; Van Vollenhoven R; Tincani A; Hanh N; Gondran G; Zahr N; Pouchot J; Piette J-C; Petri M; Isenberg D
• Journal article: BEST PRACTICE AND RESEARCH: CLINICAL RHEUMATOLOGY. 2019;33(4):101425

  Suspected systemic rheumatic diseases in patients presenting with cytopenias

  Nikolopoulos D; Adamichou C; Bertsias G
• Journal article: DATA IN BRIEF. 2019;25:104037

  Determination of the degree of PEGylation of protein bioconjugates using data from proton nuclear magnetic resonance spectroscopy

  Zaghmi A; Greschner AA; Mendez-Villuendas E; Liu JY; de Haan HW; Gauthier MA
• Article: NATURE GENETICS. 2019;51(7):1082-1091

  A genetics-led approach defines the drug target landscape of 30 immune-related traits

  Fang H; Beckmann G; Bountra C; Bowness P; Burgess-Brown N; Carpenter L; Chen L; Damerell D; Egner U; Fujii R; Howe T; Jakobsson P-J; Katopodis A; Knight JC; Marsden BD; De Martino J; Matthias G; McVean G; Mueller-Fahrnow A; Malarstig A; O'Callaghan CA; Ostermann N; Paez-cortez JR; Peeters PJ; Prinz F; Soulard P; Sundstrom M; Yabuki C; Vlach J; De Wolf H; Knezevic B; Burnham KL; Osgood J; Sanniti A; Lara AL; Kasela S; De Cesco S; Wegner JK; Handunnetthi L; McCann FE; Sekine T; Brennan PE; Sundstrom Y; Milani L; Berg L; Gohlmann HW; Fairfax BP
• Article: NEUROMUSCULAR DISORDERS. 2019;29(7):543-548

  Concurrent positive anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase antibody with reducing body myopathy: Possible double trouble

  Tanboon J; Sanmaneechai O; Charuvanij S; Sangruchi T; Galindo-Feria AS; Lundberg IE; Ohnuki Y; Shiina T; Suzuki S; Nishino I
• Review: TRENDS IN IMMUNOLOGY. 2019;40(7):648-664

  Biological Roles Of Neutrophil-Derived Granule Proteins and Cytokines

  Cassatella MA; Ostberg NK; Tamassia N; Soehnlein O
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2019;78(7):996-1002

  Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups

  Rothwell S; Chinoy H; Lamb JA; Miller FW; Rider LG; Wedderburn LR; McHugh NJ; Mammen AL; Betteridge ZE; Tansley SL; Bowes J; Vencovsky J; Deakin CT; Danko K; Vidya L; Selva-O'Callaghan A; Pachman LM; Reed AM; Molberg O; Benveniste O; Mathiesen PR; Radstake TRDJ; Doria A; de Bleecker J; Lee AT; Hanna MG; Machado PM; Ollier WE; Gregersen PK; Padyukov L; O'Hanlon TP; Cooper RG; Lundberg IE; Adams BS; Bingham CA; Cawkwell GD; Finkel TH; George SW; Gewanter HL; Goldmuntz EA; Goldsmith DP; Henrickson M; Imundo L; Katona IM; Lindsley CB; Oddis CP; Olson JC; Sherry D; Vogelgesang SA; Wallace CA; White PH; Zemel LS
• Article: BIOMEDICINE & PHARMACOTHERAPY. 2019;115:108900

  Antidepressant-like effects of ginseng fruit saponin in myocardial infarction mice

  Liu M; Liu J; Zhang L; Geng Q; Ge Y
• Article: RHEUMATOLOGY. 2019;58(7):1214-1220

  Efficacy and safety of rituximab in anti-synthetase antibody positive and negative subjects with idiopathic inflammatory myopathy: a registry-based study

  Leclair V; Galindo-Feria AS; Dastmalchi M; Holmqvist M; Lundberg IE
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2019;78(7):1006-1007

  Established organ damage reduces belimumab efficacy in systemic lupus erythematosus

  Parodis I; Gomez A; Emamikia S; Chatzidionysiou K
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2019;78(7):1010-1012

  Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort

  Mendel A; Bernatsky SB; Hanly JG; Urowitz MB; Clarke AE; Romero-Diaz J; Gordon C; Bae S-C; Wallace DJ; Merrill JT; Buyon JP; Isenberg DA; Rahman A; Ginzler EM; Petri M; Dooley MA; Fortin PR; Gladman DD; Steinsson K; Ramsey-Goldman R; Khamashta MA; Aranow C; Mackay M; Alarcon GS; Manzi S; Nived O; Jonsen A; Zoma AA; van Vollenhoven RF; Ramos-Casals M; Ruiz-Irastorza G; Lim S; Kalunian KC; Inanc M; Kamen DL; Peschken CA; Jacobsen S; Askanase A; Sanchez-Guerrero J; Bruce IN; Costedoat-Chalumeau N; Vinet E
• Article: RHEUMATOLOGY. 2019;58(7):1259-1267

  Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen

  Mendel A; Bernatsky S; Pineau CA; St-Pierre Y; Hanly JG; Urowitz MB; Clarke AE; Romero-Diaz J; Gordon C; Bae S-C; Wallace DJ; Merrill JT; Buyon J; Isenberg DA; Rahman A; Ginzler EM; Petri M; Dooley MA; Fortin P; Gladman DD; Steinsson K; Ramsey-Goldman R; Khamashta MA; Aranow C; Mackay M; Alarcon G; Manzi S; Nived O; Jonsen A; Zoma AA; van Vollenhoven RF; Ramos-Casals M; Ruiz-Irastorza G; Lim S; Kalunian KC; Inanc M; Kamen DL; Peschken CA; Jacobsen S; Askanase A; Sanchez-Guerrero J; Bruce IN; Costedoat-Chalumeau N; Vinet E
• Article: ARTHRITIS CARE AND RESEARCH. 2019;71(7):893-902

  Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort.

  Choi MY; Clarke AE; St Pierre Y; Hanly JG; Urowitz MB; Romero-Diaz J; Gordon C; Bae S-C; Bernatsky S; Wallace DJ; Merrill JT; Isenberg DA; Rahman A; Ginzler EM; Petri M; Bruce IN; Dooley MA; Fortin PR; Gladman DD; Sanchez-Guerrero J; Steinsson K; Ramsey-Goldman R; Khamashta MA; Aranow C; Alarcón GS; Manzi S; Nived O; Zoma AA; van Vollenhoven RF; Ramos-Casals M; Ruiz-Irastorza G; Lim SS; Kalunian KC; Inanc M; Kamen DL; Peschken CA; Jacobsen S; Askanase A; Stoll T; Buyon J; Mahler M; Fritzler MJ
• Article: ARTHRITIS CARE AND RESEARCH. 2019;71(7):970-976

  The Risk of Ischemic and Hemorrhagic Stroke in Patients With Idiopathic Inflammatory Myopathies: A Swedish Population-Based Cohort Study

  Moshtaghi-Svensson J; Lundberg IE; Von Euler M; Arkema EV; Holmqvist M
• Article: JOURNAL OF AUTOIMMUNITY. 2019;101:48-55

  Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients

  Betteridge Z; Tansley S; Shaddick G; Chinoy H; Cooper RG; New RP; Lilleker JB; Vencovsky J; Chazarain L; Danko K; Nagy-Vincze M; Bodoki L; Dastmalchi M; Ekholm L; Lundberg IE; McHugh N; Mann H; Krystufkova O; Klein M; Barochova T; Kubinova K; Lamb J; Rothwell S; Ahmed Y; Armstrong R; Bernstein R; Black C; Bowman S; Bruce I; Butler R; Carty J; Chattopadhyay C; Chelliah E; Clarke F; Dawes P; Denton C; Devlin J; Edwards C; Emery P; Fordham J; Fraser A; Gaston H; Gordon P; Griffiths B; Gunawardena H; Hall F; Hanna M; Harrison B; Hay E; Hilton-Jones D; Horden L; Isaacs J; Isenberg D; Jones A; Kamath S; Kennedy T; Kitas G; Klimiuk P; Knights S; Lambert J; Lanyon P; Laxminarayan R; Lecky B; Luqmani R; Machado P; Marks J; Martin M; McGonagle D; McKenna F; McLaren J; McMahon M; McRorie E; Merry P; Miles S; Miller J; Nicholls A; Nixon J; Ong V; Over K; Packham J; Pipitone N; Plant M; Pountain G; Pullar T; Roberts M; Sanders P; Scott D; Shadforth M; Sheeran T; Srinivasan A; Swinson D; Teh L-S; Webley M; Williams B; Winer J
• Article: NATIONAL MEDICAL JOURNAL OF CHINA. 2019;132(12):1390-1399

  Potential predictors for mental stress-induced myocardial ischemia in patients with coronary artery disease

  Liu M-Y; Yang Y; Zhang L-J; Pu L-H; He D-F; Liu J-Y; Hafeez A; Ding Y-C; Ma H; Geng Q-S
• Review: MEDITERRANEAN JOURNAL OF RHEUMATOLOGY. 2019;30(2):103-109

  Rheumatic disease and artistic creativity.

  Chatzidionysiou K
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2019;78(6):e53

  Response to: 'Time to personalise the treatment of anti-MDA-5 associated lung disease' by Lake et al

  Leclair V; Lundberg IE; Tjarnlund A
• Article: JOURNAL OF IMMUNOLOGY. 2019;202(11):3143-3150

  Citrullination Controls Dendritic Cell Transdifferentiation into Osteoclasts

  Krishnamurthy A; Ytterberg AJ; Sun M; Sakuraba K; Steen J; Joshua V; Tarasova NK; Malmstrom V; Wahamaa H; Rethi B; Catrina AI
• Article: JOURNAL OF RHEUMATOLOGY. 2019;46(6):555-563

  Serum Biomarkers for Prediction of Response to Methotrexate Monotherapy in Early Rheumatoid Arthritis: Results from the SWEFOT Trial

  Hambardzumyan K; Bolce RJ; Wallman JK; van Vollenhoven RF; Saevarsdottir S
• Review: AUTOIMMUNITY REVIEWS. 2019;18(6):615-620

  G-CSF-induced aortitis: Two cases and review of the literature

  Parodis I; Dani L; Notarnicola A; Martenhed G; Fernstrom P; Matikas A; Wiklander OPB
• Review: ANNALS OF THE RHEUMATIC DISEASES. 2019;78(6):736-745

  2019 update of the EULAR recommendations for the management of systemic lupus erythematosus

  Fanouriakis A; Kostopoulou M; Alunno A; Aringer M; Bajema I; Boletis JN; Cervera R; Doria A; Gordon C; Govoni M; Houssiau F; Jayne D; Kouloumas M; Kuhn A; Larsen JL; Lerstrom K; Moroni G; Mosca M; Schneider M; Smolen JS; Svenungsson E; Tesar V; Tincani A; Troldborg A; van Vollenhoven R; Wenzel J; Bertsias G; Boumpas DT
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2019;78(6):858-860

  Comparison of autoantibody specificities tested by a line blot assay and immunoprecipitation-based algorithm in patients with idiopathic inflammatory myopathies

  Espinosa-Ortega F; Holmqvist M; Alexanderson H; Storfors H; Mimori T; Lundberg IE; Ronnelid J
• Article: THE FASEB JOURNAL. 2019;33(6):6933-6947

  miR-574-5p as RNA decoy for CUGBP1 stimulates human lung tumor growth by mPGES-1 induction

  Saul MJ; Baumann I; Bruno A; Emmerich AC; Wellstein J; Ottinger SM; Contursi A; Dovizio M; Donnini S; Tacconelli S; Raouf J; Idborg H; Stein S; Korotkova M; Savai R; Terzuoli E; Sala G; Seeger W; Jakobsson P-J; Patrignani P; Suess B; Steinhilber D
• Article: ARTHRITIS CARE AND RESEARCH. 2019;71(6):811-821

  The Impact of Belimumab and Rituximab on Health-Related Quality of Life in Patients With SystemicLupus Erythematosus

  Parodis I; Benavides AHL; Zickert A; Pettersson S; Moller S; Henriksson EW; Voss A; Gunnarsson I
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2019;78:1225-1226

  DISTINCT CLINICAL PROFILES OF CHINESE AND SWEDISH IDIOPATHIC INFLAMMATORY MYOPATHY PATIENTS WITH ANTI-MELANOMA DIFFERENTIATION ASSOCIATED GENE 5 (MDA5) ANTIBODY

  So H; Wong TLV; Dastmalchi M; Leclair V; Espinosa-Ortega F; Lundberg IE
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2019;78:445

  SKELETAL TROPONIN I A POSSIBLE NOVEL BIOMARKER FOR MANAGEMENT OF PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES

  Bamberg K; Mehtala L; Arola O; Laitinen S; Nordling P; Strandberg M; Strandberg N; Paltta J; Mali M; Espinosa-Ortega F; Pirila L; Lundberg IE; Savukoski T; Pettersson K
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2019;78:1012

  DIAGNOSTIC UTILITY OF FLUORESCENCE OPTICAL IMAGING IN INDIVIDUALS WITH SUSPECTED ARTHRITIS - A PROBABILISTIC APPROACH

  Kisten Y; Levitsky A; Rezaei H; Hensvold A; Af Klint E; van Vollenhoven R; Catrina A
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2019;78:1480

  CITRULLINE REACTIVE B CELLS ARE PRESENT IN THE LUNGS OF EARLY UNTREATED RA

  Joshua V; Loberg-Haarhaus M; Wahamaa H; Hensvold A; Skold M; Grunewald J; Klareskog L; Malmstrom V; Catrina A
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2019;78:777-778

  ANTIMALARIAL AGENTS DIMINISH WHILE METHOTREXATE, AZATHIOPRINE AND MYCOPHENOLIC ACID INCREASE BAFF LEVELS IN SYSTEMIC LUPUS ERYTHEMATOSUS

  Hernandez-Breijo B; Gomez A; Soukka S; Johansson P; Parodis I
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2019;78:2040

  INTER-READER RELIABILITY AND COMPARISON OF FLUORESCENCE OPTICAL IMAGING ENHANCEMENT IN PATIENTS WITH EROSIVE HAND OSTEOARTHRITIS AND RHEUMATOID ARTHRITIS

  Maugesten O; Ohrndorf S; Glinatsi D; Ammitzboll-Danielsen M; Kisten Y; Ostergaard M; Terslev L; Uhlig T; Kvien TK; Haugen IK
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2019;78:703-704

  EFFECTIVENESS OF TNF INHIBITORS VS. NON-TNF INHIBITORS (ABATACEPT, TOCILIZUMAB AND RITUXIMAB) AFTER FAILURE OF NON-TNFI BIOLOGIC DMARD IN RHEUMATOID ARTHRITIS - COLLABORATION BETWEEN FIVE NATIONAL REGISTERS

  Chatzidionysiou K; Hetland ML; Frisell T; Di Giuseppe D; Hellgren K; Glintborg B; Nordstrom D; Aaltonen K; Trokovic N; Kristianslund E; Kvien TK; Provan SA; Gudbjornsson B; Grondal G; Dreyer L; Kristensen LE; Jorgensen TS; Jacobsson LTH; Askling J
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2019;78:1090-1091

  INVESTIGATING MECHANISMS OF AUTOANTIBODY INDUCED PAIN, BONE LOSS AND ARTHRITIS DEVELOPMENT

  Krishnamurthy A; Kisten Y; Sandor K; Circiumaru A; Wigerblad G; Damberg P; Sakurabas K; Wahamaa H; Jarvolli P; Jimenez Andrade JJ; Malmstrom V; Klareskog L; Svensson C; Rethi B; Catrina A
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2019;78:310

  DEVELOPMENT OF ULTRASOUND DETECTABLE ARTHRITIS AMONG ACPA POSITIVE SUBJECTS WITH MUSCULOSKELETAL SYMPTOMS: THE RISK RA PROSPECTIVE STUDY

  Hensvold A; Kisten Y; Circiumaru A; Hansson M; Sun M; Fei G; Vivar N; Af Klint E; Rezaei H; Klareskog L; Antovic A; Catrina A
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2019;78:781-782

  ANTIMALARIAL AGENTS IMPROVE PHYSICAL FUNCTIONING IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

  Parodis I; Soukka S; Gomez A; Enman Y; Johansson P; Emamikia S; Chatzidionysiou K
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2019;78:761

  PREDICTORS OF LOW DISEASE ACTIVITY AND CLINICAL REMISSION FOLLOWING BELIMUMAB TREATMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS

  Parodis I; Johansson P; Gomez A; Soukka S; Emamikia S; Chatzidionysiou K
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2019;78:1800.1-181800

  ANTIPROLIFERATIVE AND VASOACTIVE TREATMENT MODALITIES IN 457 CONSECUTIVE PATIENTS WITH SYSTEMIC SCLEROSIS FROM ACADEMIC CENTERS IN GREECE

  Panopoulos S; Tektonidou M; Chatzidionysiou K; Drosos A; Liossis S-N; Dimitroulas T; Sakkas L; Boumpas D; Sidiropoulos P; Bertsias G; Voulgari PV; Daoussis D; Thomas K; Georgiopoulos G; Vosvotekas G; Vassilopoulos D; Sfikakis P
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2019;78:1079

  CITRULLINE-REACTIVE B CELLS ARE PRESENT IN INFLAMED GINGIVAL TISSUE AND DISPLAY CROSS-REACTIVITY BETWEEN BACTERIAL AND HUMAN ANTIGENS

  Sherina N; Joshua V; Thyagarajan R; Sippl N; Israelsson L; Wahamaa H; Stalesen R; Eriksson K; Yucel-Lindberg T; Hensvold A; Gronwall C; Catrina A; Malmstrom V; Lanzavecchia A; Piccoli L; Amara K; Lundberg K
• Journal article: MATERIALS TODAY CHEMISTRY. 2019;12:121-131

  Mechanisms of activity loss for a multi-PEGylated protein by experiment and simulation

  Zaghmi A; Mendez-Villuendas E; Greschner AA; Liu JY; de Haan HW; Gauthier MA
• Article: CIRCULATION. 2019;139(21):2466-2482

  Germinal Center-Derived Antibodies Promote Atherosclerosis Plaque Size and Stability

  Centa M; Jin H; Hofste L; Hellberg S; Busch A; Baumgartner R; Verzaal NJ; Enoksson SL; Matic LP; Boddul SV; Atzler D; Li DY; Sun C; Hansson GK; Ketelhuth DFJ; Hedin U; Wermeling F; Lutgens E; Binder CJ; Maegdesfessel L; Malin SG
• Article: JOURNAL OF DIABETES RESEARCH. 2019;2019:2936962-8

  Protective Effect of the HIF-1A Pro582Ser Polymorphism on Severe Diabetic Retinopathy

  Ekberg NR; Eliasson S; Li YW; Zheng X; Chatzidionysiou K; Falhammar H; Gu HF; Catrina S-B
• Letter: EUROPEAN JOURNAL OF CANCER. 2019;112:47-48

  Letter in response to 'Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors'.

  Leclair V; Landon-Cardinal O; Hudson M
• Article: JOURNAL OF RHEUMATOLOGY. 2019;46(5):492-500

  Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort

  Wirestam L; Enocsson H; Skogh T; Padyukov L; Jonsen A; Urowitz MB; Gladman DD; Romero-Diaz J; Bae S-C; Fortin PR; Sanchez-Guerrero J; Clarke AE; Bernatsky S; Gordon C; Hanly JG; Wallace D; Isenberg DA; Rahman A; Merrill J; Ginzler E; Alarcon GS; Chatham WW; Petri M; Khamashta M; Aranow C; Mackay M; Dooley MA; Manzi S; Ramsey-Goldman R; Nived O; Steinsson K; Zoma A; Ruiz-Irastorza G; Lim S; Kalunian K; Inanc M; van Vollenhoven R; Ramos-Casals M; Kamen DL; Jacobsen S; Peschken C; Askanase A; Stoll T; Bruce IN; Wettero J; Sjowall C
• Letter: RHEUMATOLOGY. 2019;58(5):915-917

  Analyses of association of psoriatic arthritis and psoriasis vulgaris with functional NCF1 variants

  Loehr S; Ekici AB; Uebe S; Buettner C; Koehm M; Behrens F; Boehm B; Sticherling M; Schett G; Simon D; Moessner R; Nimeh A; Oji V; Assmann G; Rech J; Holmdahl R; Burkhardt H; Reis A; Hueffmeier U
• Article: JOURNAL OF AUTOIMMUNITY. 2019;99:24-32

  PAM3 supports the generation of M2-like macrophages from lupus patient monocytes and improves disease outcome in murine lupus

  Horuluoglu B; Bayik D; Kayraklioglu N; Goguet E; Kaplan MJ; Klinman DM
• Thesis / dissertation: 2019

  Physical function, physical activity and quality of life in systemic sclerosis

  Pettersson, Henrik
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2019;78(4):e30

  Response to: 'Detection of myositis-specific antibodies: additional notes' by Infantino et al

  Tjarnlund A; Lundberg IE; Ronnelid J
• Article: JOURNAL OF METAMORPHIC GEOLOGY. 2019;37(3):359-381

  Preservation of high-P rocks coupled to rock composition and the absence of metamorphic fluids

  Skelton A; Peillod A; Glodny J; Klonowska I; Manbro C; Lodin K; Ring U
• Conference publication: OSTEOARTHRITIS AND CARTILAGE. 2019;27:S319-S320

  FEASIBILITY, INTER-READER RELIABILITY, AND COMPARISON OF FLUORESCENCE OPTICAL IMAGING ENHANCEMENT IN PATIENTS WITH EROSIVE HAND OSTEOARTHRITIS AND RHEUMATOID ARTHRITIS

  Maugesten O; Ohrndorf S; Glinatsi D; Ammitzboll-Danielsen M; Kisten Y; Ostergaard M; Terslev L; Uhlig T; Kvien TK; Haugen IK
• Conference publication: 2019;:a108

  150 Antimalarial agents improve physical functioning in patients with systemic lupus erythematosus

  Parodis I; Soukka S; Gomez A; Johansson P; Emamikia S; Enman Y; Chatzidionysiou K
• Conference publication: 2019;:a107.1-a1a107

  148 Antimalarial agents and other immunosuppressants influence BAFF levels in opposite directions in patients with systemic lupus erythematosus

  Hernandez-Breijo B; Gomez A; Johansson P; Soukka S; Parodis I
• Article: SCIENTIFIC REPORTS. 2019;9(1):4366

  Cationic gold nanoparticles elicit mitochondrial dysfunction: a multi-omics study

  Gallud A; Kloditz K; Ytterberg J; Ostberg N; Katayama S; Skoog T; Gogvadze V; Chen Y-Z; Xue D; Moya S; Ruiz J; Astruc D; Zubarev R; Kere J; Fadeel B
• Article: ARTHRITIS RESEARCH & THERAPY. 2019;21(1):74

  Divergent roles of prostacyclin and PGE₂ in human tendinopathy

  Bergqvist F; Carr AJ; Wheway K; Watkins B; Oppermann U; Jakobsson P-J; Dakin SG
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2019;48(2):141-148

  Muscle endurance, strength, and active range of motion in patients with different subphenotypes in systemic sclerosis: a cross-sectional cohort study

  Pettersson H; Bostroem C; Bringby F; Walle-Hansen R; Jacobsson LTH; Svenungsson E; Nordin A; Alexanderson H
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2019;78(3):311-319

  Genome-wide meta-analysis reveals shared new loci in systemic seropositive rheumatic diseases

  Acosta-Herrera M; Kerick M; Gonzalez-Serna D; Wijmenga C; Franke A; Gregersen PK; Padyukov L; Worthington J; Vyse TJ; Eugenia Alarcon-Riquelme M; Mayes MD; Martin J; Miller FW; Chen W; O'Hanlon TP; Cooper RG; Vencovsky J; Rider LG; Danko K; Wedderburn LR; Lundberg IE; Pachman LM; Reed AM; Ytterberg SR; Selva-O'Callaghan A; Radstake TR; Isenberg DA; Chinoy H; Ollier WER; Scheet P; Peng B; Lee A; Lamb JA; Amos CI; Denton C; Hilton-Jones D; Plotz PH; Varsani H; Radstake TRDJ; Gorlova O; Rueda B; Martin J-E; Alizadeh BZ; Palomino-Morales R; Coenen MJ; Vonk MC; Voskuyl AE; Scheurwegh AJ; Broen JC; van Riel PLCM; van 't Slot R; Italiaander A; Ophoff RA; Riemekasten G; Hunzelmann N; Simeon CP; Ortego-Centeno N; Gonzalez-Gay MA; Gonzalez-Escribano MF; Airo P; van Laar J; Herrick A; Hesselstrand R; Smith V; de Keyser F; Houssiau F; Chee MM; Madhok R; Shiels P; Westhovens R; Kreuter A; Kiener H; de Baere E; Witte T; Klareskog L; Beretta L; Scorza R; Lie BA; Hoffman-Vold A-M; Carreira P; Varga J; Hinchcliff M; Lee AT; Ying J; Han Y; Weng S-F; Wigley FM; Hummers L; Nelson JL; Agarwal SK; Assassi S; Gourh P; Tan FK; Koeleman BPC; Arnett FC
• Article: JOURNAL OF PROTEOME RESEARCH. 2019;18(3):1208-1217

  Cytokine Profiles in Autoantibody Defined Subgroups of Systemic Lupus Erythematosus

  Torell F; Eketjall S; Idborg H; Jakobsson P-J; Gunnarsson I; Svenungsson E; Trygg J
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2019;78:A8-A9

  TENOSYNOVITIS AND HLA-SE PREDICT ARTHRITIS ONSET IN ACPA-POSITIVE INDIVIDUALS AT RISK OF DEVELOPING RHEUMATOID ARTHRITIS

  Hensvold AH; Kisten Y; Hansson M; Circiumaru A; Sun M; Fei G; Af Klint E; Rezaei H; Antovic A; Catrina AI
• Journal article: MEDITERRANEAN JOURNAL OF RHEUMATOLOGY. 2019;30(1):7-15

  Cerebrovascular Events in Systemic Lupus Erythematosus: Diagnosis and Management.

  Nikolopoulos D; Fanouriakis A; Boumpas DT
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2019;78:A16-A17

  MOLECULAR MIMICRY AND AUTOIMMUNITY: ANTI-P. GINGIVALIS ANTIBODY RESPONSE IN ACPA-POSITIVE RHEUMATOID ARTHRITIS

  Sherina N; Sippl N; Israelsson L; Le Maitre E; Kharlamova N; Hansson M; Eriksson K; Yucel-Lindberg T; Malmstrom V; Amara K; Lundberg K
• Article: ARTHRITIS RESEARCH & THERAPY. 2019;21(1):62

  Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjogren's syndrome differ in molecular signatures and treatment perspectives

  Idborg H; Zandian A; Sandberg A-S; Nilsson B; Elvin K; Truedsson L; Sohrabian A; Ronnelid J; Mo J; Grosso G; Kvarnstrom M; Gunnarsson I; Lehtio J; Nilsson P; Svenungsson E; Jakobsson P-J
• Article: ARTHRITIS RESEARCH & THERAPY. 2019;21(1):60

  Mass spectrometry-based analysis of cerebrospinal fluid from arthritis patients-immune-related candidate proteins affected by TNF blocking treatment

  Estelius J; Lengqvist J; Ossipova E; Idborg H; Le Maitre E; Andersson MLA; Brundin L; Khademi M; Svenungsson E; Jakobsson P-J; Lampa J
• Article: RHEUMATOLOGY. 2019;58(2):227-236

  Prevalence of sustained remission in rheumatoid arthritis: impact of criteria sets and disease duration, a Nationwide Study in Sweden

  Einarsson JT; Willim M; Ernestam S; Saxne T; Geborek P; Kapetanovic MC
• Article: ARTHRITIS & RHEUMATOLOGY. 2019;71(2):281-289

  Psychosis in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study

  Hanly JG; Li Q; Su L; Urowitz MB; Gordon C; Bae S-C; Romero-Diaz J; Sanchez-Guerrero J; Bernatsky S; Clarke AE; Wallace DJ; Isenberg DA; Rahman A; Merrill JT; Fortin PR; Gladman DD; Bruce IN; Petri M; Ginzler EM; Dooley MA; Steinsson K; Ramsey-Goldman R; Zoma AA; Manzi S; Nived O; Jonsen A; Khamashta MA; Alarcon GS; van Vollenhoven RF; Aranow C; Mackay M; Ruiz-Irastorza G; Ramos-Casals M; Lim SS; Inanc M; Kalunian KC; Jacobsen S; Peschken CA; Kamen DL; Askanase A; Theriault C; Farewell V
• Letter: RHEUMATOLOGY. 2019;58(2):361-363

  Clinical phenotype, autoantibody profile and HLA-DR-type in Vietnamese patients with idiopathic inflammatory myopathies

  Thuy NTP; Lan NTN; Hien NX; Ronnelid J; Padyukov L; Lundberg IE
• Article: EXPERT OPINION ON BIOLOGICAL THERAPY. 2019;19(2):157-168

  Clinical SLEDAI-2K zero may be a pragmatic outcome measure in SLE studies

  Parodis I; Emamikia S; Gomez A; Gunnarsson I; van Vollenhoven RF; Chatzidionysiou K
• Article: EBIOMEDICINE. 2019;40:517-527

  B cell alterations during BAFF inhibition with belimumab in SLE

  Ramskold D; Parodis I; Lakshmikanth T; Sippl N; Khademi M; Chen Y; Zickert A; Mikes J; Achour A; Amara K; Piehl F; Brodin P; Gunnarsson I; Malmstrom V
• Article: RHEUMATOLOGY. 2019;58(8):1367-1377

  Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register

  Frisell T; Dehlin M; Di Giuseppe D; Feltelius N; Turesson C; Askling J; Ernestam S; Klareskog L; Nisell R; Baecklund E; Kastbom A; Jacobsson L; Lindqvist E; d'Elia HF; Rantapaa-Dahlqvist S
• Article: JOURNAL OF PROTEOMICS. 2019;190:67-76

  The human CSF pain proteome

  Khoonsari PE; Ossipova E; Lengqvist J; Svensson CI; Kosek E; Kadetoff D; Jakobsson P-J; Kultima K; Lampa J
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2019;48(1):17-23

  Smoking and response to rituximab in rheumatoid arthritis: results from an international European collaboration

  Chatzidionysiou K; Lukina G; Gabay C; Hetland ML; Hauge EM; Pavelka K; Nordstrom D; Canhao H; Tomsic M; Rotar Z; Lie E; Kvien TK; van Vollenhoven RF; Saevarsdottir S
• Review: RMD OPEN. 2019;5(2):e000993

  Low rates of remission with methotrexate monotherapy in rheumatoid arthritis: review of randomised controlled trials could point towards a paradigm shift

  Chatzidionysiou K; Sfikakis PP
• Article: FRONTIERS IN PHARMACOLOGY. 2019;10:640

  Mass Spectrometry-Based Proteomics Approach Characterizes the Dual Functionality of miR-328 in Monocytes

  Saul MJ; Hegewald AB; Emmerich AC; Ossipova E; Vogel M; Baumann I; Kultima K; Lengqivst J; Steinhilber D; Jakobsson PJ
• Article: FRONTIERS IN PHARMACOLOGY. 2019;10:636

  Inhibition of mPGES-1 or COX-2 Results in Different Proteomic and Lipidomic Profiles in A549 Lung Cancer Cells

  Bergqvist F; Ossipova E; Idborg H; Raouf J; Checa A; Englund K; Englund P; Khoonsari PE; Kultima K; Wheelock CE; Larsson K; Korotkova M; Jakobsson P-J
• Review: AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH. 2019;11(11):6717-6738

  Mechanisms supporting potential use of bone marrow-derived mesenchymal stem cells in psychocardiology

  Liu J; Zhang L; Liu M
• Article: NEUROPSYCHIATRIC DISEASE AND TREATMENT. 2019;15:3041-3050

  Ginkgo biloba Extract Reduces Hippocampus Inflammatory Responses, Improves Cardiac Functions And Depressive Behaviors In A Heart Failure Mouse Model

  Zhang L; Liu J; Ge Y; Liu M
• Editorial comment: FRONTIERS IN PHARMACOLOGY. 2019;10:1604

  Editorial: New Therapies in the Field of Rheumatology

  Chighizola CB; Jakobsson P-J; Gerosa M
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2019;78(1):e8

  Response to: 'Detection of myositis-specific antibodies' by Vulsteke et al

  Tjarnlund A; Ronnelid J; Bottai M; Lundberg IE
• Article: FRONTIERS IN MICROBIOLOGY. 2019;10:3121

  sRNA scr5239 Involved in Feedback Loop Regulation of Streptomyces coelicolor Central Metabolism

  Engel F; Ossipova E; Jakobsson P-J; Vockenhuber M-P; Suess B
• Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2019;89(1):e12732

  Effect of CTLA4-Ig (abatacept) treatment on T cells and B cells in peripheral blood of patients with polymyositis and dermatomyositis

  Tang Q; Ramskold D; Krystufkova O; Mann HF; Wick C; Dastmalchi M; Lakshmikanth T; Chen Y; Mikes J; Alexanderson H; Achour A; Brodin P; Vencovsky J; Lundberg IE; Malmstrom V
• Article: JOURNAL OF MANIPULATIVE AND PHYSIOLOGICAL THERAPEUTICS. 2019;42(1):34-46

  Joint Mobilization of the Hands of Patients With Rheumatoid Arthritis: Results From an Assessor-Blinded, Randomized Crossover Trial

  Levitsky A; Kisten Y; Lind S; Nordstrom P; Hultholm H; Lyander J; Hammelin V; Gentline C; Giannakou I; Faustini F; Skillgate E; van Vollenhoven R; Sundberg T
• Article: PLOS ONE. 2019;14(2):e0212068

  Serum Axl predicts histology-based response to induction therapy and long-term renal outcome in lupus nephritis

  Parodis I; Ding H; Zickert A; Cosson G; Fathima M; Gronwall C; Mohan C; Gunnarsson I
• Article: THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE. 2019;11:1759720X19883152

  A cross-sectional investigation into the association between Porphyromonas gingivalis and autoantibodies to citrullinated proteins in a German population

  Oluwagbemigun K; Yucel-Lindberg T; Dietrich T; Tour G; Sherina N; Hansson M; Bergmann M; Lundberg K; Boeing H
• Article: DATABASE : THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION. 2019;2019:baz085

  Large expert-curated database for benchmarking document similarity detection in biomedical literature search

  Brown P; Tan A-C; El-Esawi MA; Liehr T; Blanck O; Gladue DP; Almeida GMF; Cernava T; Sorzano CO; Yeung AWK; Engel MS; Chandrasekaran AR; Muth T; Staege MS; Daulatabad SV; Widera D; Zhang J; Meule A; Honjo K; Pourret O; Yin C-C; Zhang Z; Cascella M; Flegel WA; Goodyear CS; van Raaij MJ; Bukowy-Bieryllo Z; Campana LG; Kurniawan NA; Lalaouna D; Huttner FJ; Ammerman BA; Ehret F; Cobine PA; Tan E-C; Han H; Xia W; McCrum C; Dings RPM; Marinello F; Nilsson H; Nixon B; Voskarides K; Yang L; Costa VD; Bengtsson-Palme J; Bradshaw W; Grimm DG; Kumar N; Martis E; Prieto D; Sabnis SC; Amer SEDR; Liew AWC; Perco P; Rahimi F; Riva G; Zhang C; Devkota HP; Ogami K; Basharat Z; Fierz W; Siebers R; Tan K-H; Boehme KA; Brenneisen P; Brown JAL; Dalrymple BP; Harvey DJ; Ng G; Werten S; Bleackley M; Dai Z; Dhariwal R; Gelfer Y; Hartmann MD; Miotla P; Tamaian R; Govender P; Gurney-Champion OJ; Kauppila JH; Zhang X; Echeverria N; Subhash S; Sallmon H; Tofani M; Bae T; Bosch O; Cuiv PO; Danchin A; Diouf B; Eerola T; Evangelou E; Filipp FV; Klump H; Kurgan L; Smith SS; Terrier O; Tuttle N; Ascher DB; Janga SC; Schulte LN; Becker D; Browngardt C; Bush SJ; Gaullier G; Ide K; Meseko C; Werner GDA; Zaucha J; Al-Farha AA; Greenwald NF; Popoola SI; Rahman MS; Xu J; Yang SY; Hiroi N; Alper OM; Baker CI; Bitzer M; Chacko G; Debrabant B; Dixon R; Forano E; Gilliham M; Kelly S; Klempnauer K-H; Lidbury BA; Lin MZ; Lynch I; Ma W; Maibach EW; Mather DE; Nandakumar KS; Ohgami RS; Parchi P; Tressoldi P; Xue Y; Armitage C; Barraud P; Chatzitheochari S; Coelho LP; Diao J; Doxey AC; Gobet A; Hu P; Kaiser S; Mitchell KM; Salama MF; Shabalin IG; Song H; Stevanovic D; Yadollahpour A; Zeng E; Zinke K; Alimba CG; Beyene TJ; Cao Z; Chan SS; Gatchell M; Kleppe A; Piotrowski M; Torga G; Woldesemayat AA; Cosacak MI; Haston S; Ross SA; Williams R; Wong A; Abramowitz MK; Effiong A; Lee S; Abid MB; Agarabi C; Alaux C; Albrecht DR; Atkins GJ; Beck CR; Bonvin AMJJ; Bourke E; Brand T; Braun RJ; Bull JA; Cardoso P; Carter D; Delahay RM; Ducommun B; Duijf PHG; Epp T; Eskelinen E-L; Fallah M; Farber DB; Fernandez-Triana J; Feyerabend F; Florio T; Friebe M; Furuta S; Gabrielsen M; Gruber J; Grybos M; Han Q; Heinrich M; Helantera H; Huber M; Jeltsch A; Jiang F; Josse C; Jurman G; Kamiya H; de Keersmaecker K; Kristiansson E; de Leeuw F-E; Li J; Liang S; Lopez-Escamez JA; Lopez-Ruiz FJ; Marchbank KJ; Marschalek R; Martin CS; Miele AE; Montagutelli X; Morcillo E; Nicoletti R; Niehof M; O'Toole R; Ohtomo T; Oster H; Palma J-A; Paterson R; Peifer M; Portilla M; Portillo MC; Pritchard AL; Pusch S; Raghava GPS; Roberts NJ; Ross K; Schuele B; Sergeant K; Shen J; Stella A; Sukocheva O; Uversky VN; Vanneste S; Villet MH; Viveiros M; Vorholt JA; Weinstock C; Yamato M; Zabetakis I; Zhao X; Ziegler A; Aizat WM; Atlas L; Bridges KM; Chakraborty S; Deschodt M; Domingues HS; Esfahlani SS; Falk S; Guisado JL; Kane NC; Kueberuwa G; Lau CL; Liang D; Liu E; Luu AM; Ma C; Ma L; Moyer R; Norris AD; Panthee S; Parsons JR; Peng Y; Pinto IM; Reschke CR; Sillanpaa E; Stewart CJ; Uhle F; Yang H; Zhou K; Zhu S; Ashry M; Bergsland N; Berthold M; Chen C-E; Colella V; Cuypers M; Eskew EA; Fan X; Gajda M; Gonzalezlez-Prendes R; Goodin A; Graham EB; Groen EJN; Gutierrez-Sacristan A; Habes M; Heffler E; Higginbottom DB; Janzen T; Jayaraman J; Jibb LA; Jongen S; Kinyanjui T; Koleva-Kolarova RG; Li Z; Liu Y-P; Lund BA; Lussier AA; Ma L; Mier P; Moore MD; Nagler K; Orme MW; Pearson JA; Prajapati AS; Saito Y; Troder SE; Uchendu F; Verloh N; Voutchkova DD; Abu-Zaid A; Bakkach J; Baumert P; Dono M; Hanson J; Herbelet S; Hobbs E; Kulkarni A; Kumar N; Liu S; Loft ND; Reddan T; Senghore T; Vindin H; Xu H; Bannon R; Chen B; Cheung JTK; Cooper J; Esnakul AK; Feghali KA; Ghelardi E; Gnasso A; Horbar J; Lai HM; Li J; Ma L; Ma R; Pan Z; Peres MA; Pranata R; Seow E; Sydes M; Testoni I; Westermair AL; Yang Y; Afnan M; Albiol J; Albuquerque LG; Amiya E; Amorim RM; An Q; Andersen SU; Aplin JD; Argyropoulos C; Asmann YW; Assaeed AM; Atanasov AG; Atchison DA; Avery SV; Avillach P; Baade PD; Backman L; Badie C; Baldi A; Ball E; Bardot O; Barnett AG; Basner M; Batra J; Bazanova OM; Beale A; Beddoe T; Bell ML; Berezikov E; Berners-Price S; Bernhardt P; Berry E; Bessa TB; Billington C; Birch J; Blakely RD; Blaskovich MAT; Blum R; Boelaert M; Bogdanos D; Bosch C; Bourgoin T; Bouvard D; Boykin LM; Bradley G; Braun D; Brownlie J; Bruhl A; Burt A; Butler LM; Byrareddy SN; Byrne HJ; Cabantous S; Calatayud S; Candal E; Carlson K; Casillas S; Castelvetro V; Caswell PT; Cavalli G; Cerovsky V; Chagoyen M; Chen C-S; Chen DF; Chen H; Chen H; Chen J-T; Chen Y; Cheng C; Cheng J; Chinapaw M; Chinopoulos C; Cho WCS; Chong L; Chowdhury D; Chwalibog A; Ciresi A; Cockcroft S; Conesa A; Cook PA; Cooper DN; Coqueret O; Corea EM; Costa E; Coupland C; Crawford SY; Cruz AD; Cui H; Cui Q; Culver DC; D'Angiulli A; Dahms TES; Daigle F; Dalgleish R; Danielsen HE; Darras S; Davidson SM; Day DA; Degirmenci V; Demaison L; Devriendt K; Ding J; Dogan Y; Dong XC; Donner CF; Dressick W; Drevon CA; Duan H; Ducho C; Dumaz N; Dwarakanath BS; Ebell MH; Eisenhardt S; Elkum N; Engel N; Erickson TB; Fairhead M; Faville MJ; Fejzo MS; Festa F; Feteira A; Flood-Page P; Forsayeth J; Fox SA; Franks SJ; Frentiu FD; Frilander MJ; Fu X; Fujita S; Galea I; Galluzzi L; Gani F; Ganpule AP; Garcia-Alix A; Gedye K; Giordano M; Giunta C; Gleeson PA; Goarant C; Gong H; Gora D; Gough MJ; Goyal R; Graham KE; Grande-Perez A; Graves PM; Greidanus H; Grice D; Grunau C; Gumulya Y; Guo Y; Gurevich VV; Gusev O; Hacker E; Hage SR; Hagen G; Hahn S; Haller DM; Hammerschmidt S; Han J; Han R; Handfield M; Hapuarachchi HC; Harder T; Hardingham JE; Heck M; Heers M; Hew KF; Higuchi Y; St Hilaire C; Hilton R; Hodzic E; Hone A; Hongoh Y; Hu G; Huber HP; Hueso LE; Huirne J; Hurt L; Idborg H; Ikeo K; Ingley E; Jakeman PM; Jensen A; Jia H; Jia H; Jia S; Jiang J; Jiang X; Jin Y; Jo D; Johnson AM; Johnston M; Jonscher KR; Jorens PG; Jorgensen JOL; Joubert JW; Jung S-H; Junior AM; Kahan T; Kamboj SK; Kang Y-K; Karamanos Y; Karp NA; Kelly R; Kenna R; Kennedy J; Kersten B; Khalaf RA; Khalid JM; Khatlani T; Khider T; Kijanka GS; King SRB; Kluz T; Knox P; Kobayashi T; Koch K-W; Kohonen-Corish MRJ; Kong X; Konkle-Parker D; Korpela KM; Kostrikis LG; Kraiczy P; Kratz H; Krause G; Krebsbach PH; Kristensen SR; Kumari P; Kunimatsu A; Kurdak H; Kwon YD; Lachat C; Lagisz M; Laky B; Lammerding J; Lange M; Larrosa M; Laslett AL; LeClair EE; Lee K-W; Lee M-Y; Lee M-S; Li G; Li J; Lieb K; Lim YY; Lindsey ML; Line P-D; Liu D; Liu F; Liu H; Liu H; Lloyd VK; Lo T-W; Locci E; Loidl J; Lorenzen J; Lorkowski S; Lovell NH; Lu H; Lu W; Lu Z; Luengo GS; Lundh L-G; Lysy PA; Mabb A; Mack HG; Mackey DA; Mahdavi SR; Maher P; Maher T; Maity SN; Malgrange B; Mamoulakis C; Mangoni AA; Manke T; Manstead ASR; Mantalaris A; Marsal J; Marschall H-U; Martin FL; Martinez-Raga J; Martinez-Salas E; Mathieu D; Matsui Y; Maza E; McCutcheon JE; Mckay GJ; McMillan B; McMillan N; Meads C; Medina L; Merrick BA; Metzger DW; Meunier FA; Michaelis M; Micheau O; Mihara H; Mintz EM; Mizukami T; Moalic Y; Mohapatra DP; Monteiro A; Montes M; Moran JV; Morozov SY; Mort M; Murai N; Murphy DJ; Murphy SK; Murray SA; Naganawa S; Nammi S; Nasios G; Natoli RM; Nguyen F; Nicol C; van Nieuwerburgh F; Nilsen EB; Nobile CJ; O'Mahony M; Ohlsson S; Olatunbosun O; Olofsson P; Ortiz A; Ostrikov K; Otto S; Outeiro TF; Ouyang S; Paganoni S; Page A; Palm C; Paradies Y; Parsons MH; Parsons N; Pascal P; Paul E; Peckham M; Pedemonte N; Pellizzon MA; Petrelli M; Pichugin A; Pinto CJC; Plevris JN; Pollesello P; Polz M; Ponti G; Porcelli P; Prince M; Quinn GP; Quinn TJ; Ramula S; Rappsilber J; Rehfeldt F; Reiling JH; Remacle C; Rezaei M; Riddick EW; Ritter U; Roach NW; Roberts DD; Robles G; Rodrigues T; Rodriguez C; Roislien J; Roobol MJ; Rowe JA; Ruepp A; van Ruitenbeek J; Rust P; Saad S; Sack GH; Santos M; Saudemont A; Sava G; Schrading S; Schramm A; Schreiber M; Schuler S; Schymkowitz J; Sczyrba A; Seib KL; Shi H-P; Shimada T; Shin J-S; Shortt C; Silveyra P; Skinner D; Small I; Smeets PAM; So P-W; Solano F; Sonenshine DE; Song J; Southall T; Speakman JR; Srinivasan MV; Stabile LP; Stasiak A; Steadman KJ; Stein N; Stephens AW; Stewart DI; Stine K; Storlazzi C; Stoynova NV; Strzalka W; Suarez OM; Sultana T; Sumant AV; Summers MJ; Sun G; Tacon P; Tanaka K; Tang H; Tanino Y; Targett-Adams P; Tayebi M; Tayyem R; Tebbe CC; Telfer EE; Tempel W; Teodorczyk-Injeyan JA; Thijs G; Thorne S; Thrift AG; Tiffon C; Tinnefeld P; Tjahjono DH; Tolle F; Toth E; del Tredici AL; Tsapas A; Tsirigotis K; Turak A; Tzotzos G; Udo EE; Utsumi T; Vaidyanathan S; Vaillant M; Valsesia A; Vandenbroucke RE; Veiga FH; Vendrell M; Vesk PA; Vickers P; Victor VM; Villemur R; Vohl M-C; Voolstra CR; Vuillemin A; Wakelin S; Waldron L; Walsh LJ; Wang AY; Wang F; Wang Y; Watanabe Y; Weigert A; Wen J-C; Wham C; White EP; Wiener J; Wilharm G; Wilkinson S; Willmann R; Wilson C; Wirth B; Wojan TR; Wolff M; Wong BM; Wu T-W; Wuerbel H; Xiao X; Xu D; Xu JW; Xu J; Xue B; Yalcin S; Yan H; Yang E-C; Yang S; Yang W; Ye Y; Ye Z-Q; Yli-Kauhaluoma J; Yoneyama H; Yu Y; Yuan G-C; Yuh C-H; Zaccolo M; Zeng C; Zevnik B; Zhang C; Zhang L; Zhang L; Zhang Y; Zhang Y; Zhang Z; Zhang Z-Y; Zhao Y; Zhou M; Zuberbier T; Aanei CM; Ahmad R; Al-Lawama M; Alanio A; Allardyce J; Alonso-Caneiro D; Atack JM; Baier D; Bansal A; Benezeth Y; Berbesque C; Berrevoet F; Biedermann PHW; Bijleveld E; Bittner F; Blombach F; Van den Bos W; Boudreau SA; Bramoweth AD; Braubach O; Cai Y; Campbell M; Cao Z; Catry T; Chen X; Cheng S; Chung H-J; Chavez-Fumagalli MA; Conway A; Costa BM; Cyr N; Dean LT; Denzel MS; Dlamini SV; Dudley KJ; Dufies M; Ecke T; Eckweiler D; Eixarch E; El-Adawy H; Emmrich JV; Eustace AJ; Falter-Wagner CM; Fuss J; Gao J; Gill MR; Gloyn L; Goggs R; Govinden U; Greene G; Greiff V; Grundle DS; Gruneberg P; Gumede N; Haore G; Harrison P; Hoenner X; Hojsgaard D; Hori H; Ikonomopoulou MP; Jeurissen P; Johnson DM; Kabra D; Kamagata K; Karmakar C; Kasian O; Kaye LK; Khan MM; Kim Y-M; Kish JK; Kobold S; Kohanbash G; Kohls G; Kugler J-M; Kumar G; Lacy-Colson J; Latif A; Lauschke VM; Li B; Lim CJ; Liu F; Liu X; Lu J-J; Lu Q; Mahavadi P; Marzocchi U; McGarrigle CA; van Meerten T; Min R; Moal I; Molari M; Molleman L; Mondal SR; Van de Mortel T; Moss WN; Moultos OA; Mukherjee M; Nakayama K; Narayan E; Navaratnarajah; Neumann P-A; Nie J; Nie Y; Niemeyer F; Nolan F; Nwaiwu O; Oldenmenger WH; Olumayede E; Ou J; Pallebage-Gamarallage M; Pearce SP; Pelkonen T; Pelleri MC; Pereira JL; Pheko M; Pinto KA; Piovesan A; Pluess M; Podolsky IM; Prescott J; Qi D; Qi X; Raikou VD; Ranft A; Rhodes J; Rotge J-Y; Rowe AD; Saggar M; Schuon RA; Shahid S; Shalchyan V; Shirvalkar P; Shiryayev O; Singh J; Smout MJ; Soares A; Song C; Srivastava K; Srivastava RK; Sun J; Szabo A; Szymanski W; Tai CNP; Takeuchi H; Tanadini-Lang S; Tang F; Tao W; Theron G; Tian CF; Tian Y-S; Tuttle LM; Valenti A; Verlot P; Walker M; Wang J; Welter D; Winslade M; Wu D; Wu Y-R; Xiao H; Xu B; Xu J; Xu Z; Yang D; Yang M; Yankilevich P; You Y; Yu C; Zhan J; Zhang G; Zhang K; Zhang T; Zhang Y; Zhao G; Zhao J; Zhou X; Zhu Z; Ajani PA; Anazodo UC; Bagloee SA; Bail K; Bar I; Bathelt J; Benkeser D; Bernier ML; Blanchard AM; Boakye DW; Bonatsos V; Boon MH; Bouboulis G; Bromfield E; Brown J; Bul KCM; Burton KJ; Butkowski EG; Carroll G; Chao F; Charrier EE; Chen X; Chen Y-C; Chenguang; Choi JR; Christoffersen T; Comel JC; Cosse C; Cui Y; van Dessel P; Dhaval; Diodato D; Duffey M; Dutt A; Egea LG; El-Said M; Faye M; Fernandez-Fernandez B; Foley KG; Founou LL; Fu F; Gadelkareem RA; Galimov E; Garip G; Gemmill A; Gouil Q; Grey J; Gridneva Z; Grothe MJ; Grebert T; Guerrero F; Guignard L; Haenssgen MJ; Hasler D; Holgate JY; Huang A; Hulse-Kemp AM; Jean-Quartier C; Jeon S-M; Jia Y; Jutzeler C; Kalatzis P; Karim M; Karsay K; Keitel A; Kempe A; Keown JR; Khoo CM; Khwaja N; Kievit RA; Kosanic A; Koutoukidis DA; Kramer P; Kumar D; Kirag N; Lanza G; Le TD; Leem JW; Leightley D; Leite A; Lercher L; Li Y; Lim R; Lima LRA; Lin L; Ling T; Liu Y; Liu Z; Lu Y; Lum FM; Luo H; Machhi J; Macleod A; Macwan I; Madala HR; Madani N; de Maio N; Makowiecki K; Mallinson DJ; Margelyte R; Maria C; Markonis Y; Marsili L; Mavoa S; McWilliams L; Megersa M; Mendes CSM; Menichetti J; Mercieca-Bebber R; Miller JJ; Minde D-PM; Minges A; Mishra E; Mishra VR; Moores C; Morrice N; Moskalensky AE; Navarin N; Negera E; Nolet P; Nordberg A; Norden R; Nowicki JP; Olova N; Olszewski P; Onzima R; Pan C-L; Park C; Park DI; Park S; Patil CD; Pedro SA; Perry SR; Peter J; Peterson BM; Pezzuolo A; Pozdnyakov I; Qian S; Qin L; Rafe A; Raote I; Raza A; Rebl H; Refai O; Regan T; Richa T; Richardson MF; Robinson KR; Rossoni L; Rouet R; Safaei S; Schneeberger PHH; Schwotzer D; Sebastian A; Selinski J; Seltmann S; Sha F; Shalev N; Shang J-L; Singer J; Singh M; Smith T; Solomon-Moore E; Song L; Soraggi S; Stanley R; Steckhan N; Strobl F; Subissi L; Supriyanto I; Surve CR; Suzuki T; Syme C; Sorelius K; Tang Y; Tantawy M; Tennakoon S; Teseo S; Toelzer C; Tomov N; Tovar M; Tran L; Tripathi S; Tuladhar AM; Ukubuiwe AC; Ung COL; Valgepea K; Vatanparast H; Vidal A; Wang F; Wang Q; Watari R; Webster R; Webster R; Wei J; Wibowo D; Wingenbach TSH; Xavier RM; Xiao S; Xiong P; Xu S; Xu S; Yao R; Yao W; Yin Q; Yu Y; Zaitsu M; Zeineb Z; Zhan X-Y; Zhang J; Zhang R; Zhang W; Zhang X; Zheng S; Zhou B; Zhou X; Ahmad H; Akinwumi SA; Albery GF; Alhowimel A; Ali J; Alshehri M; Alsuhaibani M; Anikin A; Azubuike SO; Bach-Mortensen A; Baltiansky L; Bartas M; Belachew KY; Bhardwaj V; Binder K; Bland NS; Boah M; Bullen B; Calabro GE; Callahan TJ; Cao B; Chalmers K; Chang W; Che Z; Chen ATY; Chen H; Chen H; Chen Y; Chen Z; Choi Y; Chowdhury MAK; Christensen MR; Cooke RSC; Cottini M; Covington NV; Cunningham C; Delarocque J; Devos L; Dhar AR; Ding K-F; Dong K; Dong Z; Dreyer N; Ekstrand C; Fardet T; Feleke BE; Feurer T; Freitas A; Gao T; Asefa NG; Giganti F; Grabowski P; Guerra-Mora JR; Guo C; Guo X; Gupta H; He S; Heijne M; Heinemann S; Hogrebe A; Huang Z; Iskander-Rizk S; Iyer LM; Jahan Y; James AS; Joel E; Joffroy B; Jegousse C; Kambondo G; Karnati P; Kaya C; Ke A; Kelly D; Kickert R; Kidibule PE; Kieselmann JP; Kim HJ; Kitazawa T; Lamberts A; Li Y; Liang H; Linn SN; Litfin T; Liusuo W; Lygirou V; Mahato AK; Mai Z-M; Major RW; Mali S; Mallis P; Mao W; Mao W; Marvin-Dowle K; Marvin-Dowle K; Mason LD; Merideth B; Merino-Plaza MJ; Merlaen B; Messina R; Mishra AK; Muhammad J; Musinguzi C; Nanou A; Naqash A; Nguyen JT; Nguyen TTH; Ni D; Nida; Notcovich S; Ohst B; Ollivier QR; Osses DF; Peng X; Plantinga A; Pulia M; Rafiq M; Raman A; Raucher-Chene D; Rawski R; Ray A; Razak LA; Rudolf K; Rusch P; Sadoine ML; Schmidt A; Schurr R; Searles S; Sharma S; Sheehan B; Shi C; Shohayeb B; Sommerlad A; Strehlow J; Sun X; Sundar R; Taherzadeh G; Tahir NDM; Tang J; Testa J; Tian Z; Tingting Q; Verheijen GP; Vickstrom C; Wang T; Wang X; Wang Z; Wei P; Wilson A; Wyart; Yassine A-A; Yousefzadeh A; Zare A; Zeng Z; Zhang C; Zhang H; Zhang L; Zhang T; Zhang W; Zhang Z; Zhou J; Zhu D; Adamo V; Adeyemo AA; Aggelidou M; Al-Owaifeer AM; Al-Riyami AZ; Alzghari SK; Andersen V; Angus K; Asaduzzaman M; Asady H; Ato D; Bai X; Baines RL; Ballantyne M; Ban B; Beck J; Ben-Nafa W; Black E; Blancher A; Blankstein R; Bodagh N; Borges PAV; Brooks A; Brox-Ponce J; Brunetti A; Canham CD; Carninci P; Carvajal R; Chang SC; Chao J; Chatterjee P; Chen H; Chen Y-C; Chhatriwalla AK; Chikowe I; Chuang T-J; Collevatti RG; Valera-Cornejo DA; Cuenda A; Dao M; Dauga D; Deng Z; Devkota K; Doan LV; Elewa YHA; Fan D; Faruk M; Feifei S; Ferguson TS; Fleres F; Foster EJ; Foster CS; Furer T; Gao Y; Garcia-Rivera EJ; Gazdar A; George RB; Ghosh S; Gianchecchi E; Gleason JM; Hackshaw A; Hall A; Hall R; Harper P; Hogg WE; Huang G; Hunter KE; IJzerman AP; Jesus C; Jian G; Lewis JSJ; Kanj SS; Kaur H; Kelly S; Kheir F; Kichatova VS; Kiyani M; Klein R; Kovesi T; Kraschnewski JL; Kumar AP; Labutin D; Lazo-Langner A; Leclercq G; Li M; Li Q; Li T; Li Y; Liao W-T; Liao Z-Y; Lin J; Lizer J; Lobreglio G; Lowies C; Lu C; Majeed H; Martin A; Martinez-Sobrido L; Meresh E; Middelveen M; Mohebbi A; Mota J; Mozaheb Z; Muyaya L; Nandhakumar A; Ng SHX; Obeidat M; Oh D-H; Owais M; Pace-Asciak P; Panwar A; Park C; Patterson C; Penagos-Tabaree F; Pianosi PT; Pinzi V; Pridans C; Psaroulaki A; Pujala RK; Pulido-Arjona L; Qi P-F; Rahman P; Rai NK; Rassaf T; Refardt J; Ricciardi W; Riess O; Rovas A; Sacks FM; Saleh S; Sampson C; Schmutz A; Sepanski R; Sharma N; Singh M; Spearman P; Subramaniapillai M; Swali R; Tan CM; Tellechea JI; Thomas L-M; Tong X; Veys R; Vitriol V; Wang H-D; Wang J; Wang J; Waugh J; Webb SA; Williams BA; Workman AD; Xiang T; Xie L-X; Xu J; Xu T; Yang C; Yoon JG; Yuan CM; Zaritsky A; Zhang Y; Zhao H; Zuckerman H; Lyu R; Pullan W; Zhou Y
• Published conference paper: ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY. 2019;1161:89-100

  Targeting the COX/mPGES-1/PGE2 Pathway in Neuroblastoma

  Larsson K; Kock A; Kogner P; Jakobsson P-J
• Article: JOURNAL OF RHEUMATOLOGY. 2019;46(1):106-111

  Perceptions of Patients, Caregivers, and Healthcare Providers of Idiopathic Inflammatory Myopathies: An International OMERACT Study

  Mecoli CA; Park JK; Alexanderson H; Regardt M; Needham M; de Groot I; Sarver C; Lundberg IE; Shea B; de Visser M; Song YW; Bingham COIII; Christopher-Stine L
• Article: FRONTIERS IN IMMUNOLOGY. 2019;10:1029

  Circulating Levels of Interferon Regulatory Factor-5 Associates With Subgroups of Systemic Lupus Erythematosus Patients

  Idborg H; Zandian A; Ossipova E; Wigren E; Preger C; Mobarrez F; Checa A; Sohrabian A; Pucholt P; Sandling JK; Fernandes-Cerqueira C; Ronnelid J; Oke V; Grosso G; Kvarnstrom M; Larsson A; Wheelock CE; Syvanen A-C; Ronnblom L; Kultima K; Persson H; Graslund S; Gunnarsson I; Nilsson P; Svenungsson E; Jakobsson P-J
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2019;71

  Fluorescence Optical Imaging in the Diagnosis of Individuals Suspected of Arthritis Development - a Probabilistic Approach

  Kisten Y; Levitsky A; Rezaei H; Hensvold A; Larsson P; Af Klint E; van Vollenhoven R; Catrina A
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2019;71

  Anti-citrullinated Protein Antibodies Induce Subclinical Inflammation, Bone Loss and Pain in Mice

  Krishnamurthy A; Kisten Y; Circiumaru A; Sandor K; Sakurabas K; Wigerblad G; Damberg P; Wahamaa H; Jarvolli P; Malmstrom V; Klareskog L; Svensson CI; Jimenez Andrade JJ; Rethi B; Catrina A
• Corrigendum: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2019;48(3):258

  Comparing patient-reported outcomes entered at home versus at hospital, and testing touch screens for initial recruitment to scientific trials in arthritis patients (vol 48, pg 178, 2019)

  Glintborg B; Lindstrom U; Aaltonen K; Kristianslund E; Gudbjornsson B; Chatzidionysiou K; Askling J; Nordstrom D; Hetland M; Di Giuseppe D; Dreyer L; Kristensen LE; Jorgensen TS; Eklund K; Grondal G; Ernestam S; Joensuu J; Tormanen MEK; Skydsgaard H; Hagfors J; Kvien TK; Lie E; Fagerli K; Geirsson AJ; Jonsson H; Provan SA; Krogh NS; Jacobsson LTH
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2019;71

  Antigen Bead Array versus ELISA to Detect anti-cN1A Antibodies in Patients with Sporadic Inclusion Body Myositis and Correlation with Clinical, Serological and Histological Features

  Notarnicola A; Bonomi F; Hellstrom C; Pin E; Idborg H; Nilsson P; Lundberg IE
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2019;71

  Self-reported Anxiety, Depression and Levels of Physical Activity in Patients with Adult Idiopathic Inflammatory Myopathies

  Andreasson K; Alexanderson H; Sandlund H
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2019;71

  Antimalarial Agents Improve Physical Functioning in Patients with Systemic Lupus Erythematosus

  Parodis I; Soukka S; Gomez A; Enman Y; Johansson P; Emamikia S; Chatzidionysiou K
• Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2019;90(6)

  Identifying novel B cell targets by screening of chemical probes in a patient-derived cell assay

  Panda SK; Sundstrom Y; Shang M-M; Gronwall C; Wermeling F; Gunnarsson I; Lundberg I; Sundstrom M; Jakobsson P-J; Berg L
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2019;71

  Autoreactivity to Acetylated Histones Defines a Subset of RA Patients and Is Associated with Acetyl - Citrulline Anti-Modified Protein Autoantibody (AMPA) Cross-Reactivity

  Sahlstrom P; Liljefors L; Joshua V; Sherina N; Thyagarajan R; Israelsson L; Stalesen R; Hansson M; Amara K; Reimer U; Padyukov L; Svenungsson E; Lundberg K; Catrina A; Klareskog L; Malmstrom V; Gronwall C
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2019;71

  Development of Ultrasound Detectable Arthritis Among ACPA Positive Subjects with Musculoskeletal Symptoms: The Risk RA Prospective Study

  Hensvold A; Kisten Y; Circiumaru A; Hansson M; Sun M; Fei G; Vivar N; af Klint E; Rezaei H; Klareskog L; Antovic A; Catrina A
• Article: EUROPEAN JOURNAL OF INFLAMMATION. 2019;17:2058739219844357

  Cross-sectional associations between inflammation, sickness behaviour, health anxiety and self-rated health in a Swedish primary care population

  Lodin K; Lekander M; Petrovic P; Nilsonne G; Hedman-Lagerlof E; Andreasson A
• Conference publication: EUROPEAN JOURNAL OF IMMUNOLOGY. 2019;49:1985-1986

  Combined data driven computational tool and B cell maturation assay for new target identification in systemic lupus erythematosus

  Shang M-M; Knezevic B; Fang H; Moller C; Panda SK; Sundstrom Y; Jakobsson P-J; Sundstrom M; Knight JC; Berg L
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2019;71

  Autoantibody Profiles Delineate Three Distinct Subsets of Scleromyositis

  D'Aoust J; Leclair V; Gyger G; Meyer A; Fritzler M; Landon-Cardinal O; O'Ferrall E; Karamchandani J; Ellezam B; Massie R; Satoh M; Troyanov Y; Hudson M
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2019;71

  Citrulline Reactive B Cells Are Present in the Lungs of Early Untreated RA

  Joshua V; Loberg-Haarhaus M; Wahamaa H; Hensvold A; Amara K; Israelsson L; Stalesen R; Skold M; Grunewald J; Gronwall C; Malmstrom V; Catrina A
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2019;71

  Cytokine and Autoantibody Profiles During Treatment with Belimumab in Patients with Systemic Lupus Erythematosus

  Parodis I; Akerstrom E; Sjowall C; Sohrabian A; Jonsen A; Gomez A; Frodlund M; Zickert A; Bengtsson A; Ronnelid J; Gunnarsson I
• Conference publication: JOURNAL OF IMMUNOLOGY. 2019;202(1)

  PAM3 supports the generation of M2-like macrophages from lupus patient monocytes and improves disease outcome in murine lupus

  Horuluoglu BH; Bayik D; Kayraklioglu N; Goguet E; Blanco LP; Kaplan MJ; Klinman DM
• Preprint: ZAPPYLAB, INC.. 2018

  Serum soluble (s)Axl assay protocol v1

  Parodis I; Ding H; Mohan C; Gunnarsson I
• Article: SCIENTIFIC REPORTS. 2018;8(1):17958

  Patients with anti-Jo1 antibodies display a characteristic IgG Fc-glycan profile which is further enhanced in anti-Jo1 autoantibodies

  Fernandes-Cerqueira C; Renard N; Notarnicola A; Wigren E; Graslund S; Zubarev RA; Lundberg IE; Lundstrom SL
• Article: JOURNAL OF INTERNAL MEDICINE. 2018;284(6):664-673

  Enhanced ventricular-arterial coupling during a 2-year physical activity programme in patients with rheumatoid arthritis: a prospective substudy of the physical activity in rheumatoid arthritis 2010 trial

  Sarajlic P; Friden C; Lund LH; Manouras A; Venkateshvaran A; Larsson SC; Nordgren B; Opava CH; Lundberg IE; Back M
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(12):e91

  Response to: 'Performance of the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies in clinical practice' by Hocevar et al

  Lundberg IE; Bottai M; Tjarnlund A
• Article: ARTHRITIS CARE AND RESEARCH. 2018;70(12):1849-1855

  Venous Thromboembolic Events in Idiopathic Inflammatory Myopathy: Occurrence and Relation to Disease Onset

  Antovic A; Notarnicola A; Svensson J; Lundberg IE; Holmqvist M
• Article: RHEUMATOLOGY. 2018;57(12):2149-2157

  Expression of interleukin-18 in muscle tissue of patients with polymyositis or dermatomyositis and effects of conventional immunosuppressive treatment

  Helmers SB; Bruton M; Loell I; Ulfgren A-K; Gracie AJ; McInnes IB; Lundberg IE
• Journal article: MEDITERRANEAN JOURNAL OF RHEUMATOLOGY. 2018;29(4):228-231

  Birth Registry of Women With Systematic Lupus Erythematosus: The Greek Experience.

  Ntali S; Pantazi L; Mpoki K; Nikolopoulos D; Fanouriakis A; Kallitsakis I; Papagoras C; Dimopoulou D; Kteniadaki E; Emmanouilidou E; Chania V; Bertsias G
• Journal article: MEDITERRANEAN JOURNAL OF RHEUMATOLOGY. 2018;29(4):232-235

  Comparative analysis of the sensitivity and specificity of the classification criteria and correlation with prognosis of disease in patients with Systemic Lupus Erythematosus.

  Adamichou C; Nikolopoulos D; Papastefanakis E; Kalogiannaki E; Gergianaki I; Kountouri A; Repa A; Avgoustidis N; Kougkas N; Sidiropoulos P; Fanouriakis A; Bertsias G
• Article: ARTHRITIS RESEARCH & THERAPY. 2018;20(1):262

  Long-term, health-enhancing physical activity is associated with reduction of pain but not pain sensitivity or improved exercise-induced hypoalgesia in persons with rheumatoid arthritis

  Lofgren M; Opava CH; Demmelmaier I; Friden C; Lundberg IE; Nordgren B; Kosek E
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2018;47(6):465-474

  Biological treatment in ankylosing spondylitis in the Nordic countries during 2010-2016: a collaboration between five biological registries

  Glintborg B; Lindstrom U; Aaltonen K; Kristianslund EK; Gudbjornsson B; Chatzidionysiou K; Askling J; Nordstrom D; Hetland ML; Di Giuseppe D; Dreyer L; Kristensen LE; Jorgensen TS; Eklund K; Grondal G; Ernestam S; Joensuu J; Tormanen MRK; Skydsgaard H; Hagfors J; Kvien TK; Lie E; Fagerli K; Geirsson AJ; Jonsson H; Provan SA; Krogh NS; Jacobsson LTH
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(11):e78

  Response to: '2017 EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: little emphasis on autoantibodies, why?' by Malaviya

  Lundberg IE; Tjarnlund A
• Article: ARTHRITIS CARE AND RESEARCH. 2018;70(10):1478-1487

  Cerebrovascular Events in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study

  Hanly JG; Li Q; Su L; Urowitz MB; Gordon C; Bae S-C; Romero-Diaz J; Sanchez-Guerrero J; Bernatsky S; Clarke AE; Wallace DJ; Isenberg DA; Rahman A; Merrill JT; Fortin P; Gladman DD; Bruce IN; Petri M; Ginzler EM; Dooley MA; Steinsson K; Ramsey-Goldman R; Zoma AA; Manzi S; Nived O; Jonsen A; Khamashta MA; Alarcon GS; Chatham W; van Vollenhoven RF; Aranow C; Mackay M; Ruiz-Irastorza G; Ramos-Casals M; Lim SS; Inanc M; Kalunian KC; Jacobsen S; Peschken CA; Kamen DL; Askanase A; Theriault C; Farewell V
• Article: ARTHRITIS CARE AND RESEARCH. 2018;70(10):1563-1567

  Tuberculosis Risk in Ankylosing Spondylitis, Other Spondyloarthritis, and Psoriatic Arthritis in Sweden: A Population-Based Cohort Study

  de Vries MK; Arkema EV; Jonsson J; Bruchfeld J; Jacobsson LTH; Askling J
• Article: ANNALS OF INTERNAL MEDICINE. 2018;169(5):291-299

  Tumor Necrosis Factor Inhibitors and Cancer Recurrence in Swedish Patients With Rheumatoid Arthritis A Nationwide Population-Based Cohort Study

  Raaschou P; Soderling J; Turesson C; Askling J
• Corrigendum: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(9):e64

  European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups (vol 76, pg 1955, 2018)

  Lundberg IE; Tjarnlund A; Bottai M
• Article: ARTHRITIS CARE AND RESEARCH. 2018;70(9):1294-1302

  Economic Evaluation of Lupus Nephritis in the Systemic Lupus International Collaborating Clinics Inception Cohort Using a Multistate Model Approach

  Barber MRW; Hanly JG; Su L; Urowitz MB; St Pierre Y; Romero-Diaz J; Gordon C; Bae S-C; Bernatsky S; Wallace DJ; Isenberg DA; Rahman A; Ginzler EM; Petri M; Bruce IN; Fortin PR; Gladman DD; Sanchez-Guerrero J; Ramsey-Goldman R; Khamashta MA; Aranow C; Mackay M; Alarcon GS; Manzi S; Nived O; Jonsen A; Zoma AA; van Vollenhoven RF; Ramos-Casals M; Ruiz-Irastorza G; Lim SS; Kalunian KC; Inanc M; Kamen DL; Peschken CA; Jacobsen S; Askanase A; Theriault C; Farewell V; Clarke AE
• Article: JOURNAL OF HEALTH PSYCHOLOGY. 2018;23(11):1452-1463

  A global measure of sickness behaviour: Development of the Sickness Questionnaire

  Andreasson A; Wicksell RK; Lodin K; Karshikoff B; Axelsson J; Lekander M
• Article: ARTHRITIS RESEARCH & THERAPY. 2018;20(1):188

  T-cell transcriptomics from peripheral blood highlights differences between polymyositis and dermatomyositis patients

  Houtman M; Ekholm L; Hesselberg E; Chemin K; Malmstrom V; Reed AM; Lundberg IE; Padyukov L
• Article: EXPERT OPINION ON BIOLOGICAL THERAPY. 2018;18(8):911-920

  Smoking reduces the efficacy of belimumab in mucocutaneous lupus

  Parodis I; Gomez A; Frodlund M; Jonsen A; Zickert A; Sjowall C; Bengtsson AA; Gunnarsson I
• Article: LUPUS. 2018;27(9):1470-1478

  Rituximab-mediated late-onset neutropenia in systemic lupus erythematosus - distinct roles of BAFF and APRIL

  Parodis I; Soder F; Faustini F; Kasza Z; Samuelsson I; Zickert A; Svenungsson E; van Vollenhoven RF; Malmstrom V; Wermeling F; Gunnarsson I
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(8):e51

  Response to: 'Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria' by Cavagna et al

  Lilleker JB; Vencovsky J; Wang G; Wedderburn LR; Diederichsen LP; Schmidt J; Jordan P; Benveniste O; Danieli MG; Danko K; Nguyen TPT; Vazquez-Del Mercado M; Andersson H; De Paepe B; De Bleecker JL; Maurer B; McCann LJ; Pipitone N; McHugh N; Betteridge Z; New P; Cooper RG; Ollier WE; Lamb JA; Krogh NS; Lundberg IE; Chinoy H
• Article: JOURNAL OF RHEUMATOLOGY. 2018;45(8):1093-1100

  An Outsourced Health-enhancing Physical Activity Program for People with Rheumatoid Arthritis: Study of the Maintenance Phase

  Nordgren B; Friden C; Demmelmaier I; Bergstrom G; Lundberg IE; Nessen T; Dufour AB; Opava CH
• Article: ARTHRITIS RESEARCH & THERAPY. 2018;20(1):158

  Serum levels of B-cell activating factor of the TNF family (BAFF) correlate with anti-Jo-1 autoantibodies levels and disease activity in patients with anti-Jo-1positive polymyositis and dermatomyositis

  Krystufkova O; Hulejova H; Mann HF; Pecha O; Putova I; Ekholm L; Lundberg IE; Vencovsky J
• Corrigendum: JOURNAL OF RHEUMATOLOGY. 2018;45(7):1071

  Advancing the Development of Patient-reported Outcomes for Adult Myositis at OMERACT 2016: An International Delphi Study (vol 44, pg 1683, 2017)

  Park JK; Mecoli CA; Alexanderson H; Regardt M; Christopher-Stine L; Casal-Dominguez M; de Groot I; Sarver C; Lundberg IE; Bingham COIII; Song YW
• Article: PHARMACOGENOMICS JOURNAL. 2018;18(4):528-538

  Genome-wide association study of response to methotrexate in early rheumatoid arthritis patients

  Taylor JC; Bongartz T; Massey J; Mifsud B; Spiliopoulou A; Scott IC; Wang J; Morgan M; Plant D; Colombo M; Orchard P; Twigg S; McInnes IB; Porter D; Freeston JE; Nam JL; Cordell HJ; Isaacs JD; Strathdee JL; Arnett D; de Hair MJH; Tak PP; Aslibekyan S; van Vollenhoven RF; Padyukov L; Bridges SL; Pitzalis C; Cope AP; Verstappen SMM; Emery P; Barnes MR; Agakov F; McKeigue P; Mushiroda T; Kubo M; Weinshilboum R; Barton A; Morgan AW; Barrett JH
• Letter: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (EJPC). 2018;25(10):1106-1108

  Impaired left atrial dynamics and its improvement by guided physical activity reveal left atrial strain as a novel early indicator of reversible cardiac dysfunction in rheumatoid arthritis

  Venkateshvaran A; Sarajlic P; Lund LH; Friden C; Nordgren B; Opava CH; Lundberg IE; Larsson SC; Manouras A; Back M
• Article: JOURNAL OF HEPATOLOGY. 2018;69(1):110-120

  Inhibition of microsomal prostaglandin E synthase-1 facilitates liver repair after hepatic injury in mice

  Nishizawa N; Ito Y; Eshima K; Ohkubo H; Kojo K; Inoue T; Raouf J; Jakobsson P-J; Uematsu S; Akira S; Narumiya S; Watanabe M; Majima M
• Article: ACS CHEMICAL BIOLOGY. 2018;13(6):1525-1535

  Stabilized Cyclic Peptides as Scavengers of Autoantibodies: Neutralization of Anticitrullinated Protein/Peptide Antibodies in Rheumatoid Arthritis

  Gunasekera S; Fernandes-Cerqueira C; Wennmalm S; Wahamaa H; Sommarin Y; Catrina AI; Jakobsson P-J; Goransson U
• Article: INTERNATIONAL JOURNAL OF RHEUMATOLOGY. 2018;2018:9152480-7

  Long-Term Dietary Changes after Diagnosis of Rheumatoid Arthritis in Swedish Women: Data from a Population-Based Cohort

  Lourdudoss C; Arnaud L; Wolk A; van Vollenhoven RF; Di Giuseppe D
• Letter: ARTHRITIS & RHEUMATOLOGY. 2018;70(6):976

  Consideration of antisynthetase syndrome features in classifying patients as having idiopathic inflammatory myopathy: comment on the article by Lundberg et al Reply

  Tjarnlund A; Bottai M; Lundberg IE
• Article: CLINICAL PHARMACOLOGY AND THERAPEUTICS. 2018;103(6):1074-1082

  A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires

  Costedoat-Chalumeau N; Houssiau F; Izmirly P; Le Guern V; Navarra S; Jolly M; Ruiz-Irastorza G; Baron G; Hachulla E; Agmon-Levin N; Shoenfeld Y; Dall'Ara F; Buyon J; Deligny C; Cervera R; Lazaro E; Bezanahary H; Leroux GE; Morel N; Viallard J-F; Pineau C; Galicier L; Van Vollenhoven R; Tincani A; Nguyen H; Gondran G; Zahr N; Pouchot J; Piette J-C; Petri M; Isenberg D
• Article: EBIOMEDICINE. 2018;32:84-92

  Inhibition of Microsomal Prostaglandin E Synthase-1 in Cancer-Associated Fibroblasts Suppresses Neuroblastoma Tumor Growth

  Kock A; Larsson K; Bergqvist F; Eissler N; Elfman LHM; Raouf J; Korotkova M; Johnsen JI; Jakobsson P-J; Kogner P
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2018;77:891

  SIGNIFICANT DECREASE OF T-CELLS BUT NOT MACROPHAGES IN THE SYNOVIUM OF PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AFTER TREATMENT WITH TOCILIZUMAB

  Chatzidionysiou K; Engstrom M; af Klint E; Hensvold A; Catrina AI
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2018;77:287-288

  ULTRASOUND DETECTED TENOSYNOVITIS PREDICTS ARTHRITIS ONSET IN INDIVIDUALS AT RISK OF DEVELOPING RHEUMATOID ARTHRITIS

  Kisten Y; Rezaei H; af Klint E; Fei G; Antovic A; Hensvold AH; Catrina AI
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2018;77:849-850

  PROGNOSTIC MARKERS FOR RESPONSE ACCORDING TO THE NEW ACR/EULAR 2016 RESPONSE CRITERIA FOR IDIOPATHIC INFLAMMATORY MYOSITIS

  Espinosa-Ortega F; Holmqvist M; Dastmalchi M; Lundberg I; Alexanderson H
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(Suppl 2):1414-1415

  AB0512 Occurrence and consequences of anti-drug antibodies to rituximab in systemic lupus erythematosus

  Faustini F; Parodis I; Dunn N; Ryner M; Fogdell-Hahn A; Gunnarsson I
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2018;77:569-570

  EVALUATION OF SERUM PROTEIN LEVELS AT BASELINE AS PREDICTORS OF RESPONSE TO METHOTREXATE IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS: RESULTS FROM SWEFOT TRIAL POPULATION

  Hambardzumyan K; Hamsten C; Idborg H; Lourido L; Saevarsdottir S; Nilsson P; van Vollenhoven RF; Jakobsson P-J
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(Suppl 2):691

  FRI0309 The impact of belimumab and rituximab on health-related quality of life in patients with systemic lupus erythematosus

  Parodis I; Benavides AHL; Zickert A; Pettersson S; Möller S; Henriksson EW; Voss A; Gunnarsson I
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2018;77:1375

  SEVERE INFECTIONS IN RHEUMATOID ARTHRITIS (RA) ARE RELATED TO THE USE OF BIOLOGIC DMARDS. ASSESSMENT OF REAL-LIFE PATIENTS

  Arce-Salinas CA; Tripp-Aguilar A; Amaya-Estrada JL; Rodriguez-Garcia F; Espinosa-Ortega F
• Corrigendum: NATURE COMMUNICATIONS. 2018;9(1):2071

  A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage

  Ladds MJGW; van Leeuwen IMM; Drummond CJ; Chu S; Healy AR; Popova G; Fernandez AP; Mollick T; Darekar S; Sedimbi SK; Nekulova M; Sachweh MCC; Campbell J; Higgins M; Tuck C; Popa M; Safont MM; Gelebart P; Fandalyuk Z; Thompson AM; Svensson R; Gustavsson A-L; Johansson L; Farnegardh K; Yngve U; Saleh A; Haraldsson M; D'Hollander ACA; Franco M; Zhao Y; Hakansson M; Walse B; Larsson K; Peat EM; Pelechano V; Lunec J; Vojtesek B; Carmena M; Earnshaw WC; McCarthy AR; Westwood NJ; Arsenian-Henriksson M; Lane DP; Bhatia R; McCormack E; Lain S
• Article: EXPERT OPINION ON BIOLOGICAL THERAPY. 2018;18(5):499-504

  Uptake of rheumatology biosimilars in the absence of forced switching

  Di Giuseppe D; Frisell T; Ernestam S; Forsblad-D'Elia H; Lindqvist E; Lindstrom U; Sjowall C; Askling J
• Article: ARTHRITIS RESEARCH & THERAPY. 2018;20(1):83

  Targeted lipidomics analysis identified altered serum lipid profiles in patients with polymyositis and dermatomyositis

  Raouf J; Idborg H; Englund P; Alexanderson H; Dastmalchi M; Jakobsson P-J; Lundberg IE; Korotkova M
• Corrigendum: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(5):786

  Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study (vol 77, pg 40, 2018)

  Dobloug GC; Svensson J; Lundberg IE; Holmqvist M
• Review: NATURE REVIEWS. RHEUMATOLOGY. 2018;14(5):269-278

  Classification of myositis

  Lundberg IE; de Visser M; Werth VP
• Journal article: JOURNAL OF IMMUNOLOGY. 2018;200(1_Supplement):175.17

  ALCAM and VCAM-1 as potential urinary biomarkers in Caucasian lupus patients

  Habazi D; Vanarsa K; Stanley S; Gokaraju S; Ding H; Parodis I; Gunnarsson I; Mohan C
• Article: IMMUNOLOGICAL MEDICINE. 2018;41(2):46-54

  Myositis an evolving spectrum of disease.

  Barsotti S; Lundberg IE
• Article: JOURNAL OF RHEUMATOLOGY. 2018;45(4):538-546

  Muscle Strength and Muscle Endurance During the First Year of Treatment of Polymyositis and Dermatomyositis: A Prospective Study

  Alexanderson H; Regardt M; Ottosson C; Munters LA; Dastmalchi M; Dani L; Lundberg IE
• Article: RHEUMATOLOGY. 2018;57(4):677-687

  Glucocorticoid use and factors associated with variability in this use in the Systemic Lupus International Collaborating Clinics Inception Cohort

  Little J; Parker B; Lunt M; Hanly JG; Urowitz MB; Clarke AE; Romero-Diaz J; Gordon C; Bae S-C; Bernatsky S; Wallace DJ; Merrill JT; Buyon J; Isenberg DA; Rahman A; Ginzler EM; Petri M; Dooley MA; Fortin P; Gladman DD; Steinsson K; Ramsey-Goldman R; Khamashta MA; Aranow C; Mackay M; Alarcon GS; Manzi S; Nived O; Jonsen A; Zoma AA; van Vollenhoven RF; Ramos-Casals M; Ruiz-Irastorza G; Lim SS; Kalunian KC; Inanc M; Kamen DL; Peschken CA; Jacobsen S; Askanase A; Sanchez-Guerrero J; Bruce IN
• Review: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(4):476-479

  2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis

  Radner H; Chatzidionysiou K; Nikiphorou E; Gossec L; Hyrich KL; Zabalan C; van Eijk-Hustings Y; Williamson PR; Balanescu A; Burmester GR; Carmona L; Dougados M; Finckh A; Haugeberg G; Hetland ML; Oliver S; Porter D; Raza K; Ryan P; Santos MJ; van der Helm-van Mil A; van Riel P; von Krause G; Zavada J; Dixon WG; Askling J
• Article: ARTHRITIS CARE AND RESEARCH. 2018;70(4):648-651

  Association of Anti-Transcription Intermediary Factor 1γ Antibodies With Paraneoplastic Rheumatic Syndromes Other Than Dermatomyositis

  Venalis P; Selickaja S; Lundberg K; Rugiene R; Lundberg IE
• Letter: JOURNAL OF RHEUMATOLOGY. 2018;45(4):581-583

  Successful Lung Transplantation in a Case of Rapidly Progressive Interstitial Lung Disease Associated with Antimelanoma Differentiation-associated Gene 5 Antibodies

  Leclair V; Labirua-Iturburu A; Lundberg IE
• Article: CURRENT RHEUMATOLOGY REPORTS. 2018;20(4):18

  New Myositis Classification Criteria-What We Have Learned Since Bohan and Peter

  Leclair V; Lundberg IE
• Article: NATURE COMMUNICATIONS. 2018;9(1):1107

  A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage

  Ladds MJGW; van Leeuwen IMM; Drummond CJ; Chu S; Healy AR; Popova G; Fernandez AP; Mollick T; Darekar S; Sedimbi SK; Nekulova M; Sachweh MCC; Campbell J; Higgins M; Tuck C; Popa M; Safont MM; Gelebart P; Fandalyuk Z; Thompson AM; Svensson R; Gustavsson A-L; Johansson L; Farnegardh K; Yngve U; Saleh A; Haraldsson M; D'Hollander ACA; Franco M; Zhao Y; Hakansson M; Walse B; Larsson K; Peat EM; Pelechano V; Lunec J; Vojtesek B; Carmena M; Earnshaw WC; McCarthy AR; Westwood NJ; Arsenian-Henriksson M; Lane DP; Bhatia R; McCormack E; Lain S
• Article: ARTHRITIS RESEARCH & THERAPY. 2018;20(1):48

  Pain sensitivity at rest and during muscle contraction in persons with rheumatoid arthritis: a substudy within the Physical Activity in Rheumatoid Arthritis 2010 study

  Lofgren M; Opava CH; Demmelmaier I; Friden C; Lundberg IE; Nordgren B; Kosek E
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2018;47(2):131-140

  Relationship between glucocorticoid dose and adverse events in systemic lupus erythematosus: data from a randomized clinical trial

  Emamikia S; Gentline C; Chatzidionysiou K; Arnaud L; van Vollenhoven R
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2018;77:A39-A40

  SIGNIFICANT DECREASE OF T-CELLS BUT NOT MACROPHAGES IN THE SYNOVIUM OF PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AFTER TREATMENT WITH TOCILIZUMAB

  Chatzidionysiou K; Engstrom M; Af Klint E; Hensvold A; Catrina AI
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2018;77:A33

  CHARACTERISATION OF THE ANTIBODY RESPONSE TO A CITRULLINATED PEPTIDE DERIVED FROM PORPHYROMONAS GINGIVALIS PAD IN RA

  Kharlamova N; Brynedal B; Sherina N; Eriksson K; Lindberg T; Hansson M; Israelsson L; Steen J; Malmstrom V; Alfredsson L; Amara K; Lundberg K
• Conference publication: 2018;:a101.2-a1a102

  PS7:134 Rituximab-mediated late-onset neutropenia in systemic lupus erythematosus – distinct roles of baff and april

  Parodis I; Söder F; Faustini F; Kasza Z; Wermeling F; Gunnarsson I
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(Suppl 1):a21-A22

  P019 Ultrasound detected tenosynovitis as a marker of subclinical inflammation prior to arthritis onset

  Kisten Y; Rezaei H; Klint EA; Fei G; Hensvold A; Catrina A
• Conference publication: 2018;:a100.3-a1a101

  PS7:132 Smoking reduces the efficacy of belimumab in mucocutaneous lupus

  Parodis I; Gomez A; Sjöwall C; Jönsen A; Zickert A; Frodlund M; Bengtsson A; Gunnarsson I
• Conference publication: 2018;:a111.2-a1a113

  PS8:153 Subtypes and location of myocardial infarctions in systemic lupus erythematosus

  Samuelsson I; Parodis I; Anan C
• Article: JMIR MEDICAL EDUCATION. 2018;4(1):e4

  Increasing Reasoning Awareness: Video Analysis of Students' Two-Party Virtual Patient Interactions.

  Edelbring S; Parodis I; Lundberg IE
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(2):241-250

  Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform research

  McCann LJ; Pilkington CA; Huber AM; Ravelli A; Appelbe D; Kirkham JJ; Williamson PR; Aggarwal A; Christopher-Stine L; Constantin T; Feldman BM; Lundberg I; Maillard S; Mathiesen P; Murphy R; Pachman LM; Reed AM; Rider LG; van Royen-Kerkof A; Russo R; Spinty S; Wedderburn LR; Beresford MW
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(2):203-211

  Anticitrullinated protein/peptide antibody multiplexing defines an extended group of ACPA-positive rheumatoid arthritis patients with distinct genetic and environmental determinants

  Ronnelid J; Hansson M; Mathsson-Alm L; Cornillet M; Reed E; Jakobsson P-J; Alfredsson L; Holmdahl R; Skriner K; Serre G; Lundberg K; Klareskog L
• Article: ARTHRITIS CARE AND RESEARCH. 2018;70(2):205-212

  Dietary Intake of Polyunsaturated Fatty Acids and Pain in Spite of Inflammatory Control Among Methotrexate-Treated Early Rheumatoid Arthritis Patients

  Lourdudoss C; Di Giuseppe D; Wolk A; Westerlind H; Klareskog L; Alfredsson L; van Vollenhoven RF; Lampa J
• Thesis / dissertation: 2018

  Inflammation and subjective health : the role of sickness behaviour

  Lodin, Karin
• Review: NATURE REVIEWS. RHEUMATOLOGY. 2018;14(2):75-93

  Moving towards a molecular taxonomy of autoimmune rheumatic diseases

  Barturen G; Beretta L; Cervera R; Van Vollenhoven R; Alarcon-Riquelme ME
• Review: CURR TREATM OPT RHEUMATOL. 2018;4(4):299-315

  Current Treatment for Myositis.

  Barsotti S; Lundberg IE
• Review: CURR TREATM OPT RHEUMATOL. 2018;4(4):289-298

  Exercise in Myositis.

  Alexanderson H
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(1):30-39

  The EuroMyositis registry: an international collaborative tool to facilitate myositis research

  Lilleker JB; Vencovsky J; Wang G; Wedderburn LR; Diederichsen LP; Schmidt J; Oakley P; Benveniste O; Danieli MG; Danko K; Nguyen TPT; Vazquez-Del Mercado M; Andersson H; De Paepe B; debleecker JL; Maurer B; McCann LJ; Pipitone N; McHugh N; Betteridge ZE; New P; Cooper RG; Ollier WE; Lamb JA; Krogh NS; Lundberg IE; Chinoy H
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(1):40-47

  Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study

  Dobloug GC; Svensson J; Lundberg IE; Holmqvist M
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(1):55-62

  Abatacept in the treatment of adult dermatomyositis and polymyositis: a randomised, phase IIb treatment delayed-start trial

  Tjarnlund A; Tang Q; Wick C; Dastmalchi M; Mann H; Studynkova JT; Chura R; Gullick NJ; Salerno R; Ronnelid J; Alexanderson H; Lindroos E; Aggarwal R; Gordon P; Vencovsky J; Lundberg IE
• Corrigendum: PLOS ONE. 2018;13(5):e0197795

  Longitudinal co-variations between inflammatory cytokines, lung function and patient reported outcomes in patients with asthma (vol 12, e0185019, 2017)

  Lodin K; Lekander M; Syk J; Alving K; Petrovic P; Andreasson A
• Corrigendum: RMD OPEN. 2018;4(1):rmdopen-2018-000655corr1

  Opportunities and challenges for real-world studies on chronic inflammatory joint diseases through data enrichment and collaboration between national registers: the Nordic example (vol 4, e000655, 2018)

  Chatzidionysiou K; Hetland ML; Frisell T
• Review: FRONTIERS IN PHARMACOLOGY. 2018;9:356

  The Effectiveness and Safety of Tripterygium wilfordii Hook. F Extracts in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

  Zhou Y-Y; Xia X; Peng W-K; Wang Q-H; Peng J-H; Li Y-L; Wu J-X; Zhang J-Y; Zhao Y; Chen X-M; Huang R-Y; Jakobsson P-J; Wen Z-H; Huang Q-C
• Review: RMD OPEN. 2018;4(1):e000655

  Opportunities and challenges for real-world studies on chronic inflammatory joint diseases through data enrichment and collaboration between national registers: the Nordic example

  Chatzidionysiou K; Hetland ML; Frisell T; Di Giuseppe D; Hellgren K; Glintborg B; Nordstrom D; Aaltonen K; Tormanen MRK; Kristianslund EK; Kvien TK; Provan SA; Guobjornsson B; Dreyer L; Kristensen LE; Jorgensen TS; Jacobsson L; Askling J
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2018;36(1):21-28

  Rheumatologists' guideline adherence in rheumatoid arthritis: a randomised controlled study on electronic decision support, education and feedback

  Lesuis N; van Vollenhoven RF; Akkermans RP; Verhoef LM; Hulscher ME; den Broeder AA
• Review: FRONTIERS IN PHARMACOLOGY. 2018;9:914

  The Bone-Protecting Efficiency of Chinese Medicines Compared With Western Medicines in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Comparative Studies

  Cai X; Chen X-M; Xia X; Bao K; Wang R-R; Peng J-H; Liu H-J; Yang Q-W; Yan J-Y; Wang M-J; Yu H; Lu J-J; Hu Y-J; Jakobsson P-J; Wen Z-H; Huang R-Y; Huang Q-C
• Article: THERANOSTICS. 2018;8(16):4477-4490

  Integration of magnetic resonance imaging and protein and metabolite CSF measurements to enable early diagnosis of secondary progressive multiple sclerosis

  Herman S; Khoonsari PE; Tolf A; Steinmetz J; Zetterberg H; Akerfeldt T; Jakobsson P-J; Larsson A; Spjuth O; Burman J; Kultima K
• Article: ARTHRITIS CARE AND RESEARCH. 2018;70(1):98-103

  Study of Flare Assessment in Systemic Lupus Erythematosus Based on Paper Patients

  Isenberg D; Sturgess J; Allen E; Aranow C; Askanase A; Sang-Cheol B; Bernatsky S; Bruce I; Buyon J; Cervera R; Clarke A; Dooley MA; Fortin P; Ginzler E; Gladman D; Hanly J; Inanc M; Jacobsen S; Kamen D; Khamashta M; Lim S; Manzi S; Nived O; Peschken C; Petri M; Kalunian K; Rahman A; Ramsey-Goldman R; Romero-Diaz J; Ruiz-Irastorza G; Sanchez-Guerrero J; Steinsson K; Sturfelt G; Urowitz M; van Vollenhoven R; Wallace DJ; Zoma A; Merrill J; Gordon C
• Article: LUPUS SCIENCE AND MEDICINE. 2018;5(1):e000287

  Predictors of persistent disease activity and long quiescence in systemic lupus erythematosus: results from the Hopkins Lupus Cohort

  Giannakou I; Chatzidionysiou K; Magder LS; Gyori N; van Vollenhoven R; Petri MA
• Article: LUPUS SCIENCE AND MEDICINE. 2018;5(1):e000260

  TNF-α and plasma albumin as biomarkers of disease activity in systemic lupus erythematosus

  Idborg H; Eketjall S; Pettersson S; Gustafsson JT; Zickert A; Kvarnstrom M; Oke V; Jakobsson P-J; Gunnarsson I; Svenungsson E
• Article: LUPUS SCIENCE AND MEDICINE. 2018;5(1):e000254

  Kynurenine pathway is altered in patients with SLE and associated with severe fatigue

  Akesson K; Pettersson S; Stahl S; Surowiec IM; Hedenstrom M; Eketjall S; Trygg J; Jakobsson P-J; Gunnarsson I; Svenungsson E; Idborg H
• Article: PLOS ONE. 2018;13(2):e0193210

  Microsomal prostaglandin E synthase-1 gene deletion impairs neuro-immune circuitry of the cholinergic anti-inflammatory pathway in endotoxaemic mouse spleen

  Revathikumar P; Estelius J; Karmakar U; Le Maitre E; Korotkova M; Jakobsson P-J; Lampa J
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2018;77:A21-A22

  ULTRASOUND DETECTED TENOSYNOVITIS AS A MARKER OF SUBCLINICAL INFLAMMATION PRIOR TO ARTHRITIS ONSET

  Kisten Y; Rezaei H; af Klint E; Fei G; Hensvold AH; Catrina AI
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2018;70

  Components of Impaired Physical Function and Disability in a Non-Rheumatic Population. Normative Values of the Health Assessment Questionnaire Disability Index

  Alejandro Arce-Salinas C; Espinosa-Ortega HF; Enriquez-Antonio O
• Corrigendum: RMD OPEN. 2018;4(1)

  Opportunities and challenges for real-world studies on chronic inflammatory joint diseases through data enrichment and collaboration between national registers: the Nordic example (vol 4, e000655, 2018)

  Chatzidionysiou K; Hetland ML; Frisell T
• Conference publication: QUALITY OF LIFE RESEARCH. 2018;27:S109-S110

  Health-related quality of life in patients investigated for suspected lung cancer

  Eriksson LE; Levitsky A; Bernhardson B-M
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2018;70

  Muscle Function and Health-Related Quality of Life in Patients with Polymyositis and Dermatomyositis

  Andreasson K; Munters LA; Alexanderson H
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2018;70

  A Role of Vascular Cell Adhesion Molecule 1 and Activated Leukocyte Cell Adhesion Molecule in Lupus Nephritis

  Parodis I; Gokaraju S; Zickert A; Zhang T; Habazi D; Larsson A; Svenungsson E; Mohan C; Gunnarsson I
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2018;70

  SLE Patients with No Organ Damage Might Benefit More from Belimumab Treatment

  Parodis I; Emamikia S; Gomez A; Chatzidionysiou K
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2018;70

  Clinical SLE Disease Activity Index Score of Zero May be a More Pragmatic Outcome Measure in SLE Studies

  Parodis I; Emamikia S; Gunnarsson I; van Vollenhoven RF; Chatzidionysiou K
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2018;70

  ACPA-Positive Risk-RA Subject without Subclinical Arthritis Are in High Risk for Later Arthritis Onset, Especially Carriers of HLA-SE Risk-Gene

  Hensvold A; Kisten Y; Hansson M; Circiumaru A; Sun M; Rezaei H; af Klint E; Fei G; Antovic A; Catrina AI
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2018;70

  Tenosynovitis Detected By Ultrasound Predicts Arthritis Onset in Individuals at Risk of Developing Rheumatoid Arthritis

  Kisten Y; Rezaei H; af Klint E; Fei G; Antovic A; Hensvold A; Catrina AI
• Conference publication: QUALITY OF LIFE RESEARCH. 2018;27:S2-S3

  Analysis of early predictive lung cancer symptoms and sensations by orthogonal projections to latent structures (OPLS)

  Levitsky A; Pernemalm M; Runesdotter S; Bernhardson B-M; Forshed J; Lehtio J; Tishelman C; Eriksson LE
• Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2018;47:2

  Systemic lupus erythematosus subgroups, with features of antiphospholipid or Sjogren's syndrome, differ in molecular signatures and treatment perspectives

  Idborg H; Zandian A; Sandberg A; Truedsson L; Nilsson B; Elvin K; Mo J; Gustafsson J; Gunnarsson I; Lehtio J; Nilsson P; Svenungsson E; Jakobsson P
• Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2018;47:31

  Evaluation of serum protein levels at baseline as predictors of response to methotrexate in patients with early rheumatoid arthritis: results from the SWEFOT trial population

  Hambardzumyan K; Hamsten C; Idborg H; Lourido L; Saevarsdottir S; Nilsson P; van Vollenhoven R; Jakobsson P
• Conference publication: JOURNAL OF IMMUNOLOGY. 2018;200(1)

  ALCAM and VCAM-1 as potential urinary biomarkers in Caucasian lupus patients

  Habazi D; Vanarsa K; Stanley S; Gokaraju S; Ding H; Parodis I; Gunnarsson I; Mohan C
• Conference publication: JOURNAL OF IMMUNOLOGY. 2018;200(1)

  Modulation of TLR2/1 by PAM3CSK4 to induce generation of immunosuppressive macrophages as a therapeutic approach for SLE

  Horuluoglu BH; Bayik D; Goguet E; Tross D; Blanco LP; Kaplan MJ; Klinman DM
• Article: ARTHRITIS RESEARCH & THERAPY. 2017;19(1):287

  Nitrated nucleosome levels and neuropsychiatric events in systemic lupus erythematosus; a multi-center retrospective case-control study

  Ferreira I; Croca S; Raimondo MG; Matharu M; Miller S; Giles I; Isenberg D; Ioannou Y; Hanly JG; Urowitz MB; Anderson N; Aranow C; Askanase A; Bae S-C; Bernatsky S; Bruce IN; Buyon J; Clarke AE; Dooley MA; Fortin P; Ginzler E; Gladman D; Gordon C; Inanc M; Jacobsen S; Kalunian K; Kamen D; Khamashta M; Lim S; Manzi S; Merrill J; Nived O; Peschken C; Petri M; Ramsey-Goldman R; Ruiz-Irastorza G; Sanchez-Guerrero J; Steinson K; Sturfelt GK; van Vollenhoven R; Wallace DJ; Zoma A; Rahman A
• Article: NPJ PRIMARY CARE RESPIRATORY MEDICINE. 2017;27(1):67

  Associations between self-rated health, sickness behaviour and inflammatory markers in primary care patients with allergic asthma: a longitudinal study

  Lodin K; Lekander M; Syk J; Alving K; Andreasson A
• Article: BMC RESEARCH NOTES. 2017;10(1):687

  The McMaster Toronto Arthritis patient preference questionnaire (MACTAR): a methodological study of reliability and minimal detectable change after a 6 week-period of acupuncture treatment in patients with rheumatoid arthritis.

  Brodin N; Grooten WJA; Stråt S; Löfberg E; Alexanderson H
• Review: MUSCULOSKELETAL CARE. 2017;15(4):316-323

  Aerobic and resistance exercise in systemic sclerosis: State of the art.

  de Oliveira NC; Portes LA; Pettersson H; Alexanderson H; Boström C
• Article: ARTHRITIS & RHEUMATOLOGY. 2017;69(12):2271-2282

  2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups

  Lundberg IE; Tjarnlund A; Bottai M; Werth VP; Pilkington C; de Visser M; Alfredsson L; Amato AA; Barohn RJ; Liang MH; Singh JA; Aggarwal R; Arnardottir S; Chinoy H; Cooper RG; Danko K; Dimachkie MM; Feldman BM; Garcia-De La Torre I; Gordon P; Hayashi T; Katz JD; Kohsaka H; Lachenbruch PA; Lang BA; Li Y; Oddis CV; Olesinska M; Reed AM; Rutkowska-Sak L; Sanner H; Selva-O'Callaghan A; Song Y-W; Vencovsky J; Ytterberg SR; Miller FW; Rider LG
• Corrigendum: JOURNAL OF RHEUMATOLOGY. 2017;44(12):1944

  Advancing the Development of Patient-reported Outcomes for Adult Myositis at OMERACT 2016: An International Delphi Study (vol 44, pg 1683, 2017)

  Park JK; Mecoli CA; Alexanderson H; Regardt M; Christopher-Stine L; Casal-Dominguez M; de Groot I; Sarver C; Lundberg IE; Bingham COIII; Song YW
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(12):1955-1964

  2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups

  Lundberg IE; Tjarnlund A; Bottai M; Werth VP; Pilkington C; de Visser M; Alfredsson L; Amato AA; Barohn RJ; Liang MH; Singh JA; Aggarwal R; Arnardottir S; Chinoy H; Cooper RG; Danko K; Dimachkie MM; Feldman BM; Garcia-De La Torre I; Gordon P; Hayashi T; Katz JD; Kohsaka H; Lachenbruch PA; Lang BA; Li Y; Oddis CV; Olesinska M; Reed AM; Rutkowska-Sak L; Sanner H; Selva-O'Callaghan A; Song Y-W; Vencovsky J; Ytterberg SR; Miller FW; Rider LG
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2017;46(6):490-495

  Self-reported physical capacity and activity in patients with systemic sclerosis and matched controls

  Pettersson H; Akerstrom A; Nordin A; Svenungsson E; Alexanderson H; Bostrom C
• Review: CURRENT OPINION IN RHEUMATOLOGY. 2017;29(6):591-597

  Novel insights of disability assessment in adult myositis

  Espinosa-Ortega HF; Moreno-Ramirez M; Alexanderson H
• Published conference paper: JOURNAL OF RHEUMATOLOGY. 2017;44(11):1683-1687

  Advancing the Development of Patient-reported Outcomes for Adult Myositis at OMERACT 2016: An International Delphi Study

  Park JK; Mecoli CA; Alexanderson H; Regardt M; Christopher-Stine L; Casal-Dominguez M; de Groot I; Sarver C; Lundberg IE; Bingham COIII; Song YW
• Review: CURRENT OPINION IN RHEUMATOLOGY. 2017;29(6):652-659

  Recent clinical trials in idiopathic inflammatory myopathies

  Leclair V; Lundberg IE
• Article: RHEUMATOLOGY. 2017;56(11):1884-1893

  2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects

  Rider LG; Ruperto N; Pistorio A; Erman B; Bayat N; Lachenbruch PA; Rockette H; Feldman BM; Huber AM; Hansen P; Oddis CV; Lundberg IE; Amato AA; Chinoy H; Cooper RG; Chung L; Danko K; Fiorentino D; Garcia-De la Torre I; Reed AM; Song YW; Cimaz R; Cuttica RJ; Pilkington CA; Martini A; van der Net J; Maillard S; Miller FW; Vencovsky J; Aggarwal R
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(11):1803-1808

  Infections and respiratory tract disease as risk factors for idiopathic inflammatory myopathies: a population-based case-control study

  Svensson J; Holmqvist M; Lundberg IE; Arkema EV
• Article: BRITISH JOURNAL OF PHARMACOLOGY. 2017;174(22):4087-4098

  Inhibition of microsomal PGE synthase-1 reduces human vascular tone by increasing PGI₂: a safer alternative to COX-2 inhibition

  Ozen G; Gomez I; Daci A; Deschildre C; Boubaya L; Teskin O; Uydes-Dogan BS; Jakobsson P-J; Longrois D; Topal G; Norel X
• Preprint: JMIR PREPRINTS. 2017

  Increasing Reasoning Awareness: Video Analysis of Students� Two-Party Virtual Patient Interactions

  Edelbring S; Parodis I; Lundberg IE
• Preprint: JMIR PREPRINTS. 2017

  Increasing Reasoning Awareness: Video Analysis of Students� Two-Party Virtual Patient Interactions (Preprint)

  Edelbring S; Parodis I; Lundberg IE
• Article: CLINICAL RHEUMATOLOGY. 2017;36(10):2289-2295

  Quality of life correlates with muscle strength in patients with dermato- or polymyositis

  Poulsen KB; Alexanderson H; Dalgard C; Jacobsen S; Weile L; Diederichsen LP
• Article: ANIMAL. 2017;11(10):1791-1797

  Effect of egg storage duration and brooding temperatures on chick growth, intestine morphology and nutrient transporters

  Yalcin S; Gursel I; Bilgen G; Horuluoglu BH; Gucluer G; Izzetoglu GT
• Article: ARTHRITIS RESEARCH & THERAPY. 2017;19(1):219

  Low levels of antibodies against common viruses associate with anti-citrullinated protein antibody-positive rheumatoid arthritis; implications for disease aetiology

  Sherina N; Hreggvidsdottir HS; Bengtsson C; Hansson M; Israelsson L; Alfredsson L; Lundberg K
• Article: LUPUS. 2017;26(10):1023-1033

  Dysregulations in circulating sphingolipids associate with disease activity indices in female patients with systemic lupus erythematosus: a cross-sectional study

  Checa A; Idborg H; Zandian A; Sar DG; Surowiec I; Trygg J; Svenungsson E; Jakobsson P-J; Nilsson P; Gunnarsson I; Wheelock CE
• Article: ARTHRITIS & RHEUMATOLOGY. 2017;69(9):1751-1761

  Transaminase Levels and Hepatic Events During Tocilizumab Treatment Pooled Analysis of Long-Term Clinical Trial Safety Data in Rheumatoid Arthritis

  Genovese MC; Kremer JM; van Vollenhoven RF; Alten R; Jose Scali J; Kelman A; Dimonaco S; Brockwell L
• Article: LUPUS. 2017;26(10):1051-1059

  The prevalence and determinants of anti-DFS70 autoantibodies in an international inception cohort of systemic lupus erythematosus patients

  Choi MY; Clarke AE; St Pierre Y; Hanly JG; Urowitz MB; Romero-Diaz J; Gordon C; Bae S-C; Bernatsky S; Wallace DJ; Merrill JT; Isenberg DA; Rahman A; Ginzler EM; Petri M; Bruce IN; Dooley MA; Fortin P; Gladman DD; Sanchez-Guerrero J; Steinsson K; Ramsey-Goldman R; Khamashta MA; Aranow C; Alarcon GS; Manzi S; Nived O; Zoma AA; van Vollenhoven RF; Ramos-Casals M; Ruiz-Irastorza G; Lim SS; Kalunian KC; Inanc M; Kamen DL; Peschken CA; Jacobsen S; Askanase A; Buyon J; Mahler M; Fritzler MJ
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2017;46(4):263-272

  Serum soluble tumour necrosis factor receptor-2 (sTNFR2) as a biomarker of kidney tissue damage and long-term renal outcome in lupus nephritis

  Parodis I; Ding H; Zickert A; Arnaud L; Larsson A; Svenungsson E; Mohan C; Gunnarsson I
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(7):1279-1284

  Tocilizumab combination therapy or monotherapy or methotrexate monotherapy in methotrexate-naive patients with early rheumatoid arthritis: 2-year clinical and radiographic results from the randomised, placebo-controlled FUNCTION trial

  Burmester GR; Rigby WF; van Vollenhoven RF; Kay J; Rubbert-Roth A; Blanco R; Kadva A; Dimonaco S
• Article: BMJ OPEN. 2017;7(6):e016154

  Are dietary vitamin D, omega-3 fatty acids and folate associated with treatment results in patients with early rheumatoid arthritis? Data from a Swedish population-based prospective study

  Lourdudoss C; Wolk A; Nise L; Alfredsson L; van Vollenhoven R
• Review: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(6):960-977

  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

  Smolen JS; Landewe R; Bijlsma J; Burmester G; Chatzidionysiou K; Dougados M; Nam J; Ramiro S; Voshaar M; van Vollenhoven R; Aletaha D; Aringer M; Boers M; Buckley CD; Buttgereit F; Bykerk V; Cardiel M; Combe B; Cutolo M; van Eijk-Hustings Y; Emery P; Finckh A; Gabay C; Gomez-Reino J; Gossec L; Gottenberg J-E; Hazes JMW; Huizinga T; Jani M; Karateev D; Kouloumas M; Kvien T; Li Z; Mariette X; McInnes I; Mysler E; Nash P; Pavelka K; Poor G; Richez C; van Riel P; Rubbert-Roth A; Saag K; da Silva J; Stamm T; Takeuchi T; Westhovens R; de Wit M; van der Heijde D
• Review: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(6):1102-1107

  Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of The EULAR recommendations for the management of rheumatoid arthritis

  Chatzidionysiou K; Emamikia S; Nam J; Ramiro S; Smolen J; van der Heijde D; Dougados M; Bijlsma J; Burmester G; Scholte M; van Vollenhoven R; Landewe R
• Article: RHEUMATOLOGY AND THERAPY. 2017;4(1):57-69

  Long-Term Maintenance of Certolizumab Pegol Safety and Efficacy, in Combination with Methotrexate and as Monotherapy, in Rheumatoid Arthritis Patients

  Fleischmann R; van Vollenhoven RF; Vencovsky J; Alten R; Davies O; Mountian I; de Longueville M; Carter D; Choy E
• Review: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(6):1101-1136

  Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis

  Ramiro S; Sepriano A; Chatzidionysiou K; Nam JL; Smolen JS; van der Heijde D; Dougados M; van Vollenhoven R; Bijlsma JW; Burmester GR; Scholte-Voshaar M; Falzon L; Landewe RBM
• Review: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(6):1113-1136

  Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis

  Nam JL; Takase-Minegishi K; Ramiro S; Chatzidionysiou K; Smolen JS; van der Heijde D; Bijlsma JW; Burmester GR; Dougados M; Scholte-Voshaar M; van Vollenhoven R; Landewe R
• Review: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(6):948-959

  2016 update of the EULAR recommendations for the management of early arthritis

  Combe B; Landewe R; Daien CI; Hua C; Aletaha D; Alvaro-Gracia JM; Bakkers M; Brodin N; Burmester GR; Codreanu C; Conway R; Dougados M; Emery P; Ferraccioli G; Fonseca J; Raza K; Silva-Fernandez L; Smolen JS; Skingle D; Szekanecz Z; Kvien TK; van der Helm-van Mil A; van Vollenhoven R
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2017;76:69-70

  PREDICTORS OF PERSISTENT DISEASE ACTIVITY AND PERSISTENT LONG QUIESCENCE IN SYSTEMIC LUPUS ERYTHEMATOSUS - RESULTS FROM THE HOPKINS LUPUS COHORT

  Giannakou I; Chatzidionysiou K; Magder L; van Vollenhoven R; Petri M
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2017;76:1027

  HOW DO WE USE BIOLOGICS IN PATIENTS WITH A HISTORY OF MALIGNANCY? AN ASSESSMENT OF TREATMENT PATTERNS USING SCANDINAVIAN REGISTERS

  Chatzidionysiou K; Aaltonen K; Nordstrom D; Gudbjornsson B; Grondal G; Geirsson AJ; Steingrimsdottir L; Frisell T; Askling J
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2017;76:567

  DOES SEROPOSITIVITY INFLUENCE DIFFERENTIALLY DRUG DISCONTINUATION OF BIOLOGIC ANTIRHEUMATIC AGENTS WITH NON-ANTI-TNF MODE OF ACTION?

  Finckh A; Courvoisier D; Gottenberg J-E; Marlette X; Morel J; Bergstra SA; Hernandez V; Codreanu C; Kviens TK; Santos MJ; Pavelka K; Hetland M; Chatzidionysiou K; Askling J; Turesson C; Gabay C; Van Vollenhoven R
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2017;76:517-518

  DETERMINING MINIMUM CLINICALLY IMPORTANT CHANGE IN MULTI BIOMARKER DISEASE ACTIVITY SCORE ASSOCIATED WITH CLINICAL IMPROVEMENT IN METHOTREXATE NAIVE PATIENTS WITH EARLY RHEUMATOID ARTHRITIS

  Chatzidionysiou K; Hensvold AH; Saevarsdottir S; Bolce RJ; Chernoff D; Hwang CC; Wang X; Catrina AI
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2017;76:626

  NEW AUTOIMMUNE TARGETS IN IDIOPATHIC INFLAMMATORY MYOPATHIES - AN ANTIGEN BEAD ARRAY APPROACH

  Notarnicola A; Hellstrom C; Mattsson C; Andersson E; Idborg H; Jemseby E; Neiman M; Jakobsson P-J; Nilsson P; Lundberg IE
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2017;76:785-786

  THE PATTERN OF ACPA REACTIVITIES IN ANTI-CCP POSITIVE INDIVIDUALS WITH NON-SPECIFIC MUSCULOSKELETAL SYMPTOMS AT RISK OF DEVELOPING RA

  Hensvold A; Kisten Y; Joshua V; Hansson M; Mathsson-Alm L; Karlsson A; Rezaei H; Af Klint E; Fei G; Catrina A
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2017;76:726

  ANALYSIS OF CORRELATION AND CAUSES FOR DISCREPANCY BETWEEN QUANTITATIVE AND SEMI-QUANTITATIVE DOPPLER SCORES IN SYNOVITIS IN RHEUMATOID ARTHRITIS

  Rezaei H; af Klint E; Hammer HB; Terslev L; D'Agostino M-A; Kisten Y; Arnaud L
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2017;76:864

  LATE-ONSET NEUTROPENIA FOLLOWING RITUXIMAB TREATMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS - A ROLE OF THE BAFF/APRIL PATHWAY

  Parodis I; Soder F; Faustini F; Wermeling F; van Vollenhoven RF; Svenungsson E; Gunnarsson I
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2017;76:686

  PRESCRIPTION PATTERNS OF TUMOUR NECROSIS FACTOR INHIBITOR AND USTEKINUMAB IN PSORIATIC ARTHRITIS: A NORDIC POPULATION-BASED COHORT STUDY

  Jorgensen TS; Dreyer L; Gudbjornsson B; Hetland ML; Glintborg B; Askling J; Chatzidionysiou K; Di Giuseppe D; Jacobsson L; Wallman JK; Kristianslund EK; Olsen IC; Fagerli K; Lie E; Nordstrom D; Aaltonen K; Joensuu J; Love TJ; Geirsson AJ; Kristensen LE
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2017;76:586

  CYTOKINES AND CORRELATIONS WITH PATIENT REPORTED OUTCOMES IN SYSTEMIC LUPUS ERYTHEMATOSUS AND POPULATION CONTROLS

  Pettersson S; Idborg H; Eketjall S; Gunnarsson I; Svenungsson E
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2017;76:341-342

  PRESCRIPTION PATTERNS OF BIOLOGICAL DISEASE MODIFYING DRUGS AND BIOSIMILARS IN ANKYLOSING SPONDYLITIS - A COLLABORATION BETWEEN BIOLOGICAL REGISTERS IN THE FIVE NORDIC COUNTRIES

  Glintborg B; Chatzidionysiou K; Askling J; Aaltonen K; Kristianslund E; Gudbjornsson B; Nordstrom D; Hetland ML; Dreyer L; Kristensen LE; Jorgensen TS; Eklund K; Grondal G; Ernestam S; Joensuu J; Kvien T; Lie E; Fagerli K; Geirsson AJ; Jonsson H; Jacobsson L
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2017;76:861-862

  HIGH ANTI-DSDNA CONTENT IN SLE IMMUNE COMPLEXES IS ASSOCIATED WITH CLINICAL REMISSION FOLLOWING BELIMUMAB TREATMENT

  Sohrabian A; Parodis I; Carlstromer-Berthen N; Sjowall C; Jonsen A; Zickert A; Frodlund M; Bengtsson A; Gunnarsson I; Ronnelid J
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2017;46(3):241-246

  Choosing wisely in daily practice: a mixed methods study on determinants of antinuclear antibody testing by rheumatologists

  Lesuis N; den Broeder AA; van Vollenhoven RF; Vriezekolk JE; Hulscher MEJL
• Article: ARTHRITIS & RHEUMATOLOGY. 2017;69(5):953-963

  A Multi-Biomarker Disease Activity Score and the Choice of Second-Line Therapy in Early Rheumatoid Arthritis After Methotrexate Failure

  Hambardzumyan K; Saevarsdottir S; Forslind K; Petersson IF; Wallman JK; Ernestam S; Bolce RJ; van Vollenhoven RF
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2017;35(3):512-515

  Use of biologic agents in idiopathic inflammatory myopathies in Sweden: a descriptive study of real life treatment

  Svensson J; Holmqvist M; Tjarnlund A; Dastmalchi M; Hanna B; Bucher SM; Lundberg IE
• Article: SEXUALLY TRANSMITTED INFECTIONS. 2017;93(3):169-174

  Herpes simplex virus specific T cell response in a cohort with primary genital infection correlates inversely with frequency of subsequent recurrences

  Franzen-Rohl E; Schepis D; Atterfelt F; Franck K; Wikstrom A; Liljeqvist J-A; Bergstrom T; Aurelius E; Karre K; Berg L; Gaines H
• Article: ARTHRITIS & RHEUMATOLOGY. 2017;69(5):1090-1099

  Immune-Array Analysis in Sporadic Inclusion Body Myositis Reveals HLA-DRB1 Amino Acid Heterogeneity Across the Myositis Spectrum

  Rothwell S; Cooper RG; Lundberg IE; Gregersen PK; Hanna MG; Machado PM; Herbert MK; Pruijn GJM; Lilleker JB; Roberts M; Bowes J; Seldin MF; Vencovsky J; Danko K; Limaye V; Selva-O'Callaghan A; Platt H; Molberg O; Benveniste O; Radstake TRDJ; Doria A; De Bleecker J; De Paepe B; Gieger C; Meitinger T; Winkelmann J; Amos CI; Ollier WE; Padyukov L; Lee AT; Lamb JA; Chinoy H
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2017;35(3):379-383

  The effects of an educational meeting and subsequent computer reminders on the ordering of laboratory tests by rheumatologists: an interrupted time series analysis

  Lesuis N; den Broeder N; Boers N; Piek E; Teerenstra S; Hulscher M; van Vollenhoven R; den Broeder AA
• Review: CURRENT OPINION IN RHEUMATOLOGY. 2017;29(3):234-240

  International collaboration including patients is essential to develop new therapies for patients with myositis

  Lundberg IE; Vencovsky J
• Article: RHEUMATOLOGY. 2017;56(5):802-810

  Incidence and prevalence of idiopathic inflammatory myopathies in Sweden: a nationwide population-based study

  Svensson J; Arkema EV; Lundberg IE; Holmqvist M
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(5):862-868

  Cytosolic 5′-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis

  Lilleker JB; Rietveld A; Pye SR; Mariampillai K; Benveniste O; Peeters MTJ; Miller JAL; Hanna MG; Machado PM; Parton MJ; Gheorghe KR; Badrising UA; Lundberg IE; Sacconi S; Herbert MK; McHugh NJ; Lecky BRF; Brierley C; Hilton-Jones D; Lamb JA; Roberts ME; Cooper RG; Saris CGJ; Pruijn GJM; Chinoy H; van Engelen BGM
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(5):792-801

  2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative

  Aggarwal R; Rider LG; Ruperto N; Bayat N; Erman B; Feldman BM; Oddis CV; Amato AA; Chinoy H; Cooper RG; Dastmalchi M; Fiorentino D; Isenberg D; Katz JD; Mammen A; de Visser M; Ytterberg SR; Lundberg IE; Chung L; Danko K; Garcia-De la Torre I; Song YW; Villa L; Rinaldi M; Rockette H; Lachenbruch PA; Miller FW; Vencovsky J
• Article: ARTHRITIS & RHEUMATOLOGY. 2017;69(5):898-910

  2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative

  Aggarwal R; Rider LG; Ruperto N; Bayat N; Erman B; Feldman BM; Oddis CV; Amato AA; Chinoy H; Cooper RG; Dastmalchi M; Fiorentino D; Isenberg D; Katz JD; Mammen A; de Visser M; Ytterberg SR; Lundberg IE; Chung L; Danko K; Garcia-De la Torre I; Song YW; Villa L; Rinaldi M; Rockette H; Lachenbruch PA; Miller FW; Vencovsky J
• Thesis / dissertation: 2017

  Predicting and monitoring disease course in rheumatoid arthritis : imaging, biomarkers, risk factors, and integrative medicine

  Levitsky, Adrian
• Article: SCIENCE IMMUNOLOGY. 2017;2(10):eaag3358

  Synovial fibroblast-neutrophil interactions promote pathogenic adaptive immunity in rheumatoid arthritis

  Carmona-Rivera C; Carlucci PM; Moore E; Lingampalli N; Uchtenhagen H; James E; Liu Y; Bicker KL; Wahamaa H; Hoffmann V; Catrina AI; Thompson PR; Buckner JH; Robinson WH; Fox DA; Kaplan MJ
• Article: TRIALS. 2017;18(1):161

  Head-to-head comparison of aggressive conventional therapy and three biological treatments and comparison of two de-escalation strategies in patients who respond to treatment: study protocol for a multicenter, randomized, open-label, blinded-assessor, phase 4 study

  Glinatsi D; Heiberg MS; Rudin A; Nordstrom D; Haavardsholm EA; Gudbjornsson B; Ostergaard M; Uhlig T; Grondal G; Horslev-Petersen K; van Vollenhoven R; Hetland ML
• Article: RHEUMATOLOGY. 2017;56(4):541-549

  Effect of tocilizumab on neutrophils in adult patients with rheumatoid arthritis: pooled analysis of data from phase 3 and 4 clinical trials

  Moots RJ; Sebba A; Rigby W; Ostor A; Porter-Brown B; Donaldson F; Dimonaco S; Rubbert-Roth A; van Vollenhoven R; Genovese MC
• Review: AUTOIMMUNITY REVIEWS. 2017;16(4):343-351

  Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus

  Parodis I; Sjowall C; Jonsen A; Ramskold D; Zickert A; Frodlund M; Sohrabian A; Arnaud L; Ronnelid J; Malmstrom V; Bengtsson AA; Gunnarsson I
• Article: BIOINFORMATICS. 2017;33(7):1099-1100

  Green listed-a CRISPR screen tool

  Panda SK; Boddul SV; Jimenez-Andrade GY; Jiang L; Kasza Z; Fernandez-Ricaud L; Wermeling F
• Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2017;188(1):154-162

  Ro52/TRIM21-deficient expression and function in different subsets of peripheral blood mononuclear cells is associated with a proinflammatory cytokine response in patients with idiopathic inflammatory myopathies

  Gomez-Martin D; Galindo-Feria AS; Barrera-Vargas A; Merayo-Chalico J; Juarez-Vega G; Torres-Ruiz J; Alcocer-Varela J
• Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2017;114(10):2735-2740

  Alterations of p11 in brain tissue and peripheral blood leukocytes in Parkinson's disease

  Green H; Zhang X; Tiklova K; Volakakis N; Brodin L; Berg L; Greengard P; Perlmann T; Svenningsson P
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2017;46(2):152-155

  Implementation of protocolized tight control and biological dose optimization in daily clinical practice: results of a pilot study

  Lesuis N; Verhoef LM; Nieboer LM; Bruyn GA; Baudoin P; van Vollenhoven RF; Hulscher MEJL; van den Hoogen FHJ; den Broeder AA
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(3):554-561

  A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)

  van Vollenhoven R; Voskuyl A; Bertsias G; Aranow C; Aringer M; Arnaud L; Askanase A; Balazova P; Bonfa E; Bootsma H; Boumpas D; Bruce I; Cervera R; Clarke A; Coney C; Costedoat-Chalumeau N; Czirjak L; Derksen R; Doria A; Doerner T; Fischer-Betz R; Fritsch-Stork R; Gordon C; Graninger W; Gyori N; Houssiau F; Isenberg D; Jacobsen S; Jayne D; Kuhn A; Le Guern V; Lerstrom K; Levy R; Machado-Ribeiro F; Mariette X; Missaykeh J; Morand E; Mosca M; Inanc M; Navarra S; Neumann I; Olesinska M; Petri M; Rahman A; Rekvig OP; Rovensky J; Shoenfeld Y; Smolen J; Tincani A; Urowitz M; van Leeuw B; Vasconcelos C; Voss A; Werth VP; Zakharova H; Zoma A; Schneider M; Ward M
• Article: JOURNAL OF AUTOIMMUNITY. 2017;78:46-56

  The host defense peptide LL-37 a possible inducer of the type I interferon system in patients with polymyositis and dermatomyositis

  Lu X; Tang Q; Lindh M; Dastmalchi M; Alexanderson H; Silwerfeldt KP; Agerberth B; Lundberg IE; Wick C
• Review: QJM - MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS. 2017;110(3):125-129

  Creating a culture of health: evolving healthcare systems and patient engagement

  Lindblad S; Ernestam S; Van Citters AD; Lind C; Morgan TS; Nelson EC
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2017;76:A52

  PROTEIN PROFILING IN PLASMA REVEALS MOLECULAR SUBGROUPS IN SYSTEMIC LUPUS ERYTHEMATOSUS

  Idborg H; Zandian A; Hellstrom C; Mattsson C; Fredolini C; Uhlen M; Schwenk JM; Ayoglu B; Neiman M; Gunnarsson I; Svenungsson E; Jakobsson P-J; Nilsson P
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2017;76:A78-A79

  SERUM LIPID AND FATTY ACID PROFILES ARE ALTERED IN PATIENTS WITH POLYMYOSITIS OR DERMATOMYOSITIS

  Raouf J; Idborg H; Olsson P; Alexanderson H; Dastmalchi M; Jakobsson P-J; Lundberg IE; Korotkova M
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(Suppl 1):a28

  02.48 Inhibition of in vitro b cell maturation and igg secretion by new chemical probes in assays using blood cells from patients with sle and iim

  Sundström Y; Bergqvist F; Sundström M; Ossipova E; Lengqvist J; Gunnarsson I; Lundberg I; Jakobsson P-J; Berg L
• Conference publication: LUPUS SCIENCE AND MEDICINE. 2017;4(Suppl 1):a44-A45

  104 A mass cytometry (CYTOF) approach to study B cell alterations during baff blockade treatment with belimumab in systemic lupus erythematosus

  Parodis I; Ramsköld D; Tadepally L; Chen Y; Zickert A; Mikes J; Amara K; Achour A; Brodin P; Gunnarsson I; Malmström V
• Conference publication: LUPUS SCIENCE AND MEDICINE. 2017;4(Suppl 1):a43-A44

  103 Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus

  Parodis I; Sjöwall C; Jönsen A; Ramsköld D; Zickert A; Frodlund M; Sohrabian A; Arnaud L; Rönnelid J; Malmström V; Bengtsson A; Gunnarsson I
• Article: JOURNAL OF PROTEOME RESEARCH. 2017;16(2):689-697

  Cytotoxic and Proinflammatory Effects of Metal-Based Nanoparticles on THP-1 Monocytes Characterized by Combined Proteomics Approaches

  Tarasova NK; Gallud A; Ytterberg AJ; Chernobrovkin A; Aranzaes JR; Astruc D; Antipov A; Fedutik Y; Fadeel B; Zubarev RA
• Article: ARTHRITIS RESEARCH & THERAPY. 2017;19(1):19

  Discovery of new candidate genes for rheumatoid arthritis through integration of genetic association data with expression pathway analysis

  Shchetynsky K; Diaz-Gallo L-M; Folkersen L; Hensvold AH; Catrina AI; Berg L; Klareskog L; Padyukov L
• Article: RHEUMATOLOGY. 2017;56(2):255-262

  Analysis of correlation and causes for discrepancy between quantitative and semi-quantitative Doppler scores in synovitis in rheumatoid arthritis

  Rezaei H; af Klint E; Hammer HB; Terslev L; D'Agostino MA; Kisten Y; Arnaud L
• Article: JOURNAL OF RHEUMATOLOGY. 2017;44(2):162-169

  Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort: Data from the CERERRA Collaboration

  Chatzidionysiou K; Lie E; Lukina G; Hetland ML; Hauge E-M; Pavelka K; Gabay C; Scherer A; Nordstrom D; Canhao H; Santos MJ; Tomsic M; Rotar Z; Victoria Hernandez M; Gomez-Reino J; Ancuta I; Kvien TK; van Vollenhoven R
• Thesis / dissertation: 2017

  Systemic lupus erythematosus : biomarkers and biologics

  Parodis, Ioannis
• Editorial comment: NATURE REVIEWS. RHEUMATOLOGY. 2017;13(2):74-76

  New tools for diagnosis and therapy

  Lundberg IE
• Article: RMD OPEN. 2017;3(2):e000507

  EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report.

  Bottai M; Tjärnlund A; Santoni G; Werth VP; Pilkington C; de Visser M; Alfredsson L; Amato AA; Barohn RJ; Liang MH; Singh JA; Aggarwal R; Arnardottir S; Chinoy H; Cooper RG; Danko K; Dimachkie MM; Feldman BM; García-De La Torre I; Gordon P; Hayashi T; Katz JD; Kohsaka H; Lachenbruch PA; Lang BA; Li Y; Oddis CV; Olesinka M; Reed AM; Rutkowska-Sak L; Sanner H; Selva-O'Callaghan A; Wook Song Y; Vencovsky J; Ytterberg SR; Miller FW; Rider LG; Lundberg IE; International Myositis Classification Criteria Pro
• Article: RMD OPEN. 2017;3(2):e000458

  Obesity is a strong predictor of worse clinical outcomes and treatment responses in early rheumatoid arthritis: results from the SWEFOT trial.

  Levitsky A; Brismar K; Hafström I; Hambardzumyan K; Lourdudoss C; van Vollenhoven RF; Saevarsdottir S
• Article: RMD OPEN. 2017;3(1):e000369

  Fully automated joint space width measurement and digital X-ray radiogrammetry in early RA.

  Platten M; Kisten Y; Kälvesten J; Arnaud L; Forslind K; van Vollenhoven R
• Article: PLOS ONE. 2017;12(9):e0185019

  Longitudinal co-variations between inflammatory cytokines, lung function and patient reported outcomes in patients with asthma

  Lodin K; Lekander M; Syk J; Alving K; Petrovic P; Andreasson A
• Article: METABOLOMICS. 2017;13(10):114

  Multivariate strategy for the sample selection and integration of multi-batch data in metabolomics

  Surowiec I; Johansson E; Torell F; Idborg H; Gunnarsson I; Svenungsson E; Jakobsson P-J; Trygg J
• Article: PLOS ONE. 2017;12(8):e0183292

  Effect of endurance exercise on microRNAs in myositis skeletal muscle-A randomized controlled study

  Boehler JF; Hogarth MW; Barberio MD; Novak JS; Ghimbovschi S; Brown KJ; Munters LA; Loell I; Chen Y-W; Gordish-Dressman H; Alexanderson H; Lundberg IE; Nagaraju K
• Letter: ARTHRITIS & RHEUMATOLOGY. 2017;69(1):243-244

  Circulating CD8+CD28^null T cytotoxic cells in polymyositis-a possible biomarker? Comment on the article by Pandya et al Reply

  Malmstrom V; Pandya JM; Lundberg IE; Fasth AER
• Letter: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2017;35(1):176-177

  Autoantibody testing in patients with myositis: clinical accuracy of a multiparametric line immunoassay

  Ghirardello A; Bettio S; Bassi N; Gatto M; Beggio M; Lundberg I; Vattemi G; Iaccarino L; Punzi L; Doria A
• Article: RMD OPEN. 2017;67(1):e000371

  A Systematic Review and Network Meta-Analysis on the Efficacy of Tumor Necrosis Factor Inhibitor-Methotrexate Combination Therapy Versus Triple Therapy in Methotrexate-Naive Patients with Rheumatoid Arthritis

  Fleischmann R; Pope JE; Tongbram V; Tang D; Chung J; Collier D; Urs S; Ndirangu K; Wells GA; van Vollenhoven RF
• Article: GERONTOLOGY. 2017;63(4):337-349

  Expression of High Mobility Group Protein B1 in Cardiac Tissue of Elderly Patients with Coronary Artery Disease with or without Inflammatory Rheumatic Disease

  Bruton M; Hollan I; Xiao J; Lindroos E; Mikkelsen K; Rynning SE; Saatvedt K; Almdahl SM; Harris HE; Lundberg IE; Wick C
• Article: LUPUS SCIENCE AND MEDICINE. 2017;4(1):e000192

  Disease activity patterns over time in patients with SLE: analysis of the Hopkins Lupus Cohort.

  Györi N; Giannakou I; Chatzidionysiou K; Magder L; van Vollenhoven RF; Petri M
• Article: ARTHRITIS & RHEUMATOLOGY. 2017;69(1):58-69

  Differences in the Spectrum of Anti-Citrullinated Protein Antibody Fine Specificities Between Malaysian and Swedish Patients With Rheumatoid Arthritis: Implications for Disease Pathogenesis

  Too CL; Murad S; Hansson M; Alm LM; Dhaliwal JS; Holmdahl R; Jakobsson P-J; Alfredsson L; Klareskog L; Ronnelid J; Padyukov L
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(1):96-104

  Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naive patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study

  Emery P; Bingham COIII; Burmester GR; Bykerk VP; Furst DE; Mariette X; van der Heijde D; van Vollenhoven R; Arendt C; Mountian I; Purcaru O; Tatla D; VanLunen B; Weinblatt ME
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(1):126-132

  Economic considerations and patients' preferences affect treatment selection for patients with rheumatoid arthritis: a discrete choice experiment among European rheumatologists

  Hifinger M; Hiligsmann M; Ramiro S; Watson V; Severens JL; Fautrel B; Uhlig T; van Vollenhoven R; Jacques P; Detert J; Canas da Silva J; Scire CA; Berghea F; Carmona L; Pentek M; Keat A; Boonen A
• Conference publication: SWISS MEDICAL WEEKLY. 2017;147:3S

  Does seropositivity influence differentially drug discontinuation of biologic antirheumatic agents with non-anti-TNF mode of action?

  Finckh A; Courvoisier DS; Gottenberg J-E; Mariette X; Morel J; Bergstra SA; Hernandez V; Codreanu C; Kvien TK; Santos MJ; Pavelka K; Hetland M; Chatzidionysiou K; Askling J; Turesson C; Gabay C; Van Vollenhoven R
• Journal article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(1):314

  Differences and similarities in rheumatology speciality training programmes across European countries (vol 74, pg 1183, 2015)

  Sivera F; Ramiro S; Cikes N
• Journal article: PLOS ONE. 2017;12(9):e0184189

  Aged blood factors decrease cellular responses associated with delayed gingival wound repair

  Paz Saldias M; Fernandez C; Morgan A; Diaz C; Morales D; Jana F; Gomez A; Silva A; Briceno F; Oyarzun A; Maldonado F; Cerda O; Smith PC; Caceres M
• Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2017;86(4):314

  Modification of hematopoietic stem cells using CRISPR/Cas9 system for investigating pathogenesis of arthritis

  Boddul S; Kaza Z; Panda S; Wermeling F
• Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2017;86(4):276

  Deciphering the IL-4Rα regulating factor, produced during inflammation, by customized CRISPR screens

  Panda SK; Kasza Z; Boddul S; Jimenez Y; Jiang L; Wigerblad G; Fernandez-Ricaud L; Wermeling F
• Corrigendum: ARTHRITIS RESEARCH & THERAPY. 2016;18(1):300

  Rheumatology training experience across Europe: analysis of core competences (vol 18, 213, 2016)

  Sivera F; Ramiro S; Cikes N; Cutolo M; Dougados M; Gossec L; Kvien TK; Lundberg IE; Mandl P; Moorthy A; Panchal S; da Silva JAP; Bijlsma JW
• Article: CLINICAL SCIENCE. 2016;130(24):2295-2303

  Deletion of mPGES-1 affects platelet functions in mice

  Raouf J; Mobarrez F; Larsson K; Jakobsson P-J; Korotkova M
• Article: LUPUS. 2016;25(14):1602-1609

  Dietary micronutrient intake and atherosclerosis in systemic lupus erythematosus

  Lourdudoss C; Elkan A-C; Hafstrom I; Jogestrand T; Gustafsson T; van Vollenhoven R; Frostegard J
• Article: ARTHRITIS CARE AND RESEARCH. 2016;68(12):1758-1766

  Infliximab Versus Conventional Combination Treatment and Seven-Year Work Loss in Early Rheumatoid Arthritis: Results of a Randomized Swedish Trial

  Eriksson JK; Wallman JK; Miller H; Petersson IF; Ernestam S; Vivar N; van Vollenhoven RF; Neovius M
• Corrigendum: ARTHRITIS RESEARCH & THERAPY. 2016;18(1):257

  Concentration of antibodies against Porphyromonas gingivalisis increased before the onset of symptoms of rheumatoid arthritis (vol 18, 201, 2016)

  Johansson L; Sherina N; Kharlamova N; Potempa B; Larsson B; Israelsson L; Potempa J; Rantapaa-Dahlqvist S; Lundberg K
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2016;34(6):1098-1100

  Do dermatomyositis and polymyositis affect similar thigh muscles? A comparative MRI-based study.

  Pipitone N; Notarnicola A; Levrini G; Spaggiari L; Scardapane A; Iannone F; Lapadula G; Pattacini P; Zuccoli G; Salvarani C
• Article: JOURNAL OF CLINICAL LABORATORY ANALYSIS. 2016;30(6):859-866

  A New Immunodot Assay for Multiplex Detection of Autoantibodies in a Cohort of Italian Patients With Idiopathic Inflammatory Myopathies.

  Tampoia M; Notarnicola A; Abbracciavento L; Fontana A; Giannini M; Louis Humbel R; Iannone F
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2016;34(6):1065-1071

  Early treatment intensification induces favourable radiographic outcomes according to predicted versus observed radiographic progression in early rheumatoid arthritis: a subanalysis of the randomised FIN-RACo and NEO-RACo trials

  Levitsky A; Wick MC; Mottonen T; Leirisalo-Repo M; Laasonen L; Korpela M; van Vollenhoven RF; Rantalaiho V
• Article: RHEUMATOLOGY. 2016;55(11):1987-1992

  Dysfunction of endothelial progenitor cells is associated with the type I IFN pathway in patients with polymyositis and dermatomyositis

  Ekholm L; Kahlenberg JM; Helmers SB; Tjarnlund A; Yalavarthi S; Zhao W; Seto N; Betteridge Z; Lundberg IE; Kaplan MJ
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(11):1939-1944

  Disease activity-guided dose optimisation of adalimumab and etanercept is a cost-effective strategy compared with non-tapering tight control rheumatoid arthritis care: analyses of the DRESS study

  Kievit W; van Herwaarden N; van den Hoogen FHJ; van Vollenhoven RF; Bijlsma JWJ; van den Bemt BJF; van der Maas A; den Broeder AA
• Article: LUPUS. 2016;25(13):1420-1430

  Safety, tolerability, efficacy and pharmacodynamics of the selective JAK1 inhibitor GSK2586184 in patients with systemic lupus erythematosus

  Kahl L; Patel J; Layton M; Binks M; Hicks K; Leon G; Hachulla E; Machado D; Staumont-Salle D; Dickson M; Condreay L; Schifano L; Zamuner S; van Vollenhoven RF
• Review: ARTHRITIS RESEARCH & THERAPY. 2016;18(1):251

  Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature

  Nikiphorou E; Radner H; Chatzidionysiou K; Desthieux C; Zabalan C; van Eijk-Hustings Y; Dixon WG; Hyrich KL; Askling J; Gossec L
• Article: QUALITY MANAGEMENT IN HEALTH CARE. 2016;25(4):203-212

  Value-Based Health Care for Chronic Care: Aligning Outcomes Measurement with the Patient Perspective

  Ebbevi D; Forsberg HH; Essen A; Ernestam S
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(10):e69

  Response to: "Let's stop fooling ourselves. In RA, only ACR/EULAR criteria define remission and equate with absence of disease!' by Boers

  Emery P; Bingham COIII; Burmester GR; Bykerk VP; Furst DE; Mariette X; van der Heijde D; van Vollenhoven R; Arendt C; Mountian I; Purcaru O; Tatla D; VanLunen B; Weinblatt ME
• Meeting abstract: BRAIN, BEHAVIOR, AND IMMUNITY. 2016;57:E30-E31

  Systemic levels of IgE as a determinant of self-rated health in patients with asthma

  Andreasson A; Lodin K; Alving K; Syk J; Lekander M
• Conference publication: BRAIN, BEHAVIOR, AND IMMUNITY. 2016;57:E24-E25

  Peripheral inflammatory mediators and p11 levels in peripheral blood mononuclear cells from patients with Parkinson's disease

  Green HF; Brodin L; Greengard P; Berg L; Svenningsson P
• Article: JOURNAL OF NEUROINFLAMMATION. 2016;13(1):256

  Immunomodulatory effects of nicotine on interleukin 1β activated human astrocytes and the role of cyclooxygenase 2 in the underlying mechanism

  Revathikumar P; Bergqvist F; Gopalakrishnan S; Korotkova M; Jakobsson P-J; Lampa J; Le Maitre E
• Article: ARTHRITIS RESEARCH & THERAPY. 2016;18(1):213

  Rheumatology training experience across Europe: analysis of core competences

  Sivera F; Ramiro S; Cikes N; Cutolo M; Dougados M; Gossec L; Kvien TK; Lundberg IE; Mandl P; Moorthy A; Panchal S; da Silva JAP; Bijlsma JW
• Article: ARTHRITIS RESEARCH & THERAPY. 2016;18(1):201

  Concentration of antibodies against Porphyromonas gingivalis is increased before the onset of symptoms of rheumatoid arthritis

  Johansson L; Sherina N; Kharlamova N; Potempa B; Larsson B; Israelsson L; Potempa J; Rantapaa-Dahlqvist S; Lundberg K
• Article: MOLECULAR MEDICINE. 2016;22:322-328

  Integration of Known DNA, RNA and Protein Biomarkers Provides Prediction of Anti-TNF Response in Rheumatoid Arthritis: Results from the COMBINE Study

  Folkersen L; Brynedal B; Diaz-Gallo LM; Ramskold D; Shchetynsky K; Westerlind H; Sundstrom Y; Schepis D; Hensvold A; Vivar N; Eloranta M-L; Ronnblom L; Brunak S; Malmstrom V; Catrina A; Moerch UGW; Klareskog L; Padyukov L; Berg L
• Article: JOURNAL OF LIPID RESEARCH. 2016;57(9):1659-1669

  Pulmonary epithelial cancer cells and their exosomes metabolize myeloid cell-derived leukotriene C₄ to leukotriene D₄

  Lukic A; Ji J; Idborg H; Samuelsson B; Palmberg L; Gabrielsson S; Radmark O
• Article: ARTHRITIS & RHEUMATOLOGY. 2016;68(9):2174-2183

  A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Treatment With Sirukumab (CNTO 136) in Patients With Active Lupus Nephritis

  Rovin BH; van Vollenhoven RF; Aranow C; Wagner C; Gordon R; Zhuang Y; Belkowski S; Hsu B
• Review: CLINICAL RHEUMATOLOGY. 2016;35(9):2363-2367

  Heterogeneous clinical spectrum of interstitial lung disease in patients with anti-EJ anti-synthetase syndrome: a case series

  Giannini M; Notarnicola A; Dastmalchi M; Lundberg IE; Lopalco G; Iannone F
• Article: MOLECULAR & CELLULAR PROTEOMICS. 2016;15(9):3017-3029

  Approach for Identifying Human Leukocyte Antigen (HLA)-DR Bound Peptides from Scarce Clinical Samples

  Heyder T; Kohler M; Tarasova NK; Haag S; Rutishauser D; Rivera NV; Sandin C; Mia S; Malmstrom V; Wheelock AM; Wahlstrom J; Holmdahl R; Eklund A; Zubarev RA; Grunewald J; Ytterberg AJ
• Article: SCIENTIFIC REPORTS. 2016;6:31995

  UPF1 regulates myeloid cell functions and S100A9 expression by the hnRNP E2/miRNA-328 balance

  Saul MJ; Stein S; Grez M; Jakobsson P-J; Steinhilber D; Suess B
• Article: AUTOIMMUNITY. 2016;49(6):421-433

  Autoantibody targets in vaccine-associated narcolepsy

  Haggmark-Manberg A; Zandian A; Forsstrom B; Khademi M; Bomfim IL; Hellstrom C; Arnheim-Dahlstrom L; Hallbook T; Darin N; Lundberg IE; Uhlen M; Partinen M; Schwenk JM; Olsson T; Nilsson P
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2016;45(sup128):64-75

  Optimizing biological treatments for rheumatoid arthritis

  Chatzidionysiou K
• Article: ARTHRITIS & RHEUMATOLOGY. 2016;68(8):2016-2026

  CD4+and CD8+CD28^null T Cells Are Cytotoxic to Autologous Muscle Cells in Patients With Polymyositis

  Pandya JM; Venalis P; Al-Khalili L; Hossain MS; Stache V; Lundberg IE; Malmstrom V; Fasth AER
• Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2016;84(2):100-109

  Autoantibody Specificities and Type I Interferon Pathway Activation in Idiopathic Inflammatory Myopathies

  Ekholm L; Vosslamber S; Tjarnlund A; de Jong TD; Betteridge Z; McHugh N; Plestilova L; Klein M; Padyukov L; Voskuyl AE; Bultink IEM; Pegtel DM; Mavragani CP; Crow MK; Vencovsky J; Lundberg IE; Verweij CL
• Article: CKJ: CLINICAL KIDNEY JOURNAL. 2016;9(4):552-555

  Ofatumumab treatment in lupus nephritis patients

  Haarhaus ML; Svenungsson E; Gunnarsson I
• Article: ARTHRITIS & RHEUMATOLOGY. 2016;68(8):1932-1944

  A Longitudinal Analysis of Outcomes of Lupus Nephritis in an International Inception Cohort Using a Multistate Model Approach

  Hanly JG; Su L; Urowitz MB; Romero-Diaz J; Gordon C; Bae S-C; Bernatsky S; Clarke AE; Wallace DJ; Merrill JT; Isenberg DA; Rahman A; Ginzler EM; Petri M; Bruce IN; Dooley MA; Fortin P; Gladman DD; Sanchez-Guerrero J; Steinsson K; Ramsey-Goldman R; Khamashta MA; Aranow C; Alarcon GS; Fessler BJ; Manzi S; Nived O; Sturfelt GK; Zoma AA; van Vollenhoven RF; Ramos-Casals M; Ruiz-Irastorza G; Lim SS; Kalunian KC; Inanc M; Kamen DL; Peschken CA; Jacobsen S; Askanase A; Theriault C; Farewell V
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(8):1558-1566

  Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups

  Rothwell S; Cooper RG; Lundberg IE; Miller FW; Gregersen PK; Bowes J; Vencovsky J; Danko K; Limaye V; Selva-O'Callaghan A; Hanna MG; Machado PM; Pachman LM; Reed AM; Rider LG; Cobb J; Platt H; Molberg O; Benveniste O; Mathiesen P; Radstake T; Doria A; De Bleecker J; De Paepe B; Maurer B; Ollier WE; Padyukov L; O'Hanlon TP; Lee A; Amos CI; Gieger C; Meitinger T; Winkelmann J; Wedderburn LR; Chinoy H; Lamb JA
• Journal article: INTEGRATIVE AND COMPLEMENTARY THERAPIES. 2016;22(4):175-179

  Clinical Roundup: Selected Treatment Options for Rheumatoid Arthritis
• Review: JOURNAL OF INTERNAL MEDICINE. 2016;280(1):39-51

  Diagnosis and classification of idiopathic inflammatory myopathies

  Lundberg IE; Miller FW; Tjarnlund A; Bottai M
• Editorial comment: JOURNAL OF INTERNAL MEDICINE. 2016;280(1):4-7

  New ways to subclassify patients with myositis

  Lundberg IE
• Article: ARTHRITIS & RHEUMATOLOGY. 2016;68(7):1738-1750

  Endurance Exercise Improves Molecular Pathways of Aerobic Metabolism in Patients With Myositis

  Munters LA; Loell I; Ossipova E; Raouf J; Dastmalchi M; Lindroos E; Chen Y-W; Esbjornsson M; Korotkova M; Alexanderson H; Nagaraju K; Crofford LJ; Jakobsson P-J; Lundberg IE
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(7):1272-1278

  Do RA or TNF inhibitors increase the risk of cervical neoplasia or of recurrence of previous neoplasia? A nationwide study from Sweden

  Wadstrom H; Frisell T; Sparen P; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(7):1336-1342

  Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study

  Gabay C; Riek M; Hetland ML; Hauge E-M; Pavelka K; Tomsic M; Canhao H; Chatzidionysiou K; Lukina G; Nordstrom DC; Lie E; Ancuta I; Victoria Hernandez M; van Riel PLMC; van Vollenhoven R; Kvien TK
• Article: JOURNAL OF PROTEOME RESEARCH. 2016;15(7):2337-2345

  Establishing a Proteomics-Based Monocyte Assay To Assess Differential Innate Immune Activation Responses

  Tarasova NK; Ytterberg AJ; Lundberg K; Zhang X-M; Harris RA; Zubarev RA
• Letter: ARTHRITIS CARE AND RESEARCH. 2016;68(7):1051

  Choosing Wisely in daily practice: an intervention study on antinuclear antibody testing by rheumatologists. Comment on the article by Lesuis et al Reply

  Lesuis N; Piek E; Demirel H; den Broeder AA; Hulscher MEJL; Meek I; van der Laan-Baalbergen N; van Vollenhoven RF
• Letter: ARTHRITIS CARE AND RESEARCH. 2016;68(7):1053-1054

  Hydroxychloroquine in systemic lupus erythematosus: comment on the article by Muangchan et al Reply

  Pope JE; Rothfield NF; Ramsey-Goldman R; Smith CD; Bernatsky SR; Furie RA; Hudson M; Burgos-Vargas R; Senecal J-L; Inanc M; van Vollenhoven RF; Chandran V; Nash PT; Muangchan C
• Article: ARTHRITIS CARE AND RESEARCH. 2016;68(7):1012-1020

  Cardiac Abnormalities in Adult Patients With Polymyositis or Dermatomyositis as Assessed by Noninvasive Modalities

  Diederichsen LP; Simonsen JA; Diederichsen AC; Hvidsten S; Hougaard M; Junker P; Sondergaard K; Lundberg IE; Tvede N; Sandgaard NCF; Christensen AF; Dreyer L; Kay S; Eskerud KS; Petersen H; Ejstrup L; Jacobsen S
• Review: JOURNAL OF INTERNAL MEDICINE. 2016;280(1):75-96

  Physical exercise as a treatment for adult and juvenile myositis

  Alexanderson H
• Article: ARTHRITIS RESEARCH & THERAPY. 2016;18:145

  Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritis

  Genovese MC; van Vollenhoven RF; Wilkinson B; Wang L; Zwillich SH; Gruben D; Biswas P; Riese R; Takiya L; Jones TV
• Corrigendum: ARTHRITIS RESEARCH & THERAPY. 2016;18(1):144

  Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration (vol 18, 50, 2016)

  Chatzidionysiou K; Lie E; Nasonov E; Lukina G; Hetland ML; Tarp U; Ancuta I; Pavelka K; Nordstrom DC; Gabay C; Canhao H; Tomsic M; van Riel PLCM; Gomez-Reino J; Kvien TK; van Vollenhoven RF
• Article: NATURE REVIEWS DISEASE PRIMERS. 2016;2:16039

  Systemic lupus erythematosus

  Kaul A; Gordon C; Crow MK; Touma Z; Urowitz MB; van Vollenhoven R; Ruiz-Irastorza G; Hughes G
• Article: ARTHRITIS RESEARCH & THERAPY. 2016;18(1):136

  Effects on muscle tissue remodeling and lipid metabolism in muscle tissue from adult patients with polymyositis or dermatomyositis treated with immunosuppressive agents

  Loell I; Raouf J; Chen Y-W; Shi R; Nennesmo I; Alexanderson H; Dastmalchi M; Nagaraju K; Korotkova M; Lundberg IE
• Article: PRESSE MEDICALE. 2016;45(6):e179-e192

  New therapeutic approaches in rheumatoid arthritis

  van Vollenhoven RF
• Article: LUPUS. 2016;25(7):699-709

  Long-term organ damage accrual and safety in patients with SLE treated with belimumab plus standard of care

  Bruce IN; Urowitz M; van Vollenhoven R; Aranow C; Fettiplace J; Oldham M; Wilson B; Molta C; Roth D; Gordon D
• Article: RHEUMATOLOGY. 2016;55(6):1031-1041

  Tofacitinib or adalimumab versus placebo: patient-reported outcomes from a phase 3 study of active rheumatoid arthritis

  Strand V; van Vollenhoven RF; Lee EB; Fleischmann R; Zwillich SH; Gruben D; Koncz T; Wilkinson B; Wallenstein G
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(6):1081-1091

  Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial

  Burmester GR; Rigby WF; van Vollenhoven RF; Kay J; Rubbert-Roth A; Kelman A; Dimonaco S; Mitchell N
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2016;75:166

  THE EULAR TASK FORCE FOR STANDARDISING MINIMUM DATA COLLECTION IN RHEUMATOID ARTHRITIS OBSERVATIONAL RESEARCH: RESULTS OF A HIERARCHICAL LITERATURE REVIEW

  Chatzidionysiou K; Nikiphorou E; Gossec L; Hyrich K; Filip C; van Eijk-Hustings Y; Williamson P; Dixon W; Askling J; Radner H
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2016;75:477-478

  ASSOCIATION BETWEEN NUMBER AND TYPE OF DIFFERENT ACPA FINE SPECIFICITIES AND PARENCHYMAL LUNG CHANGES IN HIGH RESOLUTION COMPUTED TOMOGRAPHY IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS

  Joshua V; Chatzidionysiou K; Reynisdottir G; Hensvold AH; Hansson M; Nogueira L; Eklund A; Serre G; Grunewald J; Catrina AI
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2016;75:299-300

  RELATIONSHIP BETWEEN CORTICOSTEROIDS AND UNFAVORABLE MEDICAL EFFECTS. A STUDY UNDER THE SHARE SYSTEM BASED ON THE CLINICAL TRIAL BELIMUMAB IN SUBJECTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (BLISS-76)

  Emamikia S; Gentline C; Backheden M; Chatzidionysiou K; Arnaud L; van Vollenhoven RF
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2016;75:477

  RISK FOR LUNG CANCER IN RA AND DIFFERENT RA PHENOTYPES: RESULTS FROM A POPULATION-BASED CASE-CONTROL STUDY

  Chatzidionysiou K; Reynisdottir G; Joshua V; Frisell T; Askling J; Catrina A
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2016;75:634

  AUTOMATED JOINT SPACE WIDTH MEASUREMENT AND DIGITAL X-RAY RADIOGRAMMETRY IN EARLY RA

  Platten M; Kisten Y; Kalvesten J; Arnaud L; Forslind K; Van Vollenhoven R
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2016;75:356-357

  EVALUATING PSORIATIC SKIN LESIONS IN PSORIASIS AND PSORIATIC ARTHRITIS: ULTRASOUND AS A COMPLEMENTARY MEASURE

  Kisten Y; af Klint E; Gyori N; Rezaei H; Eidsmo L; Stahle M; van Vollenhoven R
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2016;75:499

  INDUCTION-MAINTENANCE IN EARLY RA: A META-ANALYSIS OF TRIALS USING MTX PLUS TNF-INHIBITOR AS INDUCTION THERAPY

  Emamikia S; Arkema EV; Detert J; Chatzidionysiou K; Dougados M; Burmester GR; van Vollenhoven RF
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2016;75:430-431

  MULTIPLEX SCREENING OF CYTOKINES IN THE SEARCH FOR DISEASE ACTIVITY MARKERS OF SLE

  Eketjall S; Idborg H; Gustafsson JT; Zickert A; Kvarnstrom M; Oke V; Susanne P; Jakobsson P-J; Gunnarsson I; Svenungsson E
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2016;75:698-699

  HAND JOINT INFLAMMATION ON FLUORESCENCE OPTICAL IMAGING REVEAL DISTINCT PATTERNS IN SEROPOSITIVE AND SERONEGATIVE EARLY RHEUMATOID ARTHRITIS

  Kisten Y; af Klint E; Levitsky A; Rezaei H; Gyori N; Karlsson A; van Vollenhoven R; Arnaud L
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2016;75:1236-1237

  HAND JOINT INFLAMMATION IN EARLY RA: CLINICAL ULTRASOUND AND FLUORESCENCE OPTICAL IMAGING DIAGNOSTICS

  Kisten Y; af Klint E; Gyori N; Karlsson A; Levitsky A; Rezaei H; Arnaud L; van Vollenhoven R
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2016;75:1105-1106

  RISK FACTORS FOR THROMBOEMBOLIC EVENTS IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES

  Notarnicola A; Nasman L; Tang Q; Tjarlund A; Elvin K; Berg L; Norkko J; Lundberg IE; Antovic A
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2016;75:448

  OBESITY IS ASSOCIATED WITH WORSE CLINICAL OUTCOMES YET LIMITED RADIOGRAPHIC PROGRESSION IN EARLY RHEUMATOID ARTHRITIS

  Levitsky A; Saevarsdottir S; Brismar K; Hambardzumyan K; Lourdudoss C; van Vollenhoven RF
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2016;75:406-407

  TOWARDS DEVELOPMENT OF A MINIMUM CORE DATASET AND STANDARDS OF DATA COLLECTION FOR OBSERVATIONAL RHEUMATOID ARTHRITIS RESEARCH A EULAR INITIATIVE

  Radner H; Nikiphorou E; Chatzidionysiou K; Gossec L; Hyrich K; Filip C; van Eijk-Hustings Y; Williamson P; Dixon W; Askling J
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2016;75:275

  DYSREGULATIONS IN THE SPHINGOLIPID PATHWAY IN SLE PATIENTS

  Checa A; Idborg H; Sar DG; Jakobsson P-J; Wheelock CE; Gunnarsson I
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2016;75:116

  CHARACTERIZATION OF SYSTEMIC LUPUS ERYTHEMATOSUS SUBGROUPS WITH FEATURES OF ANTIPHOSPHOLIPID OR SJOGRENS'S SYNDROME UTILIZING AFFINITY PROTEOMICS

  Idborg H; Zandian A; Gustafsson JT; Gunnarsson I; Svenungsson E; Nilsson P; Jakobsson P-J
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2016;75:1063

  SERUM FERRITIN AS A BIOMARKER OF CLINICAL AND HISTOPATHOLOGICAL RESPONSE TO TREATMENT IN LUPUS NEPHRITIS

  Parodis I; Ding H; Zickert A; Arnaud L; Mohan C; Gunnarsson I
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2016;75:547

  SERUM INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 2 (IGFBP2) AS A BIOMARKER OF CLINICAL AND HISTOPATHOLOGICAL TREATMENT RESPONSE IN LUPUS NEPHRITIS

  Parodis I; Ding H; Zickert A; Arnaud L; Mohan C; Gunnarsson I
• Article: LUPUS. 2016;25(6):602-616

  Effects of a one-year physical activity programme for women with systemic lupus erythematosus - a randomized controlled study

  Bostrom C; Elfving B; Dupre B; Opava CH; Lundberg IE; Jansson E
• Article: JOURNAL OF RHEUMATOLOGY. 2016;43(5):869-874

  Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc-positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian Study.

  Varisco V; Viganò M; Batticciotto A; Lampertico P; Marchesoni A; Gibertini P; Pellerito R; Rovera G; Caporali R; Todoerti M; Covelli M; Notarnicola A; Atzeni F; Sarzi-Puttini P
• Article: ANIMAL. 2016;10(5):805-811

  Egg storage duration and hatch window affect gene expression of nutrient transporters and intestine morphological parameters of early hatched broiler chicks

  Yalcin S; Gursel I; Bilgen G; Izzetoglu GT; Horuluoglu BH; Gucluer G
• Journal article: VACCINE. 2016;34(15):1810-1815

  Venom conjugated polylactide applied as biocompatible material for passive and active immunotherapy against scorpion envenomation

  Ayari-Riabi S; Trimaille T; Mabrouk K; Bertin D; Gigmes D; Benlasfar Z; Zaghmi A; Bouhaouala-Zahar B; Elayeb M
• Article: RHEUMATOLOGY. 2016;55(4):729-734

  Does disease activity at start of biologic therapy influence work-loss in RA patients?

  Olofsson T; Johansson K; Eriksson JK; van Vollenhoven R; Miller H; Petersson IF; Askling J; Neovius M
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(4):721-729

  Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss

  Krishnamurthy A; Joshua V; Hensvold AH; Jin T; Sun M; Vivar N; Ytterberg AJ; Engstrom M; Fernandes-Cerqueira C; Amara K; Magnusson M; Wigerblad G; Kato J; Jimenez-Andrade JM; Tyson K; Rapecki S; Lundberg K; Catrina S-B; Jakobsson P-J; Svensson C; Malmstrom V; Klareskog L; Wahamaa H; Catrina AI
• Article: ARTHRITIS RESEARCH & THERAPY. 2016;18:80

  Effects of conventional immunosuppressive treatment on CD244+(CD28null) and FOXP3+T cells in the inflamed muscle of patients with polymyositis and dermatomyositis

  Pandya JM; Loell I; Hossain MS; Zong M; Alexanderson H; Raghavan S; Lundberg IE; Malmstrom V
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(4):696-701

  Disease specificity of autoantibodies to cytosolic 5′-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases

  Herbert MK; Stammen-Vogelzangs J; Verbeek MM; Rietveld A; Lundberg IE; Chinoy H; Lamb JA; Cooper RG; Roberts M; Badrising UA; De Bleecker JL; Machado PM; Hanna MG; Plestilova L; Vencovsky J; van Engelen BG; Pruijn GJM
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(4):730-738

  Autoantibodies to citrullinated proteins induce joint pain independent of inflammation via a chemokine-dependent mechanism

  Wigerblad G; Bas DB; Fernades-Cerqueira C; Krishnamurthy A; Nandakumar KS; Rogoz K; Kato J; Sandor K; Su J; Miguel Jimenez-Andrade J; Finn A; Farinotti AB; Amara K; Lundberg K; Holmdahl R; Jakobsson P-J; Malmstrom V; Catrina AI; Klareskog L; Svensson CI
• Article: ARTHRITIS CARE AND RESEARCH. 2016;68(4):562-569

  Choosing Wisely in Daily Practice: An Intervention Study on Antinuclear Antibody Testing by Rheumatologists

  Lesuis N; Hulscher MEJL; Piek E; Demirel H; van der Laan-Baalbergen N; Meek I; van Vollenhoven RF; den Broeder AA
• Article: SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES. 2016;33(1):17-28

  ALTERATIONS IN THE MEMBRANE-ASSOCIATED PROTEOME FRACTION OF ALVEOLAR MACROPHAGES IN SARCOIDOSIS

  Kjellin H; Silva E; Branca RM; Eklund A; Jakobsson P-J; Grunewald J; Lehtio J; Wheelock AM
• Article: JOURNAL OF THE NEUROLOGICAL SCIENCES. 2016;362:251-257

  High-intensity resistance training in multiple sclerosis - An exploratory study of effects on immune markers in blood and cerebrospinal fluid, and on mood, fatigue, health-related quality of life, muscle strength, walking and cognition

  Kierkegaard M; Lundberg IE; Olsson T; Johansson S; Ygberg S; Opava C; Holmqvist LW; Piehl F
• Article: JOURNAL OF NEUROMUSCULAR DISEASES. 2016;3(1):67-75

  Mortality and Causes of Death in Patients with Sporadic Inclusion Body Myositis: Survey Study Based on the Clinical Experience of Specialists in Australia, Europe and the USA.

  Price MA; Barghout V; Benveniste O; Christopher-Stine L; Corbett A; de Visser M; Hilton-Jones D; Kissel JT; Lloyd TE; Lundberg IE; Mastaglia F; Mozaffar T; Needham M; Schmidt J; Sivakumar K; DeMuro C; Tseng BS
• Corrigendum: CURRENT OPINION IN RHEUMATOLOGY. 2016;28(2):1

  The lung in rheumatoid arthritis, cause or consequence? Erratum.
• Article: JOURNAL OF CLINICAL RHEUMATOLOGY. 2016;22(2):51-56

  Clinical and Prognostic Factors Associated With Survival in Mexican Patients With Idiopathic Inflammatory Myopathies

  Shunashy Galindo-Feria A; Rojas-Serrano J; Hinojosa-Azaola A
• Article: ARTHRITIS & RHEUMATOLOGY. 2016;68(3):604-613

  Antibodies to Porphyromonas gingivalis Indicate Interaction Between Oral Infection, Smoking, and Risk Genes in Rheumatoid Arthritis Etiology

  Kharlamova N; Jiang X; Sherina N; Potempa B; Israelsson L; Quirke A-M; Eriksson K; Yucel-Lindberg T; Venables PJ; Potempa J; Alfredsson L; Lundberg K
• Article: WORK. 2016;53(2):265-277

  Work ability in patients with polymyositis and dermatomyositis: An explorative and descriptive study

  Regardt M; Henriksson EW; Sandqvist J; Lundberg IE; Schult M-L
• Article: ARTHRITIS RESEARCH & THERAPY. 2016;18:49

  Physiological evidence for diversification of IFNα- and IFNβ-mediated response programs in different autoimmune diseases

  de Jong TD; Vosslamber S; Mantel E; de Ridder S; Wesseling JG; Kraan TCTMVDP; Leurs C; Hegen H; Deisenhammer F; Killestein J; Lundberg IE; Vencovsky J; Nurmohamed MT; van Schaardenburg D; Bultink IEM; Voskuyl AE; Pegtel DM; van der Laken CJ; Bijlsma JWJ; Verweij CL
• Article: ARTHRITIS RESEARCH & THERAPY. 2016;18:50

  Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration

  Chatzidionysiou K; Lie E; Nasonov E; Lukina G; Hetland ML; Tarp U; Ancuta I; Pavelka K; Nordstrom DC; Gabay C; Canhao H; Tomsic M; van Riel PLCM; Gomez-Reino J; Kvien TK; van Vollenhoven RF
• Article: RHEUMATOLOGY. 2016;55(2):252-262

  The frequency and outcome of lupus nephritis: results from an international inception cohort study

  Hanly JG; O'Keeffe AG; Su L; Urowitz MB; Romero-Diaz J; Gordon C; Bae S-C; Bernatsky S; Clarke AE; Wallace DJ; Merrill JT; Isenberg DA; Rahman A; Ginzler EM; Fortin P; Gladman DD; Sanchez-Guerrero J; Petri M; Bruce IN; Dooley MA; Ramsey-Goldman R; Aranow C; Alarcon GS; Fessler BJ; Steinsson K; Nived O; Sturfelt GK; Manzi S; Khamashta MA; van Vollenhoven RF; Zoma AA; Ramos-Casals M; Ruiz-Irastorza G; Lim SS; Stoll T; Inanc M; Kalunian KC; Kamen DL; Maddison P; Peschken CA; Jacobsen S; Askanase A; Theriault C; Thompson K; Farewell V
• Article: RHEUMATOLOGY. 2016;55(2):230-236

  Rituximab done: what's next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritis

  Walker UA; Jaeger VK; Chatzidionysiou K; Hetland ML; Hauge E-M; Pavelka K; Nordstrom DC; Canhao H; Tomsic M; van Vollenhoven R; Gabay C
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(2):356-361

  Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial

  Kastbom A; Forslind K; Ernestam S; Geborek P; Karlsson JA; Petersson IF; Saevarsdottir S; Klareskog L; van Vollenhoven RF; Lundberg K
• Article: BEST PRACTICE AND RESEARCH: CLINICAL RHEUMATOLOGY. 2016;30(1):149-168

  Idiopathic inflammatory myositis

  Tieu J; Lundberg IE; Limaye V
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(2):332-340

  Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study

  Merrill JT; van Vollenhoven RF; Buyon JP; Furie RA; Stohl W; Morgan-Cox M; Dickson C; Anderson PW; Lee C; Berclaz P-Y; Doerner T
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2016;75:A41-A42

  FLUORESCENCE OPTICAL IMAGING COUPLED WITH ULTRASOUND RADIOGRAPHY FOR DETECTING SUBTLE HAND INFLAMMATION IN EARLY RHEUMATOID ARTHRITIS

  Kisten Y; af Klint E; Gyori N; Rezaei H; Levitsky A; Karlsson A; van Vollenhoven RF
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2016;75:A79

  RISK FOR LUNG CANCER IN RA AND DIFFERENT RA PHENOTYPES: RESULTS FROM A POPULATION-BASED CASE-CONTROL STUDY

  Chatzidionysiou K; Reynisdottir G; Joshua V; Frisell T; Askling J; Catrina AI
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2016;75:A64-A65

  EFFECTS OF WHOLE-BODY VIBRATION EXERCISE ON PHYSICAL CAPACITY AND PROSTAGLANDIN METABOLITES IN PATIENTS WITH SPORADIC INCLUSION BODY MYOSITIS

  Korotkova M; Sandstrom S; Hallen A; Idborg H; Dorph C; Alexanderson H
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2016;75:A53

  CHARACTERISATION OF SYSTEMIC LUPUS ERYTHEMATOSUS SUBGROUPS WITH FEATURES OF ANTIPHOSPHOLIPID OR SJOGRENS'S SYNDROME UTILISING AFFINITY PROTEOMICS

  Idborg H; Zandian A; Gustafsson JT; Gunnarsson I; Svenungsson E; Nilsson P; Jakobsson PJ
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2016;75:A53

  DYSREGULATIONS IN THE SPHINGOLIPID PATHWAY IN SLE PATIENTS

  Checa A; Idborg H; Sar DG; Jakobsson PJ; Wheelock CE; Gunnarsson I
• Journal article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(Suppl 1):a67

  A8.07 Characterising effects of epigenetic regulation in assays using peripheral blood mononuclear cells from patients with inflammatory diseases

  Aftab O; Sundström Y; Bergqvist F; Kultima K; Gustafsson; Larsson R; Sundström M; Ossipova E; Lengqvist J; Jakobsson P; Rubin J; Berg L
• Journal article: MOLECULAR PHARMACEUTICS. 2016;13(2):391-403

  Neuronal Uptake and Neuroprotective Properties of Curcumin-Loaded Nanoparticles on SK-N-SH Cell Line: Role of Poly(lactide-co-glycolide) Polymeric Matrix Composition

  Paka GD; Doggui S; Zaghmi A; Safar R; Dao L; Reisch A; Klymchenko A; Roullin VG; Joubert O; Ramassamy C
• Article: RMD OPEN. 2016;2(2):e000337

  Educational needs of health professionals working in rheumatology in Europe.

  Vliet Vlieland TPM; van den Ende CHM; Alliot-Launois F; Beauvais C; Gobbo M; Iagnocco A; Lundberg IE; Munuera-Martínez PV; Opava CH; Prior Y; Redmond A; Smucrova H; Wiek D
• Review: RMD OPEN. 2016;2(2):e000291

  Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies.

  Schwartz T; Diederichsen LP; Lundberg IE; Sjaastad I; Sanner H
• Article: RMD OPEN. 2016;2(2):e000342

  Inflammatory lung disease a potential risk factor for onset of idiopathic inflammatory myopathies: results from a pilot study.

  Helmers SB; Jiang X; Pettersson D; Wikman A-L; Axelman P; Lundberg Å; Lundberg IE; Alfredsson L
• Article: PLOS ONE. 2016;11(9):e0163600

  Arg126 and Asp49 Are Essential for the Catalytic Function of Microsomal Prostaglandin E₂ Synthase 1 and Ser127 Is Not

  Raouf J; Rafique N; Goodman MC; Idborg H; Bergqvist F; Armstrong RN; Jakobsson P-J; Morgenstern R; Spahiu L
• Editorial comment: CLINICAL EPIDEMIOLOGY. 2016;8:361-362

  Prevalence and comorbidity of relapsing polychondritis

  Ludvigsson JF; van Vollenhoven R
• Article: LUPUS SCIENCE AND MEDICINE. 2016;3(1):e000170

  Interferon (IFN)-λ is a potential mediator in lupus nephritis.

  Zickert A; Oke V; Parodis I; Svenungsson E; Sundström Y; Gunnarsson I
• Article: RMD OPEN. 2016;2(1):e000133

  A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remission.

  Chatzidionysiou K; Turesson C; Teleman A; Knight A; Lindqvist E; Larsson P; Cöster L; Forslind K; van Vollenhoven R; Heimbürger M
• Article: RMD OPEN. 2016;2(2):e000240

  Educational needs and preferences of young European clinicians and physician researchers working in the field of rheumatology.

  Beyer C; Ramiro S; Sivera F; Mandl P; Machado PM; Ospelt C; Moltó A; Radner H; Iagnocco A; Bijlsma JW; Lundberg IE; EMEUNET country liaisons group
• Article: RMD OPEN. 2016;2(1):e000213

  Malignancy rates in patients with rheumatoid arthritis treated with tocilizumab.

  Rubbert-Roth A; Sebba A; Brockwell L; Kelman A; Porter-Brown B; Pulley J; Napalkov P; van Vollenhoven RF
• Article: RMD OPEN. 2016;2(1):e000195

  Practice what you preach? An exploratory multilevel study on rheumatoid arthritis guideline adherence by rheumatologists.

  Lesuis N; den Broeder AA; Hulscher MEJL; van Vollenhoven RF
• Article: RMD OPEN. 2016;2(1):e000184

  Patient-initiated appointments compared with standard outpatient care for rheumatoid arthritis: a randomised controlled trial.

  Fredriksson C; Ebbevi D; Waldheim E; Lindblad S; Ernestam S
• Article: RMD OPEN. 2016;2(1):e000197

  Association of a multibiomarker disease activity score at multiple time-points with radiographic progression in rheumatoid arthritis: results from the SWEFOT trial.

  Hambardzumyan K; Bolce RJ; Saevarsdottir S; Forslind K; Wallman JK; Cruickshank SE; Sasso EH; Chernoff D; van Vollenhoven RF
• Article: RMD OPEN. 2016;2(2):e000323

  Induction maintenance with tumour necrosis factor-inhibitor combination therapy with discontinuation versus methotrexate monotherapy in early rheumatoid arthritis: a systematic review and meta-analysis of efficacy in randomised controlled trials.

  Emamikia S; Arkema EV; Györi N; Detert J; Chatzidionysiou K; Dougados M; Burmester GR; van Vollenhoven R
• Article: PLOS ONE. 2016;11(6):e0158076

  Antiphospholipid Antibodies in Lupus Nephritis

  Parodis I; Arnaud L; Gerhardsson J; Zickert A; Sundelin B; Malmstrom V; Svenungsson E; Gunnarsson I
• Review: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(1):16-22

  Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update

  Stoffer MA; Schoels MM; Smolen JS; Aletaha D; Breedveld FC; Burmester G; Bykerk V; Dougados M; Emery P; Haraoui B; Gomez-Reino J; Kvien TK; Nash P; Navarro-Compan V; Scholte-Voshaar M; van Vollenhoven R; van der Heijde D; Stamm TA
• Review: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(1):3-15

  Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force

  Smolen JS; Breedveld FC; Burmester GR; Bykerk V; Dougados M; Emery P; Kvien TK; Navarro-Compan MV; Oliver S; Schoels M; Scholte-Voshaar M; Stamm T; Stoffer M; Takeuchi T; Aletaha D; Louis Andreu J; Aringer M; Bergman M; Betteridge N; Bijlsma H; Burkhardt H; Cardiel M; Combe B; Durez P; Fonseca JE; Gibofsky A; Gomez-Reino JJ; Graninger W; Hannonen P; Haraoui B; Kouloumas M; Landewe R; Martin-Mola E; Nash P; Ostergaard M; Ostor A; Richards P; Sokka-Isler T; Thorne C; Tzioufas AG; van Vollenhoven R; de Wit M; van der Heijde D
• Article: PLOS ONE. 2016;11(3):e0152116

  Structural and Functional Analysis of Calcium Ion Mediated Binding of 5-Lipoxygenase to Nanodiscs

  Kumar RB; Zhu L; Idborg H; Radmark O; Jakobsson P-J; Rinaldo-Matthis A; Hebert H; Jegerschold C
• Article: LUPUS SCIENCE AND MEDICINE. 2016;3(1):e000163

  Off-label use of rituximab for systemic lupus erythematosus in Europe.

  Rydén-Aulin M; Boumpas D; Bultink I; Callejas Rubio JL; Caminal-Montero L; Castro A; Colodro Ruiz A; Doria A; Dörner T; Gonzalez-Echavarri C; Gremese E; Houssiau FA; Huizinga T; Inanç M; Isenberg D; Iuliano A; Jacobsen S; Jimenéz-Alonso J; Kovács L; Mariette X; Mosca M; Nived O; Oristrell J; Ramos-Casals M; Rascón J; Ruiz-Irastorza G; Sáez-Comet L; Salvador Cervelló G; Sebastiani GD; Squatrito D; Szücs G; Voskuyl A; van Vollenhoven R
• Article: LUPUS SCIENCE AND MEDICINE. 2016;3(1):e000143

  Cardiovascular events prior to or early after diagnosis of systemic lupus erythematosus in the systemic lupus international collaborating clinics cohort.

  Urowitz MB; Gladman DD; Anderson NM; Su J; Romero-Diaz J; Bae SC; Fortin PR; Sanchez-Guerrero J; Clarke A; Bernatsky S; Gordon C; Hanly JG; Wallace DJ; Isenberg D; Rahman A; Merrill J; Ginzler E; Alarcón GS; Fessler BF; Petri M; Bruce IN; Khamashta M; Aranow C; Dooley M; Manzi S; Ramsey-Goldman R; Sturfelt G; Nived O; Steinsson K; Zoma A; Ruiz-Irastorza G; Lim S; Kalunian KC; Ỉnanç M; van Vollenhoven R; Ramos-Casals M; Kamen DL; Jacobsen S; Peschken C; Askanase A; Stoll T
• Article: LUPUS SCIENCE AND MEDICINE. 2016;3(1):e000135

  The association between diet and glucocorticoid treatment in patients with SLE.

  Lourdudoss C; Hafström I; Frostegård J; van Vollenhoven R
• Review: PLOS ONE. 2016;11(8):e0160753

  Health-Related Quality of Life (HRQoL) in Idiopathic Inflammatory Myopathy: A Systematic Review

  Leclair V; Regardt M; Wojcik S; Hudson M
• Article: PLOS ONE. 2016;11(6):e0157961

  Safety of Repeated Open-Label Treatment Courses of Intravenous Ofatumumab, a Human Anti-CD20 Monoclonal Antibody, in Rheumatoid Arthritis: Results from Three Clinical Trials

  Quattrocchi E; Ostergaard M; Taylor PC; van Vollenhoven RF; Chu M; Mallett S; Perry H; Kurrasch R
• Article: PLOS ONE. 2016;11(4):e0153751

  Prostaglandin E₂ Exerts Multiple Regulatory Actions on Human Obese Adipose Tissue Remodeling, Inflammation, Adaptive Thermogenesis and Lipolysis

  Garcia-Alonso V; Titos E; Alcaraz-Quiles J; Rius B; Lopategi A; Lopez-Vicario C; Jakobsson P-J; Delgado S; Lozano J; Claria J
• Article: JOURNAL OF RHEUMATOLOGY. 2016;43(1):169-176

  Proposal for a Candidate Core Set of Fitness and Strength Tests for Patients with Childhood or Adult Idiopathic Inflammatory Myopathies

  van der Stap DKD; Rider LG; Alexanderson H; Huber AM; Gualano B; Gordon P; van der Net J; Mathiesen P; Johnson LG; Ernste FC; Feldman BM; Houghton KM; Singh-Grewal D; Kutzbach AG; Munters LA; Takken T
• Article: ARTHRITIS & RHEUMATOLOGY. 2016;68(1):46-55

  VX-509 (Decernotinib), an Oral Selective JAK-3 Inhibitor, in Combination With Methotrexate in Patients With Rheumatoid Arthritis

  Genovese MC; van Vollenhoven RF; Pacheco-Tena C; Zhang Y; Kinnman N
• Article: SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2016;1:15002-

  Intravenous immune globulin suppresses angiogenesis in mice and humans

  Yasuma R; Cicatiello V; Mizutani T; Tudisco L; Kim Y; Tarallo V; Bogdanovich S; Hirano Y; Kerur N; Li S; Yasuma T; Fowler BJ; Wright CB; Apicella I; Greco A; Brunetti A; Ambati BK; Helmers SB; Lundberg IE; Viklicky O; Leusen JHW; Verbeek JS; Gelfand BD; Bastos-Carvalho A; De Falco S; Ambati J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(1):52-58

  Full dose, reduced dose or discontinuation of etanercept in rheumatoid arthritis

  van Vollenhoven RF; Ostergaard M; Leirisalo-Repo M; Uhlig T; Jansson M; Larsson E; Brock F; Franck-Larsson K
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2016;68

  Analysis of Correlation and Causes for Discrepancy Between Quantitative and Semi Quantitative Doppler Scores in Synovitis in Rheumatoid Arthritis

  Rezaei H; Af Klint E; Hammer HB; Terslev L; d'Agostino MA; Kisten Y; Arnaud L
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2016;68

  Fluorescence Optical Imaging Reveals Distinct Patterns of Hand Joint Inflammation in Seropositive and Seronegative Early Rheumatoid Arthritis

  Kisten Y; Af Klint E; Rezaei H; Levitsky A; Larsson PT; Karlsson A; Gyori N; van Vollenhoven RF; Arnaud L
• Conference publication: NEUROPSYCHOPHARMACOLOGY. 2016;41:S174-S175

  P11 Protein Levels in Peripheral Blood Mononuclear Cells From Parkinson's Disease Patients With and Without Depression Correlate With Disease Severity

  Green H; Brodin L; Berg L; Greengard P; Svenningsson P
• Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2016;45:6

  Obesity is associated with worse clinical outcomes yet limited radiographic progression in early rheumatoid arthritis

  Levitsky A; Saevarsdottir S; Brismar K; Hambardzumyan K; Lourdudoss C; van Vollenhoven R
• Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2016;45:45

  Risk factors for thromboembolic events (TEs) in patients with idiopathic inflammatory myopathies (IIM)

  Notarnicola A; Nasman L; Tang Q; Tjarlund A; Elvin K; Berg L; Norkko J; Lundberg I; Aleksandra A
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2016;68

  Observations of Early and Late B Cell Alterations during Belimumab Treatment in Patients with Systemic Lupus Erythematosus Using Mass Cytometry (CyTOF)

  Parodis I; Ramskold D; Brodin P; Zickert A; Tadepally L; Chen Y; Mikes J; Achour A; Gurmarsson I; Malmstrom V
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2016;68

  High Baseline B Lymphocyte Stimulator (BLyS) Levels Predict Response While Smoking and Organ Damage at Baseline Predict Failure to Belimumab in Three Swedish Clinical Practice Settings

  Parodis I; Sjowall C; Jonsen A; Zickert A; Ramskold D; Frodlund M; Arnaud L; Malmstrom V; Bengtsson AA; Gunnarsson I
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2016;68

  Antibody Mediated Immunity Drives Response to Methotrexate Treatment in Rheumatoid Arthritis Patients

  Brynedal B; Westerlind H; Folkersen L; Padyukov L; Vivar N; Catrina AI; Klareskog L; Berg L
• Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2016;45:44-45

  Characterizing the effects of epigenetic regulation in assays using peripheral blood mononuclear cells from patients with inflammatory diseases

  Berg L; Sundstrom Y; Aftab O; Bergqvist F; Kultima K; Gustafsson M; Larsson R; Sundstrom M; Ossipova E; Lengqvist J; Jakobsson P-J; Rubin J
• Conference publication: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2016;34(4):S64

  INHIBITION OF IN VITRO B CELL MATURATION BY NEW CHEMICAL PROBES IN ASSAYS USING BLOOD CELLS FROM PATIENTS WITH SLE AND IIM

  Sundstrom Y; Chen T; Bergqvist F; Sundstrom M; Taunton J; Ossipova E; Lengqvist J; Gunnarsson I; Lundberg I; Jakobsson PJ; Berg L
• Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2016;45:4

  Characterization of systemic lupus erythematosus subgroups with features of antiphospholipid syndrome or Sjogren's syndrome using affinity proteomics

  Idborg H; Zandian A; Gustafsson JT; Gunnarsson I; Svenungsson E; Nilsson P; Jakobsson P-J
• Conference publication: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2016;34(4):S18

  ANTIPHOSPHOLIPID ANTIBODIES IN LUPUS NEPHRITIS

  Parodis I; Arnaud L; Gerhardsson J; Zickert A; Sundelin B; Malmstrom V; Svenungsson E; Gunnarsson I
• Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2016;45:41-42

  Antiphospholipid antibodies in lupus nephritis

  Parodis I; Arnaud L; Gerhardsson J; Zickert A; Sundelin B; Malmstrom V; Svenungsson E; Gunnarsson I
• Conference publication: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2016;34(4):S69

  SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR 2 (STNFR2) AS A BIOMARKER OF KIDNEY TISSUE DAMAGE AND LONG-TERM RENAL OUTCOME IN LUPUS NEPHRITIS

  Parodis I; Ding H; Zickert A; Arnaud L; Svenungsson E; Mohan C; Gunnarsson I
• Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2016;45:42

  Soluble tumour necrosis factor receptor 2 (sTNFR2) as a biomarker of kidney tissue damage and long-term renal outcome in lupus nephritis

  Parodis I; Ding H; Zickert A; Arnaud L; Svenungsson E; Mohan C; Gunnarsson I
• Conference publication: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2016;34(4):S75

  SERUM FERRITIN AS A MARKER OF CLINICAL AND HISTOPATHOLOGICAL RESPONSE TO TREATMENT IN LUPUS NEPHRITIS

  Parodis I; Ding H; Zickert A; Arnaud L; Mohan C; Gunnarsson I
• Conference publication: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2016;34(4):S69

  SERUM ANEXELEKTO (AXL) AS A NOVEL BIOMARKER OF RENAL ACTIVITY, TREATMENT RESPONSE AND LONG-TERM OUTCOME IN PATIENTS WITH LUPUS NEPHRITIS

  Parodis I; Ding H; Zickert A; Arnaud L; Mohan C; Gunnarsson I
• Conference publication: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2016;34(4):S69-S70

  SERUM INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 2 (IGFBP2) AS A BIOMARKER OF CLINICAL AND HISTOPATHOLOGICAL TREATMENT RESPONSE IN LUPUS NEPHRITIS

  Parodis I; Ding H; Zickert A; Arnaud L; Mohan C; Gunnarsson I
• Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2016;45:40-41

  Serum ferritin as a marker of clinical and histopathological response to treatment in lupus nephritis

  Parodis I; Ding H; Zickert A; Arnaud L; Mohan C; Gunnarsson I
• Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2016;45:43

  Serum insulin-like growth factor-binding protein 2 (IGFBP2) as a biomarker of clinical and histopathological treatment response in lupus nephritis

  Parodis I; Ding H; Zickert A; Arnaud L; Mohan C; Gunnarsson I
• Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2016;45:43-44

  Serum anexelekto (Axl) as a novel biomarker of renal activity, treatment response, and long-term outcome in patients with lupus nephritis

  Parodis I; Ding H; Zickert A; Arnaud L; Mohan C; Gunnarsson I
• Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2016;45:39-40

  The TNF-α/p-albumin ratio: a suggested biomarker for disease activity in SLE

  Svenungsson E; Eketjall S; Idborg H; Gustafsson JT; Zickert A; Kvarnstrom M; Oke V; Pettersson S; Jakobsson P-J; Gunnarsson I
• Article: LAKARTIDNINGEN. 2015;112:DRFX

  [Investigation of hypokalemia].

  Lodin K; Palmér M
• Article: JOURNAL OF RHEUMATOLOGY. 2015;42(12):2492-2495

  Patients' Experience of Myositis and Further Validation of a Myositis-specific Patient Reported Outcome Measure - Establishing Core Domains and Expanding Patient Input on Clinical Assessment in Myositis. Report from OMERACT 12

  Regardt M; Basharat P; Christopher-Stine L; Sarver C; Bjorn A; Lundberg IE; Song YW; Bingham COIII; Alexanderson H
• Article: JOURNAL OF CLINICAL INVESTIGATION. 2015;125(12):4612-4624

  Development of autoantibodies against muscle-specific FHL1 in severe inflammatory myopathies

  Albrecht I; Wick C; Hallgren A; Tjarnlund A; Nagaraju K; Andrade F; Thompson K; Coley W; Phadke A; Diaz-Gallo L-M; Bottai M; Nennesmo I; Chemin K; Herrath J; Johansson K; Wikberg A; Ytterberg AJ; Zubarev RA; Danielsson O; Krystufkova O; Vencovsky J; Landegren N; Wahren-Herlenius M; Padyukov L; Kampe O; Lundberg IE
• Editorial comment: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(12):2103-2106

  Remission in SLE: closing in on the target

  van Vollenhoven RF; Voskuyl A; Morand E; Aranow C
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(12):2260-2261

  Adalimumab and etanercept serum (anti)drug levels are not predictive for successful dose reduction or discontinuation in rheumatoid arthritis

  van Herwaarden N; Bouman CAM; van der Maas A; van Vollenhoven RF; Bijlsma JW; van den Hoogen FHJ; den Broeder AA; van den Bemt BJF
• Article: JOURNAL OF RHEUMATOLOGY. 2015;42(12):2288-2295

  Safety and Efficacy of Belimumab to Treat Systemic Lupus Erythematosus in Academic Clinical Practices

  Hui-Yuen JS; Reddy A; Taylor J; Li X; Eichenfield AH; Bermudez LM; Starr AJ; Imundo LF; Buyon J; Furie RA; Kamen DL; Manzi S; Petri M; Ramsey-Goldman R; van Vollenhoven RF; Wallace DJ; Askanase A
• Article: ARTHRITIS RESEARCH & THERAPY. 2015;17:325

  Twenty-eight-week results from the REALISTIC phase IIIb randomized trial: efficacy, safety and predictability of response to certolizumab pegol in a diverse rheumatoid arthritis population

  Weinblatt ME; Fleischmann R; van Vollenhoven RF; Emery P; Huizinga TWJ; Cutolo M; van der Heijde D; Duncan B; Davies O; Luijtens K; Dougados M
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2015;44(6):431-437

  Effectiveness and survival-on-drug of certolizumab pegol in rheumatoid arthritis in clinical practice: results from the national Swedish register

  Chatzidionysiou K; Kristensen L-E; Eriksson J; Askling J; van Vollenhoven R
• Article: ARTHRITIS & RHEUMATOLOGY. 2015;67(11):2855-2860

  Enhancement of Patient Recruitment in Rheumatoid Arthritis Clinical Trials Using a Multi-Biomarker Disease Activity Score as an Inclusion Criterion

  van Vollenhoven RF; Bolce R; Hambardzumyan K; Saevarsdottir S; Forslind K; Petersson IF; Sasso EH; Hwang CC; Segurado OG; Geborek P
• Article: ARTHRITIS & RHEUMATOLOGY. 2015;67(11):2828-2836

  Safety and Efficacy of Atacicept in Combination With Rituximab for Reducing the Signs and Symptoms of Rheumatoid Arthritis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Pilot Trial

  van Vollenhoven RF; Wax S; Li Y; Tak PP
• Article: INTERNAL AND EMERGENCY MEDICINE. 2015;10(7):823-830

  Evaluation of differences in carotid intima-media thickness in patients affected by systemic rheumatic diseases.

  Ciccone MM; Scicchitano P; Zito A; Cortese F; Rotondo C; Coladonato L; Gesualdo M; Notarnicola A; Iannone F
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(10):1907-1914

  Nitrosative modifications of the Ca²⁺ release complex and actin underlie arthritis-induced muscle weakness

  Yamada T; Fedotovskaya O; Cheng AJ; Cornachione AS; Minozzo FC; Aulin C; Friden C; Turesson C; Andersson DC; Glenmark B; Lundberg IE; Rassier DE; Westerblad H; Lanner JT
• Article: GENES AND IMMUNITY. 2015;16(7):470-480

  Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes

  Miller FW; Chen W; O'Hanlon TP; Cooper RG; Vencovsky J; Rider LG; Danko K; Wedderburn LR; Lundberg IE; Pachman LM; Reed AM; Ytterberg SR; Padyukov L; Selva-O'Callaghan A; Radstake TR; Isenberg DA; Chinoy H; Ollier WER; Scheet P; Peng B; Lee A; Byun J; Lamb JA; Gregersen PK; Amos CI
• Article: JOURNAL OF RHEUMATOLOGY. 2015;42(10):1761-1766

  Longterm Safety of Rituximab: Final Report of the Rheumatoid Arthritis Global Clinical Trial Program over 11 Years

  van Vollenhoven RF; Fleischmann RM; Furst DE; Lacey S; Lehane PB
• Article: BMC MEDICINE. 2015;13:247

  Serum survivin predicts responses to treatment in active rheumatoid arthritis: a post hoc analysis from the SWEFOT trial

  Levitsky A; Erlandsson MC; van Vollenhoven RF; Bokarewa MI
• Article: ARTHRITIS RESEARCH & THERAPY. 2015;17(1):245

  Certolizumab pegol plus methotrexate 5-year results from the rheumatoid arthritis prevention of structural damage (RAPID) 2 randomized controlled trial and long-term extension in rheumatoid arthritis patients

  Smolen JS; van Vollenhoven R; Kavanaugh A; Strand V; Vencovsky J; Schiff M; Landewe R; Haraoui B; Arendt C; Mountian I; Carter D; van der Heijde D
• Article: JOURNAL OF PROTEOME RESEARCH. 2015;14(9):3940-3947

  Proteomics Reveals a Role for Attachment in Monocyte Differentiation into Efficient Proinflammatory Macrophages

  Tarasova NK; Ytterberg AJ; Lundberg K; Zhang X-M; Harris RA; Zubarev RA
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2015;44(5):348-353

  Predicted vs. observed radiographic progression in early rheumatoid arthritis (POPeRA): results from a randomized trial

  Levitsky A; Forslind K; van Vollenhoven RF
• Article: JOURNAL OF REHABILITATION MEDICINE. 2015;47(8):748-752

  IMPROVED OXYGENATION DURING STANDING PERFORMANCE OF DEEP BREATHING EXERCISES WITH POSITIVE EXPIRATORY PRESSURE AFTER CARDIAC SURGERY: A RANDOMIZED CONTROLLED TRIAL

  Pettersson H; Faager G; Westerdahl E
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(9):1772-1777

  Shared immunological targets in the lungs and joints of patients with rheumatoid arthritis: identification and validation

  Ytterberg AJ; Joshua V; Reynisdottir G; Tarasova NK; Rutishauser D; Ossipova E; Hensvold AH; Eklund A; Skold CM; Grunewald J; Malmstrom V; Jakobsson PJ; Ronnelid J; Padyukov L; Zubarev RA; Klareskog L; Catrina AI
• Editorial comment: PROSTAGLANDINS AND OTHER LIPID MEDIATORS. 2015;121(Pt A):1-3

  Special Issue 5th European Workshop on Lipid Mediators

  Topal G; Claria J; Norel X; Steinhilber D; Jakobsson P-J; Dogan SU; Bannenberg G
• Article: PROSTAGLANDINS AND OTHER LIPID MEDIATORS. 2015;121(Pt B):155-162

  Impaired vagus-mediated immunosuppression in microsomal prostaglandin E synthase-1 deficient mice

  Le Maitre E; Revathikumar P; Idborg H; Raouf J; Korotkova M; Jakobsson P-J; Lampa J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(9):1706-1713

  Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort

  Bruce IN; O'Keeffe AG; Farewell V; Hanly JG; Manzi S; Su L; Gladman DD; Bae S-C; Sanchez-Guerrero J; Romero-Diaz J; Gordon C; Wallace DJ; Clarke AE; Bernatsky S; Ginzler EM; Isenberg DA; Rahman A; Merrill JT; Alarcon GS; Fessler BJ; Fortin PR; Petri M; Steinsson K; Dooley MA; Khamashta MA; Ramsey-Goldman R; Zoma AA; Sturfelt GK; Nived O; Aranow C; Mackay M; Ramos-Casals M; van Vollenhoven RF; Kalunian KC; Ruiz-Irastorza G; Lim S; Kamen DL; Peschken CA; Inanc M; Urowitz MB
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2015;33(5):706-714

  Cardiac abnormalities assessed by non-invasive techniques in patients with newly diagnosed idiopathic inflammatory myopathies

  Diederichsen LP; Simonsen JA; Diederichsen ACP; Kim WY; Hvidsten S; Hougaard M; Junker P; Lundberg IE; Petersen H; Hansen ESS; Eskerud KS; Kay SD; Jacobsen S
• Article: ARTHRITIS CARE AND RESEARCH. 2015;67(9):1237-1245

  Treatment Algorithms in Systemic Lupus Erythematosus

  Muangchan C; van Vollenhoven RF; Bernatsky SR; Smith CD; Hudson M; Inanc M; Rothfield NF; Nash PT; Furie RA; Senecal J-L; Chandran V; Burgos-Vargas R; Ramsey-Goldman R; Pope JE
• Review: ARTHRITIS RESEARCH & THERAPY. 2015;17(1):181

  Sustained biologic-free and drug-free remission in rheumatoid arthritis, where are we now?

  Nagy G; van Vollenhoven RF
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(8):1567-1570

  Efficacy and safety of tabalumab, an anti-B-cell-activating factor monoclonal antibody, in patients with rheumatoid arthritis who had an inadequate response to methotrexate therapy: results from a phase III multicentre, randomised, double-blind study

  Smolen JS; Weinblatt ME; van der Heijde D; Rigby WFC; van Vollenhoven R; Bingham COIII; Veenhuizen M; Gill A; Zhao F; Komocsar WJ; Berclaz P-Y; Ortmann R; Lee C
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(8):1509-1514

  Current smoking status is a strong predictor of radiographic progression in early rheumatoid arthritis: results from the SWEFOT trial

  Saevarsdottir S; Rezaei H; Geborek P; Petersson I; Ernestam S; Albertsson K; Forslind K; van Vollenhoven RF
• Article: RHEUMATOLOGY. 2015;54(8):1472-1477

  Does disease activity at the start of biologic therapy influence health care costs in patients with RA?

  Johansson K; Eriksson JK; van Vollenhoven R; Miller H; Askling J; Neovius M
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(8):1530-1536

  Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort

  Parker B; Urowitz MB; Gladman DD; Lunt M; Donn R; Bae S-C; Sanchez-Guerrero J; Romero-Diaz J; Gordon C; Wallace DJ; Clarke AE; Bernatsky S; Ginzler EM; Isenberg DA; Rahman A; Merrill JT; Alarcon GS; Fessler BJ; Fortin PR; Hanly JG; Petri M; Steinsson K; Dooley MA; Manzi S; Khamashta MA; Ramsey-Goldman R; Zoma AA; Sturfelt GK; Nived O; Aranow C; Mackay M; Ramos-Casals M; van Vollenhoven RF; Kalunian KC; Ruiz-Irastorza G; Lim SS; Kamen DL; Peschken CA; Inanc M; Bruce IN
• Article: HEPATOLOGY. 2015;62(1):40-46

  Safety of long-term biologic therapy in rheumatologic patients with a previously resolved hepatitis B viral infection.

  Barone M; Notarnicola A; Lopalco G; Viggiani MT; Sebastiani F; Covelli M; Iannone F; Avolio AW; Di Leo A; Cantarini L; Lapadula G
• Article: ARTHRITIS & RHEUMATOLOGY. 2015;67(7):1837-1847

  Mood Disorders in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study

  Hanly JG; Su L; Urowitz MB; Romero-Diaz J; Gordon C; Bae S-C; Bernatsky S; Clarke AE; Wallace DJ; Merrill JT; Isenberg DA; Rahman A; Ginzler EM; Petri M; Bruce IN; Dooley MA; Fortin P; Gladman DD; Sanchez-Guerrero J; Steinsson K; Ramsey-Goldman R; Khamashta MA; Aranow C; Alarcon GS; Fessler BJ; Manzi S; Nived O; Sturfelt GK; Zoma AA; van Vollenhoven RF; Ramos-Casals M; Ruiz-Irastorza G; Lim SS; Kalunian KC; Inanc M; Kamen DL; Peschken CA; Jacobsen S; Askanase A; Theriault C; Thompson K; Farewell V
• Article: PROSTAGLANDINS AND OTHER LIPID MEDIATORS. 2015;120:161-165

  Inhibition of microsomal prostaglandin E synthase-1 as targeted therapy in cancer treatment

  Larsson K; Jakobsson P-J
• Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2015;112(26):8070-8075

  COX/mPGES-1/PGE₂ pathway depicts an inflammatory-dependent high-risk neuroblastoma subset

  Larsson K; Kock A; Idborg H; Henriksson MA; Martinsson T; Johnsen JI; Korotkova M; Kogner P; Jakobsson P-J
• Article: ARTHRITIS RESEARCH & THERAPY. 2015;17(1):155

  Targeting of anti-citrullinated protein/peptide antibodies in rheumatoid arthritis using peptides mimicking endogenously citrullinated fibrinogen antigens

  Fernandes-Cerqueira C; Ossipova E; Gunasekera S; Hansson M; Mathsson L; Catrina AI; Sommarin Y; Klareskog L; Lundberg K; Ronnelid J; Goransson U; Jakobsson P-J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(6):1183-1187

  Differences and similarities in rheumatology specialty training programmes across European countries

  Sivera F; Ramiro S; Cikes N; Dougados M; Gossec L; Kvien TK; Lundberg IE; Mandl P; Moorthy A; Panchal S; da Silva JAP; Bijlsma JW
• Article: RHEUMATOLOGY. 2015;54(6):1065-1073

  An outsourced health-enhancing physical activity programme for people with rheumatoid arthritis: exploration of adherence and response

  Nordgren B; Friden C; Demmelmaier I; Bergstroem G; Lundberg IE; Dufour AB; Opava CH
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(6):1102-1109

  Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial

  Hambardzumyan K; Bolce R; Saevarsdottir S; Cruickshank SE; Sasso EH; Chernoff D; Forslind K; Petersson IF; Geborek P; van Vollenhoven RF
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(6):1094-1101

  Cost-effectiveness of infliximab versus conventional combination treatment in methotrexate-refractory early rheumatoid arthritis: 2-year results of the register-enriched randomised controlled SWEFOT trial

  Eriksson JK; Karlsson JA; Bratt J; Petersson IF; van Vollenhoven RF; Ernestam S; Geborek P; Neovius M
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2015;74:484-485

  SMOKING AND RESPONSE TO RITUXIMAB IN ANTI-CCP POSITIVE AND NEGATIVE RHEUMATOID ARTHRITIS - RESULTS FROM AN INTERNATIONAL EUROPEAN COLLABORATION

  Chatzidionysiou K; Lie E; Nasonov E; Lukina G; Hetland ML; Hauge E; Pavelka K; Gabay C; Nordstrom D; Canhao H; Tomsic M; van Riel P; Gomez-Reino J; Ancuta I; Kvien T; van Vollenhoven R; Saevarsdottir S
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2015;74:798-799

  DISEASE ACTIVITY PATTERNS OVER TIME IN PATIENTS WITH SLE - A RETROSPECTIVE DESCRIPTIVE ANALYSIS OF THE HOPKINS LUPUS COHORT

  Gyori N; Chatzidionysiou A; Magder L; van Vollenhoven R; Petri M
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2015;74:492

  RITUXIMAB DONE! WHAT'S NEXT IN RHEUMATOID ARTHRITIS? A EUROPEAN OBSERVATIONAL LONGITUDINAL STUDY ASSESSING THE EFFECTIVENESS OF BIOLOGICS AFTER RITUXIMAB TREATMENT IN RHEUMATOID ARTHRITIS

  Walker UA; Jaeger VK; Chatzidionysiou K; Hetland ML; Hauge E-M; Pavelka K; Nordstrom DC; Canhao H; Tomsic M; van Vollenhoven R; Gabay C
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2015;74:958

  ALTERED SERUM FATTY ACID PROFILES IN PATIENTS WITH POLYMYOSITIS OR DERMATOMYOSITIS COMPARED TO HEALTHY INDIVIDUALS AND IN RELATION TO IMMUNOSUPPRESSIVE TREATMENT

  Raouf J; Idborg H; Olsson P; Jakobsson P-J; Lundberg IE; Korolkova M
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2015;74:174

  ANALYSIS OF THE AUTOANTIBODY REPERTOIRE IN IDIOPATHIC INFLAMMATORY MYOPATHIES USING ANTIGEN BEAD ARRAY

  Notarnicola A; Mattsson C; Idborg H; Hellstrom C; Jemseby E; Jacobsson P-J; Nilsson P; Lundberg IE
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2015;74:886-887

  THE CLINICAL USE OF DIGITAL JOINT SPACE WIDTH AND X-RAY RADIOGRAMMETRY AS MARKERS FOR EARLY RADIOGRAPHIC PROGRESSION IN RA

  Platten M; Kisten Y; Kalvesten J; Forslind K; van Vollenhoven R
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2015;74:1062

  KALTENBORN'S MANUAL MOBILIZATION METHOD FOR PAIN RELIEF IN RA HAND JOINTS: CLINICAL AND ULTRASOUND FINDINGS IN A PILOT STUDY

  Levitsky A; Kisten Y; Nordstrom P; Lind S; Vivar N; van Vollenhoven RF
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2015;74:224

  SERUM SURVIVIN PREDICTS TREATMENT RESPONSE IN ACTIVE RHEUMATOID ARTHRITIS

  Levitsky A; Erlandsson M; van Vollenhoven RF; Bokarewa MI
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2015;74:890

  QUANTIFICATION OF HAND AND WRIST SYNOVITIS USING DIGITAL ACTIVITY FLUORESCENCE OPTICAL IMAGING

  Kisten Y; Gyori N; af Klint E; Rezaei H; Levitsky A; Karlsson A; van Vollenhoven R
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2015;74:804

  ANTIPHOSPHOLIPID ANTIBODIES IN LUPUS NEPHRITIS AND THEIR ROLE IN LONG-TERM OUTCOME

  Parodis I; Svenungsson E; Gerhardsson J; Zickert A; Malmstrom V; Gunnarsson I
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2015;44(3):192-199

  Two-year survival rates of anti-TNF-α therapy in psoriatic arthritis (PsA) patients with either polyarticular or oligoarticular PsA.

  Iannone F; Lopriore S; Bucci R; Scioscia C; Anelli MG; Notarnicola A; Lapadula G
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2015;44(3):224-228

  Correlation between serum levels of IL-15 and IL-17 in patients with idiopathic inflammatory myopathies

  Notarnicola A; Lapadula G; Natuzzi D; Lundberg IE; Iannone F
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2015;44(3):206-210

  Determination of the minimal clinically important difference for seven measures of fatigue in Swedish patients with systemic lupus erythematosus

  Pettersson S; Lundberg IE; Liang MH; Pouchot J; Henriksson EW
• Article: JOINT BONE SPINE. 2015;82(3):187-191

  Obesity reduces the drug survival of second line biological drugs following a first TNF-α inhibitor in rheumatoid arthritis patients.

  Iannone F; Fanizzi R; Notarnicola A; Scioscia C; Anelli MG; Lapadula G
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(5):890-896

  Effectiveness of TNF inhibitor switch in RA: results from the national Swedish register

  Chatzidionysiou K; Askling J; Eriksson J; Kristensen LE; van Vollenhoven R
• Letter: LUPUS. 2015;24(6):648-649

  DRESS syndrome and reversible liver function abnormalities in patients with systemic lupus erythematosus treated with the highly selective JAK-1 inhibitor GSK2586184

  van Vollenhoven RF; Layton M; Kahl L; Schifano L; Hachulla E; Machado D; Staumont-Salle D; Patel J
• Article: ARTHRITIS CARE AND RESEARCH. 2015;67(6):848-854

  Traditional Cardiovascular Risk Factors and Coronary Artery Calcification in Adults With Polymyositis and Dermatomyositis: A Danish Multicenter Study

  Diederichsen LP; Diederichsen ACP; Simonsen JA; Junker P; Sondergaard K; Lundberg IE; Tvede N; Gerke O; Christensen AF; Dreyer L; Petersen H; Ejstrup L; Kay SD; Jacobsen S
• Article: JOURNAL OF INTERNAL MEDICINE. 2015;277(5):594-604

  The autoimmune spectrum of myasthenia gravis: a Swedish population-based study

  Fang F; Sveinsson O; Thormar G; Granqvist M; Askling J; Lundberg IE; Ye W; Hammarstrom L; Pirskanen R; Piehl F
• Article: ONCOTARGET. 2015;6(12):10284-10296

  MPGES-1-derived PGE2 suppresses CD80 expression on tumor-associated phagocytes to inhibit anti-tumor immune responses in breast cancer

  Olesch C; Sha W; Angioni C; Sha LK; Acaf E; Patrignani P; Jakobsson P-J; Radeke HH; Groesch S; Geisslinger G; von Knethen A; Weigert A; Bruene B
• Article: THE BMJ. 2015;350:h1389

  Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial

  van Herwaarden N; van der Maas A; Minten MJM; van den Hoogen FHJ; Kievit W; van Vollenhoven RF; Bijlsma JWJ; van den Bemt BJF; den Broeder AA
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2015;33(2):159-165

  C-reactive protein polymorphisms influence serum CRP-levels independent of disease activity in ankylosing spondylitis.

  Claushuis TAM; de Vries MK; van der Weijden MAC; Visman IM; Nurmohamed MT; Twisk JWR; Van der Horst-Bruinsma IE; Crusius JBA
• Editorial comment: NATURE REVIEWS DRUG DISCOVERY. 2015;14(3):149-150

  Preclinical target validation using patient-derived cells

  Edwards AM; Arrowsmith CH; Bountra C; Bunnage ME; Feldmann M; Knight JC; Patel DD; Prinos P; Taylor MD; Sundstrom M
• Article: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2015;191(5):574-583

  Proteomic Profiling Reveals Autoimmune Targets in Sarcoidosis

  Haggmark A; Hamsten C; Wiklundh E; Lindskog C; Mattsson C; Andersson E; Lundberg IE; Gronlund H; Schwenk JM; Eklund A; Grunewald J; Nilsson P
• Article: NEUROMUSCULAR DISORDERS. 2015;25(3):268-272

  205th ENMC International Workshop: Pathology diagnosis of idiopathic inflammatory myopathies Part II 28-30 March 2014, Naarden, The Netherlands

  De Bleecker JL; De Paepe B; Aronica E; de Visser M; Amato A; Aronica E; Benveniste O; De Bleecker J; de Boer O; De Paepe B; de Visser M; Dimachkie M; Gherardi R; Goebel HH; Hilton-Jones D; Holton J; Lundberg IE; Mammen A; Mastaglia F; Nishino I; Rushing E; Schroder HD; Selcen D; Stenzel W
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2015;74:A44

  THE QUANTIFICATION OF DIGITAL ACTIVITY FLUORESCENCE OPTICAL IMAGING OF HAND AND WRIST INFLAMMATION IN RHEUMATIC DISEASES

  Kisten Y; Gyori N; af Klint E; Rezaei H; Levitsky A; Karlsson A; van Vollenhoven R
• Article: ARTHRITIS & RHEUMATOLOGY. 2015;67(2):508-516

  Cardiomyopathy in Murine Models of Systemic Sclerosis

  Venalis P; Kumanovics G; Schulze-Koops H; Distler A; Dees C; Zerr P; Palumbo-Zerr K; Czirjak L; Mackevic Z; Lundberg IE; Distler O; Schett G; Distler JHW
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(2):375-380

  Environmental and genetic factors in the development of anticitrullinated protein antibodies (ACPAs) and ACPA-positive rheumatoid arthritis: an epidemiological investigation in twins

  Hensvold AH; Magnusson PKE; Joshua V; Hansson M; Israelsson L; Ferreira R; Jakobsson P-J; Holmdahl R; Hammarstrom L; Malmstrom V; Askling J; Klareskog L; Catrina AI
• Article: RMD OPEN. 2015;1(1):e000044

  The incidence of tuberculosis in patients treated with certolizumab pegol across indications: impact of baseline skin test results, more stringent screening criteria and geographic region.

  Mariette X; Vencovsky J; Lortholary O; Gomez-Reino J; de Longueville M; Ralston P; Weinblatt M; van Vollenhoven R
• Article: RMD OPEN. 2015;1(1):e000106

  Detection of clinically manifest and silent synovitis in the hands and wrists by fluorescence optical imaging.

  Kisten Y; Györi N; Af Klint E; Rezaei H; Levitsky A; Karlsson A; van Vollenhoven R
• Article: PLOS ONE. 2015;10(7):e0133669

  Expression of Prostaglandin E₂ Enzymes in the Synovium of Arthralgia Patients at Risk of Developing Rheumatoid Arthritis and in Early Arthritis Patients

  de Hair MJH; Leclerc P; Newsum EC; Maijer KI; van de Sande MGH; Ramwadhdoebe TH; van Schaardenburg D; van Baarsen LGM; Korotkova M; Gerlag DM; Tak P-P; Jakobsson P-J
• Article: LUPUS. 2015;24(1):42-49

  Anti-C1q antibodies in systemic lupus erythematosus

  Orbai A-M; Truedsson L; Sturfelt G; Nived O; Fang H; Alarcon GS; Gordon C; Merrill JT; Fortin PR; Bruce IN; Isenberg DA; Wallace DJ; Ramsey-Goldman R; Bae S-C; Hanly JG; Sanchez-Guerrero J; Clarke AE; Aranow CB; Manzi S; Urowitz MB; Gladman DD; Kalunian KC; Costner MI; Werth VP; Zoma A; Bernatsky S; Ruiz-Irastorza G; Khamashta MA; Jacobsen S; Buyon JP; Maddison P; Dooley MA; Van Vollenhoven RF; Ginzler E; Stoll T; Peschken C; Jorizzo JL; Callen JP; Lim SS; Fessler BJ; Inanc M; Kamen DL; Rahman A; Steinsson K; Franks AGJ; Sigler L; Hameed S; Pham N; Brey R; Weisman MH; McGwin GJ; Magder LS; Petri M
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(1):96-103

  Update on the safety profile of certolizumab pegol in rheumatoid arthritis: an integrated analysis from clinical trials

  Bykerk VP; Cush J; Winthrop K; Calabrese L; Lortholary O; de Longueville M; van Vollenhoven R; Mariette X
• Article: LUPUS SCIENCE AND MEDICINE. 2015;2(1):e000061

  Evaluation of B lymphocyte stimulator and a proliferation inducing ligand as candidate biomarkers in lupus nephritis based on clinical and histopathological outcome following induction therapy.

  Parodis I; Zickert A; Sundelin B; Axelsson M; Gerhardsson J; Svenungsson E; Malmström V; Gunnarsson I
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(1):204-210

  Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease

  Varsani H; Charman SC; Li CK; Marie SKN; Amato AA; Banwell B; Bove KE; Corse AM; Emslie-Smith AM; Jacques TS; Lundberg IE; Minetti C; Nennesmo I; Rushing EJ; Sallum AME; Sewry C; Pilkington CA; Holton JL; Wedderburn LR
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2015;67

  Clinical Utility of Joint Space Width and X-Ray Radiogrammetry in RA: Markers for Early Radiographic Progression

  Platten M; Kisten Y; Kalvesten J; Forslind K; van Vollenhoven RF
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2015;67

  Adipokines and Insulin-like Growth Factor 1 As Predictors of Clinical and Radiographic Outcomes in Early Rheumatoid Arthritis

  Levitsky A; Brismar K; Saevarsdottir S; Hambardzumyan K; Andersson A; van Vollenhoven RF
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2015;67

  Altered Serum Fatty Acid Profiles in Patients with Polymyositis or Dermatomyositis Compared to Healthy Individuals and in Relation to Immunosuppressive Treatment

  Raouf J; Idborg H; Olsson P; Jakobsson PJ; Lundberg IE; Korotkova M
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2015;67

  Decreased Disease Activity and Corticosteroid Usage and Improved Quality of Life during Belimumab Treatment in Patients with Systemic Lupus Erythematosus - a Prospective Real-Life Observational Study

  Parodis I; Sjowall C; Jonsen A; Zickert A; Frodlund M; Ramskold D; Bengtsson AA; Gunnarsson I
• Conference publication: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2015;33(3):S35

  Decreased disease activity and corticosteroid usage and improved quality of life during belimumab treatment in patients with systemic lupus erythematosus - a prospective real-life observational study

  Parodis I; Sjowall C; Jonsen A; Frodlund M; Ramskold D; Bengtsson A; Gunnarsson I
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2015;67

  Serum Survivin Predicts Responses to Treatment in Active Rheumatoid Arthritis

  Levitsky A; Erlandsson MC; van Vollenhoven RF; Bokarewa MI
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2015;67

  Early Intensification of Treatment Induces Superior Outcomes in Two Randomized Trials According to Predicted Vs. Observed Radiographic Progression in Rheumatoid Arthritis

  Levitsky A; Wick MC; Mottonen T; Leirisalo-Repo M; Laasonen L; Kautiainen H; Korpela M; van Vollenhoven RF; Rantalaiho V
• Conference publication: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2015;33(3):S65-S66

  Disease activity patterns over time in patients with SLE - A retrospective descriptive analysis of the Hopkins Lupus Cohort

  Gyori N; Chatzidionysiou A; Magder L; van Vollenhoven R; Petri M
• Conference publication: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2015;33(3):S16

  Antiphospholipid antibodies in lupus nephritis and their role in long-term renal outcome

  Parodis I; Svenungsson E; Gerhardsson J; Zickert A; Malmstrom V; Gunnarsson I
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2015;67

  Late-Onset Neutropenia Following Rituximab Treatment in Patients with Systemic Lupus Erythematosus

  Parodis I; Soder F; van Vollenhoven RF; Svenungsson E; Gunnarsson I
• Conference publication: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2015;33(3):S29

  Late-onset neutropenia following rituximab treatment in patients with systemic lupus erythematosus

  Parodis I; Soder F; van Vollenhoven R; Svenungsson E; Gunnarsson I
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2015;67

  Serum Axl and Tumor Necrosis Factor Receptor II Portend Long-Term Renal Outcome in Lupus Nephritis

  Parodis I; Ding H; Zickert A; Mohan C; Gunnarsson I
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2015;67

  Serum Ferritin and Insulin-like Growth Factor-Binding Protein 2 As Biomarkers of Clinical and Histopathological Treatment Response in Lupus Nephritis

  Parodis I; Ding H; Zickert A; Mohan C; Gunnarsson I
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2015;67

  The Ratio Between TNF-a and P-Albumin - a Suggested Measure of Disease Activity in SLE

  Eketjall S; Idborg H; Gustafsson J; Zickert A; Kvarnstrom M; Oke V; Pettersson S; Jakobsson PJ; Gunnarsson I; Svenungsson E
• Article: PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS. 2014;91(6):269-275

  Evaluation of urinary prostaglandin E₂ metabolite as a biomarker in infants with fever due to viral infection

  Idborg H; Pawelzik S-C; Perez-Manso M; Bjork L; Hamrin J; Herlenius E; Jakobsson P-J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2014;73(12):2094-2100

  Long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatment of rheumatoid arthritis: 5-year results from the RAPID 1 trial and open-label extension

  Keystone E; Landewe R; van Vollenhoven R; Combe B; Strand V; Mease P; Shaughnessy L; VanLunen B; van der Heijde D
• Letter: JOURNAL OF RHEUMATOLOGY. 2014;41(12):2492-2494

  Pregnancy Outcome in Idiopathic Inflammatory Myopathy Patients in a Multicenter Study

  Nagy-Vincze M; Vencovsky J; Lundberg IE; Danko K
• Article: REUMATISMO. 2014;66(3):215-223

  Possible interplay between interleukin-15 and interleukin-17 into the pathogenesis of idiopathic inflammatory myopathies.

  Notarnicola A; Lapadula G; Natuzzi D; Iannone F
• Review: CURRENT OPINION IN RHEUMATOLOGY. 2014;26(6):704-711

  Therapy of myositis: biological and physical

  Lundberg IE; Vencovsky J; Alexanderson H
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2014;73(11):e73

  Response to: 'MBDA: what is it good for?' by Yazici et al

  van Vollenhoven R; Hambardzumyan K; Chernoff D; Bolce R
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2014;32(6):883-890

  Effects of adalimumab treatment on endothelial cell activation markers in the skeletal muscle of patients with rheumatoid arthritis

  Bergstrom U; Grundtman C; Lundberg IE; Jacobsson LTH; Nilsson K; Turesson C
• Thesis / dissertation: 2014

  The role of X-ray imaging and musculoskeletal ultrasound in the diagnosis and management of rheumatoid arthritis

  Rezaei, Hamed
• Article: ARTHRITIS RESEARCH & THERAPY. 2014;16(5):454

  Expression of BAFF receptors in muscle tissue of myositis patients with anti-Jo-1 or anti-Ro52/anti-Ro60 autoantibodies

  Krystufkova O; Helmers SB; Venalis P; Malmstrom V; Lindroos E; Vencovsky J; Lundberg IE
• Letter: JOINT BONE SPINE. 2014;81(5):458-459

  Different switching rate of anti-TNF-α drugs in monotherapy and in combination with methotrexate in a cohort of rheumatoid arthritis patients in the real life.

  Iannone F; Notarnicola A; Lopalco G; Lapadula G
• Article: ARTHRITIS RESEARCH & THERAPY. 2014;16(5):448

  Diagnostic utility of musculoskeletal ultrasound in patients with suspected arthritis - a probabilistic approach

  Rezaei H; Torp-Pedersen S; af Klint E; Backheden M; Kisten Y; Gyeri N; van Vollenhoven RF
• Conference publication: CANCER RESEARCH. 2014;74(19):3986

  Characterization of prostaglandin signaling in primary neuroblastoma

  Kock A; Larsson K; Ljungblad L; Idborg H; Korotkova M; Elfman L; Johnsen J-I; Jakobsson P-J; Kogner P
• Review: COCHRANE DATABASE OF SYSTEMATIC REVIEWS. 2014;(9):CD010455

  Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity

  van Herwaarden N; den Broeder AA; Jacobs W; van der Maas A; Bijlsma JWJ; van Vollenhoven RF; van den Bemt BHJF
• Article: MUSCULOSKELETAL CARE. 2014;12(3):160-172

  Hand exercise intervention in patients with polymyositis and dermatomyositis: a pilot study.

  Regardt M; Schult M-L; Axelsson Y; Aldehag A; Alexanderson H; Lundberg IE; Henriksson EW
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2014;73(9):1750-1752

  Genotyping of immune-related genetic variants identifies TYK2 as a novel associated locus for idiopathic inflammatory myopathies

  Jani M; Massey J; Wedderburn LR; Vencovsky J; Danko K; Lundberg IE; Padyukov L; Selva-O'Callaghan A; Radstake T; Platt H; Warren RB; Griffiths CE; Lee A; Gregersen PK; Miller FW; Ollier WE; Cooper RG; Chinoy H; Lamb JA
• Letter: MOLECULAR PSYCHIATRY. 2014;19(9):962-964

  Preliminary evidence that early reduction in p11 levels in natural killer cells and monocytes predicts the likelihood of antidepressant response to chronic citalopram

  Svenningsson P; Berg L; Matthews D; Ionescu DF; Richards EM; Niciu MJ; Malinger A; Toups M; Manji H; Trivedi MH; Zarate CAJ; Greengard P
• Article: ARTHRITIS RESEARCH & THERAPY. 2014;16(4):R167

  Affinity purified anti-citrullinated protein/peptide antibodies target antigens expressed in the rheumatoid joint

  Ossipova E; Cerqueira CF; Reed E; Kharlamova N; Israelsson L; Holmdahl R; Nandakumar KS; Engstrom M; Harre U; Schett G; Catrina AI; Malmstrom V; Sommarin Y; Klareskog L; Jakobsson P-J; Lundberg K
• Article: IMMUNOLOGY. 2014;142(4):581-593

  Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts

  Nielsen N; Pascal V; Fasth AER; Sundstrom Y; Galsgaard ED; Ahern D; Andersen M; Baslund B; Bartels EM; Bliddal H; Feldmann M; Malmstrom V; Berg L; Spee P; Soderstrom K
• Article: ARTHRITIS CARE AND RESEARCH. 2014;66(8):1167-1176

  25-Hydroxyvitamin D and Cardiovascular Disease in Patients With Systemic Lupus Erythematosus: Data From a Large International Inception Cohort

  Lertratanakul A; Wu P; Dyer A; Urowitz M; Gladman D; Fortin P; Bae S-C; Gordon C; Clarke A; Bernatsky S; Hanly JG; Isenberg D; Rahman A; Merrill J; Wallace DJ; Ginzler E; Khamashta M; Bruce I; Nived O; Sturfelt G; Steinsson K; Manzi S; Dooley MA; Kalunian K; Petri M; Aranow C; Font J; van Vollenhoven R; Stoll T; Ramsey-Goldman R
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2014;73(8):1541-1544

  Patients with regular physical activity before onset of rheumatoid arthritis present with milder disease

  Sandberg MEC; Wedren S; Klareskog L; Lundberg IE; Opava CH; Alfredsson L; Saevarsdottir S
• Article: CURRENT RHEUMATOLOGY REPORTS. 2014;16(7):429

  New Insights into the Benefits of Exercise for Muscle Health in Patients with Idiopathic Inflammatory Myositis

  Munters LA; Alexanderson H; Crofford LJ; Lundberg IE
• Article: NEW ENGLAND JOURNAL OF MEDICINE. 2014;370(25):2377-2386

  Tofacitinib versus Methotrexate in Rheumatoid Arthritis

  Lee EB; Fleischmann R; Hall S; Wilkinson B; Bradley JD; Gruben D; Koncz T; Krishnaswami S; Wallenstein GV; Zang C; Zwillich SH; van Vollenhoven RF
• Article: JOURNAL OF RHEUMATOLOGY. 2014;41(6):1124-1132

  Resistive Home Exercise in Patients with Recent-onset Polymyositis and Dermatomyositis - A Randomized Controlled Single-blinded Study with a 2-year Followup

  Alexanderson H; Munters LA; Dastmalchi M; Loell I; Heimbuerger M; Opava CH; Lundberg IE
• Review: ANNALS OF THE RHEUMATIC DISEASES. 2014;73(6):958-967

  Treat-to-target in systemic lupus erythematosus: recommendations from an international task force

  van Vollenhoven RF; Mosca M; Bertsias G; Isenberg D; Kuhn A; Lerstrom K; Aringer M; Bootsma H; Boumpas D; Bruce IN; Cervera R; Clarke A; Costedoat-Chalumeau N; Czirjak L; Derksen R; Doerner T; Gordon C; Graninger W; Houssiau F; Inanc M; Jacobsen S; Jayne D; Jedryka-Goral A; Levitsky A; Levy R; Mariette X; Morand E; Navarra S; Neumann I; Rahman A; Rovensky J; Smolen J; Vasconcelos C; Voskuyl A; Voss A; Zakharova H; Zoma A; Schneider M
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2014;73:601-602

  RETENTION OF TOCILIZUMAB THERAPY: A COMPARISON BETWEEN TOCILIZUMAB IN MONOTHERAPY AND IN COMBINATION WITH DMARDS BASED ON THE TOCERRA COLLABORATION

  Gabay C; Riek M; Hetland M; Hauge EM; Pavelka K; Tomsic M; Canhao H; Chatzidionysiou K; van Vollenhoven R; Lukina G; Nordstrom D; Lie E; Ancuta I; Loza Santamaria E; van Riel P; Kvien T
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2014;73:674

  EFFECTIVENESS OF REPEATED COURSES OF RITUXIMAB IN RA - RESULTS FROM THE CERERRA COLLABORATION

  Chatzidionysiou K; Lie E; Nasonov E; Lukina G; Hetland ML; Tarp U; Pavelka K; Gabay C; Nordstrom DC; Canhao H; Tomsic M; van Riel PL; Gomez-Reino J; Ancuta I; Kvien TK; van Vollenhoven RF
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2014;73:505-506

  FIXED VERSUS ON-FLARE RETREATMENT WITH RITUXIMAB IN RA - RESULTS FROM THE CERERRA COLLABORATION

  Chatzidionysiou K; Lie E; Nasonov E; Lukina G; Hetland ML; Tarp U; Pavelka K; Gabay C; Nordstrom DC; Canhao H; Tomsic M; van Riel PL; Gomez-Reino J; Ancuta I; Kvien TK; van Vollenhoven RF
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2014;73:671

  THE DIAGNOSTIC UTILITY OF FLUORESCENCE OPTICAL IMAGING IN EVALUATING SYNOVITIS OF THE HANDS AND WRISTS

  Gyori N; Kisten Y; Rezaei H; Karlsson A; Romanus C; af Klint E; van Vollenhoven R
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2014;73:1139

  CLINICALLY "SILENT" SYNOVITIS: DETECTED BY FLUORESCENCE OPTICAL IMAGING OF THE HANDS & WRISTS

  Kisten Y; Gyori N; Rezaei H; Karlsson A; Romanus C; af Kint E; van Vollenhoven R
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2014;73:259-260

  SERUM SURVIVIN IN EARLY RHEUMATOID ARTHRITIS - RESULTS FROM THE SWEFOT TRIAL

  Levitsky A; Erlandsson M; Bokarewa M; van Vollenhoven RF
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2014;73:829-830

  EFFECT OF MPGES-1 TARGETING ON LIPID METABOLISM IN HUMAN CELLS

  Korotkova M; Idborg H; Raouf J; Ossipova E; Checa A; Olsson P; Leclerc P; Oliynyk G; Wheelock C; Jakobsson P-J
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2014;73:366

  BLYS AND APRIL IN LUPUS NEPHRITIS: CORRELATIONS WITH SEROLOGY - BLYS AS A NON-INVASIVE PREDICTOR OF RESPONSE

  Parodis I; Zickert A; Axelsson M; Svenungsson E; Malmstrom V; Gunnarsson I
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2014;73:968

  DECREASED SLE DISEASE ACTIVITY AND CORTICOSTEROID USAGE AND NO RENAL FLARES DURING BELIMUMAB TREATMENT

  Parodis I; Svenungsson E; Axelsson M; Gunnarsson I
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2014;73:363

  INTERFERON (IFN)-LAMBDA1/3, BUT NOT IFN-ALPHA, IS A MARKER OF POOR RESPONSE TO TREATMENT IN LUPUS NEPHRITIS

  Zickert A; Oke V; Parodis I; Svenungsson E; Gunnarsson I
• Thesis / dissertation: 2014

  Biological therapy in rheumatoid arthritis : epidemiological studies

  Chatzidionysiou, Katerina
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2014;73(5):913-920

  Anakinra treatment in patients with refractory inflammatory myopathies and possible predictive response biomarkers: a mechanistic study with 12 months follow-up

  Zong M; Dorph C; Dastmalchi M; Alexanderson H; Pieper J; Amoudruz P; Helmers SB; Nennesmo I; Malmstrom V; Lundberg IE
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2014;32(3):390-394

  Dose reduction of tocilizumab in rheumatoid arthritis patients with low disease activity

  van Herwaarden N; Herfkens-Hol S; van der Maas A; van den Bemt BJF; van Vollenhoven RF; Bijlsma JWJ; den Broeder AA
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2014;32(3):315-323

  The early clinical course of infliximab treatment in rheumatoid arthritis: results from the REMARK observational study

  Westhovens R; van Vollenhoven RF; Boumpas DT; Brzosko M; Svensson K; Bjorneboe O; Meeuwisse CM; Srinivasan S; Gaudin P; Smolen JS; Rahman MU; Nelissen RL; Vastesaeger N
• Review: NATURE REVIEWS. RHEUMATOLOGY. 2014;10(5):295-303

  The skeletal muscle arachidonic acid cascade in health and inflammatory disease

  Korotkova M; Lundberg IE
• Article: JOURNAL OF RHEUMATOLOGY. 2014;41(5):875-880

  American College of Rheumatology Criteria at Inception, and Accrual over 5 Years in the SLICC Inception Cohort

  Urowitz MB; Gladman DD; Ibanez D; Sanchez-Guerrero J; Romero-Diaz J; Gordon C; Bae S-C; Clarke AE; Bernatsky S; Fortin PR; Hanly JG; Isenberg D; Rahman A; Wallace DJ; Ginzler E; Petri M; Bruce IN; Merrill JT; Nived O; Sturfelt G; Dooley MA; Alarcon GS; Fessler B; Steinsson K; Ramsey-Goldman R; Zoma A; Khamashta M; Manzi S; van Vollenhoven R; Ramos-Casals M; Aranow C; Stoll T
• Article: JOURNAL OF DIABETES. 2014;6(3):267-270

  Obesity phenotypes and subclinical cardiovascular diseases in a mixed-ancestry South African population: A cross-sectional study

  Matsha TE; Hartnick MD; Kisten Y; Eramus RT; Kengne AP
• Review: NATURE REVIEWS. RHEUMATOLOGY. 2014;10(4):229-241

  Persisting eicosanoid pathways in rheumatic diseases

  Korotkova M; Jakobsson P-J
• Article: REUMATISMO. 2014;65(6):298-301

  A false occult hepatitis B virus infection developed in a patient with psoriatic arthritis under infliximab and methotrexate therapy.

  Notarnicola A; Iannone F; Lopalco G; Covelli M; Lapadula G
• Review: RHEUMATOLOGY. 2014;53(3):397-405

  Immune mechanisms in polymyositis and dermatomyositis and potential targets for therapy

  Venalis P; Lundberg IE
• Article: JOURNAL OF RHEUMATOLOGY. 2014;41(3):581-592

  Patient-reported Outcomes and Adult Patients' Disease Experience in the Idiopathic Inflammatory Myopathies. Report from the OMERACT 11 Myositis Special Interest Group

  Alexanderson H; Del Grande M; Bingham COIII; Orbai A-M; Sarver C; Clegg-Smith K; Lundberg IE; Song YW; Christopher-Stine L
• Article: LUPUS. 2014;23(3):299-304

  Mycophenolate mofetil in the treatment of SLE and systemic vasculitis: experience at a single university center

  Lourdudoss C; van Vollenhoven R
• Article: TRAVEL MEDICINE AND INFECTIOUS DISEASE. 2014;12(2):134-142

  Hepatitis A vaccine for immunosuppressed patients with rheumatoid arthritis: A prospective, open-label, multi-centre study

  Askling HH; Rombo L; van Vollenhoven R; Hallen I; Thorner A; Nordin M; Herzog C; Kantele A
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2014;73:A94

  EFFECT OF MPGES-1 TARGETING ON LIPID METABOLISM IN HUMAN CELLS

  Idborg H; Raouf J; Ossipova E; Checa A; Olsson P; Leclerc P; Oliynik G; Wheelock C; Jakobsson P-J; Korotkova M
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2014;73:A53

  SCREENING OF SPHINGOLIPIDS IN SLE - BEFORE AND AFTER TREATMENT

  Idborg H; Checa A; Sar D; Jakobsson P-J; Wheelock C; Gunnarsson I
• Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2014;111(8):3068-3073

  JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation

  Lu B; Antoine DJ; Kwan K; Lundback P; Wahamaa H; Schierbeck H; Robinson M; Van Zoelen MAD; Yang H; Li J; Erlandsson-Harris H; Chavan SS; Wang H; Andersson U; Tracey KJ
• Article: BMC RESEARCH NOTES. 2014;7:86

  Intensive aerobic and muscle endurance exercise in patients with systemic sclerosis: a pilot study.

  Alexanderson H; Bergegård J; Björnådal L; Nordin A
• Editorial comment: BMC MEDICINE. 2014;12:25

  Early start and stop of biologics: has the time come?

  van Vollenhoven RF; Nagy G; Tak PP
• Letter: ARTHRITIS & RHEUMATOLOGY. 2014;66(2):480

  Relevance of different results of different anti-double-stranded DNA assays in reporting clinical studies: comment on the article by Petri et al Reply

  Petri MA; van Vollenhoven RF; Buyon J; Levy RA; Navarra SV; Cervera R; Zhong ZJ; Freimuth WW
• Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2014;79(2):149-155

  Peripheral and Site-Specific CD4⁺CD28^null T Cells from Rheumatoid Arthritis Patients Show Distinct Characteristics

  Pieper J; Johansson S; Snir O; Linton L; Rieck M; Buckner JH; Winqvist O; van Vollenhoven R; Malmstrom V
• Article: THE LANCET. 2014;383(9914):321-332

  Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial

  Smolen JS; Emery P; Fleischmann R; van Vollenhoven RF; Pavelka K; Durez P; Guerette B; Kupper H; Redden L; Arora V; Kavanaugh A
• Review: F1000 PRIME REPORTS. 2014;6:31

  Advances in the treatment of rheumatoid arthritis.

  Vivar N; Van Vollenhoven RF
• Article: MEDIATORS OF INFLAMMATION. 2014;2014:620281-8

  No Signs of Inflammation during Knee Surgery with Ischemia: A Study Involving Inhaled Nitric Oxide

  Hallstrom L; Frostell C; Herrlin A; Lindroos E; Lundberg I; Soop A
• Article: PLOS ONE. 2014;9(11):e113924

  IgG Antibodies to Cyclic Citrullinated Peptides Exhibit Profiles Specific in Terms of IgG Subclasses, Fc-Glycans and a Fab-Peptide Sequence

  Lundstrom SL; Fernandes-Cerqueira C; Ytterberg AJ; Ossipova E; Hensvold AH; Jakobsson P-J; Malmstrom V; Catrina AI; Klareskog L; Lundberg K; Zubarev RA
• Article: PLOS ONE. 2014;9(8):e103683

  Synergistic Effects of Ethanol and Isopentenyl Pyrophosphate on Expansion of γδ T Cells in Synovial Fluid from Patients with Arthritis

  Laurent AJ; Bindslev N; Johansson B; Berg L
• Article: CURRENT RHEUMATOLOGY REPORTS. 2014;16(9):444

  Rituximab and Lupus - A Promising Pair?

  Eko SL; van Vollenhoven RF
• Article: DISABILITY AND REHABILITATION. 2014;36(21):1762-1767

  Disabilities of importance for patients to improve - using a patient preference tool in rheumatoid arthritis

  Munters LA; Brodin N; Fberg EL; Strat S; Alexanderson H
• Article: JOURNAL OF REHABILITATION MEDICINE. 2014;46(1):67-72

  ELEVATED EXPRESSION OF PROSTAGLANDIN E₂ SYNTHETIC PATHWAY IN SKELETAL MUSCLE OF PRIOR POLIO PATIENTS

  Melin E; Lindroos E; Lundberg IE; Borg K; Korotkova M
• Review: BASIC AND CLINICAL PHARMACOLOGY AND TOXICOLOGY. 2014;114(1):13-17

  Neutralization of AntiCitrullinated Protein Antibodies in Rheumatoid Arthritis - A Way to Go?

  Cerqueira CF; Klareskog L; Jakobsson P-J
• Article: LUPUS SCIENCE AND MEDICINE. 2014;1(1):e000028

  Editorial.

  Buyon J; van Vollenhoven R
• Article: LUPUS SCIENCE AND MEDICINE. 2014;1(1):e000033

  Lupus Science and Medicine: the Editors present highlights for the bedside and for the bench in the inaugural issue.

  Buyon J; van Vollenhoven R
• Article: PLOS ONE. 2014;9(5):e97285

  Targeting of the MYCN Protein with Small Molecule c-MYC Inhibitors

  Muller I; Larsson K; Frenzel A; Oliynyk G; Zirath H; Prochownik EV; Westwood NJ; Henriksson MA
• Article: PLOS ONE. 2014;9(2):e87951

  Differentially Expressed Proteins in Malignant and Benign Adrenocortical Tumors

  Kjellin H; Johansson H; Hoog A; Lehtio J; Jakobsson P-J; Kjellman M
• Review: BASIC AND CLINICAL PHARMACOLOGY AND TOXICOLOGY. 2014;114(1):64-69

  Characterization of Microsomal Prostaglandin E Synthase 1 Inhibitors

  Korotkova M; Jakobsson P-J
• Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2014;43:16-17

  Subclinical synovitis of the hands and wrists detected by fluorescence optical imaging and ultrasound

  Kisten Y; Gyori N; Rezaei H; Karlsson A; af Klint E; van Vollenhoven R
• Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2014;43:15

  Diagnostic utility of musculoskeletal ultrasound in patients with suspected arthritis: a probabilistic approach

  Rezaei H; Torp-Pedersen S; af Klint E; Kisten Y; Gyori N; van Vollenhoven RF
• Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2014;43:13

  The diagnostic utility of hand and wrist fluorescence optical imaging in evaluating active synovitis

  Kisten Y; Gyori N; Rezaei H; Karlsson A; af Klint E; van Vollenhoven R
• Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2014;43:95

  Proteomics and metabolomics in the classification of SLE subsets

  Jakobsson P-J; Svenungsson E; Idborg H; Nilsson P; Wheelock C; Gunnarsson I; Trygg J; Lehtio J; Koistinen IS
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2014;66:S930

  The Utility of Digital Activity Fluorescence Optical Imaging in Quantifying Hand and Wrist Inflammation in Rheumatic Diseases.

  Kisten Y; Gyori N; Rezaei H; Levitsky A; Karlsson A; af Klint E; van Vollenhoven R
• Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2014;43:34-35

  Kaltenborn's manual mobilization method for pain relief in RA hand joints: clinical and ultrasound findings in a pilot study

  Lind S; Nordstrom P; Kisten Y; Levitsky A; Vivar N; van Vollenhoven R
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2014;66:S1099

  Serum Survivin in Early Rheumatoid Arthritis

  Levitsky A; Erlandsson M; Bokarewa M; van Vollenhoven RF
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2014;66:S292

  Decreased Disease Activity and Corticosteroid Usage and No Renal Flares during Belimumab Treatment in Patients with Systemic Lupus Erythematosus

  Parodis I; Svenungsson E; Axelsson M; Gunnarsson I
• Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2014;43:90-91

  Decreased disease activity and corticosteroid usage and no renal flares during belimumab treatment in patients with systemic lupus erythematosus

  Parodis I; Svenungsson E; Axelsson M; Gunnarsson I
• Conference publication: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2014;43:10

  Interferon (IFN)-λ1/3, but not IFN-α, is a marker of poor response to treatment in lupus nephritis

  Zickert A; Oke V; Parodis I; Svenungsson E; Gunnarsson I
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2013;72(12):1927-1933

  Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial

  Karlsson JA; Neovius M; Nilsson J-A; Petersson IF; Bratt J; van Vollenhoven RF; Ernestam S; Geborek P
• Article: EUROPEAN JOURNAL OF HEALTH ECONOMICS. 2013;14(6):863-873

  The cost-effectiveness of TNF-inhibitors for the treatment of rheumatoid arthritis in Swedish clinical practice

  Lekander I; Borgstrom F; Lysholm J; van Vollenhoven RF; Lindblad S; Geborek P; Kobelt G
• Article: PROSTAGLANDINS AND OTHER LIPID MEDIATORS. 2013;107:26-34

  Characterization of a human and murine mPGES-1 inhibitor and comparison to mPGES-1 genetic deletion in mouse models of inflammation

  Leclerc P; Idborg H; Spahiu L; Larsson C; Nekhotiaeva N; Wannberg J; Stenberg P; Korotkova M; Jakobsson P-J
• Article: PROSTAGLANDINS AND OTHER LIPID MEDIATORS. 2013;107:18-25

  Effects of mPGES-1 deletion on eicosanoid and fatty acid profiles in mice

  Idborg H; Olsson P; Leclerc P; Raouf J; Jakobsson P-J; Korotkova M
• Article: ARTHRITIS & RHEUMATOLOGY. 2013;65(12):3239-3247

  Genome-Wide Association Study of Dermatomyositis Reveals Genetic Overlap With Other Autoimmune Disorders

  Miller FW; Cooper RG; Vencovsky J; Rider LG; Danko K; Wedderburn LR; Lundberg IE; Pachman LM; Reed AM; Ytterberg SR; Padyukov L; Selva-O'Callaghan A; Radstake TRDJ; Isenberg DA; Chinoy H; Ollier WER; O'Hanlon TP; Peng B; Lee A; Lamb JA; Chen W; Amos CI; Gregersen PK
• Article: ARTHRITIS CARE AND RESEARCH. 2013;65(12):1959-1968

  Improvement in Health and Possible Reduction in Disease Activity Using Endurance Exercise in Patients With Established Polymyositis and Dermatomyositis: A Multicenter Randomized Controlled Trial With a 1-Year Open Extension Followup

  Munters LA; Dastmalchi M; Andgren V; Emilson C; Bergegard J; Regardt M; Johansson A; Tholander IO; Hanna B; Liden M; Esbjornsson M; Alexanderson H
• Journal article: DIABETES RESEARCH AND CLINICAL PRACTICE. 2013;102(3):233-241

  Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for end-stage renal disease/mortality in type 2 diabetes.

  Campbell HM; Khan N; Raisch DW; Borrego ME; Sather MR; Murata GH
• Review: CURRENT OPINION IN RHEUMATOLOGY. 2013;25(6):729-734

  Registries in idiopathic inflammatory myopathies

  Lundberg IE; Svensson J
• Article: ARTHRITIS & RHEUMATOLOGY. 2013;65(11):2887-2897

  Headache in Systemic Lupus Erythematosus Results From a Prospective, International Inception Cohort Study

  Hanly JG; Urowitz MB; O'Keeffe AG; Gordon C; Bae S-C; Sanchez-Guerrero J; Romero-Diaz J; Clarke AE; Bernatsky S; Wallace DJ; Ginzler EM; Isenberg DA; Rahman A; Merrill JT; Petri M; Fortin PR; Gladman DD; Fessler BJ; Alarcon GS; Bruce IN; Dooley MA; Steinsson K; Khamashta MA; Ramsey-Goldman R; Manzi S; Sturfelt GK; Nived O; Zoma AA; van Vollenhoven RF; Ramos-Casals M; Aranow C; Mackay M; Ruiz-Irastorza G; Kalunian KC; Lim SS; Inanc M; Kamen DL; Peschken CA; Jacobsen S; Theriault C; Thompson K; Farewell V
• Article: NEUROMUSCULAR DISORDERS. 2013;23(11):945-951

  193rd ENMC International workshop Pathology diagnosis of idiopathic inflammatory myopathies 30 November 2 December 2012, Naarden, The Netherlands

  De Bleecker JL; Lundberg IE; de Visser M
• Article: BMC MUSCULOSKELETAL DISORDERS. 2013;14:299

  Dose REduction strategy of subcutaneous TNF inhibitors in rheumatoid arthritis: design of a pragmatic randomised non inferiority trial, the DRESS study

  den Broeder AA; van Herwaarden N; van der Maas A; van den Hoogen FHJ; Bijlsma JW; van Vollenhoven RF; van den Bemt BJF
• Article: LUPUS. 2013;22(11):1118-1127

  Health-related quality of life, fatigue and mood in patients with SLE and high levels of pain compared to controls and patients with low levels of pain

  Waldheim E; Elkan A-C; Pettersson S; van Vollenhoven R; Bergman S; Frostegard J; Henriksson EW
• Article: ARTHRITIS & RHEUMATOLOGY. 2013;65(10):2661-2671

  Phase I, Randomized, Double-Blind, Placebo-Controlled, Multiple Intravenous, Dose-Ascending Study of Sirukumab in Cutaneous or Systemic Lupus Erythematosus

  Szepietowski JC; Nilganuwong S; Wozniacka A; Kuhn A; Nyberg F; van Vollenhoven RF; Bengtsson AA; Reich A; de Vries DE; van Hartingsveldt B; Robinson DWJ; Gordon R; Hsu B
• Article: PROSTAGLANDINS AND OTHER LIPID MEDIATORS. 2013;106:99-105

  Genetic deletion of microsomal prostaglandin E synthase-1 suppresses mouse mammary tumor growth and angiogenesis

  Howe LR; Subbaramaiah K; Kent CV; Zhou XK; Chang S-H; Hla T; Jakobsson P-J; Hudis CA; Dannenberg AJ
• Letter: NEW ENGLAND JOURNAL OF MEDICINE. 2013;369(12):1174

  Case 16-2013: A Girl with Irritability, Hypersomnia, and Somatic Symptoms

  van Vollenhoven RF
• Review: CURRENT OPINION IN RHEUMATOLOGY. 2013;25(5):606-615

  Challenges and opportunities in SLE clinical trials

  van Vollenhoven RF
• Editorial comment: ANNALS OF THE RHEUMATIC DISEASES. 2013;72(9):1433-1435

  Novel targeted therapies: the future of rheumatoid arthritis? Mavrilumab and tabalumab as examples

  Combe B; van Vollenhoven R
• Editorial comment: NATURE REVIEWS. RHEUMATOLOGY. 2013;9(9):510-512

  RHEUMATOID ARTHRITIS Triple therapy or etanercept after methotrexate failure in RA?

  van Vollenhoven RF; Chatzidionysiou K
• Article: ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY. 2013;33(9):2193-2201

  NOD2-Mediated Innate Immune Signaling Regulates the Eicosanoids in Atherosclerosis

  Liu H-Q; Zhang X-Y; Edfeldt K; Nijhuis MO; Idborg H; Back M; Roy J; Hedin U; Jakobsson P-J; Laman JD; de Kleijn DP; Pasterkamp G; Hansson GK; Yan Z-Q
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2013;72(9):1496-1502

  Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients

  van Vollenhoven RF; Emery P; Bingham COIII; Keystone EC; Fleischmann RM; Furst DE; Tyson N; Collinson N; Lehane PB
• Journal article: BRAIN, BEHAVIOR, AND IMMUNITY. 2013;32:e31

  108. Self-rated health is associated with fatigue, but not inflammatory cytokines or fraction of exhaled nitric oxide in men and women with allergic asthma

  Lodin K; Syk J; Undén A; Alving K; Lekander M; Andreasson AN
• Journal article: BRAIN, BEHAVIOR, AND IMMUNITY. 2013;32:e14

  49. Development and preliminary validation of the Sickness Questionnaire (SicknessQ)

  Andreasson AN; Wicksell R; Karshikoff B; Lodin K; Axelsson J; Höglund CO; Lekander M
• Article: ARTHRITIS RESEARCH & THERAPY. 2013;15(4):R83

  Improved exercise performance and increased aerobic capacity after endurance training of patients with stable polymyositis and dermatomyositis

  Munters LA; Dastmalchi M; Katz A; Esbjornsson M; Loell I; Hanna B; Liden M; Westerblad H; Lundberg IE; Alexanderson H
• Article: JAMA INTERNAL MEDICINE. 2013;173(15):1407-1414

  Biological vs Conventional Combination Treatment and Work Loss in Early Rheumatoid Arthritis A Randomized Trial

  Eriksson JK; Neovius M; Bratt J; Petersson IF; van Vollenhoven RF; Geborek P; Ernestam S
• Article: BMC IMMUNOLOGY. 2013;14:34

  CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients

  Pieper J; Herrath J; Raghavan S; Muhammad K; van Vollenhoven R; Malmstrm V
• Article: DISABILITY AND REHABILITATION. 2013;35(16):1350-1356

  Higher pain sensitivity and lower muscle strength in postmenonpausal women with early rheumatoid arthritis compared with age-matched healthy women - a pilot study

  Friden C; Thoors U; Glenmark B; Kosek E; Nordmark B; Lundberg IE; Opava CH
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2013;72(8):1390-1399

  TLR4 as receptor for HMGB1 induced muscle dysfunction in myositis

  Zong M; Bruton JD; Grundtman C; Yang H; Li JH; Alexanderson H; Palmblad K; Andersson U; Harris HE; Lundberg IE; Westerblad H
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2013;72(8):1308-1314

  Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort

  Parker B; Urowitz MB; Gladman DD; Lunt M; Bae S-C; Sanchez-Guerrero J; Romero-Diaz J; Gordon C; Wallace DJ; Clarke AE; Bernatsky S; Ginzler EM; Isenberg DA; Rahman A; Merrill JT; Alarcon GS; Fessler BJ; Fortin PR; Hanly JG; Petri M; Steinsson K; Dooley M-A; Manzi S; Khamashta MA; Ramsey-Goldman R; Zoma AA; Sturfelt GK; Nived O; Aranow C; Mackay M; Ramos-Casals M; van Vollenhoven RF; Kalunian KC; Ruiz-Irastorza G; Lim S; Kamen DL; Peschken CA; Inanc M; Bruce IN
• Article: ARTHRITIS & RHEUMATOLOGY. 2013;65(8):2143-2153

  Baseline Predictors of Systemic Lupus Erythematosus Flares: Data From the Combined Placebo Groups in the Phase III Belimumab Trials

  Petri MA; van Vollenhoven RF; Buyon J; Levy RA; Navarra SV; Cervera R; Zhong ZJ; Freimuth WW
• Journal article: AFRICAN JOURNAL OF PRIMARY HEALTH CARE & FAMILY MEDICINE. 2013;5(1):414

  Duplex ultrasound: A diagnostic tool for carotid stenosis management in type 2 diabetes mellitus

  Kisten Y; Govender P; Naidoo NG; Gihwala D; Isaacs F
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2013;31(4):S82-S85

  New drugs in systemic lupus erythematosus: when to start and when to stop

  Mosca M; van Vollenhoven R
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2013;72(7):1156-1162

  Association of joint space narrowing with impairment of physical function and work ability in patients with early rheumatoid arthritis: protection beyond disease control by adalimumab plus methotrexate

  Smolen JS; van der Heijde DM; Keystone EC; van Vollenhoven RF; Goldring MB; Guerette B; Cifaldi MA; Chen N; Liu S; Landewe RBM
• Article: LUPUS. 2013;22(8):793-801

  Drivers of cost and health-related quality of life in patients with systemic lupus erythematosus (SLE): a Swedish nationwide study based on patient reports

  Bexelius C; Wachtmeister K; Skare P; Jonsson L; van Vollenhoven R
• Article: LUPUS. 2013;22(8):819-826

  Limitations of current treatments for systemic lupus erythematosus: a patient and physician survey

  Strand V; Galateanu C; Pushparajah DS; Nikai E; Sayers J; Wood R; van Vollenhoven RF
• Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2013;110(25):10258-10263

  MYC inhibition induces metabolic changes leading to accumulation of lipid droplets in tumor cells

  Zirath H; Frenzel A; Oliynyk G; Segerstrom L; Westermark UK; Larsson K; Persson MM; Hultenby K; Lehtio J; Einvik C; Pahlman S; Kogner P; Jakobsson P-J; Henriksson MA
• Article: JOURNAL OF PROTEOME RESEARCH. 2013;12(6):2622-2629

  Mass Spectrometry-Based Proteomics Identifies UPF1 as a Critical Gene Expression Regulator in MonoMac 6 Cells

  Ochs MJ; Ossipova E; Oliynyk G; Steinhilber D; Suess B; Jakobsson P-J
• Article: JOURNAL OF RHEUMATOLOGY. 2013;40(6):768-780

  Longterm Safety and Efficacy of Tocilizumab in Patients with Rheumatoid Arthritis: A Cumulative Analysis of Up to 4.6 Years of Exposure

  Genovese MC; Rubbert-Roth A; Smolen JS; Kremer J; Khraishi M; Gomez-Reino J; Sebba A; Pilson R; Williams S; Van Vollenhoven R
• Article: BEST PRACTICE AND RESEARCH: CLINICAL RHEUMATOLOGY. 2013;27(3):341-349

  Biologics in SLE: Towards new approaches

  van Vollenhoven RF; Parodis I; Levitsky A
• Article: ARTHRITIS CARE AND RESEARCH. 2013;65(6):870-878

  Incidence of Rheumatoid Arthritis in Sweden: A Nationwide Population-Based Assessment of Incidence, Its Determinants, and Treatment Penetration

  Eriksson JK; Neovius M; Ernestam S; Lindblad S; Simard JF; Askling J
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2013;71:517-518

  TREATMENT WITH CERTOLIZUMAB PEGOL IN RA - DATA FROM THE NATIONAL REGISTRY ARTIS (ANTIRHEUMATIC THERAPIES IN SWEDEN)

  Chatzidionysiou K; van Vollenhoven R
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2013;71:315-316

  ROLE OF PROSTAGLANDINS IN THE INFLAMMATORY REFLEX: IMPAIRED VAGUS-MEDIATED IMMUNOSUPPRESSION IN MICE DEFICIENT IN MICROSOMAL PROSTAGLANDIN E SYNTHASE-1 (MPGES-1)

  Le Maitre E; Revathikumar P; Idborg H; Korotkova M; Jakobsson P-J; Lampa J
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2013;71:182

  SEROPOSITIVITY AND RESPONSE TO RTX: DATA FROM THE CERERRA COLLABORATION

  Chatzidionysiou K; Lie E; Nasonov E; Lukina G; Hetland M; Tarp U; Ancuta I; Pavelka K; Nordstrom D; Gabay C; Canhao H; Tomsic M; van Riel P; Gomez-Reino J; Kvien T; van Vollenhoven R
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2013;71:62

  EFFICACY OF DIFFERENT DOSES OF RITUXIMAB FOR THE TREATMENT OF RA: DATA FROM THE CERERRA COLLABORATION

  Chatzidionysiou K; Lie E; Nasonov E; Lukina G; Hetland M; Tarp U; Ancuta I; Pavelka K; Nordstrom D; Gabay C; Canhao H; Tomsic M; van Riel P; Gomez-Reino J; Kvien T; van Vollenhoven R
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2013;71:101

  MASKING CD94/NKG2A USING A NOVEL THERAPEUTIC MAB RESULTS IN SIGNIFICANT SUPPRESSION OF IL-6 LEVELS AND REDUCED OSTEOCLAST FORMATION IN RHEUMATOID ARTHRITIS EX VIVO CULTURES

  Soderstrom K; Sundstrom Y; Berg L; Schepis D; Galsgaard ED; Klareskog L; Wagtmann N
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2013;71:326

  HMGB-1 PROMOTES THE PGE2 BIOSYNTHESIS PATHWAY IN SYNOVIAL FIBROBLASTS

  Leclerc P; Wahamaa H; Idborg H; Jakobsson P-J
• Journal article: ANNALS OF THE RHEUMATIC DISEASES. 2013;71(Suppl 3):641

  AB0071 Characterization of NNC141-0100, a therapeutic antibody targeting inhibitory CD94/NKG2A receptors expressed in inflamed joints of rheumatoid arthritis patients

  Pascal V; Sundström Y; Fasth A; Malmström V; Berg L; Kvist PH; Spee P; Galsgaard ED
• Journal article: ANNALS OF THE RHEUMATIC DISEASES. 2013;72(Suppl 3):a798

  AB0042 Deletion of mpges-1 affects fatty acid composition and eicosanoid profiles in mice

  Idborg H; Olsson P; Leclerc P; Raouf J; Jakobsson P-J; Korotkova M
• Journal article: ANNALS OF THE RHEUMATIC DISEASES. 2013;72(Suppl 3):a466

  FRI0271 Stratification of sle patients for improved diagnosis and treatment

  Idborg H; Rännar S; Oliynyk G; Forshed J; Branca RM; Donten M; Bennett K; Gustafsson J; Vikerfors A; Elvin K; Truedsson L; Nilsson B; Gunnarsson I; Trygg J; Lehtiö J; Lundstedt T; Svenungsson E; Jakobsson P-J
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2013;71:532

  SYSTEMS BIOLOGY OF SLE: BIOCHEMICAL CHARACTERIZATION OF SUBGROUPS WITHIN SLE FOR IMPROVED DIAGNOSIS AND TREATMENT

  Idborg H; Oliynyk G; Rannar S; Forshed J; Branca RM; Donten M; Gustafsson J; Vikerfors A; Gunnarsson I; Trygg J; Lehtio J; Lundstedt T; Svenungsson E; Jakobsson P-J
• Journal article: ANNALS OF THE RHEUMATIC DISEASES. 2013;72(Suppl 3):a221

  THU0170 Predicted Versus Observed Radiographic Progression in a RA Randomized Trial

  Levitsky A; Forslind K; van Vollenhoven RF; group TST
• Journal article: ANNALS OF THE RHEUMATIC DISEASES. 2013;72(Suppl 3):a900-A901

  AB0371 State of the art for treating-to-target in sle: a systematic literature review

  Bertsias G; Mosca M; Levitsky A; Van Vollenhoven RF; party TTSW
• Article: THE LANCET. 2013;381(9877):1541-1550

  Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial

  Gabay C; Emery P; van Vollenhoven R; Dikranian A; Alten R; Pavelka K; Klearman M; Musselman D; Agarwal S; Green J; Kavanaugh A
• Review: CURRENT OPINION IN RHEUMATOLOGY. 2013;25(3):391-397

  Small molecular compounds in development for rheumatoid arthritis

  van Vollenhoven RF
• Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2013;77(5):350-360

  IL-1 β/HMGB1 Complexes Promote The PGE₂ Biosynthesis Pathway in Synovial Fibroblasts

  Leclerc P; Wahamaa H; Idborg H; Jakobsson PJ; Harris HE; Korotkova M
• Article: CARCINOGENESIS. 2013;34(5):1081-1088

  Low-dose aspirin delays an inflammatory tumor progression in vivo in a transgenic mouse model of neuroblastoma

  Carlson L-M; Rasmuson A; Idborg H; Segerstrom L; Jakobsson P-J; Sveinbjornsson B; Kogner P
• Article: RHEUMATOLOGY. 2013;52(5):847-855

  Long-term follow-up in lupus nephritis patients treated with rituximab-clinical and histopathological response

  Jonsdottir T; Zickert A; Sundelin B; Henriksson EW; van Vollenhoven RF; Gunnarsson I
• Journal article: КЛИНИЧЕСКАЯ ПРАКТИКА. 2013;10(3):233-236

  Latest developments in the treatment of rheumatoid arthritis: is there new hope for patients?

  Chatzidionysiou K; van Vollenhoven R
• Journal article: CANCER RESEARCH. 2013;73(8_Supplement):2746

  Abstract 2746: Microsomal prostaglandin E2 synthase-1 may provide a novel specific therapeutic target in neuroblastoma.

  Kock A; Rasmuson A; Korotkova M; Idborg H; Johnsen JI; Jakobsson P-J; Kogner P
• Editorial comment: LUPUS. 2013;22(4):341

  B-cell-directed therapies in systemic lupus erythematosus - where do we stand? FOREWORD

  van Vollenhoven RF
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2013;72(4):512-516

  Low serum levels of vitamin D in idiopathic inflammatory myopathies

  Azali P; Helmers SB; Kockum I; Olsson T; Alfredsson L; Charles PJ; Aulin KP; Lundberg IE
• Article: PROSTAGLANDINS AND OTHER LIPID MEDIATORS. 2013;102:1-12

  Characterization of a new mPGES-1 inhibitor in rat models of inflammation

  Leclerc P; Pawelzik S-C; Idborg H; Spahiu L; Larsson C; Stenberg P; Korotkova M; Jakobsson P-J
• Article: LUPUS. 2013;22(4):372-380

  Belimumab for systemic lupus erythematosus: a practice-based view

  Parodis I; Axelsson M; Gunnarsson I
• Article: ARTHRITIS & RHEUMATOLOGY. 2013;65(4):899-910

  Multiplex Analyses of Antibodies Against Citrullinated Peptides in Individuals Prior to Development of Rheumatoid Arthritis

  Brink M; Hansson M; Mathsson L; Jakobsson P-J; Holmdahl R; Hallmans G; Stenlund H; Ronnelid J; Klareskog L; Rantapaa-Dahlqvist S
• Conference publication: PRESSE MEDICALE. 2013;42(4):712

  GPA and MPA patients have different serum cytokine profiles

  Avik A; Sundstrom Y; Berg L; Bruchfeld A; Malmstrom V; Gunnarsson I
• Article: BMC MUSCULOSKELETAL DISORDERS. 2013;14:79

  Evaluation of hand bone loss by digital X-ray radiogrammetry as a complement to clinical and radiographic assessment in early rheumatoid arthritis: results from the SWEFOT trial

  Rezaei H; Saevarsdottir S; Geborek P; Petersson IF; van Vollenhoven RF; Forslind K
• Article: VALUE IN HEALTH. 2013;16(2):251-258

  The Comparison of Trial Data-Based and Registry Data-Based Cost-Effectiveness of Infliximab Treatment for Rheumatoid Arthritis in Sweden Using a Modeling Approach

  Lekander I; Kobelt G; Svarvar P; Ljung T; van Vollenhoven R; Borgstrom F
• Article: ANNALS OF NEUROLOGY. 2013;73(3):397-407

  Autoantibodies to cytosolic 5′-nucleotidase 1A in inclusion body myositis

  Pluk H; van Hoeve BJA; van Dooren SHJ; Stammen-Vogelzangs J; van der Heijden A; Schelhaas HJ; Verbeek MM; Badrising UA; Arnardottir S; Gheorghe K; Lundberg IE; Boelens WC; van Engelen BG; Pruijn GJM
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2013;72:A80

  STRATIFICATION OF SLE PATIENTS FOR IMPROVED DIAGNOSIS AND TREATMENT

  Idborg H; Rannar S; Oliynyk G; Forshed J; Branca RM; Donten M; Bennett K; Gustafsson J; Vikerfors A; Truedsson L; Nilsson B; Gunnarsson I; Trygg J; Lehtio J; Lundstedt T; Svenungsson E; Jakobsson P-J
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2013;72:A76

  CHARACTERISATION OF A NEW MPGES-1 INHIBITOR IN HUMAN AND MURINE MODELS OF INFLAMMATION

  Leclerc P; Idborg H; Stenberg P; Korotkova M; Jakobsson P-J
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2013;72:A65

  DELETION OF mPGES-1 AFFECTS FATTY ACID COMPOSITION AND EICOSANOID PROFILES IN MICE

  Idborg H; Olsson P; Leclerc P; Raouf J; Jakobsson P-J; Korotkova M
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2013;72:A34

  DISAPPEARANCE AND REAPPEARANCE OF IGG, IGA AND IGM AUTOANTIBODY ISOTYPES AND IMMUNE COMPLEXES IN RITUXIMAB-TREATED SLE PATIENTS

  Persson B; McAree F; Muller M; Trollmo T; Parodis I; Jonsdottir T; Malmstrom V; Gunnarsson I; Ronnelid J
• Article: LUPUS. 2013;22(2):144-154

  Safety profile of belimumab: pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosus

  Wallace DJ; Navarra S; Petri MA; Gallacher A; Thomas M; Furie R; Levy RA; van Vollenhoven RF; Cooper S; Zhong ZJ; Freimuth W; Cervera R
• Article: LUPUS. 2013;22(2):136-143

  Extent and characteristics of self-reported pain in patients with systemic lupus erythematosus

  Waldheim E; Elkan A-C; Bergman S; Frostegard J; van Vollenhoven R; Henriksson EW
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2013;72(2):293-299

  Activated LTB4 pathway in muscle tissue of patients with polymyositis or dermatomyositis

  Loell I; Munters LA; Pandya J; Zong M; Alexanderson H; Fasth AE; Hallengren CS; Radmark O; Lundberg IE; Jakobsson P-J; Korotkova M
• Editorial comment: NATURE REVIEWS. RHEUMATOLOGY. 2013;9(2):70-72

  Progress in RA genetics, pathology and therapy

  van Vollenhoven RF
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2013;42(3):190-195

  Rituximab versus anti-TNF in patients who previously failed one TNF inhibitor in an observational cohort

  Chatzidionysiou K; van Vollenhoven RF
• Article: ARTHRITIS RESEARCH & THERAPY. 2013;15(6):R205

  Synovial membrane immunohistology in early-untreated rheumatoid arthritis reveals high expression of catabolic bone markers that is modulated by methotrexate

  Revu S; Neregard P; af Klint E; Korotkova M; Catrina AI
• Article: JOURNAL OF BIOMOLECULAR STRUCTURE AND DYNAMICS. 2013;31(1):87-95

  Dynamic clustering of lipids in hydrated two-component membranes: results of computer modeling and putative biological impact

  Pyrkova DV; Tarasova NK; Krylov NA; Nolde DE; Pentkovsky VM; Efremov RG
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2013;65:S839

  The Utility Of Fluorescence Optical Imaging For Detecting Clinically Silent Synovitis Of The Hands and Wrists

  Kisten Y; Gyori N; Rezaei H; Karlsson A; Romanus C; van Vollenhoven R; af Klint E
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2013;65:S835-S836

  The Diagnostic Utility Of Musculoskeletal Ultrasound In Early Arthritis - a Probabilistic (Bayesian) Approach

  Rezaei H; af Klint E; Kisten Y; van Vollenhoven RF
• Conference publication: NEUROPSYCHOPHARMACOLOGY. 2013;38:S366-S367

  Reduced p11 in Blood Cells Predicts Antidepressant Response to Citalopram

  Svenningsson P; Berg L; Matthews D; Malinger A; Toups M; Trivedi M; Zarate CA; Greengard P
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2013;65:S236-S237

  Evidence For Involvement Of C5a Receptor in Human and Murine Lupus Nephritis

  Hess C; Tornehave D; Kvist PH; Sundstrom Y; Berg L; Gunnarsson I; Jacobsen S; Haase C; Hornum L
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2013;72:900-901

  STATE OF THE ART FOR TREATING-TO-TARGET IN SLE: A SYSTEMATIC LITERATURE REVIEW

  Bertsias G; Mosca M; Levitsky A; Van Vollenhoven RF
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2013;72:221

  PREDICTED VERSUS OBSERVED RADIOGRAPHIC PROGRESSION IN A RA RANDOMIZED TRIAL

  Levitsky A; Forslind K; van Vollenhoven RF
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2013;65:S564

  Predicted Versus Observed Radiographic Progression In a Rheumatoid Arthritis Randomized Trial.

  Levitsky A; Forslind K; van Vollenhoven RF
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2013;72:798

  DELETION OF MPGES-1 AFFECTS FATTY ACID COMPOSITION AND EICOSANOID PROFILES IN MICE

  Idborg H; Olsson P; Leclerc P; Raouf J; Jakobsson P-J; Korotkova M
• Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2013;72:466

  STRATIFICATION OF SLE PATIENTS FOR IMPROVED DIAGNOSIS AND TREATMENT

  Idborg H; Rannar S; Oliynyk G; Forshed J; Branca RM; Donten M; Bennett K; Gustafsson J; Vikerfors A; Elvin K; Truedsson L; Nilsson B; Gunnarsson I; Trygg J; Lehtio J; Lundstedt T; Svenungsson E; Jakobsson P-J
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 2013;65:S1197

  B-Lymphocyte Stimulator and A Proliferation Inducing Ligand In Lupus Nephritis: Low Serum Levels Of BLyS Predict Treatment Response

  Parodis I; Zickert A; Svenungsson E; Malmstrom V; Gunnarsson I
• Article: RHEUMATOLOGY. 2012;51(12):2204-2214

  Efficacy and safety of certolizumab pegol in a broad population of patients with active rheumatoid arthritis: results from the REALISTIC phase IIIb study

  Weinblatt ME; Fleischmann R; Huizinga TWJ; Emery P; Pope J; Massarotti EM; van Vollenhoven RF; Wollenhaupt J; Bingham COIII; Duncan B; Goel N; Davies OR; Dougados M
• Article: LAKARTIDNINGEN. 2012;109(47):2159-2161

  [Value-based health care--strategy for efficient Swedish health care. Care should be organized based on what gives value to the patient].

  Höglund PJ; Essén A; Choi S; Ernestam S; Kaarme J; Neovius M
• Article: PEDIATRIC RESEARCH. 2012;72(5):460-467

  mPGES-1 and prostaglandin E₂: vital role in inflammation, hypoxic response, and survival

  Siljehav V; Hofstetter AO; Jakobsson P-J; Herlenius E
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2012;71(11):1865-1867

  Incidence of progressive multifocal leukoencephalopathy in patients with rheumatoid arthritis: a national population-based study

  Arkema EV; van Vollenhoven RF; Askling J
• Article: JOURNAL OF RHEUMATOLOGY. 2012;39(11):2134-2141

  The Myositis Activities Profile - Initial Validation for Assessment of Polymyositis/Dermatomyositis in the USA

  Alexanderson H; Reed AM; Ytterberg SR
• Review: ANNALS OF THE RHEUMATIC DISEASES. 2012;71(11):1771-1782

  Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis

  Bertsias GK; Tektonidou M; Amoura Z; Aringer M; Bajema I; Berden JHM; Boletis J; Cervera R; Doerner T; Doria A; Ferrario F; Floege J; Houssiau FA; Ioannidis JPA; Isenberg DA; Kallenberg CGM; Lightstone L; Marks SD; Martini A; Moroni G; Neumann I; Praga M; Schneider M; Starra A; Tesar V; Vasconcelos C; van Vollenhoven RF; Zakharova H; Haubitz M; Gordon C; Jayne D; Boumpas DT
• Article: ARTHRITIS RESEARCH & THERAPY. 2012;14(5):R201

  Validation of a multiplex chip-based assay for the detection of autoantibodies against citrullinated peptides

  Hansson M; Mathsson L; Schlederer T; Israelsson L; Matsson P; Nogueira L; Jakobsson P-J; Lundberg K; Malmstrom V; Serre G; Holmdahl R; Nystrand M; Klareskog L; Ronnelid J
• Article: JOURNAL OF RHEUMATOLOGY. 2012;39(10):2008-2011

  Beneficial Effect of Interleukin 1 Inhibition with Anakinra in Adult-onset Still's Disease. An Open, Randomized, Multicenter Study

  Nordstrom D; Knight A; Luukkainen R; van Vollenhoven R; Rantalaiho V; Kajalainen A; Brun JG; Proven A; Ljung L; Kautiainen H; Pettersson T
• Article: RHEUMATOLOGY. 2012;51(9):1628-1638

  Sustained efficacy of certolizumab pegol added to methotrexate in the treatment of rheumatoid arthritis: 2-year results from the RAPID 1 trial

  Keystone EC; Combe B; Smolen J; Strand V; Goel N; van Vollenhoven R; Mease P; Landewe R; Fleischmann R; Luijtens K; van der Heijde D
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2012;71(9):1502-1509

  Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study

  Hanly JG; Urowitz MB; Su L; Gordon C; Bae S-C; Sanchez-Guerrero J; Romero-Diaz J; Wallace DJ; Clarke AE; Ginzler EM; Merrill JT; Isenberg DA; Rahman A; Petri M; Fortin PR; Gladman DD; Bruce IN; Steinsson K; Dooley MA; Khamashta MA; Alarcon GS; Fessler BJ; Ramsey-Goldman R; Manzi S; Zoma AA; Sturfelt GK; Nived O; Aranow C; Mackay M; Ramos-Casals M; van Vollenhoven RF; Kalunian KC; Ruiz-Irastorza G; Lim S; Kamen DL; Peschken CA; Inanc M; Theriault C; Thompson K; Farewell V
• Article: NEW ENGLAND JOURNAL OF MEDICINE. 2012;367(6):508-519

  Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis

  van Vollenhoven RF; Fleischmann R; Cohen S; Lee EB; Garcia Meijide JA; Wagner S; Forejtova S; Zwillich SH; Gruben D; Koncz T; Wallenstein GV; Krishnaswami S; Bradley JD; Wilkinson B
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2012;71(8):1343-1349

  Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response

  van Vollenhoven RF; Petri MA; Cervera R; Roth DA; Ji BN; Kleoudis CS; Zhong ZJ; Freimuth W
• Article: CYTOKINE. 2012;59(2):392-399

  Pregnancy-associated inflammatory markers are elevated in pregnant women with systemic lupus erythematosus

  Bjorkander S; Bremme K; Persson J-O; van Vollenhoven RF; Sverremark-Ekstrom E; Holmlund U
• Article: ARTHRITIS & RHEUMATOLOGY. 2012;64(8):2677-2686

  Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus

  Petri M; Orbai A-M; Alarcon GS; Gordon C; Merrill JT; Fortin PR; Bruce IN; Isenberg D; Wallace DJ; Nived O; Sturfelt G; Ramsey-Goldman R; Bae S-C; Hanly JG; Sanchez-Guerrero J; Clarke A; Aranow C; Manzi S; Urowitz M; Gladman D; Kalunian K; Costner M; Werth VP; Zoma A; Bernatsky S; Ruiz-Irastorza G; Khamashta MA; Jacobsen S; Buyon JP; Maddison P; Dooley MA; van vollenhoven RF; Ginzler E; Stoll T; Peschken C; Jorizzo JL; Callen JP; Lim SS; Fessler BJ; Inanc M; Kamen DL; Rahman A; Steinsson K; Franks AGJ; Sigler L; Hameed S; Fang H; Ngoc P; Brey R; Weisman MH; McGwin GJ; Magder LS
• Article: BMC MEDICINE. 2012;10:82

  Gender and the treatment of immune-mediated chronic inflammatory diseases: rheumatoid arthritis, inflammatory bowel disease and psoriasis: an observational study

  Lesuis N; Befrits R; Nyberg F; van Vollenhoven RF
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2012;30(4):S112-S115

  Treat-to-target in systemic lupus erythematosus: where are we today?

  Mosca M; Boumpas D; Bruce IN; Cervera R; Czirjak L; Doerner T; Houssiau F; Jacobsen S; Schneider M; Smolen JS; Voskuyl AE; van Vollenhoven RF
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2012;71(7):1203-1206

  Is there a sex bias in prescribing anti-tumour necrosis factor medications to patients with rheumatoid arthritis? A nation-wide cross-sectional study

  Arkema EV; Neovius M; Joelsson JK; Simard JF; van Vollenhoven RF
• Review: MEDICINE (UNITED KINGDOM). 2012;91(4):206-211

  Anti-PL-7 (Anti-Threonyl-tRNA Synthetase) Antisynthetase Syndrome Clinical Manifestations in a Series of Patients From a European Multicenter Study (EUMYONET) and Review of the Literature

  Labirua-Iturburu A; Selva-O'Callaghan A; Vincze M; Danko K; Vencovsky J; Fisher B; Charles P; Dastmalchi M; Lundberg IE
• Article: CIRCULATION. 2012;125(23):2904-2913

  Lack of Microsomal Prostaglandin E₂ Synthase-1 in Bone Marrow-Derived Myeloid Cells Impairs Left Ventricular Function and Increases Mortality After Acute Myocardial Infarction

  Degousee N; Simpson J; Fazel S; Scholich K; Angoulvant D; Angioni C; Schmidt H; Korotkova M; Stefanski E; Wang X-H; Lindsay TF; Ofek E; Pierre S; Butany J; Jakobsson P-J; Keating A; Li R-K; Nahrendorf M; Geisslinger G; Backx PH; Rubin BB
• Article: CURRENT RHEUMATOLOGY REPORTS. 2012;14(3):244-251

  Exercise in Inflammatory Myopathies, Including Inclusion Body Myositis

  Alexanderson H
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2012;71(6):1055-1063

  Effects of immunosuppressive treatment on interleukin-15 and interleukin-15 receptor α expression in muscle tissue of patients with polymyositis or dermatomyositis

  Zong M; Loell I; Lindroos E; Nader GA; Alexanderson H; Hallengren CS; Borg K; Arnardottir S; McInnes IB; Lundberg IE
• Review: AUTOIMMUNITY REVIEWS. 2012;11(8):563-567

  Rituximab - Shadow, illusion or light?

  van Vollenhoven RF
• Letter: JOURNAL OF RHEUMATOLOGY. 2012;39(6):1299-1303

  Progressive Multifocal Leukoencephalopathy in a Patient with Polymyositis: Case Report and Literature Review

  Dastmalchi M; Laki J; Lundberg IE; Iacobaeus E
• Article: JOURNAL OF INTERNAL MEDICINE. 2012;271(6):589-597

  KL-6: a serological biomarker for interstitial lung disease in patients with polymyositis and dermatomyositis

  Fathi M; Helmers SB; Lundberg IE
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2012;71(6):961-965

  Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study

  Chinoy H; Adimulam S; Marriage F; New P; Vincze M; Zilahi E; Kapitany A; Gyetvai A; Ekholm L; Novota P; Remakova M; Charles P; McHugh NJ; Padyukov L; Alfredsson L; Vencovsky J; Lundberg IE; Danko K; Ollier WE; Cooper RG
• Article: ARTHRITIS RESEARCH & THERAPY. 2012;14(3):R121

  Limited effect of anti-rheumatic treatment on 15-prostaglandin dehydrogenase in rheumatoid arthritis synovial tissue

  Gheorghe KR; Sadique S; Leclerc P; Idborg H; Wobst I; Catrina AI; Jakobsson P-J; Korotkova M
• Article: THE LANCET. 2012;379(9827):1712-1720

  Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial

  van Vollenhoven RF; Geborek P; Forslind K; Albertsson K; Ernestam S; Petersson IF; Chatzidionysiou K; Bratt J
• Review: ANNALS OF MEDICINE. 2012;44(3):225-232

  Biologicals for the treatment of systemic lupus erythematosus?

  Gunnarsson I; van Vollenhoven RF
• Article: ARTHRITIS & RHEUMATOLOGY. 2012;64(5):1579-1588

  Pharmacokinetics, tolerability, and preliminary efficacy of paquinimod (ABR-215757), a new quinoline-3-carboxamide derivative: Studies in lupus-prone mice and a multicenter, randomized, double-blind, placebo-controlled, repeat-dose, dose-ranging study in patients with systemic lupus erythematosus

  Bengtsson AA; Sturfelt G; Lood C; Ronnblom L; van Vollenhoven RF; Axelsson B; Sparre B; Tuvesson H; Ohman MW; Leanderson T
• Article: ARTHRITIS RESEARCH & THERAPY. 2012;14(3):R100

  Anti-type II collagen antibodies are associated with early radiographic destruction in rheumatoid arthritis

  Mullazehi M; Wick MC; Klareskog L; van Vollenhoven R; Ronnelid J
• Article: JOURNAL OF CLINICAL INVESTIGATION. 2012;122(5):1791-1802

  Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin

  Harre U; Georgess D; Bang H; Bozec A; Axmann R; Ossipova E; Jakobsson P-J; Baum W; Nimmerjahn F; Szarka E; Sarmay G; Krumbholz G; Neumann E; Toes R; Scherer H-U; Catrina AI; Klareskog L; Jurdic P; Schett G
• Conference publication: CANCER RESEARCH. 2012;72:1420

  Microsomal prostaglandin E2 synthase 1 (mPGES-1) is expressed in neuroblastoma and may represent a novel target for therapy

  Kock A; Rasmuson A; Idborg H; Johnsen JI; Kogner P
• Article: BIOCHEMISTRY. 2012;51(11):2348-2356

  Observation of Two Modes of Inhibition of Human Microsomal Prostaglandin E Synthase 1 by the Cyclopentenone 15-Deoxy-Δ^12,14-prostaglandin J₂

  Prage EB; Morgenstern R; Jakobsson P-J; Stec DF; Voehler MW; Armstrong RN
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2012;71(3):374-377

  Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration

  Chatzidionysiou K; Lie E; Nasonov E; Lukina G; Hetland ML; Tarp U; van Riel PLCM; Nordstrom DC; Gomez-Reino J; Pavelka K; Tomsic M; Kvien TK; van Vollenhoven RF; Gabay C
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2012;71(3):351-357

  Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE

  Tak PP; Rigby W; Rubbert-Roth A; Peterfy C; van Vollenhoven RF; Stohl W; Healy E; Hessey E; Reynard M; Shaw T
• Review: CURRENT OPINION IN RHEUMATOLOGY. 2012;24(2):201-207

  Exercise as a therapeutic modality in patients with idiopathic inflammatory myopathies

  Alexanderson H; Lundberg IE
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2012;71(2):186-191

  In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial

  Rezaei H; Saevarsdottir S; Forslind K; Albertsson K; Wallin H; Bratt J; Ernestam S; Geborek P; Petersson IF; van Vollenhoven RF
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2012;71:A77

  ROLE OF PROSTAGLANDINS IN THE INFLAMMATORY REFLEX: IMPAIRED VAGUS-MEDIATED IMMUNOSUPPRESSION IN MICE DEFICIENT IN MICROSOMAL PROSTAGLANDIN E SYNTHASE-1 (MPGES-1)

  Le Maitre E; Revathikumar P; Idborg H; Korotkova M; Jakobsson P-J; Lampa J
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2012;71:A14-U75

  EFFICACY OF TNF SWITCH AFTER FAILURE OF ONE TNF INHIBITOR - RESULTS FROM A NATION-WIDE OBSERVATIONAL STUDY

  Chatzidionysiou K; Eriksson J; Askling J; van Vollenhoven RF
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2012;71:a13-A14

  EFFICACY OF DIFFERENT DOSES OF RITUXIMAB FOR THE TREATMENT OF RA: DATA FROM THE CERERRA COLLABORATION

  Chatzidionysiou K; Lie E; Nasonov EL; Lukina G; Hetland ML; Tarp U; Ancuta I; Pavelka K; Nordstrom DC; Gabay C; Canhao H; Tomsic M; van Riel PLC; Gomez-Reino JJ; Kvien TK; van Vollenhoven RF
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2012;71:a12

  SYSTEMS BIOLOGY OF SLE: BIOCHEMICAL CHARACTERISATION OF SUBGROUPS WITHIN SLE FOR IMPROVED DIAGNOSIS AND TREATMENT

  Idborg H; Oliynyk G; Rannar S; Forshed J; Branca RM; Donten M; Gustafsson J; Vikerfors A; Gunnarsson I; Trygg J; Lehtio J; Lundstedt T; Svenungsson E; Jakobsson P-J
• Article: LAKARTIDNINGEN. 2012;109(1-2):40

  [Rheumatologic research with animal experiments is important for our patients].

  Rudin A; Sturfelt G; Carlsten H; Hafström I; Lundberg I; Klareskog L; Rönnblom L; Jacobsson L; van Vollenhoven R; Rantapää-Dahlqvist S; Skogh T; Saxne T
• Article: INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY. 2012;25(1):311-316

  Possible role of oral ibandronate administration in Osteonecrosis of the Jaw: a case report.

  Notarnicola A; Lisi S; Sisto M; De Marino AV; D'Amore M
• Article: PLOS ONE. 2012;7(10):e46709

  Autoantibodies Produced at the Site of Tissue Damage Provide Evidence of Humoral Autoimmunity in Inclusion Body Myositis

  Ray A; Amato AA; Bradshaw EM; Felice KJ; DiCapua DB; Goldstein JM; Lundberg IE; Nowak RJ; Ploegh HL; Spooner E; Wu Q; Willis SN; O'Connor KC
• Article: BMJ OPEN. 2012;2(5):e001524

  Influence of FCGR3A genotype on the therapeutic response to rituximab in rheumatoid arthritis: an observational cohort study

  Kastbom A; Coster L; Arlestig L; Chatzidionysiou A; van Vollenhoven RF; Padyukov L; Rantapaa-Dahlqvist S; Saevarsdottir S
• Article: PHARMACOGENETICS AND GENOMICS. 2012;22(1):1-9

  Patterns of interaction between genetic and nongenetic attributes and methotrexate efficacy in rheumatoid arthritis

  Dervieux T; Wessels JAM; Kremer JM; Padyukov L; Seddighzadeh M; Saevarsdottir S; van Vollenhoven RF; Klareskog L; Huizinga TW; Guchelaar H-J
• Article: ARTHRITIS CARE AND RESEARCH. 2012;64(1):132-137

  Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort

  Urowitz MB; Gladman DD; Ibanez D; Fortin PR; Bae SC; Gordon C; Clarke A; Bernatsky S; Hanly JG; Isenberg D; Rahman A; Sanchez-Guerrero J; Wallace DJ; Ginzler E; Alarcon GS; Merrill JT; Bruce IN; Sturfelt G; Nived O; Steinsson K; Khamashta M; Petri M; Manzi S; Ramsey-Goldman R; Dooley MA; van Vollenhoven RF; Ramos M; Stoll T; Zoma A; Kalunian K; Aranow C
• Article: CLINICAL AND DEVELOPMENTAL IMMUNOLOGY. 2012;2012:618608-11

  Polymerized-Type I Collagen Induces Upregulation of Foxp3-Expressing CD4 Regulatory T Cells and Downregulation of IL-17-Producing CD4⁺ T Cells (Th17) Cells in Collagen-Induced Arthritis

  Furuzawa-Carballeda J; Macip-Rodriguez P; Galindo-Feria AS; Cruz-Robles D; Soto-Abraham V; Escobar-Hernandez S; Aguilar D; Alpizar-Rodriguez D; Ferez-Blando K; Llorente L
• Article: ARTHRITIS RESEARCH & THERAPY. 2012;14(2):R46

  Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study

  Gustafsson JT; Simard JF; Gunnarsson I; Elvin K; Lundberg IE; Hansson L-O; Larsson A; Svenungsson E
• Article: PARASITOLOGY. 2011;138(14):1898-1909

  The interplay between Leishmania promastigotes and human Natural Killer cells in vitro leads to direct lysis of Leishmania by NK cells and modulation of NK cell activity by Leishmania promastigotes

  Lieke T; Nylen S; Eidsmo L; Schmetz C; Berg L; Akuffo H
• Article: ARTHRITIS & RHEUMATOLOGY. 2011;63(12):3918-3930

  A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

  Furie R; Petri M; Zamani O; Cervera R; Wallace DJ; Tegzova D; Sanchez-Guerrero J; Schwarting A; Merrill JT; Chatham WW; Stohl W; Ginzler EM; Hough DR; Zhong ZJ; Freimuth W; van Vollenhoven RF
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2011;70(11):1895-1904

  Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis

  Mariette X; Matucci-Cerinic M; Pavelka K; Taylor P; van Vollenhoven R; Heatley R; Walsh C; Lawson R; Reynolds A; Emery P
• Article: ARTHRITIS & RHEUMATOLOGY. 2011;63(11):3448-3457

  The Role of TRAIL in Mediating Autophagy in Myositis Skeletal Muscle A Potential Nonimmune Mechanism of Muscle Damage

  Alger HM; Raben N; Pistilli E; Francia DL; Rawat R; Getnet D; Ghimbovschi S; Chen Y-W; Lundberg IE; Nagaraju K
• Article: ARTHRITIS CARE AND RESEARCH. 2011;63(0 11):S118-S157

  Measures of Adult and Juvenile Dermatomyositis, Polymyositis, and Inclusion Body Myositis Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), Physician Global Damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI)

  Rider LG; Werth VP; Huber AM; Alexanderson H; Rao AP; Ruperto N; Herbelin L; Barohn R; Isenberg D; Miller FW
• Review: CHEMICAL REVIEWS. 2011;111(10):5821-5865

  Enzymes of the Cyclooxygenase Pathways of Prostanoid Biosynthesis

  Smith WL; Urade Y; Jakobsson P-J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2011;70(10):1726-1732

  Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus

  Hanly JG; Urowitz MB; Su L; Bae S-C; Gordon C; Clarke A; Bernatsky S; Vasudevan A; Isenberg D; Rahman A; Wallace DJ; Fortin PR; Gladman D; Romero-Dirz J; Sanchez-Guerrero J; Dooley MA; Bruce I; Steinsson K; Khamashta M; Manzi S; Ramsey-Goldman R; Sturfelt G; Nived O; van Vollenhoven R; Ramos-Casals M; Aranow C; Mackay M; Kalunian K; Alarcon GS; Fessler BJ; Ruiz-Irastorza G; Petri M; Lim S; Kamen D; Peschken C; Farewell V; Thompson K; Theriault C; Merrill JT
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2011;70(10):1822-1825

  Delays in assessment of patients with rheumatoid arthritis: variations across Europe

  Raza K; Stack R; Kumar K; Filer A; Detert J; Bastian H; Burmester GR; Sidiropoulos P; Kteniadaki E; Repa A; Saxne T; Turesson C; Mann H; Vencovsky J; Catrina A; Chatzidionysiou A; Hensvold A; Rantapaa-Dahlqvist S; Binder A; Machold K; Kwiakowska B; Ciurea A; Tamborrini G; Kyburz D; Buckley CD
• Article: VIRAL IMMUNOLOGY. 2011;24(5):359-368

  NK Cell Function and Antibodies Mediating ADCC in HIV-1-Infected Viremic and Controller Patients

  Johansson SE; Rollman E; Chung AW; Center RJ; Hejdeman B; Stratov I; Hinkula J; Wahren B; Kaerre K; Kent SJ; Berg L
• Article: BIOCHEMISTRY. 2011;50(35):7684-7693

  Location of Inhibitor Binding Sites in the Human Inducible Prostaglandin E Synthase, MPGES1

  Prage EB; Pawelzik S-C; Busenlehner LS; Kim K; Morgenstern R; Jakobsson P-J; Armstrong RN
• Article: JOURNAL OF RHEUMATOLOGY. 2011;38(9):1891-1897

  Expression of APRIL in Diffuse Large B Cell Lymphomas from Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis

  Lofstrom B; Backlin C; Pettersson T; Lundberg IE; Baecklund E
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2011;70(9):1575-1580

  Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries

  Chatzidionysiou K; Lie E; Nasonov E; Lukina G; Hetland ML; Tarp U; Gabay C; van Riel PLCM; Nordstrom DC; Gomez-Reino J; Pavelka K; Tomsic M; Kvien TK; van Vollenhoven RF
• Article: ARTHRITIS RESEARCH & THERAPY. 2011;13(4):R136

  High mobility group box protein 1 in complex with lipopolysaccharide or IL-1 promotes an increased inflammatory phenotype in synovial fibroblasts

  Wahamaa H; Schierbeck H; Hreggvidsdottir HS; Palmblad K; Aveberger A-C; Andersson U; Harris HE
• Article: EUROPEAN JOURNAL OF HUMAN GENETICS. 2011;19(8):908-914

  Variants of gene for microsomal prostaglandin E2 synthase show association with disease and severe inflammation in rheumatoid arthritis

  Korotkova M; Daha NA; Seddighzadeh M; Ding B; Catrina AI; Lindblad S; Huizinga TWJ; Toes REM; Alfredsson L; Klareskog L; Jakobsson P-J; Padyukov L
• Article: ADVANCES IN HEALTH SCIENCES EDUCATION. 2011;16(3):331-345

  Experiencing virtual patients in clinical learning: a phenomenological study

  Edelbring S; Dastmalchi M; Hult H; Lundberg IE; Dahlgren LO
• Article: JOURNAL OF IMMUNOLOGICAL METHODS. 2011;370(1-2):14-23

  Novel antigen design for the generation of antibodies to G-protein-coupled receptors

  Larsson K; Hofstrom C; Lindskog C; Hansson M; Angelidou P; Hokfelt T; Uhlen M; Wernerus H; Graslund T; Hober S
• Article: ARTHRITIS & RHEUMATOLOGY. 2011;63(7):1782-1792

  Atacicept in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate Results of a Phase II, Randomized, Placebo-Controlled Trial

  van Vollenhoven RF; Kinnman N; Vincent E; Wax S; Bathon J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2011;70(7):1272-1276

  Interrater reliability and aspects of validity of the myositis damage index

  Sultan SM; Allen E; Cooper RG; Agarwal S; Kiely P; Oddis CV; Vencovsky J; Lundberg IE; Dastmalchi M; Hanna MG; Isenberg DA
• Article: ARTHRITIS CARE AND RESEARCH. 2011;63(7):1068-1072

  Decreased Live Births in Women With Systemic Lupus Erythematosus

  Vinet E; Clarke AE; Gordon C; Urowitz MB; Hanly JG; Pineau CA; Isenberg D; Rahman A; Wallace D; Alarcon GS; Bruce I; Petri M; Dooley MA; Kalunian K; Maddison P; Aranow C; van Vollenhoven R; Bernatsky S
• Review: JOURNAL OF INTERNAL MEDICINE. 2011;269(6):614-625

  When to initiate and discontinue biologic treatments for rheumatoid arthritis?

  Chatzidionysiou K; van Vollenhoven RF
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2011;70(6):996-1002

  Certolizumab pegol plus methotrexate provides broad relief from the burden of rheumatoid arthritis: analysis of patient-reported outcomes from the RAPID 2 trial

  Strand V; Smolen JS; van Vollenhoven RF; Mease P; Burmester GR; Hiepe F; Khanna D; Nikai E; Coteur G; Schiff M
• Review: ANNALS OF THE RHEUMATIC DISEASES. 2011;70(6):909-920

  Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis

  Buch MH; Smolen JS; Betteridge N; Breedveld FC; Burmester G; Doerner T; Ferraccioli G; Gottenberg J-E; Isaacs J; Kvien TK; Mariette X; Martin-Mola E; Pavelka K; Tak PP; van der Heijde D; van Vollenhoven RF; Emery P
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2011;70(6):1172-1173

  Rituximab-treated membranous lupus nephritis: clinical outcome and effects on electron dense deposits

  Jonsdottir T; Sundelin B; Henriksson EW; van Vollenhoven RF; Gunnarsson I
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2011;70(6):1095-1098

  Antibodies to citrullinated α-enolase peptide 1 and clinical and radiological outcomes in rheumatoid arthritis

  Fisher BA; Plant D; Brode M; van Vollenhoven RF; Mathsson L; Symmons D; Lundberg K; Ronnelid J; Venables PJ
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2011;70(6):961-967

  SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus

  Hanly JG; Urowitz MB; Jackson D; Bae SC; Gordon C; Wallace DJ; Clarke A; Bernatsky S; Vasudevan A; Isenberg D; Rahman A; Sanchez-Guerrero J; Romero-Diaz J; Merrill JT; Fortin PR; Gladman DD; Bruce IN; Steinsson K; Khamashta M; Alarcon GS; Fessler B; Petri M; Manzi S; Nived O; Sturfelt G; Ramsey-Goldman R; Dooley MA; Aranow C; Van Vollenhoven R; Ramos-Casals M; Zoma A; Kalunian K; Farewell V
• Article: RHEUMATIC DISEASE CLINICS OF NORTH AMERICA. 2011;37(2):159-v

  Polymyositis and Dermatomyositis: Pathophysiology

  Nagaraju K; Lundberg IE
• Review: NATURE REVIEWS. RHEUMATOLOGY. 2011;7(5):297-306

  Pathogenesis, classification and treatment of inflammatory myopathies

  Zong M; Lundberg IE
• Article: ISRN RHEUMATOLOGY. 2011;2011:463124-5

  Patient preference assessment reveals disease aspects not covered by recommended outcomes in polymyositis and dermatomyositis.

  Alemo Munters L; van Vollenhoven RF; Alexanderson H
• Article: AMERICAN JOURNAL OF PATHOLOGY. 2011;178(4):1676-1688

  Expression of Prostaglandin E Synthases in Periodontitis Immunolocalization and Cellular Regulation

  Bage T; Kats A; Lopez BS; Morgan G; Nilsson G; Burt I; Korotkova M; Corbett L; Knox AJ; Pino L; Jakobsson P-J; Modeer T; Yucel-Lindberg T
• Article: CLINICAL AND VACCINE IMMUNOLOGY. 2011;18(4):655-660

  Increased Cell-Mediated Immune Responses in Patients with Recurrent Herpes Simplex Virus Type 2 Meningitis

  Franzen-Rohl E; Schepis D; Lagrelius M; Franck K; Jones P; Liljeqvist J-A; Bergstrom T; Aurelius E; Karre K; Berg L; Gaines H
• Review: NATURE REVIEWS. RHEUMATOLOGY. 2011;7(4):205-215

  Unresolved issues in biologic therapy for rheumatoid arthritis

  van Vollenhoven RF
• Review: JOURNAL OF INTERNAL MEDICINE. 2011;269(3):243-257

  Can muscle regeneration fail in chronic inflammation: a weakness in inflammatory myopathies?

  Loell I; Lundberg IE
• Article: LUPUS. 2011;20(3):250-255

  Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity

  Ippolito A; Wallace DJ; Gladman D; Fortin PR; Urowitz M; Werth V; Costner M; Gordon C; Alarcon GS; Ramsey-Goldman R; Maddison P; Clarke A; Bernatsky S; Manzi S; Bae S-C; Merrill JT; Ginzler E; Hanly JG; Nived O; Sturfelt G; Sanchez-Guerrero J; Bruce I; Aranow C; Isenberg D; Zoma A; Magder LS; Buyon J; Kalunian K; Dooley MA; Steinsson K; van Vollenhoven RF; Stoll T; Weisman M; Petri M
• Editorial comment: ARTHRITIS & RHEUMATOLOGY. 2011;63(3):594-596

  More or Less Rituximab? Biology and Clinic, Regulators and Researchers

  van Vollenhoven RF
• Review: CLINICAL RHEUMATOLOGY. 2011;30:S19-S24

  Observational studies: a valuable source for data on the true value of RA therapies

  van Vollenhoven RF; Severens JL
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2011;70(3):469-475

  Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial

  Saevarsdottir S; Wallin H; Seddighzadeh M; Ernestam SA; Geborek P; Petersson IF; Bratt J; van Vollenhoven RF
• Article: RHEUMATOLOGY. 2011;50(3):578-585

  Patients with polymyositis or dermatomyositis have reduced grip force and health-related quality of life in comparison with reference values: an observational study

  Regardt M; Henriksson EW; Alexanderson H; Lundberg IE
• Article: CYTOTHERAPY. 2011;13(3):269-278

  Fetal and adult multipotent mesenchymal stromal cells are killed by different pathways

  Gotherstrom C; Lundqvist A; Duprez IR; Childs R; Berg L; le Blanc K
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2011;70:a23-A24

  PROTEOME ANALYSIS REVEALS AN UPREGULATION OF HEAT-SHOCK PROTEINS IN LPS-INDUCED PERITONEAL MACROPHAGES FROM MPGES-1 KNOCK-OUT MICE

  Korotkova M; Ossipova E; Idborg H; Ghorghe K; Leclerc P; Jakobsson P-J
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2011;70:A75

  LIMITED EFFECTS OF METHOTREXATE ON ENZYMES OF THE PGE₂ PATHWAY IN RHEUMATOID ARTHRITIS SYNOVIAL TISSUE

  Gheorghe KR; Sadique S; Idborg H; Wobst Y; Catrina AI; Jakobsson P-J; Korotkova M
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2011;70:A3

  HUMORAL IMMUNE RESPONSE AGAINST FIBRINOGEN EPITOPES CITRULLINATED IN VIVO IN RHEUMATOID ARTHRITIS SYNOVIAL TISSUE DETECTED BY AUTOANTIBODY MULTIPLEXING

  Ronnelid J; Ossipova E; Mathsson L; Catrina A; Matsson P; Israelsson L; Malmstrom V; Klareskog L; Jakobsson P-J
• Editorial comment: CLINICAL RHEUMATOLOGY. 2011;30:1-2

  Introduction

  van Vollenhoven RF; Severens JL
• Article: TUMORI. 2011;97(2):248-251

  Distribution of coding apoptotic gene polymorphisms in women with extreme phenotypes of breast cancer predisposition and tolerance

  Ulybina YM; Kuligina ES; Mitiushkina NV; Sherina NY; Baholdin DV; Voskresenskiy DA; Polyakov IS; Togo AV; Semiglazov VF; Imyanitov EN
• Article: AMINO ACIDS. 2011;40(2):697-711

  Observed peptide pI and retention time shifts as a result of post-translational modifications in multidimensional separations using narrow-range IPG-IEF

  Lengqvist J; Eriksson H; Gry M; Uhlen K; Bjorklund C; Bjellqvist B; Jakobsson P-J; Lehtio J
• Article: PLOS ONE. 2011;6(1):e16378

  Prostaglandin E₂ Synthesizing Enzymes in Rheumatoid Arthritis B Cells and the Effects of B Cell Depleting Therapy on Enzyme Expression

  Gheorghe KR; Thurlings RM; Westman M; Boumans MJ; Malmstrom V; Trollmo C; Korotkova M; Jakobsson P-J; Tak P-P
• Article: ARTHRITIS RESEARCH & THERAPY. 2011;13(5):R141

  Integrated safety in tocilizumab clinical trials

  Schiff MH; Kremer JM; Jahreis A; Vernon E; Isaacs JD; van Vollenhoven RF
• Article: RHEUMATOLOGY. 2011;50(1):204-213

  Ten years with biologics: to whom do data on effectiveness and safety apply?

  Simard JF; Arkema EV; Sundstrom A; Geborek P; Saxne T; Baecklund E; Coster L; Dackhammar C; Jacobsson L; Feltelius N; Lindblad S; Rantapaa-Dahlqvist S; Klareskog L; van Vollenhoven RF; Neovius M; Askling J
• Article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 2011;31(1):18-25

  Higher proportion of fast-twitch (type II) muscle fibres in idiopathic inflammatory myopathies - evident in chronic but not in untreated newly diagnosed patients

  Loell I; Helmers SB; Dastmalchi M; Alexanderson H; Munters LA; Nennesmo I; Lindroos E; Borg K; Lundberg IE; Esbjornsson M
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2011;70(1):39-46

  Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial

  Tak PP; Rigby WF; Rubbert-Roth A; Peterfy CG; van Vollenhoven RF; Stohl W; Hessey E; Chen A; Tyrrell H; Shaw TM
• Article: CELLULAR IMMUNOLOGY. 2011;272(1):71-78

  Accumulation and activation of natural killer cells in local intraperitoneal HIV-1/MuLV infection results in early control of virus infected cells

  Johansson SE; Brauner H; Hinkula J; Wahren B; Berg L; Johansson MH
• Article: ARTHRITIS CARE AND RESEARCH. 2011;63(1):128-134

  American College of Rheumatology Hybrid Analysis of Certolizumab Pegol Plus Methotrexate in Patients With Active Rheumatoid Arthritis: Data From a 52-Week Phase III Trial

  van Vollenhoven RF; Felson D; Strand V; Weinblatt ME; Luijtens K; Keystone EC
• Article: SOFT MATTER. 2011;7(6):2569-2579

  Atomic-scale lateral heterogeneity and dynamics of two-component lipid bilayers composed of saturated and unsaturated phosphatidylcholines

  Pyrkova DV; Tarasova NK; Pyrkov TV; Krylov NA; Efremov RG
• Article: BIOLOGICHESKIE MEMBRANY. 2011;28(4):298-306

  Lateral Clustering of Lipids in Hydrated Bilayers Composed of Dioleoylphosphatidylcholine and Dipalmitoylphosphatidylcholine

  Pyrkova DV; Tarasova NK; Krylov NA; Nolde DE; Efremov RG
• Article: CLINICAL RHEUMATOLOGY. 2010;29(12):1433-1438

  Discovertebral (Andersson) lesions in severe ankylosing spondylitis: a study using MRI and conventional radiography.

  de Vries MK; van Drumpt AS; van Royen BJ; van Denderen JC; Manoliu RA; van der Horst-Bruinsma IE
• Article: RHEUMATOLOGY. 2010;49(12):2370-2374

  Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay

  Ghirardello A; Rampudda M; Ekholm L; Bassi N; Tarricone E; Zampieri S; Zen M; Vattemi GA; Lundberg IE; Doria A
• Review: ANNALS OF THE RHEUMATIC DISEASES. 2010;69(12):2074-2082

  EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs

  Bertsias GK; Ioannidis JPA; Aringer M; Bollen E; Bombardieri S; Bruce IN; Cervera R; Dalakas M; Doria A; Hanly JG; Huizinga TWJ; Isenberg D; Kallenberg C; Piette JC; Schneider M; Scolding N; Smolen J; Stara A; Tassiulas I; Tektonidou M; Tincani A; van Buchem MA; van Vollenhoven R; Ward M; Gordon C; Boumpas DT
• Editorial comment: NATURE REVIEWS. RHEUMATOLOGY. 2010;6(12):679-681

  PAIN How macrophages mediate inflammatory pain via ATP signaling

  Jakobsson P-J
• Article: JOURNAL OF RHEUMATOLOGY. 2010;37(11):2340-2344

  pANCA, ASCA, and OmpC antibodies in patients with ankylosing spondylitis without inflammatory bowel disease.

  de Vries M; van der Horst-Bruinsma I; van Hoogstraten I; van Bodegraven A; von Blomberg BME; Ratnawati H; Dijkmans B
• Review: CURRENT OPINION IN RHEUMATOLOGY. 2010;22(6):633-638

  Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls

  Labirua A; Lundberg IE
• Article: MOLECULAR MEDICINE. 2010;16(11-12):455-464

  A Longitudinal, Integrated, Clinical, Histological and mRNA Profiling Study of Resistance Exercise in Myositis

  Nader GA; Dastmalchi M; Alexanderson H; Grundtman C; Gernapudi R; Esbjornsson M; Wang Z; Ronnelid J; Hoffman EP; Nagaraju K; Lundberg IE
• Article: ARTHRITIS & RHEUMATOLOGY. 2010;62(11):3457-3466

  Expanded T Cell Receptor V_β-Restricted T Cells From Patients With Sporadic Inclusion Body Myositis Are Proinflammatory and Cytotoxic CD28^null T Cells

  Pandya JM; Fasth AER; Zong M; Arnardottir S; Dani L; Lindroos E; Malmstrom V; Lundberg IE
• Article: RHEUMATOLOGY. 2010;49(11):2098-2103

  Patient-reported 28 swollen and tender joint counts accurately represent RA disease activity and can be used to assess therapy responses at the group level

  Riazzoli J; Nilsson J-A; Teleman A; Petersson IF; Rantapaa-Dahlqvist S; Jacobsson LTH; van Vollenhoven RF
• Article: EUROPEAN JOURNAL OF OBSTETRICS AND GYNECOLOGY AND REPRODUCTIVE BIOLOGY. 2010;152(2):205-209

  C. albicans activates cyclooxygenase but not its product prostaglandin E₂ in HPV 16-stabilized cells

  Deva R; Sczepanski M; Saha S; Zafiriou M-P; Kerstin N; Jakobsson P-J; Inoue Y; Nigam S
• Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2010;285(38):29254-29261

  Identification of Key Residues Determining Species Differences in Inhibitor Binding of Microsomal Prostaglandin E Synthase-1

  Pawelzik S-C; Uda NR; Spahiu L; Jegerschold C; Stenberg P; Hebert H; Morgenstern R; Jakobsson P-J
• Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2010;162(1):146-155

  Characterization of long-term mixed donor-donor chimerism after double cord blood transplantation

  Gertow J; Berglund S; Okas M; Uzunel M; Berg L; Karre K; Mattsson J; Uhlin M
• Article: MOLECULAR MEDICINE. 2010;16(9-10):343-351

  Immunomodulatory Drugs Regulate HMGB1 Release from Activated Human Monocytes

  Schierbeck H; Wahamaa H; Andersson U; Harris HE
• Article: EXPERIMENTAL GERONTOLOGY. 2010;45(9):726-729

  Evidence for depletion of CASP5 Ala90Thr heterozygous genotype in aged subjects

  Ulybina YM; Kuligina ES; Mitiushkina NV; Sherina NY; Yanus GA; Gorodnova TV; Katanugina AS; Koloskov AV; Togo AV; Imyanitov EN
• Article: RHEUMATOLOGY. 2010;49(8):1502-1504

  Clinical improvements in proliferative vs membranous lupus nephritis following B-cell depletion: pooled data from two cohorts

  Jonsdottir T; Gunnarsson I; Mourao AF; Lu TY; van Vollenhoven RF; Isenberg D
• Article: LUPUS. 2010;19(8):949-956

  Disease activity and damage accrual during the early disease course in a multinational inception cohort of patients with systemic lupus erythematosus

  Nossent J; Kiss E; Rozman B; Pokorny G; Vlachoyiannopoulos P; Olesinska M; Marchesoni A; Mosca M; Pai S; Manger K; Schneider M; Nielsen H; van Vollenhoven R; Swaak T
• Article: EUROPEAN JOURNAL OF HUMAN GENETICS. 2010;18(7):821-826

  Evidence for interaction between 5-hydroxytryptamine (serotonin) receptor 2A and MHC type II molecules in the development of rheumatoid arthritis

  Seddighzadeh M; Korotkova M; Kallberg H; Ding B; Daha N; Kurreeman FAS; Toes REM; Huizinga TW; Catrina AI; Alfredsson L; Klareskog L; Padyukov L
• Review: ANNALS OF THE RHEUMATIC DISEASES. 2010;69(7):1269-1274

  European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies

  Mosca M; Tani C; Aringer M; Bombardieri S; Boumpas D; Brey R; Cervera R; Doria A; Jayne D; Khamashta MA; Kuhn A; Gordon C; Petri M; Rekvig OP; Schneider M; Sherer Y; Shoenfeld Y; Smolen JS; Talarico R; Tincani A; van Vollenhoven RF; Ward MM; Werth VP; Carmona L
• Review: CURRENT PAIN AND HEADACHE REPORTS. 2010;14(3):244-251

  Migraine and Olfactory Stimuli

  Sjostrand C; Savic I; Laudon-Meyer E; Hillert L; Lodin K; Waldenlind E
• Review: ANNALS OF THE RHEUMATIC DISEASES. 2010;69(6):976-986

  Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA

  Nam JL; Winthrop KL; van Vollenhoven RF; Pavelka K; Valesini G; Hensor EMA; Worthy G; Landewe R; Smolen JS; Emery P; Buch MH
• Review: ANNALS OF THE RHEUMATIC DISEASES. 2010;69(6):964-975

  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

  Smolen JS; Landewe R; Breedveld FC; Dougados M; Emery P; Gaujoux-Viala C; Gorter S; Knevel R; Nam J; Schoels M; Aletaha D; Buch M; Gossec L; Huizinga T; Bijlsma JWJW; Burmester G; Combe B; Cutolo M; Gabay C; Gomez-Reino J; Kouloumas M; Kvien TK; Martin-Mola E; McInnes I; Pavelka K; van Riel P; Scholte M; Scott DL; Sokka T; Valesini G; van Vollenhoven R; Winthrop KL; Wong J; Zink A; van der Heijde D
• Article: ARTHRITIS CARE AND RESEARCH. 2010;62(6):881-887

  Atherosclerotic Vascular Events in a Multinational Inception Cohort of Systemic Lupus Erythematosus

  Urowitz MB; Gladman D; Ibanez D; Bae SC; Sanchez-Guerrero J; Gordon C; Clarke A; Bernatsky S; Fortin PR; Hanly JG; Wallace DJ; Isenberg D; Rahman A; Alarcon GS; Merrill JT; Ginzler E; Khamashta M; Nived O; Sturfelt G; Bruce IN; Steinsson K; Manzi S; Ramsey-Goldman R; Dooley MA; Zoma A; Kalunian K; Ramos M; Van Vollenhoven RF; Aranow C; Stoll T; Petri M; Maddison P
• Article: BEST PRACTICE AND RESEARCH: CLINICAL RHEUMATOLOGY. 2010;24(3):427-440

  Treatment-resistant inflammatory myopathy

  Mann HF; Vencovsky J; Lundberg IE
• Article: PROTEOMICS - CLINICAL APPLICATIONS. 2010;4(5):511-518

  MS analysis of rheumatoid arthritic synovial tissue identifies specific citrullination sites on fibrinogen

  Hermansson M; Artemenko K; Ossipova E; Eriksson H; Lengqvist J; Makrygiannakis D; Catrina AI; Nicholas AP; Klareskog L; Savitski M; Zubarev RA; Jakobsson P-J
• Article: LAKARTIDNINGEN. 2010;107(15):970

  [Rheumatism patients benefit from dynamic training. Cochrane analysis gives scientific support].

  Lundberg IE; Opava C
• Article: AUTOIMMUNITY. 2010;43(3):239-243

  The type I interferon system in idiopathic inflammatory myopathies

  Lundberg IE; Helmers SB
• Article: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 2010;1801(4):462-472

  Hyperforin induces Ca²⁺-Andependent arachidonic acid release in human platelets by facilitating cytosolic phospholipase A₂ activation through select phospholipid interactions

  Hoffmann M; Lopez JJ; Pergola C; Feisst C; Pawelczik S; Jakobsson P-J; Sorg BL; Glaubitz C; Steinhilber D; Werz O
• Article: DISCOVERY MEDICINE. 2010;9(47):319-327

  New and Future Agents in the Treatment of Rheumatoid Arthritis

  van Vollenhoven RF
• Article: ARTHRITIS & RHEUMATOLOGY. 2010;62(3):667-673

  Cardiovascular Disease in Patients With Inflammatory Rheumatic Disease Is Associated With Up-Regulation of Markers of Inflammation in Cardiac Microvessels and Cardiomyocytes

  Grundtman C; Hollan I; Forre OT; Saatvedt K; Mikkelsen K; Lundberg IE
• Article: JOURNAL OF RHEUMATOLOGY. 2010;37(3):558-567

  Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials

  van Vollenhoven RF; Emery P; Bingham COIII; Keystone EC; Fleischmann R; Furst DE; Macey K; Sweetser M; Kelman A; Rao R
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2010;69(3):529-535

  Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus

  Hanly JG; Urowitz MB; Su L; Bae SC; Gordon C; Wallace DJ; Clarke A; Bernatsky S; Isenberg D; Rahman A; Alarcon GS; Gladman DD; Fortin PR; Sanchez-Guerrero J; Romero-Diaz J; Merrill JT; Ginzler E; Bruce IN; Steinsson K; Khamashta M; Petri M; Manzi S; Dooley MA; Ramsey-Goldman R; Van Vollenhoven R; Nived O; Sturfelt G; Aranow C; Kalunian K; Ramos-Casals M; Zoma A; Douglas J; Thompson K; Farewell V
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2010;69:a52-A53

  EFFECT OF IMMUNOSUPPRESSIVE TREATMENT ON INTERLEUKIN 15 IN MUSCLE TISSUE OF PATIENTS

  Zong M; Loell I; Lindroos E; Nader G; McInnes IB; Lundberg IE
• Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2010;69:a4-A5

  IDENTIFICATION OF SPECIFIC CITRULLINATION SITES ON FIBRINOGEN IN RA

  Ossipova E; Malmstrom V; Catrina AI; Klareskog L; Zubarev R; Jakobsson P-J
• Article: NEUROSCIENCE LETTERS. 2010;470(1):10-12

  Cyclooxygenase-1 mediates the immediate corticosterone response to peripheral immune challenge induced by lipopolysaccharide

  Elander L; Ruud J; Korotkova M; Jakobsson P-J; Blomqvist A
• Article: ARTHRITIS & RHEUMATOLOGY. 2010;62(2):351-358

  The Selective Estrogen Receptor α Agonist Org 37663 Induces Estrogenic Effects but Lacks Antirheumatic Activity

  van Vollenhoven RF; Houbiers JGA; Buttgereit F; in't Hout J; Boers M; Leij S; Kvien TK; Dijkmans BAC; Szczepanski L; Szombati I; Sierakowski S; Miltenburg AMM
• Article: JOURNAL OF AUTOIMMUNITY. 2010;34(1):66-72

  AIRE deficiency leads to impaired iNKT cell development

  Lindh E; Rosmaraki E; Berg L; Brauner H; Karlsson MCI; Peltonen L; Hoglund P; Winqvist O
• Article: CLINICAL IMMUNOLOGY. 2010;134(2):158-168

  NK cell activation by KIR-binding antibody 1-7F9 and response to HIV-infected autologous cells in viremic and controller HIV-infected patients

  Johansson SE; Hejdeman B; Hinkula J; Johansson MH; Romagne F; Wahren B; Wagtmann NR; Karre K; Berg L
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2010;69(2):394-399

  Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions

  Van den Bosch F; Manger B; Goupille P; McHugh N; Rodevand E; Holck P; van Vollenhoven RF; Leirisalo-Repo M; FitzGerald O; Kron M; Frank M; Kary S; Kupper H
• Article: ARTHRITIS CARE AND RESEARCH. 2010;62(2):226-234

  Improvement in Work Place and Household Productivity for Patients With Early Rheumatoid Arthritis Treated With Adalimumab Plus Methotrexate: Work Outcomes and Their Correlations With Clinical and Radiographic Measures From a Randomized Controlled Trial Companion Study

  van Vollenhoven RF; Cifaldi MA; Ray S; Chen N; Weisman MH
• Article: THE FASEB JOURNAL. 2010;24(2):570-578

  Effects of HMGB1 on in vitro responses of isolated muscle fibers and functional aspects in skeletal muscles of idiopathic inflammatory myopathies

  Grundtman C; Bruton J; Yamada T; Ostberg T; Pisetsky DS; Harris HE; Andersson U; Lundberg IE; Westerblad H
• Journal article: CANCER GENETICS. 2010;197(1):91-94

  High sensitivity of BRCA1-associated tumors to cisplatin monotherapy: report of two cases

  Moiseyenko VM; Protsenko SA; Brezhnev NV; Maximov SY; Gershveld ED; Hudyakova MA; Lobeiko OS; Gergova MM; Krzhivitskiy PI; Semionov II; Matsko DE; Iyevleva AG; Sokolenko AP; Sherina NY; Kuligina ES; Suspitsin EN; Togo AV; Imyanitov EN
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2010;39(1):38-41

  The relationship between disease-related characteristics and conduction disturbances in ankylosing spondylitis.

  Dik VK; Peters MJL; Dijkmans PA; Van der Weijden MAC; De Vries MK; Dijkmans BAC; Van der Horst-Bruinsma IE; Nurmohamed MT
• Article: FRONTIERS IN PHARMACOLOGY. 2010;1:146

  Microsomal prostaglandin E synthase-1 in rheumatic diseases

  Korotkova M; Jakobsson P-J
• Article: INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE. 2010;26(1):54-61

  Cost-effectiveness of real-world infliximab use in patients with rheumatoid arthritis in Sweden

  Lekander I; Borgstrom F; Svarvar P; Ljung T; Carli C; van Vollenhoven RF
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2010;69(1):126-131

  Patients with rheumatoid arthritis treated with tumour necrosis factor antagonists increase their participation in the workforce: potential for significant long-term indirect cost gains (data from a population-based registry)

  Augustsson J; Neovius M; Cullinane-Carli C; Eksborg S; van Vollenhoven RF
• Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2010;71(6):508

  Characterization of mPGES-1 Inhibition in Rat Models of Inflammation

  Leclerc P; Larsson C; Spahiu L; Pawelzik S-C; Idborg H; Stenberg P; Korotkova M; Jakobsson P-J
• Article: ARTHRITIS & RHEUMATOLOGY. 2009;61(11):1484-1490

  Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis.

  de Vries MK; van Eijk IC; van der Horst-Bruinsma IE; Peters MJL; Nurmohamed MT; Dijkmans BAC; Hazenberg BPC; Wolbink GJ
• Article: ARTHRITIS & RHEUMATOLOGY. 2009;61(11):1592-1600

  Effect of Certolizumab Pegol With Methotrexate on Home and Work Place Productivity and Social Activities in Patients With Active Rheumatoid Arthritis

  Kavanaugh A; Smolen JS; Emery P; Purcaru O; Keystone E; Richard L; Strand V; van Vollenhoven RF
• Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2009;106(44):18757-18762

  Microsomal prostaglandin E synthase 1 determines tumor growth in vivo of prostate and lung cancer cells

  Hanaka H; Pawelzik S-C; Johnsen JI; Rakonjac M; Terawaki K; Rasmuson A; Sveinbjornsson B; Schumacher MC; Hamberg M; Samuelsson B; Jakobsson P-J; Kogner P; Radmark O
• Editorial comment: ANNALS OF THE RHEUMATIC DISEASES. 2009;68(11):1787-1788

  Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formation.

  de Vries MK; Brouwer E; van der Horst-Bruinsma IE; Spoorenberg A; van Denderen JC; Jamnitski A; Nurmohamed MT; Dijkmans BAC; Aarden LA; Wolbink GJ
• Review: CURRENT OPINION IN RHEUMATOLOGY. 2009;21(6):599-603

  Exercise as an anti-inflammatory intervention to combat inflammatory diseases of muscle

  Nader GA; Lundberg IE
• Article: ARTHRITIS & RHEUMATOLOGY. 2009;60(11):3280-3289

  Impaired Myofibrillar Function in the Soleus Muscle of Mice With Collagen-Induced Arthritis

  Yamada T; Place N; Kosterina N; Ostberg T; Zhang S-J; Grundtman C; Erlandsson-Harris H; Lundberg IE; Glenmark B; Bruton JD; Westerblad H
• Article: ARTHRITIS & RHEUMATOLOGY. 2009;60(11):3180-3189

  Cancer Risk in Patients With Rheumatoid Arthritis Treated With Anti-Tumor Necrosis Factor α Therapies Does the Risk Change With the Time Since Start of Treatment?

  Askling J; van Vollenhoven RF; Granath F; Raaschou P; Fored CM; Baecklund E; Dackhammar C; Feltelius N; Coster L; Geborek P; Jacobsson LT; Lindblad S; Rantapaa-Dahlqvist S; Saxne T; Klareskog L
• Article: AUTOIMMUNITY. 2009;42(7):615-626

  Vascular involvement in the pathogenesis of idiopathic inflammatory myopathies

  Grundtman C; Lundberg IE
• Journal article: AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY. 2009;62(5):348

  Women with Pre-Eclampsia have an Altered NKG2A and NKG2C Receptor Expression on Peripheral Blood Natural Killer Cells (vol 62, pg 147, 2009)

  Bachmayer N; Sohlberg E; Sundstrom Y; Hamad RR; Berg L; Bremme K; Sverremark-Ekstrom E
• Article: JOURNAL OF IMMUNOLOGY. 2009;183(7):4792-4799

  T Cell Infiltrates in the Muscles of Patients with Dermatomyositis and Polymyositis Are Dominated by CD28^null T Cells

  Fasth AER; Dastmalchi M; Rahbar A; Salomonsson S; Pandya JM; Lindroos E; Nennesmo I; Malmberg K-J; Soderberg-Naucler C; Trollmo C; Lundberg IE; Malmstrom V
• Article: RHEUMATOLOGY. 2009;48(10):1222-1226

  Myeloid leukaemia in systemic lupus erythematosus-a nested case-control study based on Swedish registers

  Lofstrom B; Backlin C; Sundstrom C; Hellstrom-Lindberg E; Ekbom A; Lundberg IE
• Review: NATURE REVIEWS. RHEUMATOLOGY. 2009;5(10):531-541

  Treatment of rheumatoid arthritis: state of the art 2009

  van Vollenhoven RF
• Article: AUTOIMMUNITY REVIEWS. 2009;9(1):58-61

  Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies

  Ronnelid J; Helmers SB; Storfors H; Grip K; Ronnblom L; Franck-Larsson K; Nordmark G; Lundberg IE
• Article: AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY. 2009;62(3):147-157

  Women with Pre-Eclampsia Have an Altered NKG2A and NKG2C Receptor Expression on Peripheral Blood Natural Killer Cells

  Bachmayer N; Sohlberg E; Sundstrom Y; Hamad RR; Berg L; Bremme K; Sverremark-Ekstrom E
• Article: THE LANCET. 2009;374(9688):459-466

  Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial

  van Vollenhoven RF; Ernestam S; Geborek P; Petersson IF; Coster L; Waltbrand E; Zickert A; Theander J; Thorner A; Hellstrom H; Teleman A; Dackhammar C; Akre F; Forslind K; Ljung L; Oding R; Chatzidionysiou A; Wornert M; Bratt J
• Review: CLINICAL RHEUMATOLOGY. 2009;28(8):883-892

  Discovertebral (Andersson) lesions of the spine in ankylosing spondylitis revisited.

  Bron JL; de Vries MK; Snieders MN; van der Horst-Bruinsma IE; van Royen BJ
• Article: ARTHRITIS & RHEUMATOLOGY. 2009;60(8):2524-2530

  Sera From Anti-Jo-1-Positive Patients With Polymyositis and Interstitial Lung Disease Induce Expression of Intercellular Adhesion Molecule 1 in Human Lung Endothelial Cells

  Helmers SB; Englund P; Engstrom M; Ahlin E; Fathi M; Janciauskiene S; Heimburger M; Ronnelid J; Lundberg IE
• Editorial comment: ANNALS OF THE RHEUMATIC DISEASES. 2009;68(8):1237-1239

  How to dose infliximab in rheumatoid arthritis: new data on a serious issue

  van Vollenhoven RF
• Article: JOURNAL OF RHEUMATOLOGY. 2009;36(7):1429-1441

  Less Radiographic Progression with Adalimumab Plus Methotrexate Versus Methotrexate Monotherapy Across the Spectrum of Clinical Response in Early Rheumatoid Arthritis

  Emery P; Genovese MC; van Vollenhoven R; Sharp JT; Patra K; Sasso EH
• Article: LEUKEMIA AND LYMPHOMA. 2009;50(7):1198-1203

  Lymphoblastic T-cell lymphoma in mice is unaffected by Celecoxib as single agent or in combination with cyclophosphamide

  Johansson A-S; Pawelzik S-C; Larefalk A; Jakobsson P-J; Holmberg D; Lindskog M
• Article: JOURNAL OF LEUKOCYTE BIOLOGY. 2009;86(3):655-662

  The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation

  Hreggvidsdottir HS; Ostberg T; Wahamaa H; Schierbeck H; Aveberger A-C; Klevenvall L; Palmblad K; Ottosson L; Andersson U; Harris HE
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2009;68(6):836-843

  Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies

  Krystufkova O; Vallerskog T; Helmers SB; Mann H; Putova I; Belacek J; Malmstrom V; Trollmo C; Vencovsky J; Lundberg IE
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2009;68(6):797-804

  Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial

  Smolen J; Landewe RB; Mease P; Brzezicki J; Mason D; Luijtens K; van Vollenhoven RF; Kavanaugh A; Schiff M; Burmester GR; Strand V; Vencovsky J; van der Heijde D
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2009;68(6):805-811

  Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study

  Fleischmann R; Vencovsky J; van Vollenhoven RF; Borenstein D; Box J; Coteur G; Goel N; Brezinschek H-P; Innes A; Strand V
• Article: ARTHRITIS & RHEUMATOLOGY. 2009;60(5):1324-1330

  Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis.

  van Eijk IC; de Vries MK; Levels JHM; Peters MJL; Huizer EE; Dijkmans BAC; van der Horst-Bruinsma IE; Hazenberg BPC; van de Stadt RJ; Wolbink GJ; Nurmohamed MT
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2009;68(5):648-653

  Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register

  Askling J; Baecklund E; Granath F; Geborek P; Fored M; Backlin C; Bertilsson L; Coster L; Jacobsson LT; Lindblad S; Lysholm J; Rantapaa-Dahlqvist S; Saxne T; van Vollenhoven R; Klareskog L; Feltelius N
• Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2009;69(5):429-436

  Herpes Simplex Virus Infection Downmodulates NKG2D Ligand Expression

  Schepis D; D'Amato M; Studahl M; Bergstrom T; Karre K; Berg L
• Article: MUSCLE AND NERVE. 2009;39(5):674-682

  UPREGULATION OF MHC CLASS I IN TRANSGENIC MICE RESULTS IN REDUCED FORCE-GENERATING CAPACITY IN SLOW-TWITCH MUSCLE

  Salomonsson S; Grundtman C; Zhang S-J; Lanner JT; Li C; Katz A; Wedderburn LR; Nagaraju K; Lundberg IE; Westerblad H
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2009;68(4):531-535

  Immunogenicity does not influence treatment with etanercept in patients with ankylosing spondylitis.

  de Vries MK; van der Horst-Bruinsma IE; Nurmohamed MT; Aarden LA; Stapel SO; Peters MJL; van Denderen JC; Dijkmans BAC; Wolbink GJ
• Review: ANNALS OF THE RHEUMATIC DISEASES. 2009;68(4):477-483

  EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints

  Bertsias GK; Ioannidis JPA; Boletis J; Bombardieri S; Cervera R; Dostal C; Font J; Gilboe IM; Houssiau F; Huizinga T; Isenberg D; Kallenberg CGM; Khamashta M; Piette JC; Schneider M; Smolen J; Sturfelt G; Tincani A; van Vollenhoven R; Boumpas DT; Gordon C
• Review: ANNALS OF THE RHEUMATIC DISEASES. 2009;68(4):470-476

  EULAR points to consider for conducting clinical trials in systemic lupus erythematosus

  Gordon C; Bertsias G; Ioannidis JPA; Boletis J; Bombardieri S; Cervera R; Dostal C; Font J; Gilboe I-M; Houssiau F; Huizinga TWJ; Isenberg D; Kallenberg CGM; Khamashta MA; Piette J-C; Schneider M; Smolen JS; Sturfelt G; Tincani A; Van Vollenhoven R; Boumpas DT
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2009;68(4):456-459

  Guidelines for initiation of anti-tumour necrosis factor therapy in rheumatoid arthritis: similarities and differences across Europe

  Emery P; Van Vollenhoven R; Ostergaard M; Choy E; Combe B; Graninger W; Krueger K; Matucci-Cerinic M; Navarro F; van Riel P; Settas L; Steinfeld S
• Editorial comment: BMC MEDICINE. 2009;7:12

  Sex differences in rheumatoid arthritis: more than meets the eye ...

  van Vollenhoven RF
• Other: LAKARTIDNINGEN. 2009;106(12):871

  [Future care requires future ways of working].

  Ahlberg A; Berner J; Ernestam S; Hallén K; Hägglund H; Liljegren A; Löfberg E; Martling C-R; Sarkar N; Wickström R
• Article: JOURNAL OF IMMUNOLOGICAL METHODS. 2009;342(1-2):20-32

  Characterization of PrEST-based antibodies towards human Cytokeratin-17

  Larsson K; Eriksson C; Schwenk JM; Berglund L; Wester K; Uhlen M; Hober S; Wernerus H
• Review: CURRENT OPINION IN RHEUMATOLOGY. 2009;21(2):158-163

  Exercise effects in patients with adult idiopathic inflammatory myopathies

  Alexanderson H
• Journal article: HEREDITARY CANCER IN CLINICAL PRACTICE. 2009;7(1):5

  High frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patients

  Suspitsin EN; Sherina NY; Ponomariova DN; Sokolenko AP; Iyevleva AG; Gorodnova TV; Zaitseva OA; Yatsuk OS; Togo AV; Tkachenko NN; Shiyanov GA; Lobeiko OS; Krylova NY; Matsko DE; Maximov SY; Urmancheyeva AF; Porhanova NV; Imyanitov EN
• Article: JOURNAL OF IMMUNOLOGY. 2009;182(4):2511-2517

  Herpesvirus Seropositivity in Childhood Associates with Decreased Monocyte-Induced NK Cell IFN-γ Production

  Saghafian-Hedengren S; Sundstrom Y; Sohlberg E; Nilsson C; Linde A; Troye-Blomberg M; Berg L; Sverremark-Ekstrom E
• Article: JOURNAL OF NEUROSCIENCE. 2009;29(5):1404-1413

  Inducible Prostaglandin E₂ Synthesis Interacts in a Temporally Supplementary Sequence with Constitutive Prostaglandin-Synthesizing Enzymes in Creating the Hypothalamic-Pituitary-Adrenal Axis Response to Immune Challenge

  Elander L; Engstrom L; Ruud J; Mackerlova L; Jakobsson P-J; Engblom D; Nilsberth C; Blomqvist A
• Article: IMMUNOLOGY. 2009;126(1):140-146

  Increased proportion of CD56^bright natural killer cells in active and inactive systemic lupus erythematosus

  Schepis D; Gunnarsson I; Eloranta M-L; Lampa J; Jacobson SH; Karre K; Berg L
• Article: ARTHRITIS RESEARCH & THERAPY. 2009;11(6):R186

  Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study

  Gustafsson J; Gunnarsson I; Borjesson O; Pettersson S; Moller S; Fei G-Z; Elvin K; Simard JF; Hansson L-O; Lundberg IE; Larsson A; Svenungsson E
• Article: ARTHRITIS RESEARCH & THERAPY. 2009;11(6):R170

  Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year: results from the RAPID 1 randomized controlled trial

  Strand V; Mease P; Burmester GR; Nikai E; Coteur G; van Vollenhoven R; Combe B; Keystone EC; Kavanaugh A
• Article: ARTHRITIS RESEARCH & THERAPY. 2009;11(3):R83

  Expression of 5-lipoxygenase and 15-lipoxygenase in rheumatoid arthritis synovium and effects of intraarticular glucocorticoids

  Gheorghe KR; Korotkova M; Catrina AI; Backman L; Af Klint E; Claesson H-E; Radmark O; Jakobsson P-J
• Article: ARTHRITIS RESEARCH & THERAPY. 2009;11(3):R76

  Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis

  Hueber W; Tomooka BH; Batliwalla F; Li W; Monach PA; Tibshirani RJ; Van Vollenhoven RF; Lampa J; Saito K; Tanaka Y; Genovese MC; Klareskog L; Gregersen PK; Robinson WH
• Journal article: CLINICAL IMMUNOLOGY. 2009;131:s82

  Copolymerized-type I Collagen Decreases Th17 Meanwhile Increases Tregs on CIA

  Furuzawa-Carballeda J; Galindo-Feria A; Cruz-Robles D; Soto-Abraham V; Escobar-Hernandez S; Macip-Rodriguez P; Alpizar-Rodriguez D
• Letter: NEW ENGLAND JOURNAL OF MEDICINE. 2008;359(23):2496

  Adalimumab in juvenile rheumatoid arthritis.

  de Vries MK; van der Horst-Bruinsma IE; Wolbink GJ
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2008;67(12):1670-1677

  A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies

  Dastmalchi M; Grundtman C; Alexanderson H; Mavragani CP; Einarsdottir H; Helmers SB; Elvin K; Crow MK; Nennesmo I; Lundberg IE
• Thesis / dissertation: 2008

  HMGB1 in inflammation : secretion and function

  Wähämaa, Heidi
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2008;67(11):1596-1602

  Effects of immunosuppressive treatment on microsomal prostaglandin E synthase 1 and cyclooxygenases expression in muscle tissue of patients with polymyositis or dermatomyositis

  Korotkova M; Helmers SB; Loell I; Alexanderson H; Grundtman C; Dorph C; Lundberg IE; Jakobsson P-J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2008;67(11):1516-1523

  IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial

  Emery P; Keystone E; Tony HP; Cantagrel A; van Vollenhoven R; Sanchez A; Alecock E; Lee J; Kremer J
• Article: ARTHRITIS & RHEUMATOLOGY. 2008;58(11):3319-3329

  Certolizumab Pegol Plus Methotrexate Is Significantly More Effective Than Placebo Plus Methotrexate in Active Rheumatoid Arthritis Findings of a Fifty-Two-Week, Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study

  Keystone E; van der Heijde D; Mason DJ; Landewe R; van Vollenhoven R; Combe B; Emery P; Strand V; Mease P; Desai C; Pavelka K
• Article: ARTHRITIS & RHEUMATOLOGY. 2008;58(11):3593-3599

  Reliability and Validity of the Myositis Disease Activity Assessment Tool

  Sultan SM; Allen E; Oddis CV; Kiely P; Cooper RG; Lundberg IE; Vencovsky J; Isenberg DA
• Review: NATURE CLINICAL PRACTICE RHEUMATOLOGY. 2008;4(11):597-604

  Molecular effects of exercise in patients with inflammatory rheumatic disease

  Lundberg IE; Nader GA
• Article: ARTHRITIS & RHEUMATOLOGY. 2008;59(10):1371-1377

  Reporting Disease Activity in Clinical Trials of Patients With Rheumatoid Arthritis: EULAR/ACR Collaborative Recommendations

  Aletaha D; Landewe R; Karonitsch T; Bathon J; Boers M; Bombardier C; Bombardieri S; Choi H; Combe B; Dougados M; Emery P; Gomez-Reino J; Keystone E; Koch G; Kvien TK; Martin-Mola E; Matucci-Cerinic M; Michaud K; O'Dell J; Paulus H; Pincus T; Richards P; Simon L; Siegel J; Smolen JS; Sokka T; Strand V; Tugwell P; van der Heijde D; van Riel P; Vlad S; van Vollenhoven R; Ward M; Weinblatt M; Wells G; White B; Wolfe F; Zhang B; Zink A; Felson D
• Journal article: CANCER GENETICS. 2008;186(2):122-124

  Ovarian cancer patient with germline mutations in both BRCA1 and NBN genes

  Porhanova NV; Sokolenko AP; Sherina NY; Ponomariova DN; Tkachenko NN; Matsko DE; Imyanitov EN
• Article: ARTHRITIS & RHEUMATOLOGY. 2008;58(10):3224-3238

  Vascular Endothelial Growth Factor Is Highly Expressed in Muscle Tissue of Patients With Polymyositis and Patients With Dermatomyositis

  Grundtman C; Tham E; Ulfgren A-K; Lundberg IE
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2008;67(10):1493-1494

  Prolonged B-cell depletion following rituximab therapy in systemic lupus erythematosus: a report of two cases

  Lu TY-T; Jonsdottir T; van Vollenhoven RF; Isenberg DA
• Review: ANNALS OF THE RHEUMATIC DISEASES. 2008;67(10):1365-1373

  Methods of deriving EULAR/ACR recommendations on reporting disease activity in clinical trials of patients with rheumatoid arthritis

  Karonitsch T; Aletaha D; Boers M; Bombardieri S; Combe B; Dougados M; Emery P; Felson D; Gomez-Reino J; Keystone E; Kvien TK; Martin-Mola E; Matucci-Cerinic M; Richards P; van Riel P; Siegel J; Smolen JS; Sokka T; van der Heijde D; van Vollenhoven R; Ward M; Wells G; Zink A; Landewe R
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2008;67(10):1360-1364

  Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations

  Aletaha D; Landewe R; Karonitsch T; Bathon J; Boers M; Bombardier C; Bombardieri S; Choi H; Combe B; Dougados M; Emery P; Gomez-Reino J; Keystone E; Koch G; Kvien TK; Martin-Mola E; Matucci-Cerinic M; Michaud K; O'Dell J; Paulus H; Pincus T; Richards P; Simon L; Siegel J; Smolen JS; Sokka T; Strand V; Tugwell P; van der Heijde D; van Riel P; Vlad S; van Vollenhoven R; Ward M; Weinblatt M; Wells G; White B; Wolfe F; Zhang B; Zink A; Felson D
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2008;67(9):1267-1270

  Level of radiographic damage and radiographic progression are determinants of physical function: a longitudinal analysis of the TEMPO trial

  van der Heijde D; Landewe R; van Vollenhoven R; Fatenejad S; Klareskog L
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2008;26(5):S109-S114

  Mortality in idiopathic inflammatory myopathies

  Lundberg IE; Forbess CJ
• Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2008;105(32):11110-11115

  Structural basis for induced formation of the inflammatory mediator prostaglandin E₂

  Jegerschold C; Paweizik S-C; Purhonen P; Bhakat P; Gheorghe KR; Gyobu N; Mitsuoka K; Morgenstern R; Jakobsson P-J; Hebert H
• Article: PROTEOMICS. 2008;8(15):3008-3018

  Quantitative membrane proteomics applying narrow range peptide isoelectric focusing for studies of small cell lung cancer resistance mechanisms

  Eriksson H; Lengqvist J; Hedlund J; Uhlen K; Orre LM; Bjellqvist B; Persson B; Lehtio J; Jakobsson P-J
• Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2008;153(2):221-230

  Leishmania surface protein gp63 binds directly to human natural killer cells and inhibits proliferation

  Lieke T; Nylen S; Eidsmo L; McMaster WR; Mohammadi AM; Khamesipour A; Berg L; Akuffo H
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2008;37(4):269-277

  Reliability and validity of the Fatigue Severity Scale in Swedish for patients with systemic lupus erythematosus

  Mattsson M; Moller B; Lundberg IE; Gard G; Bostrom C
• Letter: RHEUMATOLOGY. 2008;47(7):1106-1107

  Comment on:: Modelling the cost effectiveness of TNF-α antagonists in the management of rheumatoid arthritis:: results from the British Society for Rheumatology Biologics Registry

  van Vollenhoven RF
• Article: ARTHRITIS & RHEUMATOLOGY. 2008;58(6):1784-1788

  Systemic lupus international collaborating clinics renal activity/response exercise - Development of a renal activity score and renal response index

  Petri M; Kasitanon N; Lee S-S; Link K; Magder L; Bae S-C; Hanly JG; Isenberg DA; Nived O; Sturfelt G; van Vollenhoven R; Wallace DJ; Alarcon GS; Adu D; Avila-Casado C; Bernatsky SR; Bruce IN; Clarke AE; Contreras G; Fine DM; Gladman DD; Gordon C; Kalunian KC; Madaio MP; Rovin BH; Sanchez-Guerrero J; Steinsson K; Aranow C; Balow JE; Buyon JP; Ginzler EM; Khamashta MA; Urowitz MB; Dooley MA; Merrill JT; Ramsey-Goldman R; Font J; Tumlin J; Stoll T; Zoma A
• Article: ARTHRITIS & RHEUMATOLOGY. 2008;58(6):1789-1795

  Systemic lupus international collaborating clinics renal activity/response exercise -: Comparison of agreement in rating renal response

  Petri M; Kasitanon N; Singh S; Link K; Magder L; Bae S-C; Hanly JG; Nived O; Sturfelt G; van Vollenhoven R; Wallace DJ; Alarcon GS; Adu D; Avila-Casado C; Bernatsky SR; Bruce IN; Clarke AE; Contreras G; Fine DM; Gladman DD; Gordon C; Kalunian KC; Madaio MP; Rovin BH; Sanchez-Guerrero J; Steinsson K; Aranow C; Balow JE; Buyon JP; Ginzler EM; Khamashta MA; Urowitz MB; Dooley MA; Merrill JT; Ramsey-Goldman R; Font J; Tumlin J; Stoll T; Zoma A
• Article: ARTHRITIS & RHEUMATOLOGY. 2008;59(5):721-729

  Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study

  Hanly JG; Urowitz MB; Su L; Sanchez-Guerrero J; Bae SC; Gordon C; Wallace DJ; Isenberg D; Alarcon GS; Merrill JT; Clarke A; Bernatsky S; Dooley MA; Fortin PR; Gladman D; Steinsson K; Petri M; Bruce IN; Manzi S; Khamashta M; Zoma A; Font J; Van Vollenhoven R; Aranow C; Ginzler E; Nived O; Sturfelt G; Ramsey-Goldman R; Kalunian K; Douglas J; Qi KQ; Thompson K; Farewell V
• Article: ARTHRITIS & RHEUMATOLOGY. 2008;59(5):677-685

  Interstitial lung disease in polymyositis and dermatomyositis: Longitudinal evaluation by pulmonary function and radiology

  Fathi M; Vikgren J; Boijsen M; Tylen U; Jorfeldt L; Tornling G; Lundberg IE
• Published conference paper: LUPUS. 2008;17(5):447-449

  The Janus of lupus - benefits and risks with B-cell therapy

  van Vollenhoven RF
• Review: RHEUMATOLOGY. 2008;47(4):392-398

  Clinical identification and treatment of a rapidly progressing disease state in patients with rheumatoid arthritis

  Emery P; McInnes IB; van Vollenhoven R; Kraan MC
• Article: CIRCULATION. 2008;117(13):1701-1710

  Microsomal prostaglandin E₂ synthase-1 deletion leads to adverse left ventricular remodeling after myocardial infarction

  Degousee N; Fazel S; Angoulvant D; Stefanski E; Pawelzik S-C; Korotkova M; Arab S; Liu P; Lindsay TF; Zhuo S; Butany J; Li R-K; Audoly L; Schmidt R; Angioni C; Geisslinger G; Jakobsson P-J; Rubin BB
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2008;67(3):330-334

  Treatment of refractory SLE with rituximab plus cyclophosphamide:: clinical effects, serological changes, and predictors of response

  Jonsdottir T; Gunnarsson I; Risselada A; Henriksson EW; Klareskog L; van Vollenhoven RF
• Article: ARTHRITIS & RHEUMATOLOGY. 2008;58(3):843-853

  Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis

  Hanly JG; Urowitz MB; Siannis F; Farewell V; Gordon C; Bae SC; Isenberg D; Dooley MA; Clarke A; Bernatsky S; Gladman D; Fortin PR; Manzi S; Steinsson K; Bruce IN; Ginzler E; Aranow C; Wallace DJ; Ramsey-Goldman R; van Vollenhoven R; Sturfelt G; Nived O; Sanchez-Guerrero J; Alarcon GS; Petri M; Khamashta M; Zoma A; Font J; Kalunian K; Douglas J; Qi Q; Thompson K; Merrill JT
• Article: ARTHRITIS & RHEUMATOLOGY. 2008;59(2):176-180

  Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort.

  Urowitz MB; Gladman D; Ibañez D; Fortin P; Sanchez-Guerrero J; Bae S; Clarke A; Bernatsky S; Gordon C; Hanly J; Wallace D; Isenberg D; Ginzler E; Merrill J; Alarcón GS; Steinsson K; Petri M; Dooley MA; Bruce I; Manzi S; Khamashta M; Ramsey-Goldman R; Zoma A; Sturfelt G; Nived O; Maddison P; Font J; van Vollenhoven R; Aranow C; Kalunian K; Stoll T; Systemic Lupus International Collaborating Clinics
• Article: IMMUNOLOGY. 2008;123(2):164-170

  Altered distribution of natural killer cell subsets identified by CD56, CD27 and CD70 in primary and chronic human immunodeficiency virus-1 infection

  Titanji K; Sammicheli S; De Milito A; Mantegani P; Fortis C; Berg L; Karre K; Travi G; Tassandin C; Lopalco L; Rethi B; Tambussi G; Chiodi F
• Article: LUPUS. 2008;17(2):100-104

  Aerobic capacity correlates to self-assessed physical function but not to overall disease activity or organ damage in women with systemic lupus erythematosus with low-to-moderate disease activity and organ damage

  Bostrom C; Dupre B; Tengvar P; Jansson E; Opava CH; Lundberg IE
• Review: ANNALS OF THE RHEUMATIC DISEASES. 2008;67(2):195-205

  EULAR recommendations for the management of systemic lupus erythematosus. Report of a task force of the EULAR standing committee for international clinical studies including therapeutics

  Bertsias G; Ioannidis JPA; Boletis J; Bombardieri S; Cervera R; Dostal C; Font J; Gilboe IM; Houssiau F; Huizinga T; Isenberg D; Kallenberg CGM; Khamashta M; Piette JC; Schneider M; Smolen J; Sturfelt G; Tincani A; van Vollenhoven R; Gordon C; Boumpas DT
• Letter: ARTHRITIS & RHEUMATOLOGY. 2008;58(2):634

  CD20 epitope masking by rituximab:: comment on the article by Gunnarsson et al -: Reply

  Gunnarsson I; Jonsdottir T; van Vollenhoven RF
• Article: JOURNAL OF LEUKOCYTE BIOLOGY. 2008;83(1):31-38

  Pivotal Advance:: Inhibition of HMGB1 nuclear translocation as a mechanism for the anti-rheumatic effects of gold sodium thiomalate

  Zetterstrom CK; Jiang W; Wahamaa H; Ostberg T; Aveberger A-C; Schierbeck H; Lotze MT; Andersson U; Pisetsky DS; Harris HE
• Article: ARTHRITIS RESEARCH & THERAPY. 2008;10(1):R1

  Oxaliplatin retains HMGB1 intranuclearly and ameliorates collagen type II-induced arthritis

  Ostberg T; Wahamaa H; Palmblad K; Ito N; Stridh P; Shoshan M; Lotze MT; Harris HE; Andersson U
• Article: ARTHRITIS & RHEUMATOLOGY. 2008;58(1):36-45

  Antibodies against citrullinated vimentin in rheumatoid arthritis

  Mathsson L; Mullazehi M; Wick MC; Sjoberg O; van Vollenhoven R; Klareskog L; Ronnelid J
• Review: ARTHRITIS RESEARCH & THERAPY. 2008;10(5):220

  Developments in the scientific and clinical understanding of inflammatory myopathies

  Lundberg IE; Grundtman C
• Article: ARTHRITIS RESEARCH & THERAPY. 2008;10(2):R33

  Systemic TNF blockade does not modulate synovial expression of the pro-inflammatory mediator HMGB1 in rheumatoid arthritis patients - a prospective clinical study

  Sundberg E; Grundtman C; Klint EAF; Lindberg J; Ernestam S; Ulfgren A-K; Harris HE; Andersson U
• Editorial comment: ARTHRITIS RESEARCH & THERAPY. 2008;10(2):105

  Rheumatologists, take heart! We may be doing something right

  van Vollenhoven RF
• Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2008;68(2):232-233

  A decreased proportion of CD56^bright human natural killer cells in cord blood increases the risk of allergy development

  Sundstrom Y; Berg L; Nilsson C; Lilja G; Karre K; Troye-Blomberg M
• Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2008;68(2):225-226

  Pre-eclampsia does not influence the peripheral natural killer cell population with regard to their subpopulations and receptor expression

  Bachmayer N; Sundstrom Y; Berg L; Sohlberg E; Hamad RR; Bremme K; Sverremark-Ekstrom E
• Journal article: CLINICAL IMMUNOLOGY. 2008;127:s95-s96

  Copolymerized-Type I collagen increase Tregs and decrease Th 17 subset in CIA

  Escobar-Hernandez S; Galindo-Feria A; Vargas-Rojas MI; Diaz-Zamudio M; Cruz-Robles D; Soto-Abraham V; Escobar-Hernandez S; Macip-Rodriguez P; Alpizar-Rodriguez D; Limon-Camacho L
• Journal article: CLINICAL IMMUNOLOGY. 2008;127:s83

  Amebic peptide reduces inflammation in CIA mice model by down-regulation of adhesion molecules and matrix metalloproteinases

  Godina-Gonzalez S; Escobar-Hernandez S; Galindo-Feria A; Macip-Rodriguez P; Alcocer-Varela J; Teran L; Velazquez J
• Article: ARTHRITIS & RHEUMATOLOGY. 2007;56(12):3896-3908

  Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis

  Keystone E; Fleischmann R; Emery P; Furst DE; van Vollenhoven R; Bathon J; Dougados M; Baldassare A; Ferraccioli G; Chubick A; Udell J; Cravets MW; Agarwal S; Cooper S; Magrini F
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2007;66(12):1627-1632

  A closer look at non-Hodgkin's lymphoma cases in a national Swedish systemic lupus erythematosus cohort:: a nested case-control study

  Lofstrom B; Backlin C; Sundstrom C; Ekbom A; Lundberg IE
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2007;25(6 Suppl 47):153-158

  Disease-specific quality indicators, outcome measures and guidelines in polymyositis and dermatomyositis.

  Alexanderson H; Lundberg IE
• Article: IMMUNOLOGY. 2007;122(3):430-437

  The novel inflammatory cytokine high mobility group box protein 1 (HMGB1) is expressed by human term placenta

  Holmlund U; Wahamaa H; Bachmayer N; Bremme K; Sverremark-Ekstrom E; Palmblad K
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2007;36(6):418-423

  Infliximab dosage and infusion frequency in clinical practice: experiences in the Stockholm biologics registry STURE

  van Vollenhoven RF; Klareskog L
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2007;66(11):1462-1466

  Low-dose glucocorticoid therapy decreases risk for treatment-limiting infusion reaction to infliximab in patients with rheumatoid arthritis

  Augustsson J; Eksborg S; Ernestam S; Gullstrom E; van Vollenhoven R
• Article: ARTHRITIS & RHEUMATOLOGY. 2007;57(7):1192-1201

  International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: A tool for potential use in clinical trials

  Wedderburn LR; Varsani H; Li CKC; Newton KR; Amato AA; Banwell B; Bove KE; Corse AM; Emslie-Smith A; Harding B; Hoogendijk J; Lundberg IE; Marie S; Minetti C; Nennesmo I; Rushing EJ; Sewry C; Charman SC; Pilkington CA; Holton JL
• Article: ARTHRITIS & RHEUMATOLOGY. 2007;57(7):1303-1310

  Effect of physical training on the proportion of slow-twitch type I muscle fibers, a novel nonimmune-mediated mechanism for muscle impairment in polymyositis or dermatomyositis

  Dastmalchi M; Alexanderson H; Loell I; Stahlberg M; Borg K; Lundberg IE; Esbjoernsson M
• Thesis / dissertation: 2007

  Studies of immunopathogenic mechanisms and treatment of chronic, inflammatory myopathies, myositis

  Dastmalchi, Maryam
• Article: IMMUNOLOGY. 2007;122(2):291-301

  Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients:: role of CD94/NKG2A in control of cytokine secretion

  de Matos CT; Berg L; Michaelsson J; Fellander-Tsai L; Kaerre K; Soederstroem K
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2007;66(10):1276-1283

  Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies

  Helmers SB; Dastmalchi M; Alexanderson H; Nennesmo I; Esbjornsson M; Lindvall B; Lundberg IE
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2007;66(10):1339-1344

  Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists

  Askling J; Fored CM; Brandt L; Baecklund E; Bertilsson L; Feltelius N; Coster L; Geborek P; Jacobsson LT; Lindblad S; Lysholm J; Rantapaa-Dahlqvist S; Saxne T; van Vollenhoven RF; Klareskog L
• Journal article: HEREDITARY CANCER IN CLINICAL PRACTICE. 2007;5(3):153-156

  CHEK2 1100delC mutation in Russian ovarian cancer patients

  Krylova NY; Ponomariova DN; Sherina NY; Ogorodnikova NY; Logvinov DA; Porhanova NV; Lobeiko OS; Urmancheyeva AF; Maximov SY; Togo AV; Suspitsin EN; Imyanitov EN
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2007;66(9):1252-1254

  Decreased clinical response to infliximab in ankylosing spondylitis is correlated with anti-infliximab formation.

  de Vries MK; Wolbink GJ; Stapel SO; de Vrieze H; van Denderen JC; Dijkmans BAC; Aarden LA; van der Horst-Bruinsma IE
• Review: PHARMACOLOGICAL REVIEWS. 2007;59(3):207-224

  Membrane prostaglandin E synthase-1: A novel therapeutic target

  Samuelsson B; Morgenstern R; Jakobsson P-J
• Article: ARTHRITIS & RHEUMATOLOGY. 2007;56(9):3112-3124

  A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52/anti-Ro 60 autoantibodies

  Eloranta M-L; Helmers SB; Ulfgren A-K; Ronnblom L; Alm GV; Lundberg IE
• Article: RHEUMATOLOGY. 2007;46(9):1417-1421

  Association between SLE nephritis and polymorphic variants of the CRP and FcγRIIIa genes

  Jonsen A; Gunnarsson I; Gullstrand B; Svenungsson E; Bengtsson AA; Nived O; Lundberg IE; Truedsson L; Sturfelt G
• Review: CURRENT RHEUMATOLOGY REPORTS. 2007;9(4):273-279

  Inflammatory muscle disease: clinical presentation and assessment of patients.

  Alexanderson H; Lundberg IE
• Review: SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE. 2007;28(4):451-458

  Pulmonary complications of polymyositis and dermatomyositis

  Fathi M; Lundberg IE; Tornling G
• Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2007;66(2-3):335-344

  The expression of human natural killer cell receptors in early life

  Sundstrom Y; Nilsson C; Lilja G; Karre K; Troye-Blomberg M; Berg L
• Editorial comment: ANNALS OF THE RHEUMATIC DISEASES. 2007;66(7):849-851

  Switching between anti-tumour necrosis factors: trying to get a handle on a complex issue

  van Vollenhoven RF
• Article: JOURNAL OF RHEUMATOLOGY. 2007;34(7):1451-1458

  Increased DHEAS levels in patients with rheumatoid arthritis after treatment with tumor necrosis factor antagonists:: Evidence for improved adrenal function

  Ernestam S; Hafstrom I; Werner S; Carlstrom K; Tengstrand B
• Article: ARTHRITIS & RHEUMATOLOGY. 2007;57(5):768-777

  Benefits of intensive resistance training in patients with chronic polymyositis or dermatomyositis

  Alexanderson H; Dastmalchi M; Esbjornsson-Liljedahl M; Opava CH; Lundberg IE
• Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2007;104(23):9894-9899

  The induced prostaglandin E₂ pathway is a key regulator of the respiratory response to infection and hypoxia in neonates

  Hofstetter AO; Saha S; Siljehav V; Jakobsson P-J; Herlenius E
• Article: ARTHRITIS & RHEUMATOLOGY. 2007;57(4):694-702

  Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment:: Six-month, double-blind, randomized, placebo-controlled trial

  Chung Y-L; Alexanderson H; Pipitone N; Morrison C; Dastmalchi M; Stahl-Hallengren C; Richards S; Thomas EL; Hamilton G; Bell JD; Lundberg IE; Scott DL
• Review: NATURE CLINICAL PRACTICE RHEUMATOLOGY. 2007;3(5):282-290

  Technology insight: tools for research, diagnosis and clinical assessment of treatment in idiopathic inflammatory myopathies

  Lundberg IE; Alexanderson H
• Article: ARTHRITIS & RHEUMATOLOGY. 2007;56(4):1263-1272

  Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis

  Gunnarsson I; Sundelin B; Jonsdottir T; Jacobson SH; Henriksson EW; van Vollenhoven RF
• Article: JOURNAL OF IMMUNOLOGY. 2007;178(6):3536-3543

  Increased expression of leukocyte Ig-like receptor-1 and activating role of UL18 in the response to cytomegalovirus infection

  Wagner CS; Riise GC; Bergstrom T; Karre K; Carbone E; Berg L
• Article: CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS. 2007;85(2):179-185

  Enhanced multivariate analysis by correlation scaling and fusion of LC/MS and ¹H NMR data

  Forshed J; Stolt R; Idborg H; Jacobsson SP
• Article: ARTHRITIS & RHEUMATOLOGY. 2007;56(2):674-687

  Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies

  Grundtman C; Salomonsson S; Dorph C; Bruton J; Andersson U; Lundberg IE
• Article: ARTHRITIS & RHEUMATOLOGY. 2007;56(2):448-452

  Fcγ receptor type IIIA genotype and response to tumor necrosis factor α-blocking agents in patients with rheumatoid arthritis

  Kastbom A; Bratt J; Ernestam S; Lampa J; Padyukov L; Soderkvist P; Skogh T
• Article: LUPUS. 2007;16(9):731-735

  Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort.

  Urowitz MB; Gladman D; Ibañez D; Fortin P; Sanchez-Guerrero J; Bae S; Clarke A; Bernatsky S; Gordon C; Hanly J; Wallace D; Isenberg D; Ginzler E; Merrill J; Alarcon G; Steinsson K; Petri M; Dooley MA; Bruce I; Manzi S; Khamashta M; Ramsey-Goldman R; Zoma A; Sturfelt G; Nived O; Maddison P; Font J; van Vollenhoven R; Aranow C; Kalunian K; Stoll T; Buyon J
• Review: ARTHRITIS RESEARCH & THERAPY. 2007;9(2):208

  Immune mechanisms in the pathogenesis of idiopathic inflammatory myopathies

  Grundtman C; Malmstroem V; Lundberg IE
• Article: ARTHRITIS RESEARCH & THERAPY. 2007;9(5):R87

  Skewed distribution of proinflammatory CD4⁺CD28^null T cells in rheumatoid arthritis

  Fasth AE; Snir O; Johansson AA; Nordmark B; Rahbar A; af Klint E; Bjorkstrom NK; Ulfgren A-K; van Vollenhoven RF; Malmstrom V; Trollmo C
• Editorial comment: ANNALS OF THE RHEUMATIC DISEASES. 2007;66(1):133-134

  Inefficacy of infliximab in ankylosing spondylitis is correlated with antibody formation.

  de Vries MK; Wolbink GJ; Stapel SO; de Groot ER; Dijkmans BAC; Aarden LA; van der Horst-Bruinsma IE
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2007;25(6):S153-S158

  Disease-specific quality indicators, outcome measures and guidelines in polymyositis and dermatomyositis

  Alexanderson H; Lundberg IE
• Article: CLINICAL IMMUNOLOGY. 2007;122(1):62-74

  Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE

  Vallerskog T; Gunnarsson I; Widhe M; Risselada A; Klareskog L; van Vollenhoven R; Malmstrom V; Trollmo C
• Published conference paper: JOURNAL OF LEUKOCYTE BIOLOGY. 2007;81(1):129-136

  HMGB1-secreting capacity of multiple cell lineages revealed by a novel HMGB1 ELISPOT assay

  Wahamaa H; Vallerskog T; Qin S; Lunderius C; LaRosa G; Andersson U; Harris HE
• Article: ARTHRITIS & RHEUMATOLOGY. 2007;56(1):372-383

  Restricted T cell receptor BV gene usage in the lungs and muscles of patients with idiopathic inflammatory myopathies

  Englund P; Wahlstrom J; Fathi M; Rasmussen E; Grunewald J; Tornling G; Lundberg IE
• Article: ARTHRITIS & RHEUMATOLOGY. 2007;56(1):265-273

  Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus -: An international inception cohort study

  Hanly JG; Urowitz MB; Sanchez-Guerrero J; Bae SC; Gordon C; Wallace DJ; Isenberg D; Alarcon GS; Clarke A; Bernatsky S; Merrill JT; Petri M; Dooley MA; Gladman D; Fortin PR; Steinsson K; Bruce I; Manzi S; Khamashta M; Zoma A; Aranow C; Ginzler E; Van Vollenhoven R; Font J; Sturfelt G; Nived O; Ramsey-Goldman R; Kalunian K; Douglas J; Thompson K; Farewell V
• Article: CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS. 2007;85(1):102-109

  Evaluation of different techniques for data fusion of LC/MS and ¹H-NMR

  Forshed J; Idborg H; Jacobsson SP
• Article: FAMILIAL CANCER. 2007;6(3):281-286

  Founder mutations in early-onset, familial and bilateral breast cancer patients from Russia

  Sokolenko AP; Rozanov ME; Mitiushkina NV; Sherina NY; Iyevleva AG; Chekmariova EV; Buslov KG; Shilov ES; Togo AV; Bit-Sava EM; Voskresenskiy DA; Chagunava OL; Devilee P; Cornelisse C; Semiglazov VF; Imyanitov EN
• Editorial comment: JOURNAL OF RHEUMATOLOGY. 2006;33(12):2372-2375

  Why are only 50% of courses of anti-tumor necrosis factor agents continued for only 2 years in some settings? Need for longterm observations in standard care to complement clinical trials

  Pincus T; Yazici Y; van Vollenhoven R
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2006;65(12):1565-1571

  Signs of inflammation in both symptomatic and asymptomatic muscles from patients with polymyositis and dermatomyositis

  Dorph C; Englund P; Nennesmo I; Lundberg IE
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2006;65(12):1635-1638

  Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy

  Hengstman GJD; ter Laak HJ; Egberts WMV; Lundberg IE; Moutsopoulos HM; Vencovsky J; Doria A; Mosca M; van Venrooij WJ; van Engelen BGM
• Article: ARTHRITIS & RHEUMATOLOGY. 2006;54(10):3119-3125

  Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate -: Results from the trial of etanercept and methotrexate with radiographic and patient outcomes

  Landewe R; van der Heijde D; Klareskog L; van Vollenhoven R; Fatenejad S
• Article: RHEUMATOLOGY. 2006;45:18-21

  The heart in dermatomyositis and polymyositis

  Lundberg IE
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2006;65(9):1219-1222

  Citrullination is an inflammation-dependent process

  Makrygiannakis D; af Klint E; Lundberg IE; Lofberg R; Ulfgren A-K; Klareskog L; Catrina AI
• Article: JOURNAL OF IMMUNOLOGICAL METHODS. 2006;315(1-2):110-120

  Multiplexed PrEST immunization for high-throughput affinity proteomics

  Larsson K; Wester K; Nilsson P; Uhlen M; Hober S; Wernerus H
• Article: JOURNAL OF AUTOIMMUNITY. 2006;27(1):62-68

  Genetically determined imbalance between serum levels of tumour necrosis factor (TNF) and interleukin (IL)-10 is associated with anti-Jo-1 and anti-Ro52 autoantibodies in patients with poly- and dermatomyositis

  Hassan AB; Fathi M; Dastmalchi M; Lundberg IE; Padyukov L
• Article: THE FASEB JOURNAL. 2006;20(9):1352-1360

  Inhibition of prostaglandin E₂ synthesis by SC-560 is independent of cyclooxygenase 1 inhibition

  Brenneis C; Maier TJ; Schmidt R; Hofacker A; Zulauf L; Jakobsson P-J; Scholich K; Geisslinger G
• Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2006;281(24):16443-16452

  c-Jun N-terminal kinase-mediated stabilization of microsomal prostaglandin E₂ synthase-1 mRNA regulates delayed microsomal prostaglandin E₂ synthase-1 expression and prostaglandin E₂ biosynthesis by cardiomyocytes

  Degousee N; Angoulvant D; Fazel S; Stefanski E; Saha S; Iliescu K; Lindsay TF; Fish JE; Marsden PA; Li R-K; Audoly LP; Jakobsson P-J; Rubin BB
• Review: CURRENT RHEUMATOLOGY REPORTS. 2006;8(3):188-195

  Pathogenesis of idiopathic inflammatory myopathies.

  Grundtman C; Lundberg IE
• Letter: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2006;21(6):1742-1743

  Rituximab-induced long-term remission of membranous lupus nephritis

  Jacobson SH; van Vollenhoven R; Gunnarsson I
• Review: ANNALS OF THE RHEUMATIC DISEASES. 2006;65(6):707-712

  Swedish registers to examine drug safety and clinical issues in RA

  Askling J; Fored CM; Geborek P; Jacobsson LTH; van Vollenhoven R; Feltelius N; Lindblad S; Klareskog L
• Review: AUTOIMMUNITY. 2006;39(3):177-190

  Cytokines in idiopathic inflammatory myopathies

  Salomonsson S; Lundberg IE
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2006;35(3):182-188

  Interleukin-1β influences the effect of infliximab on temporomandibular joint pain in rheumatoid arthritis

  Kopp S; Alstergren P; Ernestam S; Nordahl S; Bratt J
• Article: ARTHRITIS & RHEUMATOLOGY. 2006;54(5):1390-1400

  The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment - Results of a phase IIb randomized, double-blind, placebo-controlled, dose-ranging trial

  Emery P; Fleischmann R; Filipowicz-Sosnowska A; Schechtman J; Szczepanski L; Kavanaugh A; Racewicz AJ; Van Vollenhoven RF; Li NF; Agarwal S; Hessey EW; Shaw TM
• Article: JOURNAL OF AUTOIMMUNE DISEASES. 2006;3:2

  Endothelial cell activation and neovascularization are prominent in dermatomyositis.

  Nagaraju K; Rider LG; Fan C; Chen Y-W; Mitsak M; Rawat R; Patterson K; Grundtman C; Miller FW; Plotz PH; Hoffman E; Lundberg IE
• Article: ARTHRITIS & RHEUMATOLOGY. 2006;55(1):114-122

  Functional index-2:: Validity and reliability of a disease-specific measure of impairment in patients with polymyositis and dermatomyositis

  Alexanderson H; Broman L; Tollbäck A; Josefson A; Lundberg IE; Stenström CH
• Review: ARTHRITIS & RHEUMATOLOGY. 2006;54(2):421-432

  The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials

  Liang MH; Schur PH; Fortin P; St Clair EW; Balow JE; Costenbader K; Crofford L; de Pablo P; Dooley MA; Finckh A; Gordon CP; Lundberg IE; Meyrier A; Nived O; Ponticelli C; Schneider MK; Singh A; Wallace DJ
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2006;65(2):242-245

  Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2β antigen

  Hengstman GJD; Egberts WTMV; Seelig HP; Lundberg IE; Moutsopoulos HM; Doria A; Mosca M; Vencovsky J; van Venrooij WJ; van Engelen BGM
• Thesis / dissertation: 2006

  Rheumatoid arthritis : pharmacological modulation of cytokines : aspects of clinical response and endocrine regulation

  Ernestam, Sofia
• Review: NESTLE NUTRITION WORKSHOP SERIES: PEDIATRIC PROGRAM. 2006;57:223-233

  Perinatal PUFA intake affects leptin and oral tolerance in neonatal rats and possibly immunoreactivity in intrauterine growth retardation in man.

  Hanson LA; Korotkova M; Hahn-Zoric M; Zaman S; Malik A; Ashraf R; Amu S; Padyukov L; Telemo E; Strandvik B
• Conference publication: JOURNAL OF IMMUNOLOGY. 2006;176:S280

  Normal NK cell development in absence of Aire

  Lundgren EK; Rosmaraki E; Berg L; Hoglund P; Winqvist O
• Article: ARTHRITIS RESEARCH & THERAPY. 2006;8(1):R18

  Synovial expression of IL-15 in rheumatoid arthritis is not influenced by blockade of tumour necrosis factor

  Ernestam S; Klint EA; Catrina AI; Sundberg E; Engström M; Klareskog L; Ulfgren K
• Article: ARTHRITIS & RHEUMATOLOGY. 2006;54(1):26-37

  The PREMIER study - A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment

  Breedveld FC; Weisman MH; Kavanaugh AF; Cohen SB; Pavelka K; van Vollenhoven R; Sharp J; Perez JL; Spencer-Green GT
• Article: ARTHRITIS & RHEUMATOLOGY. 2006;54(1):76-81

  Anti-tumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis

  Catrina AI; af Klint E; Ernestam S; Catrina SB; Makrygiannakis D; Botusan IR; Klareskog L; Ulfgren AK
• Review: CURRENT TOPICS IN MICROBIOLOGY AND IMMUNOLOGY. 2006;298:259-277

  NK cells in autoimmune disease

  Johansson S; Hall H; Berg L; Höglund P
• Meeting abstract: CLINICAL IMMUNOLOGY. 2006;119:S71

  Hyperresponsive TNF- and IFN-γ-secreting CD28null T-Cells may contribute to the inflammation in polymyositis and dermatomyositis.

  Fasth A; Dastmolchi M; Lindroos E; Solomonsson S; Trollmo C; Lundberg I
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2005;34(5):353-358

  Adalimumab (Humira®) restores clinical response in patients with secondary loss of efficacy from infliximab (Remicade®) or etanercept (Enbrel®):: results from the STURE registry at Karolinska University Hospital

  Wick MC; Ernestam S; Lindblad S; Bratt J; Klareskog L; van Vollenhoven RF
• Article: JOURNAL OF CHROMATOGRAPHY B: ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. 2005;828(1-2):14-20

  Metabolic fingerprinting of rat urine by LC/MS Part 2. Data pretreatment methods for handling of complex data

  Idborg H; Zamani L; Edlund PO; Schuppe-Koistinen I; Jacobsson SP
• Article: JOURNAL OF CHROMATOGRAPHY B: ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. 2005;828(1-2):9-13

  Metabolic fingerprinting of rat urine by LC/MS Part 1. Analysis by hydrophilic interaction liquid chromatography-electrospray ionization mass spectrometry

  Idborg H; Zamani L; Edlund PO; Schuppe-Koistinen I; Jacobsson SP
• Article: LAKARTIDNINGEN. 2005;102(49):3788-3793

  [TNF blockade in rheumatoid arthritis can cause severe fibrosing alveolitis. Six case reports].

  Tengstrand B; Ernestam S; Engvall I-L; Rydvald Y; Hafström I
• Letter: ARTHRITIS & RHEUMATOLOGY. 2005;52(12):4050-4051

  In lupus nephritis, the benefit of rituximab monotherapy, as opposed to rituximab plus cyclophosphamide combination therapy, remains uncertain: comment on the article by Sfikakis et al

  van Vollenhoven R; Gunnarsson I
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2005;64(12):1744-1749

  Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis:: anti-CP status predicts worse disease activity and greater radiological progression

  Rönnelid J; Wick MC; Lampa J; Lindblad S; Nordmark B; Klareskog L; van Vollenhoven RF
• Article: MOLECULAR & CELLULAR PROTEOMICS. 2005;4(12):1920-1932

  A human protein atlas for normal and cancer tissues based on antibody proteomics

  Uhlén M; Björling E; Agaton C; Szigyarto CA; Amini B; Andersen E; Andersson AC; Angelidou P; Asplund A; Asplund C; Berglund L; Bergström K; Brumer H; Cerjan D; Ekström M; Elobeid A; Eriksson C; Fagerberg L; Falk R; Fall J; Forsberg M; Björklund MG; Gumbel K; Halimi A; Hallin I; Hamsten C; Hansson M; Hedhammar M; Hercules G; Kampf C; Larsson K; Linskog M; Lodewyckx W; Lund J; Lundeberg J; Magnusson K; Malm E; Nilsson P; Ödling J; Oksvold P; Olsson I; Öster E; Ottosson J; Paavilainen L; Persson A; Rimini R; Rockberg J; Runeson M; Sivertsson Å; Sköllermo A; Steen J; Stenvall M; Sterky F; Strömberg S; Sundberg M; Tegel H; Tourle S; Wahlund E; Waldén A; Wan JH; Wernérus H; Westberg J; Wester K; Wrethagen U; Xu LL; Hober S; Pontén F
• Article: ARTHRITIS & RHEUMATOLOGY. 2005;52(11):3439-3447

  Effects of antirheumatic treatments on the prostaglandin E₂ Biosynthetic pathway

  Korotkova M; Westman M; Gheorghe KR; af Klint E; Trollmo C; Ulfgren AK; Klareskog L; Jakobsson PJ
• Article: PROTEOMICS. 2005;5(17):4327-4337

  Towards a human proteome atlas:: High-throughput generation of mono-specific antibodies for tissue profiling

  Nilsson P; Paavilainen L; Larsson K; Ödling J; Sundberg M; Andersson AC; Kampf C; Persson A; Szigyarto CAK; Ottosson J; Björling E; Hober S; Wernérus H; Wester K; Pontén F; Uhlen M
• Review: CURRENT OPINION IN RHEUMATOLOGY. 2005;17(6):701-706

  Interstitial lung disease in polymyositis and dermatomyositis

  Fathi M; Lundberg IE
• Review: TRENDS IN IMMUNOLOGY. 2005;26(11):613-618

  NK cells:: elusive players in autoimmunity

  Johansson S; Berg L; Hall H; Höglund P
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2005;23(5):S195-S200

  Rheumatoid arthritis registries in Sweden

  van Vollenhoven RF; Askling J
• Letter: ARTHRITIS & RHEUMATOLOGY. 2005;53(4):626

  Dehydroepiandrosterone versus placebo for Sjogren's syndrome: comment on the article by Pillemer et al

  van Vollenhoven R
• Article: RHEUMATIC DISEASE CLINICS OF NORTH AMERICA. 2005;31(3):535-viii

  The prognosis of mixed connective tissue disease

  Lundberg IE
• Article: ARTHRITIS & RHEUMATOLOGY. 2005;52(6):1824-1835

  Activation of the endoplasmic reticulum stress response in autoimmune myositis - Potential role in muscle fiber damage and dysfunction

  Nagaraju K; Casciola-Rosen L; Lundberg I; Rawat R; Cutting S; Thapliyal R; Chang J; Dwivedi S; Mitsak M; Chen YW; Plotz P; Rosen A; Hoffman E; Raben N
• Article: BASIC AND CLINICAL PHARMACOLOGY AND TOXICOLOGY. 2005;96(6):453-464

  Subchronic toxicity of Baltic herring oil and its fractions in the rat (III) bone tissue composition and dimension, and ratio of n-6/n-3 fatty acids in serum phospholipids

  Stern N; Korotkova M; Strandvik B; Oxlund H; Öberg M; Håkansson H; Lind PM
• Article: AMERICAN JOURNAL OF PHYSIOLOGY. REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY. 2005;288(5):R1100-R1107

  Impaired febrile responses to immune challenge in mice deficient in microsomal prostaglandin E synthase-1

  Saha S; Engstrom L; Mackerlova L; Jakobsson PJ; Blomqvist A
• Review: CURRENT RHEUMATOLOGY REPORTS. 2005;7(2):115-124

  Exercise: an important component of treatment in the idiopathic inflammatory myopathies.

  Alexanderson H
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2005;64(4):654

  Feasibility of 1 hour infliximab infusions

  van Vollenhoven RF; Gullström E; Klareskog L
• Editorial comment: ARTHRITIS & RHEUMATOLOGY. 2005;52(4):991-994

  The treatment of rheumatoid arthritis: Getting better all the time?

  van Vollenhoven RF; Klareskog L
• Article: THE FEBS JOURNAL. 2005;272(7):1688-1703

  Bioinformatic and enzymatic characterization of the MAPEG superfamily

  Bresell A; Weinander R; Lundqvist G; Raza H; Shimoji M; Sun TH; Balk L; Wiklund R; Eriksson J; Jansson C; Persson B; Jakobsson PJ; Morgenstern R
• Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2005;6(1):65-66

  Lipid-peroxidation is enhanced in sle patients and associated with arterial and renal disease manifestations

  Frostegard J; Svenungsson E; Wu R; Gunnarsson I; Lundberg I; Klareskog L; Hörkkö S; Witztum J
• Article: LAKARTIDNINGEN. 2005;102(12-13):950-954

  [Temporal arteritis].

  Bornefalk E; Lundberg IE
• Article: ARTHRITIS & RHEUMATOLOGY. 2005;52(3):697-706

  Women in Academic Rheumatology

  Lundberg IE; Ozen S; Gunes-Ayata A; Kaplan MJ
• Review: CURRENT OPINION IN RHEUMATOLOGY. 2005;17(2):164-171

  The role of exercise in the rehabilitation of idiopathic inflammatory myopathies

  Alexanderson H; Lundberg IE
• Article: AMERICAN JOURNAL OF PHYSIOLOGY. REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY. 2005;288(3):R575-R579

  Gender-related long-term effects in adult rats by perinatal dietary ratio of n-6/n-3 fatty acids

  Korotkova M; Gabrielsson BG; Holmäng A; Larsson BM; Hanson L; Strandvik B
• Article: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 2005;1686(3):248-254

  Perinatal essential fatty acid deficiency influences body weight and bone parameters in adult male rats

  Korotkova M; Ohlsson C; Gabrielsson B; Hanson L; Strandvik B
• Article: ARTHRITIS & RHEUMATOLOGY. 2005;52(1):192-200

  Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations

  Frostegård J; Svenungsson E; Wu RH; Gunnarsson I; Lundberg IE; Klareskog L; Hörkko S; Witztum JL
• Article: CELLULAR AND MOLECULAR LIFE SCIENCES. 2005;62(1):87-94

  Microsomal glutathione S-transferases:: selective up-regulation of leukotriene C₄ synthase during lipopolysaccharide-induced pyresis

  Schröder O; Sjöström M; Qiu H; Jakobsson PJ; Haeggström JZ
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2005;64(1):134-137

  Estimated prediagnosis radiological progression: an important tool for studying the effects of early disease modifying antirheumatic drug treatment in rheumatoid arthritis

  Wick MC; Lindblad S; Weiss RJ; Klareskog L; van Vollenhoven RF
• Article: LUPUS. 2005;14(9):708-712

  Cardiac involvement in autoimmune myositis and mixed connective tissue disease

  Lundberg IE
• Published conference paper: CELLS TISSUES ORGANS. 2005;180(1):22-30

  Reduction of temporomandibular joint pain after treatment with a combination of methotrexate and infliximab is associated with changes in synovial fluid and plasma cytokines in rheumatoid arthritis

  Kopp S; Alstergren P; Ernestam S; Nordahl S; Morin P; Bratt J
• Review: METHODS IN ENZYMOLOGY. 2005;401:147-161

  Human microsomal prostaglandin E synthase 1:: A member of the MAPEG protein superfamily

  Pettersson PL; Thorén S; Jakobsson PJ
• Meeting abstract: ARTHRITIS RESEARCH & THERAPY. 2005;7:S34

  Effects of anti-rheumatic treatments on the prostaglandin E₂ biosynthetic pathway in synovial tissue and synovial fluid cells from patients with rheumatoid arthritis

  Korotkova M; Westman M; Gheorghe KR; af Klint E; Trollmo C; Ulfgren A-K; Klareskog L; Jakobsson P-J
• Meeting abstract: ARTHRITIS RESEARCH & THERAPY. 2005;7:S23

  Expression of IL-18 in muscle tissue of patients with treatment-resistant idiopathic inflammatory myopathies

  Lundberg IE; Barbasso S; Ulfgren AK; Gracie JA; McInnes IB
• Meeting abstract: ARTHRITIS RESEARCH & THERAPY. 2005;7:S35

  Expression of microsomal prostaglandin E synthase-1 in muscle tissue of patients with idiopathic inflammatory myopathies

  Korotkova I; Barbasso S; Jakobsson P-J; Lundberg I
• Meeting abstract: ARTHRITIS RESEARCH & THERAPY. 2005;7:S33

  Marked expression of IL-1 receptors in cell nuclei and muscle fiber membrane in muscle tissue of patients with idiopathic inflammatory myopathies

  Grundtman C; Salomonsson S; Dorph C; Burton J; Andersson U; Lundberg IE
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2004;33(6):423-427

  Biopsy-verified response of severe lupus nephritis to treatment with rituximab (anti-CD20 monoclonal antibody) plus cyclophosphamide after biopsy-documented failure to respond to cyclophosphamide alone

  van Vollenhoven RF; Gunnarsson I; Welin-Henriksson E; Sundelin B; Österborg A; Jacobson SH; Klareskog L
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2004;33(6):380-384

  Clinical and radiological disease-course in a Swedish DMARD-treated early RA-inception cohort: an observational study

  Wick MC; Lindblad S; Weiss RJ; Klareskog L; van Vollenhoven RF
• Article: BRITISH JOURNAL OF NUTRITION. 2004;92(4):643-648

  Dietary n-6:n-3 fatty acid ratio in the perinatal period affects bone parameters in adult female rats

  Korotkova M; Ohlsson C; Hanson L; Strandvik B
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2004;22(5):S122-S125

  Benefits and risks of biological agents: Lymphomas

  van Vollenhoven RF
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2004;22(5):S115-S121

  Switching between biological agents

  van Vollenhoven RF
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2004;63(9):1075-1078

  Treatment with tumour necrosis factor a antagonists in patients with rheumatoid arthritis induces anticardiolipin antibodies

  Jonsdottir T; Forslid J; van Vollenhoven A; Harju A; Brannemark S; Klareskog L; van Vollenhoven RF
• Published conference paper: ARTHRITIS & RHEUMATOLOGY. 2004;50(9):2858-2868

  Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus - Results of a multicenter randomized, double-blind, placebo-controlled trial

  Petri MA; Mease PJ; Merrill JT; Lahita RG; Iannini MJ; Yocum DE; Ginzler EM; Katz RS; Gluck OS; Genovese MC; Van Vollenhoven R; Kalunian KC; Manzi S; Greenwald MW; Buyon JP; Olsen NJ; Schiff MH; Kavanaugh AF; Caldwell JR; Ramsey-Goldman R; St Clair EW; Goldman AL; Egan RM; Polisson RP; Moder KG; Rothfield NF; Spencer RT; Hobbs K; Fessler BJ; Calabrese LH; Moreland LW; Cohen SB; Quarles BJ; Strand V; Gurwith M; Schwartz KE
• Meeting abstract: PEDIATRIC RESEARCH. 2004;56(3):482

  Reduced expression of microsomal prostaglandin synthase 1 attenuates ventilatory effects of interleukin-1A in neonatal DBA/1LacJ mice

  Hofstetter AO; Saha S; Lagercrantz H; Jakobsson PJ; Herlenius E
• Letter: NEUROLOGY. 2004;63(2):402

  Polymyositis: An overdiagnosed entity

  Miller FW; Rider LG; Plotz PH; Rutkove SB; Pestronk A; Wortmann RL; Lundberg IE; Argov Z; Isenberg DA; Lacomis D; Oddis CV
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2004;63(7):848-852

  Relationship between inflammation and joint destruction in early rheumatoid arthritis: a mathematical description

  Wick MC; Lindblad S; Klareskog L; van Vollenhoven RF
• Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2004;60(1-2):199-208

  CD28^nullCD4⁺ T cells -: Characterization of an effector memory T-cell population in patients with rheumatoid arthritis

  Fasth AER; Cao D; van Vollenhoven R; Trollmo C; Malmström V
• Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2004;137(2):237-244

  The ratio of n-6 to n-3 fatty acids in maternal diet influences the induction of neonatal immunological tolerance to ovalbumin

  Korotkova M; Telemo E; Yamashiro Y; Hanson L; Strandvik B
• Article: ARTHRITIS & RHEUMATOLOGY. 2004;50(6):1774-1780

  Expression of microsomal prostaglandin E synthase 1 in rheumatoid arthritis synovium

  Westman M; Korotkova M; af Klint E; Stark A; Audoly LP; Klareskog L; Ulfgren AK; Jakobsson P
• Article: RAPID COMMUNICATIONS IN MASS SPECTROMETRY. 2004;18(9):944-954

  Multivariate approaches for efficient detection of potential metabolites from liquid chromatography/mass spectrometry data

  Idborg H; Edlund PO; Jacobsson SP
• Other: NEUROMUSCULAR DISORDERS. 2004;14(5):337-345

  119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands.

  Hoogendijk JE; Amato AA; Lecky BR; Choy EH; Lundberg IE; Rose MR; Vencovsky J; de Visser M; Hughes RA
• Article: ARTHRITIS & RHEUMATOLOGY. 2004;50(5):1586-1594

  Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids

  Ulfgren AK; Grundtman C; Borg K; Alexanderson H; Andersson U; Harris HE; Lundberg IE
• Article: JOURNAL OF PHYSIOLOGY. 2004;556(3):983-1000

  Leukocytes, cytokines, growth factors and hormones in human skeletal muscle and blood after uphill or downhill running

  Malm C; Sjödin B; Sjöberg B; Lenkei R; Renström P; Lundberg IE; Ekblom B
• Article: PEDIATRIC ALLERGY AND IMMUNOLOGY. 2004;15(2):112-122

  Modulation of neonatal immunological tolerance to ovalbumin by maternal essential fatty acid intake

  Korotkova M; Telemo E; Hanson L; Strandvik B
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2004;63(4):426-430

  Dose escalation of infliximab in clinical practice: improvements seen may be explained by a regression-like effect

  van Vollenhoven RF; Brannemark S; Klareskog L
• Letter: ARTHRITIS & RHEUMATOLOGY. 2004;50(3):1013-1015

  Association of the proinflammatory haplotype (MICA5.1/TNF2/TNFa2/DRB1*03) with polymyositis and dermatomyositis

  Hassan AB; Nikitina-Zake L; Sanjeevi CB; Lundberg IE; Padyukov L
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2004;63(3):297-301

  Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis

  Fathi M; Dastmalchi M; Rasmussen E; Lundberg IE; Tornling G
• Article: BEST PRACTICE AND RESEARCH: CLINICAL RHEUMATOLOGY. 2004;18(1):7-19

  Corticosteroids - from an idea to clinical use

  Lundberg IE; Grundtman C; Larsson E; Klareskog L
• Meeting abstract: ARTHRITIS RESEARCH & THERAPY. 2004;6:S32-S33

  Effects of anti-rheumatic treatments on expression of microsomal prostaglandin E synthase-1 in rheumatoid arthritis synovium

  Korotkova M; Westman M; af Klint E; Ulfgren AK; Klareskog L; Jakobsson PJ
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2004;63(5):608

  Do etanercept-naive patients with rheumatoid arthritis respond better to infliximab than patients for whom etanercept has failed? Reply

  van Vollenhoven RF
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2004;63(8):1005-1006

  Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis - Reply

  Lundberg I; Fathi M; Forslid J
• Article: RHEUMATOLOGY. 2004;43(1):49-54

  International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease

  Isenberg DA; Allen E; Farewell V; Ehrenstein MR; Hanna MG; Lundberg IE; Oddis C; Pilkington C; Plotz P; Scott D; Vencovsky J; Cooper R; Rider L; Miller F
• Article: ARTHRITIS RESEARCH & THERAPY. 2004;6(4):R335-R346

  CD25^brightCD4⁺ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease

  Cao DJ; van Vollenhoven R; Klareskog L; Trollmo C; Malmström V
• Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2003;312(2):271-276

  Molecular and catalytic properties of three rat leukotriene C₄ synthase homologs

  Schröder O; Sjöström M; Qiu H; Stein J; Jakobsson PJ; Haeggström JZ
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2003;62(12):1195-1198

  Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa:: data from the STURE registry showing that switching tumour necrosis factor α blockers can make sense

  van Vollenhoven R; Harju A; Brannemark S; Klareskog L
• Article: INTERNATIONAL JOURNAL OF CANCER. 2003;107(4):551-556

  Expression of microsomal prostaglandin E synthase-1 in intestinal type gastric adenocarcinoma and in gastric cancer cell lines

  van Rees BP; Sivula A; Thorén S; Yokozaki H; Jakobsson PJ; Offerhaus GJA; Ristimäki A
• Editorial comment: CURRENT OPINION IN RHEUMATOLOGY. 2003;15(6):675-678

  Clinical symptoms in patients with myositis - an acquired metabolic myopathy?

  Lundberg IE
• Article: NATURE NEUROSCIENCE. 2003;6(11):1137-1138

  Microsomal prostaglandin E synthase-1 is the central switch during immune-induced pyresis

  Engblom D; Saha S; Engström L; Westman M; Audoly LP; Jakobsson PJ; Blomqvist A
• Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2003;107(3):485-493

  Cytokine production in synovial tissue of mice with collagen-induced arthritis (CIA)

  Mussener A; Litton MJ; Lindroos E; Klareskog L
• Article: ANALYTICAL CHEMISTRY. 2003;75(18):4784-4792

  Screening of biomarkers in rat urine using LC/electrospray ionization-MS and two-way data analysis

  Idborg-Björkman H; Edlund PO; Kvalheim OM; Schuppe-Koistinen I; Jacobsson SP
• Review: LAKARTIDNINGEN. 2003;100(36):2754-2759

  [Exercise is beneficial for patients with myositis. Both pharmaceuticals and physical activity should be included in the therapy of chronic rheumatic muscle inflammation].

  Lundberg IE; Alexanderson H; Arnardottir S; Borg K
• Article: ARTHRITIS & RHEUMATOLOGY. 2003;48(9):2533-2540

  Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor α/tumor necrosis factor receptor system in systemic lupus erythematosus

  Svenungsson E; Gunnarsson I; Fei GZ; Lundberg IE; Klareskog L; Frostegård J
• Thesis / dissertation: 2003

  Exercise and outcome measures in patients with polymyositis and dermatomyositis

  Alexanderson, Helene
• Article: JOURNAL OF RHEUMATOLOGY. 2003;30(8):1748-1755

  Evidence for immunostimulatory effects of intramuscular gold in patients with rheumatoid arthritis:: Correlation with skin reactions

  Ernestam S; Lampa J; Rogberg S; Rönnelid J; Klareskog L; Hafström I
• Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2003;100(15):9044-9049

  Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase

  Trebino CE; Stock JL; Gibbons CP; Naiman BM; Wachtmann TS; Umland JP; Pandher K; Lapointe JM; Saha S; Roach ML; Carter D; Thomas NA; Durtschi BA; McNeish JD; Hambor JE; Jakobsson PJ; Carty TJ; Perez JR; Audoly LP
• Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2003;278(25):22199-22209

  Human microsomal prostaglandin E synthase-1 -: Purification, functional characterization, and projection structure determination

  Thorén S; Weinander R; Saha S; Jegerschöld C; Pettersson PL; Samuelsson B; Hebert H; Hamberg M; Morgenstern R; Jakobsson PJ
• Article: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 2003;1627(2-3):79-84

  Basal expression of the human MAPEG members microsomal glutathione transferase 1 and prostaglandin E synthase genes is mediated by Sp1 and Sp3

  Ekström L; Lyrenäs L; Jakobsson PJ; Morgenstern R; Kelner MJ
• Article: ARTHRITIS & RHEUMATOLOGY. 2003;48(6):1500-1503

  Clinical responses to tumor necrosis factor α antagonists do not show a bimodal distribution -: Data from the Stockholm tumor necrosis factor α followup registry

  van Vollenhoven RF; Klareskog L
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2003;62(6):526-529

  Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis

  Padyukov L; Lampa J; Heimbürger M; Ernestam S; Cederholm T; Lundkvist I; Andersson P; Hermansson Y; Harju A; Klareskog L; Bratt J
• Published conference paper: ANNALS OF ALLERGY, ASTHMA AND IMMUNOLOGY. 2003;90(6 Suppl 3):59-63

  Breast-feeding, infant formulas, and the immune system.

  Hanson LA; Korotkova M; Telemo E
• Published conference paper: ANNALS OF ALLERGY, ASTHMA AND IMMUNOLOGY. 2003;90(6 Suppl 3):28-33

  Antigen presentation and processing in the intestinal mucosa and lymphocyte homing.

  Telemo E; Korotkova M; Hanson LA
• Published conference paper: ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. 2003;987:199-206

  The transfer of immunity from mother to child

  Hanson L; Korotkova M; Lundin S; Håversen L; Silfverdal SA; Mattsby-Baltzer I; Strandvik B; Telemo E
• Article: MUSCLE AND NERVE. 2003;27(4):442-448

  CBA/J mice infected with Trypanosoma cruzi:: An experimental model for inflammatory myopathies

  Andersson J; Englund P; Sunnemark D; Dahlstedt A; Westerblad H; Nennesmo I; Örn A; Lundberg IE
• Article: THE LANCET. 2003;361(9363):1099-1101

  LIR-1 expression on lymphocytes, and cytomegalovirus disease in lung-transplant recipients

  Berg L; Riise GC; Cosman D; Bergström T; Olofsson S; Kärre W; Carbone E
• Article: JOURNAL OF RHEUMATOLOGY. 2003;30(3):449-454

  Allele and antigen-specific treatment of rheumatoid arthritis: A double blind, placebo controlled phase 1 trial

  Kavanaugh A; Genovese M; Baughman J; Kivitz A; Bulpitt K; Olsen N; Weisman M; Matteson E; Furst D; van Vollenhoven R; Anderson J; Cohen S; Wei N; Meijerink J; Jacobs C; Mocci S
• Article: HUMAN IMMUNOLOGY. 2003;64(2):290-296

  MICA4/HLA-DRB1*04/TNF1 haplotype is associated with mixed connective tissue disease in Swedish patients

  Hassan AB; Nikitina-Zake L; Padyukov L; Karlsson G; Gupta M; Lundberg IE; Sanjeevi CB
• Article: ARTHRITIS RESEARCH & THERAPY. 2003;5(6):R347-R351

  Etanercept versus etanercept plus methotrexate: a registry-based study suggesting that the combination is clinically more efficacious

  van Vollenhoven RF; Ernestam S; Harju A; Bratt J; Klareskog L
• Article: JOURNAL OF REHABILITATION MEDICINE. 2003;35(1):31-35

  Sporadic inclusion body myositis: Pilot study on the effects of a home exercise program on muscle function, histopathology and inflammatory reaction

  Arnardottir S; Alexanderson H; Lundberg IE; Borg K
• Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2003;4(2):317

  TNF-alpha, dyslipoproteinemia and LDL oxidation are risk factors for CVD in SLE

  Svenungsson E; Fei GZ; Gunnarsson I; Lundberg IE; Wu R; Witztum JL; Frostegard J
• Article: NATURE GENETICS. 2002;32(4):666-669

  A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans

  Prokunina L; Castillejo-López C; Öberg F; Gunnarsson I; Berg L; Magnusson V; Brookes AJ; Tentler D; Kristjansdóttir H; Gröndal G; Bolstad AI; Svenungsson E; Lundberg I; Sturfelt G; Jönssen A; Truedsson L; Lima G; Alcocer-Varela J; Jonsson R; Gyllensten UB; Harley JB; Alarcón-Segovia D; Steinsson K; Alarcón-Riquelme ME
• Article: BEST PRACTICE AND RESEARCH: CLINICAL RHEUMATOLOGY. 2002;16(5):817-832

  Idiopathic inflammatory myopathies - myositis

  Dorph C; Lundberg IE
• Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2002;277(47):44877-44885

  Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides

  Kozak KR; Crews BC; Morrow JD; Wang LH; Ma YH; Weinander R; Jakobsson PJ; Marnett LJ
• Review: RHEUMATIC DISEASE CLINICS OF NORTH AMERICA. 2002;28(4):799-822

  Possible pathogenic mechanisms in inflammatory myopathies

  Lundberg IE; Dastmalchi M
• Article: JOURNAL OF RHEUMATOLOGY. 2002;29(11):2386-2392

  Development of the myositis activities profile -: Validity and reliability of a self-administered questionnaire to assess activity limitations in patients with polymyositis/dermatomyositis

  Alexanderson H; Lundberg IE; Stenström CH
• Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2002;56(5):530-537

  Transforming growth factor-β (TGF-β) and tissue transglutaminase expression in the small intestine in children with coeliac disease

  Hansson T; Ulfgren AK; Lindroos E; Dannæus A; Dahlbom I; Klareskog L
• Editorial comment: CURRENT OPINION IN RHEUMATOLOGY. 2002;14(6):639-642

  New possibilities to achieve increased understanding of disease mechanisms in idiopathic inflammatory myopathies

  Lundberg IE
• Article: JOURNAL OF COMPARATIVE NEUROLOGY. 2002;452(3):205-214

  Induction of microsomal prostaglandin E synthase in the rat brain endothelium and parenchyma in adjuvant-induced arthritis

  Engblom D; Ek M; Andersson IM; Saha S; Dahlström M; Jakobsson PJ; Ericsson-Dahlstrand A; Blomqvist A
• Article: JOURNAL OF RHEUMATOLOGY. 2002;29(10):2114-2121

  VH4-34 encoded antibody in systemic lupus erythematosus: Effect of Isotype

  Bhat NM; Lee LM; van Vollenhoven RF; Teng NNH; Bieber MM
• Article: JOURNAL OF LIPID RESEARCH. 2002;43(10):1743-1749

  Leptin levels in rat offspring are modified by the ratio of linoleic to α-linolenic acid in the maternal diet

  Korotkova M; Gabrielsson B; Lönn M; Hanson L; Strandvik B
• Published conference paper: ANALYTICA CHIMICA ACTA. 2002;468(2):263-274

  Sonic spray ionization interface for liquid chromatography-mass spectrometry

  Björkman HT; Edlund PO; Jacobsson SP
• Article: PEDIATRICS INTERNATIONAL. 2002;44(4):347-352

  Breast-feeding, a complex support system for the offspring

  Hanson L; Korotkova M; Håversen L; Mattsby-Baltzer I; Hahn-Zoric M; Silfverdal SA; Strandvik B; Telemo E
• Review: SEMINARS IN FETAL AND NEONATAL MEDICINE. 2002;7(4):275-281

  The role of breastfeeding in prevention of neonatal infection.

  Hanson LA; Korotkova M
• Published conference paper: ARTHRITIS & RHEUMATOLOGY. 2002;46(7):1820-1829

  Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.

  Petri MA; Lahita RG; Van Vollenhoven RF; Merrill JT; Schiff M; Ginzler EM; Strand V; Kunz A; Gorelick KJ; Schwartz KE; GL601 Study Group
• Article: PEDIATRIC RESEARCH. 2002;52(1):78-84

  Maternal dietary intake of essential fatty acids affects adipose tissue growth and leptin mRNA expression in suckling rat

  Korotkova M; Gabrielsson B; Hanson L; Strandvik B
• Article: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 2002;1583(1):53-62

  Human mast cells express two leukotriene C₄ synthase isoenzymes and the CysLT₁ receptor

  Sjöström M; Jakobsson PJ; Juremalm M; Ahmed A; Nilsson G; Macchia L; Haeggström JZ
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2002;31(3):133-139

  Serial analysis of Ro/SSA and La/SSB antibody levels and correlation with clinical disease activity in patients with systemic lupus erythematosus

  Hassan AB; Lundberg IE; Isenberg D; Wahren-Herlenius M
• Article: RHEUMATOLOGY. 2002;41(5):484-489

  Anti-tumour necrosis factor (TNF)-α therapy (etanercept) down-regulates serum matrix metalloproteinase (MMP)-3 and MMP-1 in rheumatoid arthritis

  Catrina AI; Lampa J; Ernestam S; af Klint E; Bratt J; Klareskog L; Ulfgren AK
• Article: ARTHRITIS & RHEUMATOLOGY. 2002;46(4):1044-1055

  Interleukin-1α expression in capillaries and major histocompatibility complex class I expression in type II muscle fibers from polymyositis and dermatomyositis patients -: Important pathogenic features independent of inflammatory cell clusters in muscle tissue

  Englund P; Nennesmo I; Klareskog L; Lundberg IE
• Article: JOURNAL OF RHEUMATOLOGY. 2002;29(4):693-699

  Repeated renal biopsy in proliferative lupus nephritis -: Predictive role of serum C1q and albuminuria

  Gunnarsson I; Sundelin B; Heimbürger M; Forslid J; van Vollenhoven R; Lundberg I; Jacobson SH
• Article: SCANDINAVIAN JOURNAL OF PUBLIC HEALTH. 2002;30(4):259-266

  Self-rated health and mortality among young men: what is the relation and how may it be explained?

  Larsson D; Hemmingsson T; Allebeck P; Lundberg I
• Review: EXPERT OPINION ON PHARMACOTHERAPY. 2002;3(1):23-31

  Dehydroepiandrosterone for the treatment of systemic lupus erythematosus.

  van Vollenhoven RF
• Article: NEUROSCIENCE. 2002;115(3):891-897

  Expression of microsomal glutathione S-transferase type 3 mRNA in the rat nervous system

  Fetissov SO; Schröder O; Jakobsson PJ; Samuelsson B; Haeggström JZ; Hökfelt T
• Article: LUPUS. 2002;11(7):435-442

  Increased T-lymphocyte apoptosis/necrosis and IL-10 producing cells in patients and their spouses in Icelandic systemic lupus erythematosus multicase families

  Gröndal G; Traustadottir KH; Kristjansdottir H; Lundberg I; Klareskog L; Erlendsson K; Steinsson K
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2002;31(2):66-71

  Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus

  Björnådal L; Löfström B; Yin L; Lundberg IE; Ekbom A
• Published conference paper: ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY. 2002;507:287-291

  Characterization of microsomal, glutathione dependent prostaglandin E synthase

  Jakobsson PJ; Thorén S; Morgenstern R; Samuelsson B
• Published conference paper: ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY. 2002;503:99-106

  Immune system modulation by human milk.

  Hanson LA; Silfverdal S-A; Korotkova M; Erling V; Strömbeck L; Olcén P; Ulanova M; Hahn-Zoric M; Zaman S; Ashraf R; Telemo E
• Review: JOURNAL OF MOLECULAR MEDICINE. 2002;80(1):5-15

  Prostaglandins as inflammatory messengers across the blood-brain barrier

  Engblom D; Ek M; Saha S; Ericsson-Dahlstrand A; Jakobsson PJ; Blomqvist A
• Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2001;120(1):174-182

  Down-regulation of the T cell receptor CD3ζ chain in rheumatoid arthritis (RA) and its influence on T cell responsiveness

  Berg L; Rönnelid J; Klareskog L; Bucht A
• Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2001;115(3):561-566

  Antibodies to adult human endothelial cells cross-react with oxidized low-density lipoprotein and β₂- glycoprotein I (β₂-GPI) in systemic lupus erythematosus

  Wu R; Svenungsson E; Gunnarsson I; Haegerstrand-Gillis C; Andersson B; Lundberg I; Elinder LS; Frostegård J
• Article: RHEUMATOLOGY. 2001;40(12):1346-1354

  Increased endothelial expression of HLA-DQ and interleukin 1α in extra-articular rheumatoid arthritis.: Results from immunohistochemical studies of skeletal muscle

  Turesson C; Englund P; Jacobsson LTH; Sturfelt G; Truedsson L; Nennesmo I; Lundberg IE
• Article: CLINICAL CANCER RESEARCH. 2001;7(12):3971-3976

  Inducible microsomal prostaglandin E synthase is overexpressed in colorectal adenomas and cancer

  Yoshimatsu K; Golijanin D; Paty PB; Soslow RA; Jakobsson PJ; DeLellis RA; Subbaramaiah K; Dannenberg AJ
• Editorial comment: CURRENT OPINION IN RHEUMATOLOGY. 2001;13(6):457-460

  Idiopathic inflammatory myopathies: why do the muscles become weak?

  Lundberg IE
• Article: RHEUMATOLOGY. 2001;40(11):1262-1273

  Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies

  Miller FW; Rider LG; Chung YL; Cooper R; Danko K; Farewell V; Lundberg I; Morrison C; Oakley L; Oakley I; Pilkington C; Vencovsky J; Vincent K; Scott DL; Isenberg DA
• Review: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2001;31(2):127-132

  Catastrophic antiphospholipid syndrome: Remission following leg amputation in 2 cases

  Amital H; Levy Y; Davidson C; Lundberg I; Harju A; Kosach Y; Asherson RA; Shoenfeld Y
• Article: AMERICAN JOURNAL OF PATHOLOGY. 2001;159(4):1263-1273

  Skeletal muscle fibers express major histocompatibility complex class II antigens independently of inflammatory infiltrates in inflammatory myopathies

  Englund P; Lindroos E; Nennesmo I; Klareskog L; Lundberg IE
• Article: CLINICAL CANCER RESEARCH. 2001;7(9):2669-2674

  Inducible prostaglandin E synthase is overexpressed in non-small cell lung cancer

  Yoshimatsu K; Altorki NK; Golijanin D; Zhang F; Jakobsson PJ; Dannenberg AJ; Subbaramaiah K
• Article: JOURNAL OF RHEUMATOLOGY. 2001;28(7):1591-1599

  Percutaneous conchotome muscle biopsy. A useful diagnostic and assessment tool

  Dorph C; Nennesmo I; Lundberg IE
• Article: JOURNAL OF IMMUNOLOGY. 2001;167(1):469-474

  Microsomal prostaglandin E synthase is regulated by proinflammatory cytokines and glucocorticoids in primary rheumatoid synovial cells

  Stichtenoth DO; Thorén S; Bian HM; Peters-Golden M; Jakobsson PJ; Crofford LJ
• Article: JOURNAL OF GENERAL VIROLOGY. 2001;82(Pt 6):1299-1308

  Humoral and CD4⁺ T helper (Th) cell responses to the hepatitis C virus non-structural 3 (NS3) protein:: NS3 primes Th 1-like responses more effectively as a DNA-based immunogen than as a recombinant protein

  Lazdina U; Hultgren C; Frelin L; Chen M; Lodin K; Weiland O; Leroux-Roels G; Quiroga JA; Peterson DL; Milich DR; Sällberg M
• Article: THE FEBS JOURNAL. 2001;268(9):2578-2586

  Human umbilical vein endothelial cells generate leukotriene C₄ via microsomal glutathione S-transferase type 2 and express the CysLT₁ receptor

  Sjöström M; Jakobsson PJ; Heimburger M; Palmblad J; Haeggström JZ
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2001;60(4):423-426

  MRI guided muscle biopsy confirmed polymyositis diagnosis in a patient with interstitial lung disease

  Lampa J; Nennesmo I; Einarsdottir H; Lundberg I
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2001;60(4):372-379

  Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus

  Svenungsson E; Andersson M; Brundin L; van Vollenhoven R; Khademi M; Tarkowski A; Greitz D; Dahlström M; Lundberg I; Klareskog L; Olsson T
• Article: NATURE. 2001;410(6827):430-431

  Inflammatory response - Pathway across the blood-brain barrier

  Ek M; Engblom D; Saha S; Blomqvist A; Jakobsson PJ; Ericsson-Dahlstrand A
• Published conference paper: ACTA PHYSIOLOGICA. 2001;171(3):207-213

  The physiology of inflammatory myopathies: an overview

  Lundberg IE
• Article: JOURNAL OF LIPID RESEARCH. 2001;42(3):359-365

  Maternal essential fatty acid deficiency depresses serum leptin levels in suckling rat pups

  Korotkova M; Gabrielsson B; Hanson L; Strandvik B
• Review: LAKARTIDNINGEN. 2001;98(8):828-831

  [Blockade of TNFalpha--new therapeutic principle in severe rheumatoid arthritis].

  Larsson P; Bratt J; Harju A; van Vollenhoven R; Klareskog L
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2001;60(2):133-139

  Increased peripheral T cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNFα receptors

  Berg L; Lampa J; Rogberg S; van Vollenhoven R; Klareskog L
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2001;60(2):116-123

  Autoantibody profiles in the sera of European patients with myositis

  Brouwer R; Hengstman GJD; Egberts WV; Ehrfeld H; Bozic B; Ghirardello A; Grondal G; Hietarinta M; Isenberg D; Kalden JR; Lundberg I; Moutsopoulos H; Roux-Lombard P; Vencovsky J; Wikman A; Seelig HP; van Engelen BGM; van Venrooij WJ
• Conference publication: AMERICAN JOURNAL OF HUMAN GENETICS. 2001;69(4):568

  SLEB2 region in human SLE:: locus-gene-mutation.

  Prokunina L; Castillejo-Lpez C; Gunnarsson I; Berg L; Tentler D; Öberg F; Alarcon-Riquelme M
• Published conference paper: CHEMICO-BIOLOGICAL INTERACTIONS. 2001;133(1-3):153-154

  Prostaglandin E synthase:: a microsomal, glutathione dependent, inducible member of the MAPEG superfamily

  Jakobsson PJ; Thorén S; Morgenstern R; Samuelsson B
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2001;30(5):282-289

  Longitudinal study of interleukin-10, tumor necrosis factor-α, anti-U1-snRNP antibody levels and disease activity in patients with mixed connective tissue disease

  Hassan AB; Gunnarsson I; Karlsson G; Klareskog L; Forslid J; Lundberg IE
• Published conference paper: CHEMICO-BIOLOGICAL INTERACTIONS. 2001;133(1-3):301-303

  Structure and transcriptional regulation of the human microsomal glutathione transferase 1 (MGST1) and prostaglandin E synthase (PGES) genes

  Forsberg L; Persson L; Kelner MJ; Jakobsson PJ; Morgenstern R
• Article: GENOMICS. 2000;70(3):307-314

  Fine mapping of the SLEB2 locus involved in susceptibility to systemic lupus erythematosus

  Magnusson V; Lindqvist AKB; Castillejo-López C; Kristjánsdottir H; Steinsson K; Gröndal G; Sturfelt G; Truedsson L; Svenungsson E; Lundberg I; Gunnarsson I; Bolstad AI; Haga HJ; Jonsson R; Klareskog L; Alcocer-Varela J; Alarcón-Segovia D; Terwilliger JD; Gyllensten UB; Alarcón-Riquelme ME
• Article: JOURNAL OF PHYSIOLOGY. 2000;529(1):243-262

  Immunological changes in human skeletal muscle and blood after eccentric exercise and multiple biopsies

  Malm C; Nyberg P; Engström M; Sjödin B; Lenkei R; Ekblom B; Lundberg I
• Article: THE FEBS JOURNAL. 2000;267(21):6428-6434

  Coordinate up- and down-regulation of glutathione-dependent prostaglandin E synthase and cyclooxygenase-2 in A549 cells -: Inhibition by NS-398 and leukotriene C₄

  Thorén S; Jakobsson PJ
• Thesis / dissertation: 2000

  Functional studies of T-cells in rheumatoid arthritis

  Berg, Louise
• Article: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 2000;1487(2-3):319-325

  Essential fatty acid deficiency affects the fatty acid composition of the rat small intestinal and colonic mucosa differently

  Korotkova M; Strandvik B
• Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2000;276(2):488-492

  Functional coupling of cyclooxygenase 1 and 2 to discrete prostanoid synthases in liver macrophages

  Dieter P; Scheibe R; Jakobsson PJ; Watanabe K; Kolada A; Kamionka S
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2000;18(5):565-570

  Cytokine production, serum levels and disease activity in systemic lupus erythematosus

  Gröndal G; Gunnarsson I; Rönnelid J; Rogberg S; Klareskog L; Lundberg I
• Letter: RHEUMATOLOGY. 2000;39(8):929-930

  Dehydroepiandrosterone in the treatment of systemic lupus erythematosus

  van Vollenhoven RF
• Article: GENES AND IMMUNITY. 2000;1(6):380-385

  Association analysis with microsatellite and SNP markers does not support the involvement of BCL-2 in systemic lupus erythematosus in Mexican and Swedish patients and their families

  Johansson C; Castillejo-López C; Johanneson B; Svenungsson E; Gunnarsson I; Frostegård J; Sturfelt G; Truedsson L; Löfström B; Alcocer-Varela J; Lundberg I; Gyllensten UB; Alarcón-Segovia D; Alarcón-Riquelme ME
• Review: CURRENT RHEUMATOLOGY REPORTS. 2000;2(3):216-224

  The role of cytokines, chemokines, and adhesion molecules in the pathogenesis of idiopathic inflammatory myopathies.

  Lundberg IE
• Article: RHEUMATIC DISEASE CLINICS OF NORTH AMERICA. 2000;26(2):349-362

  Dehydroepiandrosterone in systemic lupus erythematosus.

  van Vollenhoven RF
• Letter: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2000;18(3):422

  A retrospective evaluation of the treatment of 7 patients with Churg-Strauss syndrome

  Larsson P; Lundberg I
• Article: JOURNAL OF AUTOIMMUNITY. 2000;14(3):267-274

  Kinetics of anti-fibrillin-1 autoantibodies in MCTD and CREST syndrome

  Lundberg I; Antohi S; Takeuki K; Arnett F; Steiner G; Brumeanu TD; Klareskog L; Bona C
• Article: FEBS LETTERS. 2000;471(1):78-82

  Human glutathione dependent prostaglandin E synthase:: gene structure and regulation

  Forsberg L; Leeb L; Thorén S; Morgenstern R; Jakobsson PJ
• Article: JOURNAL OF RHEUMATOLOGY. 2000;27(4):940-948

  Increased expression of interleukin 1α and MHC class I in muscle tissue of patients with chronic, inactive polymyositis and dermatomyositis

  Nyberg P; Wikman AL; Nennesmo I; Lundberg I
• Article: JOURNAL OF AUTOIMMUNITY. 2000;14(2):169-178

  A susceptibility locus for human systemic lupus erythematosus (hSLE1) on chromosome 2q

  Lindqvist AKB; Steinsson K; Johanneson B; Kristjánsdóttir H; Arnasson A; Gröndal G; Jonasson I; Magnusson V; Sturfelt G; Truedsson L; Svenungsson E; Lundberg I; Terwilliger JD; Gyllensten UB; Alarcón-Riquelme ME
• Article: BLOOD. 2000;95(4):1456-1464

  Aberrant expression of active leukotriene C₄ synthase in CD16⁺ neutrophils from patients with chronic myeloid leukemia

  Sjölinder M; Stenke L; Näsman-Glaser B; Widell S; Doucet J; Jakobsson PJ; Lindgren J
• Article: ARTHRITIS & RHEUMATOLOGY. 2000;43(2):336-348

  Decreased expression of interleukin-1α, interleukin-1β, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis

  Lundberg I; Kratz AK; Alexanderson H; Patarroyo M
• Published conference paper: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2000;161(2):S20-S24

  Membrane-associated proteins in eicosanoid and glutathione metabolism (MAPEG) - A widespread protein superfamily

  Jakobsson PJ; Morgenstern R; Mancini J; Ford-Hutchinson A; Persson B
• Article: LAKARTIDNINGEN. 2000;97(1-2):30-33

  [Future treatment of rheumatism. A compromise in the game between inflammation and infections].

  Klareskog L; Lundberg I
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2000;29(5):295-301

  The safety of a resistive home exercise program in patients with recent onset active polymyositis or dermatomyositis

  Alexanderson H; Stenström CH; Jenner G; Lundberg I
• Review: ARTHRITIS RESEARCH & THERAPY. 2000;2(1):75-84

  Interferon-γ production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1*0401 and HLA-DQ8

  Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
• Review: RHEUMATOLOGY. 2000;39(1):7-17

  Treatment and investigation of idiopathic inflammatory myopathies

  Lundberg I; Chung YL
• Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1999;96(25):14487-14492

  Key residues revealed in a major conformational epitope of the U1-70K protein

  Henriksson EW; Wahren-Herlenius M; Lundberg I; Mellquist E; Pettersson I
• Article: JOURNAL OF RHEUMATOLOGY. 1999;26(10):2153-2158

  Psychosocial correlates of morbidity in women with systemic lupus erythematosus.

  Ward MM; Lotstein DS; Bush TM; Lambert RE; van Vollenhoven R; Neuwelt CM
• Article: JOURNAL OF RHEUMATOLOGY. 1999;26(10):2148-2152

  Genetic analysis of the contribution of IL10 to systemic lupus erythematosus

  Alarcón-Riquelme ME; Lindqvist AKB; Jonasson I; Johanneson B; Sandino S; Alcocer-Varela J; Granados J; Kristjánsdóttir H; Gröndal G; Svenungsson E; Lundberg I; Steinsson K; Klareskog L; Sturfelt G; Truedsson L; Alarcon-Segovia D; Gyllensten UB
• Article: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 1999;1420(1-2):86-94

  Composition and permeability of syncytiotrophoblast plasma membranes in pregnancies complicated by intrauterine growth restriction

  Powell TL; Jansson T; Illsley NP; Wennergren M; Korotkova M; Strandvik B
• Article: JOURNAL OF CLINICAL RHEUMATOLOGY. 1999;5(4):228-232

  Treatment of severe CNS lupus with intravenous immunoglobulin.

  Engel G; van Vollenhoven RF
• Published conference paper: JOURNAL OF AUTOIMMUNITY. 1999;13(1):137-141

  A comparison of genome-scans performed in multicase families with systemic lupus erythematosus from different population groups

  Johanneson N; Steinsson K; Lindqvist AK; Kristjánsdóttir H; Gröndal G; Sandino S; Tjernström F; Sturfelt G; Granados-Arriola J; Alcocer-Varela J; Lundberg I; Jonasson I; Truedsson L; Svenungssons E; Klareskog L; Alarcón-Segovia D; Gyllensten UB; Alarcón-Riquelme ME
• Article: NEUROPEPTIDES. 1999;33(4):260-264

  Exercise and variations in neuropeptide concentrations in rheumatoid arthritis -: A pilot study

  Stenström CH; Alexanderson H; Lundberg I; Lundeberg T; Theodorsson E; Nisell R
• Article: JOURNAL OF RHEUMATOLOGY. 1999;26(8):1727-1733

  VH4-34 encoded antibodies in systemic lupus erythematosus: A specific diagnostic marker that correlates with clinical disease characteristics

  van Vollenhoven RF; Bieber MM; Powell MJ; Gupta PK; Bhat NM; Richards KL; Albano SA; Teng NNH
• Article: ARTHRITIS & RHEUMATOLOGY. 1999;42(8):1649-1654

  Increased number of interleukin-10-producing cells in systemic lupus erythematosus patients and their first-degree relatives and spouses in Icelandic multicase families

  Gröndal G; Kristjansdottir H; Gunnlaugsdottir B; Arnason A; Lundberg I; Klareskog L; Steinsson K
• Article: RHEUMATOLOGY. 1999;38(7):608-611

  Safety of a home exercise programme in patients with polymyositis and dermatomyositis:: a pilot study

  Alexanderson H; Stenström CH; Lundberg I
• Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1999;96(13):7220-7225

  Identification of human prostaglandin E synthase:: A microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target

  Jakobsson PJ; Thorén S; Morgenstern R; Samuelsson B
• Article: PROTEIN SCIENCE. 1999;8(3):689-692

  Common structural features of MAPEG -: A widespread superfamily of membrane associated proteins with highly divergent functions in eicosanoid and glutathione metabolism

  Jakobsson PJ; Morgenstern R; Mancini J; Ford-Hutchinson A; Persson B
• Article: JOURNAL OF CLINICAL RHEUMATOLOGY. 1999;5(1):9-16

  Influence of hormonal events on disease expression in patients with the combination of systemic lupus erythematosus and rheumatoid arthritis.

  Sundaramurthy SG; Karsevar MP; van Vollenhoven RF
• Article: JOURNAL OF RHEUMATOLOGY. 1999;26(1):197

  Severe rheumatoid arthritis.

  van Vollenhoven RF
• Article: LUPUS. 1999;8(3):181-187

  A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus

  van Vollenhoven RF; Park JL; Genovese MC; West JP; McGuire JL
• Article: LUPUS. 1999;8(2):142-150

  Antibodies against lysophosphatidylcholine and oxidized LDL in patients with SLE

  Wu R; Svenungsson E; Gunnarsson I; Andersson B; Lundberg I; Elinder LS; Frostegård J
• Article: JOURNAL OF RHEUMATOLOGY. 1998;25(12):2352-2356

  Dehydroepiandrosterone in systemic lupus erythematosus: relationship between dosage, serum levels, and clinical response.

  Barry NN; McGuire JL; van Vollenhoven RF
• Review: CURRENT OPINION IN RHEUMATOLOGY. 1998;10(6):521-529

  New developments in the role of cytokines and chemokines in inflammatory myopathies.

  Lundberg IE; Nyberg P
• Published conference paper: JOURNAL OF AUTOIMMUNITY. 1998;11(5):503-508

  Increased serum levels of immunoglobulins, C-reactive protein, type 1 and type 2 cytokines in patients with mixed connective tissue disease

  Hassan AB; Ronnelid J; Gunnarsson I; Karlsson G; Berg L; Lundberg I
• Article: ANNALS OF NEUROLOGY. 1998;44(4):704-706

  Central nervous system nitric oxide formation in cerebral systemic lupus erythematosus

  Brundin L; Svenungsson E; Morcos E; Andersson M; Olsson T; Lundberg I; Wiklund NP
• Letter: ARTHRITIS & RHEUMATOLOGY. 1998;41(10):1897

  Role of sex steroids in the Th1/Th2 cytokine balance: comment on the article by Miossec and van den Berg.

  van Vollenhoven RF
• Article: JOURNAL OF RHEUMATOLOGY. 1998;25(9):1720-1729

  Socioeconomic status and health in women with systemic lupus erythematosus.

  Lotstein DS; Ward MM; Bush TM; Lambert RE; van Vollenhoven R; Neuwelt CM
• Journal article: JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. 1998;26(5):592

  ESSENTIAL FATTY ACID DEFICIENCY DIFFERENTLY AFFECTS THE FATTY ACID COMPOSITION OF THE RAT INTESTINAL AND COLONIC MUCOSA.

  Korotkova M; A. D-H; Hanson LÅ; Strandvik B
• Article: JOURNAL OF RHEUMATOLOGY. 1998;25(2):285-289

  Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months.

  van Vollenhoven RF; Morabito LM; Engleman EG; McGuire JL
• Article: POSTGRADUATE MEDICINE. 1998;103(2):137-142

  Corticosteroids in rheumatic disease. Understanding their effects is key to their use.

  van Vollenhoven RF
• Article: JOURNAL OF AUTOIMMUNITY. 1998;11(1):29-38

  Ro/SS-A and La/SS-B antibody level variation in patients with Sjogren's syndrome and systemic lupus erythematosus

  Wahren M; Tengner P; Gunnarsson I; Lundberg I; Hedfors E; Ringertz NR; Pettersson I
• Article: POSTGRADUATE MEDICINE. 1998;103(2):103-123

  Rheumatoid arthritis. Designing and implementing a treatment plan.

  Gremillion RB; van Vollenhoven RF
• Editorial comment: POSTGRADUATE MEDICINE. 1998;103(2):67

  Rheumatology in primary care - A five-article symposium

  van Vollenhoven RF
• Article: BRITISH JOURNAL OF RHEUMATOLOGY. 1998;37(1):7-14

  Production of T-cell cytokines at the single-cell level in patients with inflammatory arthritides:: Enhanced activity in synovial fluid compared to blood

  Rönnelid J; Berg L; Rogberg S; Nilsson A; Albertsson K; Klareskog L
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 1998;41(9):S164

  T-cell reactivity to collagen type II in rheumatoid arthritis is associated with HLA-DR4 and HLA-DQ8.

  Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
• Conference publication: ARTHRITIS & RHEUMATOLOGY. 1998;41(9):S35

  T-cell receptor CD3ζ chain expression in rheumatoid arthritis and its influence on in vitro cellular hyporesponsiveness.

  Berg L; Rönnelid J; Klareskog L; Bucht A
• Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 1997;12(11):2263-2268

  Occurrence of anti-C1q antibodies in IgA nephropathy

  Gunnarsson I; Ronnelid J; Lundberg I; Jacobson SH
• Article: BRITISH JOURNAL OF RHEUMATOLOGY. 1997;36(10):1089-1094

  Predisposing factors in sulphasalazine-induced systemic lupus erythematosus

  Gunnarsson I; Kanerud L; Pettersson E; Lundberg I; Lindblad S; Ringertz B
• Article: CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY. 1997;85(1):40-46

  Characterization of adhesion molecule expression in the pathogenesis of homologous collagen-induced arthritis in the DA rat

  Harris HE; Liljestrom M; Lindroos E; Kleinau S
• Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 1997;272(36):22934-22939

  Identification and characterization of a novel microsomal enzyme with glutathione-dependent transferase and peroxidase activities.

  Jakobsson PJ; Mancini JA; Riendeau D; Ford-Hutchinson AW
• Article: AMERICAN JOURNAL OF MEDICINE. 1997;103(3):233-241

  Skeletal status of men with early and late ankylosing spondylitis.

  Lee YS; Schlotzhauer T; Ott SM; van Vollenhoven RF; Hunter J; Shapiro J; Marcus R; McGuire JL
• Article: JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING. 1997;17(1):15-19

  Characterization of microsomal GST-II by western blot and identification of a novel LTC4 isomer.

  Jakobsson PJ; Scoggan KA; Yergey J; Mancini JA; Ford-Hutchinson AW
• Article: CELL DEATH AND DIFFERENTIATION. 1997;4(6):479-486

  Inhibitors of arachidonic acid metabolism reduce DNA and nuclear fragmentation induced by TNF plus cycloheximide in U937 cells

  Vanags DM; Larsson P; Feltenmark S; Jakobsson PJ; Orrenius S; Claesson HE; AguilarSantelises M
• Article: ARTHRITIS & RHEUMATOLOGY. 1997;40(5):865-874

  Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies

  Lundberg I; Ulfgren AK; Nyberg P; Andersson U; Klareskog L
• Journal article: IMMUNOLOGY LETTERS. 1997;56:406

  Inverse regulation of single cell production of IL-6 and IL-10 in peripheral blood and synovial fluid of arthritis patients

  Rönnelid J; Rogberg S; Berg L; Albertsson K; Klareskog L
• Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 1997;272(15):10182-10187

  Production of leukotriene C4 in different human tissues is attributable to distinct membrane bound biosynthetic enzymes.

  Scoggan KA; Jakobsson PJ; Ford-Hutchinson AW
• Article: BRITISH JOURNAL OF RHEUMATOLOGY. 1997;36(1):32-37

  Association between ongoing anti-Clq antibody production in peripheral blood and proliferative nephritis in patients with active systemic lupus erythematosus

  Gunnarsson I; Ronnelid J; Huang YH; Rogberg S; Nilsson B; Lundberg I; Klareskog L
• Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 1996;271(36):22203-22210

  Identification and characterization of a novel human microsomal glutathione S-transferase with leukotriene C4 synthase activity and significant sequence identity to 5-lipoxygenase-activating protein and leukotriene C4 synthase.

  Jakobsson PJ; Mancini JA; Ford-Hutchinson AW
• Article: IMMUNOLOGY. 1996;89(1):41-45

  Induction of cytotoxic T-cell response by optimal-length peptides does not require CD4(+) T-cell help

  Fayolle C; AbdelMotal UM; Berg L; Deriaud E; Jondal M; Leclerc C
• Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 1996;26(3):544-551

  Immunization with glycosylated K-b-binding peptides generates carbohydrate-specific, unrestricted cytotoxic T cells

  AbdelMotal UM; Berg L; Rosten A; Bengtsson M; Thorpe CJ; Kihlberg J; Dahmen J; Magnusson G; Karlsson KA; Jondal M
• Article: ANNALES DE MEDECINE INTERNE. 1996;147(4):290-296

  Studies of dehydroepiandrosterone (DHEA) as a therapeutic agent in systemic lupus erythematosus.

  Van Vollenhoven RF; McGuire JL
• Review: ANNALES DE MEDECINE INTERNE. 1996;147(4):265-273

  Systemic lupus erythematosus and pregnancy.

  Druzin ML; Van Vollenhoven RF
• Editorial comment: ANNALES DE MEDECINE INTERNE. 1996;147(4):239-240

  Hormones and systemic lupus erythematosus

  VanVollenhoven RF
• Article: JOURNAL OF IMMUNOLOGICAL METHODS. 1995;188(1):21-31

  Major histocompatibility complex class I binding glycopeptides for the estimation of 'empty' class I molecules

  AbdelMotal UM; Berg L; Bengtsson M; Dahmen J; Kihlberg J; Magnusson G; Nilsson U; Jondal M
• Article: ARTHRITIS & RHEUMATOLOGY. 1995;38(12):1826-1831

  Dehydroepiandrosterone in systemic lupus erythematosus. Results of a double-blind, placebo-controlled, randomized clinical trial.

  van Vollenhoven RF; Engleman EG; McGuire JL
• Article: JOURNAL OF NEUROIMMUNOLOGY. 1995;63(1):9-16

  Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy, and non-weak controls

  Lundberg I; Brengman JM; Engel AG
• Letter: NEW ENGLAND JOURNAL OF MEDICINE. 1995;333(21):1424

  BREAST IMPLANTS AND CONNECTIVE-TISSUE DISEASES

  VANVOLLENHOVEN R
• Article: THE FEBS JOURNAL. 1995;232(1):37-46

  STUDIES ON THE REGULATION AND LOCALIZATION OF 5-LIPOXYGENASE IN HUMAN B-LYMPHOCYTES

  JAKOBSSON PJ; SHASKIN P; LARSSON P; FELTENMARK S; ODLANDER B; AGUILARSANTELISES M; JONDAL M; BIBERFELD P; CLAESSON HE
• Article: BRITISH JOURNAL OF HAEMATOLOGY. 1995;90(3):585-594

  DIVERSE EXPRESSION OF CYTOSOLIC PHOSPHOLIPASE-A(2), 5-LIPOXYGENASE AND PROSTAGLANDIN-H SYNTHASE-2 IN ACUTE PRE-B-LYMPHOCYTIC LEUKEMIA-CELLS

  FELTENMARK S; RUNARSSON G; LARSSON P; JAKOBSSON PJ; BJORKHOLM M; CLAESSON HE
• Review: ADVANCES IN PROSTAGLANDIN, THROMBOXANE, AND LEUKOTRIENE RESEARCH. 1995;23:293-298

  THE 5-LIPOXYGENASE PATHWAY IN NORMAL AND MALIGNANT HUMAN B-LYMPHOCYTES

  JAKOBSSON PJ; LARSSON P; FELTENMARK S; ODLANDER B; RUNARSSON G; BJORKHOLM M; CLAESSON HE
• Journal article: EUROPEAN JOURNAL OF IMMUNOLOGY. 1992;22(12):3085-3090

  INVIVO PRIMING OF CYTOTOXIC LYMPHOCYTE-T RESPONSES IN RELATION TO INVITRO UP-REGULATION OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I MOLECULES BY SHORT SYNTHETIC PEPTIDES

  ZHOU XZ; MOTAL UMA; BERG L; JONDAL M
• Journal article: JOURNAL OF IMMUNOLOGICAL METHODS. 1992;153(1-2):193-200

  INVIVO PRIMARY INDUCTION OF VIRUS-SPECIFIC CTL BY IMMUNIZATION WITH 9-MER SYNTHETIC PEPTIDES

  ZHOU XZ; BERG L; MOTAL UMA; JONDAL M
• Show more